text,title,id,project_number,terms,administration,organization,mechanism,year,funding,score
"CUTANEOUS PATTERN PERCEPTION The proposed research will investigate the perception of tactile patterns by human subjects.  The tactile patterns will be generated on arrays of stimulators that fit against the subject's fingertips.  Each array consists of 144 stimulators arranged in a matrix 6 columns by 24 rows.  Sets of patterns differing along such dimensions as location, intensity, number of line segments, and so forth will be generated and presented to subjects. Response measures will include identification, discrimination, reaction time, and pattern matching.  Three aspects of tactile pattern perception will be examined:  masking, interactions among multiple sites of stimulation, and the role of experience.  A temporal masking paradigm will be used to see how the perception of tactile patterns is interfered with by tactile maskers and how the nature of the interference changes with changes in the type of masker and in the temporal separation between target and masker.  In the studies of interaction among multiple sites, patterns will be presented to as many as three sites on the fingertips and palm.  This paradigm will be used to assess the role of attention in tactile information processing. The role of short-term experience will be examined by measuring changes in pattern perception as subjects learn to identify and discriminate tactile patterns.  The effect of long-term experience will be evaluated by comparing the performance of groups of subjects who differ in the amount and nature of their experience with complex tactile patterns.  One group will be Optacon users, blind individuals who can read by means of a tactile array.  The other groups will be blind individuals without Optacon experience and several groups of sighted subjects with varying amounts of tactile experience.  The proposed research will be concerned with drawing parallels between tactile processing and visual and auditory processing, with developing measures relevant to understanding the neural coding of tactile patterns, and with improving cutaneous communication systems for the blind, deaf, and deaf-blind.  n/a",CUTANEOUS PATTERN PERCEPTION,3215656,R01DC000095,"['artificial intelligence', ' attention', ' blindness', ' cutaneous sensory nerve', ' fingers', ' form /pattern perception', ' human subject', ' mechanoreceptors', ' neural information processing', ' neurophysiology', ' perceptual maskings', ' psychometrics', ' psychophysics', ' sensory discrimination', ' sensory disorders', ' sensory thresholds', ' sequential perception', ' skin', ' somesthesis', ' space perception', ' stimulus /response', ' stimulus interval', ' substitute sight', ' touch', ' vibration perception']",NIDCD,INDIANA UNIVERSITY BLOOMINGTON,R01,1993,90716,0.08533801347310618
"CUTANEOUS PATTERN PERCEPTION The proposed research will investigate the perception of tactile patterns by human subjects.  The tactile patterns will be generated on arrays of stimulators that fit against the subject's fingertips.  Each array consists of 144 stimulators arranged in a matrix 6 columns by 24 rows.  Sets of patterns differing along such dimensions as location, intensity, number of line segments, and so forth will be generated and presented to subjects. Response measures will include identification, discrimination, reaction time, and pattern matching.  Three aspects of tactile pattern perception will be examined:  masking, interactions among multiple sites of stimulation, and the role of experience.  A temporal masking paradigm will be used to see how the perception of tactile patterns is interfered with by tactile maskers and how the nature of the interference changes with changes in the type of masker and in the temporal separation between target and masker.  In the studies of interaction among multiple sites, patterns will be presented to as many as three sites on the fingertips and palm.  This paradigm will be used to assess the role of attention in tactile information processing. The role of short-term experience will be examined by measuring changes in pattern perception as subjects learn to identify and discriminate tactile patterns.  The effect of long-term experience will be evaluated by comparing the performance of groups of subjects who differ in the amount and nature of their experience with complex tactile patterns.  One group will be Optacon users, blind individuals who can read by means of a tactile array.  The other groups will be blind individuals without Optacon experience and several groups of sighted subjects with varying amounts of tactile experience.  The proposed research will be concerned with drawing parallels between tactile processing and visual and auditory processing, with developing measures relevant to understanding the neural coding of tactile patterns, and with improving cutaneous communication systems for the blind, deaf, and deaf-blind.  n/a",CUTANEOUS PATTERN PERCEPTION,3215659,R01DC000095,"['artificial intelligence', ' attention', ' blindness', ' cutaneous sensory nerve', ' fingers', ' form /pattern perception', ' human subject', ' mechanoreceptors', ' neural information processing', ' neurophysiology', ' perceptual maskings', ' psychometrics', ' psychophysics', ' sensory discrimination', ' sensory disorders', ' sensory thresholds', ' sequential perception', ' skin', ' somesthesis', ' space perception', ' stimulus /response', ' stimulus interval', ' substitute sight', ' touch', ' vibration perception']",NIDCD,INDIANA UNIVERSITY BLOOMINGTON,R01,1992,220382,0.08533801347310618
"CUTANEOUS PATTERN PERCEPTION The proposed research will investigate the perception of tactile patterns by human subjects.  The tactile patterns will be generated on arrays of stimulators that fit against the subject's fingertips.  Each array consists of 144 stimulators arranged in a matrix 6 columns by 24 rows.  Sets of patterns differing along such dimensions as location, intensity, number of line segments, and so forth will be generated and presented to subjects. Response measures will include identification, discrimination, reaction time, and pattern matching.  Three aspects of tactile pattern perception will be examined:  masking, interactions among multiple sites of stimulation, and the role of experience.  A temporal masking paradigm will be used to see how the perception of tactile patterns is interfered with by tactile maskers and how the nature of the interference changes with changes in the type of masker and in the temporal separation between target and masker.  In the studies of interaction among multiple sites, patterns will be presented to as many as three sites on the fingertips and palm.  This paradigm will be used to assess the role of attention in tactile information processing. The role of short-term experience will be examined by measuring changes in pattern perception as subjects learn to identify and discriminate tactile patterns.  The effect of long-term experience will be evaluated by comparing the performance of groups of subjects who differ in the amount and nature of their experience with complex tactile patterns.  One group will be Optacon users, blind individuals who can read by means of a tactile array.  The other groups will be blind individuals without Optacon experience and several groups of sighted subjects with varying amounts of tactile experience.  The proposed research will be concerned with drawing parallels between tactile processing and visual and auditory processing, with developing measures relevant to understanding the neural coding of tactile patterns, and with improving cutaneous communication systems for the blind, deaf, and deaf-blind.  n/a",CUTANEOUS PATTERN PERCEPTION,3215658,R01DC000095,"['artificial intelligence', ' attention', ' blindness', ' cutaneous sensory nerve', ' fingers', ' form /pattern perception', ' human subject', ' mechanoreceptors', ' neural information processing', ' neurophysiology', ' perceptual maskings', ' psychometrics', ' psychophysics', ' sensory discrimination', ' sensory disorders', ' sensory thresholds', ' sequential perception', ' skin', ' somesthesis', ' space perception', ' stimulus /response', ' stimulus interval', ' substitute sight', ' touch', ' vibration perception']",NIDCD,INDIANA UNIVERSITY BLOOMINGTON,R01,1991,206811,0.08533801347310618
"CUTANEOUS PATTERN PERCEPTION The proposed research will investigate the perception of tactile patterns by human subjects.  The tactile patterns will be generated on arrays of stimulators that fit against the subject's fingertips.  Each array consists of 144 stimulators arranged in a matrix 6 columns by 24 rows.  Sets of patterns differing along such dimensions as location, intensity, number of line segments, and so forth will be generated and presented to subjects. Response measures will include identification, discrimination, reaction time, and pattern matching.  Three aspects of tactile pattern perception will be examined:  masking, interactions among multiple sites of stimulation, and the role of experience.  A temporal masking paradigm will be used to see how the perception of tactile patterns is interfered with by tactile maskers and how the nature of the interference changes with changes in the type of masker and in the temporal separation between target and masker.  In the studies of interaction among multiple sites, patterns will be presented to as many as three sites on the fingertips and palm.  This paradigm will be used to assess the role of attention in tactile information processing. The role of short-term experience will be examined by measuring changes in pattern perception as subjects learn to identify and discriminate tactile patterns.  The effect of long-term experience will be evaluated by comparing the performance of groups of subjects who differ in the amount and nature of their experience with complex tactile patterns.  One group will be Optacon users, blind individuals who can read by means of a tactile array.  The other groups will be blind individuals without Optacon experience and several groups of sighted subjects with varying amounts of tactile experience.  The proposed research will be concerned with drawing parallels between tactile processing and visual and auditory processing, with developing measures relevant to understanding the neural coding of tactile patterns, and with improving cutaneous communication systems for the blind, deaf, and deaf-blind.  n/a",CUTANEOUS PATTERN PERCEPTION,3215657,R01DC000095,"['artificial intelligence', ' attention', ' blindness', ' cutaneous sensory nerve', ' fingers', ' form /pattern perception', ' human subject', ' mechanoreceptors', ' neural information processing', ' neurophysiology', ' perceptual maskings', ' psychometrics', ' psychophysics', ' sensory discrimination', ' sensory disorders', ' sensory thresholds', ' sequential perception', ' skin', ' somesthesis', ' space perception', ' stimulus /response', ' stimulus interval', ' substitute sight', ' touch', ' vibration perception']",NIDCD,INDIANA UNIVERSITY BLOOMINGTON,R01,1990,192523,0.08533801347310618
"CUTANEOUS PATTERN PERCEPTION The proposed research will investigate the perception of tactile patterns by human subjects.  The tactile patterns will be generated on arrays of stimulators that fit against the subject's fingertips.  Each array consists of 144 stimulators arranged in a matrix 6 columns by 24 rows.  Sets of patterns differing along such dimensions as location, intensity, number of line segments, and so forth will be generated and presented to subjects. Response measures will include identification, discrimination, reaction time, and pattern matching.  Three aspects of tactile pattern perception will be examined:  masking, interactions among multiple sites of stimulation, and the role of experience.  A temporal masking paradigm will be used to see how the perception of tactile patterns is interfered with by tactile maskers and how the nature of the interference changes with changes in the type of masker and in the temporal separation between target and masker.  In the studies of interaction among multiple sites, patterns will be presented to as many as three sites on the fingertips and palm.  This paradigm will be used to assess the role of attention in tactile information processing. The role of short-term experience will be examined by measuring changes in pattern perception as subjects learn to identify and discriminate tactile patterns.  The effect of long-term experience will be evaluated by comparing the performance of groups of subjects who differ in the amount and nature of their experience with complex tactile patterns.  One group will be Optacon users, blind individuals who can read by means of a tactile array.  The other groups will be blind individuals without Optacon experience and several groups of sighted subjects with varying amounts of tactile experience.  The proposed research will be concerned with drawing parallels between tactile processing and visual and auditory processing, with developing measures relevant to understanding the neural coding of tactile patterns, and with improving cutaneous communication systems for the blind, deaf, and deaf-blind.  n/a",CUTANEOUS PATTERN PERCEPTION,3215660,R01DC000095,"['artificial intelligence', ' attention', ' blindness', ' cutaneous sensory nerve', ' fingers', ' form /pattern perception', ' human subject', ' mechanoreceptors', ' neural information processing', ' neurophysiology', ' perceptual maskings', ' psychometrics', ' psychophysics', ' sensory discrimination', ' sensory disorders', ' sensory thresholds', ' sequential perception', ' skin', ' somesthesis', ' space perception', ' stimulus /response', ' stimulus interval', ' substitute sight', ' touch', ' vibration perception']",NIDCD,INDIANA UNIVERSITY BLOOMINGTON,R01,1989,230027,0.08533801347310618
"DNA pattern identification and analysis    DESCRIPTION (provided by applicant):    We will continue the development of computer methods for analyzing gene regulation. We will further enhance methods to identify regulatory sites from the promoter regions of co-regulated genes with special emphasis on taking advantage of orthologous promoter regions from additional species. Included in the improvements will be better ways to identify multiple transcription factors that act coordinately to regulate gene expression.      We will develop computational methods to help determine which transcription factors within a genome interact with which regulatory sites. The methods will be developed initially using bacterial genomes where a large number of genome sequences, from a wide range of phylogenetic distances, already exist. We will test the ability of different types of information, including genomic location, phylogenetic correlation and recognition code predictions, to aid in the identification of the associations between factors and sites.      We will continue the development and enhancement of methods to predict RNA motifs composed of both sequence and structure constraints. We will go beyond the capabilities of programs like FOLDALIGN to detect conserved structures that are complex, including pseudoknots. Two approaches will be tested, one general one that should work on any collection of common RNA motifs and the other designed specifically to take advantage of phylogenetically conserved motifs in orthologous regions of multiple species.      Each of these projects will be enhanced through collaborations with other groups, primarily experimentalists, who are interested in the application of our methods to their biological problems.         n/a",DNA pattern identification and analysis,7061308,R01HG000249,"['artificial intelligence', 'binding sites', 'computer assisted sequence analysis', 'computer system design /evaluation', 'functional /structural genomics', 'genetic regulation', 'method development', 'nucleic acid sequence', 'protein structure', 'transcription factor']",NHGRI,WASHINGTON UNIVERSITY,R01,2006,298809,0.0033760945802303807
"DNA pattern identification and analysis    DESCRIPTION (provided by applicant):    We will continue the development of computer methods for analyzing gene regulation. We will further enhance methods to identify regulatory sites from the promoter regions of co-regulated genes with special emphasis on taking advantage of orthologous promoter regions from additional species. Included in the improvements will be better ways to identify multiple transcription factors that act coordinately to regulate gene expression.      We will develop computational methods to help determine which transcription factors within a genome interact with which regulatory sites. The methods will be developed initially using bacterial genomes where a large number of genome sequences, from a wide range of phylogenetic distances, already exist. We will test the ability of different types of information, including genomic location, phylogenetic correlation and recognition code predictions, to aid in the identification of the associations between factors and sites.      We will continue the development and enhancement of methods to predict RNA motifs composed of both sequence and structure constraints. We will go beyond the capabilities of programs like FOLDALIGN to detect conserved structures that are complex, including pseudoknots. Two approaches will be tested, one general one that should work on any collection of common RNA motifs and the other designed specifically to take advantage of phylogenetically conserved motifs in orthologous regions of multiple species.      Each of these projects will be enhanced through collaborations with other groups, primarily experimentalists, who are interested in the application of our methods to their biological problems.         n/a",DNA pattern identification and analysis,7066955,R01HG000249,"['artificial intelligence', 'binding sites', 'computer assisted sequence analysis', 'computer system design /evaluation', 'functional /structural genomics', 'genetic regulation', 'method development', 'nucleic acid sequence', 'protein structure', 'transcription factor']",NHGRI,WASHINGTON UNIVERSITY,R01,2005,3458,0.0033760945802303807
"DNA pattern identification and analysis    DESCRIPTION (provided by applicant):    We will continue the development of computer methods for analyzing gene regulation. We will further enhance methods to identify regulatory sites from the promoter regions of co-regulated genes with special emphasis on taking advantage of orthologous promoter regions from additional species. Included in the improvements will be better ways to identify multiple transcription factors that act coordinately to regulate gene expression.      We will develop computational methods to help determine which transcription factors within a genome interact with which regulatory sites. The methods will be developed initially using bacterial genomes where a large number of genome sequences, from a wide range of phylogenetic distances, already exist. We will test the ability of different types of information, including genomic location, phylogenetic correlation and recognition code predictions, to aid in the identification of the associations between factors and sites.      We will continue the development and enhancement of methods to predict RNA motifs composed of both sequence and structure constraints. We will go beyond the capabilities of programs like FOLDALIGN to detect conserved structures that are complex, including pseudoknots. Two approaches will be tested, one general one that should work on any collection of common RNA motifs and the other designed specifically to take advantage of phylogenetically conserved motifs in orthologous regions of multiple species.      Each of these projects will be enhanced through collaborations with other groups, primarily experimentalists, who are interested in the application of our methods to their biological problems.         n/a",DNA pattern identification and analysis,6890911,R01HG000249,"['artificial intelligence', 'binding sites', 'computer assisted sequence analysis', 'computer system design /evaluation', 'functional /structural genomics', 'genetic regulation', 'method development', 'nucleic acid sequence', 'protein structure', 'transcription factor']",NHGRI,WASHINGTON UNIVERSITY,R01,2005,306000,0.0033760945802303807
"DNA pattern identification and analysis    DESCRIPTION (provided by applicant):    We will continue the development of computer methods for analyzing gene regulation. We will further enhance methods to identify regulatory sites from the promoter regions of co-regulated genes with special emphasis on taking advantage of orthologous promoter regions from additional species. Included in the improvements will be better ways to identify multiple transcription factors that act coordinately to regulate gene expression.      We will develop computational methods to help determine which transcription factors within a genome interact with which regulatory sites. The methods will be developed initially using bacterial genomes where a large number of genome sequences, from a wide range of phylogenetic distances, already exist. We will test the ability of different types of information, including genomic location, phylogenetic correlation and recognition code predictions, to aid in the identification of the associations between factors and sites.      We will continue the development and enhancement of methods to predict RNA motifs composed of both sequence and structure constraints. We will go beyond the capabilities of programs like FOLDALIGN to detect conserved structures that are complex, including pseudoknots. Two approaches will be tested, one general one that should work on any collection of common RNA motifs and the other designed specifically to take advantage of phylogenetically conserved motifs in orthologous regions of multiple species.      Each of these projects will be enhanced through collaborations with other groups, primarily experimentalists, who are interested in the application of our methods to their biological problems.         n/a",DNA pattern identification and analysis,6774554,R01HG000249,"['artificial intelligence', 'binding sites', 'computer assisted sequence analysis', 'computer system design /evaluation', 'functional /structural genomics', 'genetic regulation', 'method development', 'nucleic acid sequence', 'protein structure', 'transcription factor']",NHGRI,WASHINGTON UNIVERSITY,R01,2004,306000,0.0033760945802303807
"A computational approach to early sepsis detection Abstract Significance: In this SBIR project, we propose to improve the performance of InSight, a machine-learning- based sepsis screening system, in situations of limited training data from the target clinical site. The proposed work will make possible prospective clinical deployments to sites which are smaller or lack clinical data repositories, by significantly reducing the amount of training data necessary down to a few weeks of clinical observation. Classically, a machine-learning-based system like InSight requires complete retraining for each new clinical setting, in turn requiring a new and large collection of data from each target deployment site. We will circumvent this requirement via transfer learning techniques, which transfer knowledge acquired previously in a source clinical setting to a new, target setting. Research Questions: Which transfer learning methods and paired classification algorithms are most suitable for use with InSight, requiring minimal target-site training data while maintaining strong performance? Are these methods and algorithms robust across the several common sepsis-spectrum definitions? Prior Work: We have developed InSight using the MIMIC-III retrospective data set, on which it attains an area under the receiver operating characteristic curve (AUROC) of 0.88 for sepsis detection, and 0.74 for 4-hour early sepsis prediction. We have also conducted pilot transfer learning  â‰¥ experiments in a different clinical task, mortality forecasting, in which transfer learning yields a 10-fold reduction in the amount of target-site training data required to achieve AUROC 0.80. Specific Aims: Aim 1 - to implement and assess side-by-side four diverse transfer learning methods for a retrospective clinical sepsis prediction task, where the source data set is MIMIC-III and the simulated clinical target is a data set drawn from UCSF. Aim 2 - to determine which among the best methods from Aim 1 also provide robust performance when applied to two additional sepsis-spectrum gold standards. Methods: We will prepare implementations of transfer learning methods which use instance transfer, residual learning and/or feature augmentation, kernel length scale transfer, and feature transfer. We will test these methods with applicable classifiers on subsets of the UCSF set, using cross-validation and quantifying discrimination performance in terms of AUROC. The best method/classifier pairs will require no more than 30 examples of septic patients from the target set and attain AUROC superiorities of 0.05 in 0- and 4-hour pre-onset sepsis prediction/detection, relative to the best tested alternative screening systems (Aim 1). The top three pairs will then be tested for robustness to gold standard choice, using septic shock (0- and 4-hour) and SIRS-based sepsis (0-hour) gold standards; in these tests, at least one pair must again attain 0.05 margin of superiority in AUROC versus the alternative screening systems (Aim 2). Future Directions: The results of these experiments will enable InSight to be robustly deployed to diverse clinical sites, yielding high performance without the need for extensive target-site data acquisition. Narrative Clinical decision support (CDS) systems present critical information to medical professionals by examining patient data and providing relevant information. Machine learning is a powerful method for creating CDS tools, but accessing its full strength requires re-training with retrospective data from each target clinical site. We will use transfer learning techniques to dramatically reduce the amount of target-site training data required by InSight, our machine-learning-based CDS tool for sepsis prediction, and empirically evaluate several such methods on a patient data set, using three different sepsis-related gold standards.",A computational approach to early sepsis detection,9557664,R43TR002221,"['Address', 'Age', 'Algorithms', 'Area', 'Cessation of life', 'Classification', 'Clinical', 'Clinical Decision Support Systems', 'Collection', 'Custom', 'Data', 'Data Collection', 'Data Set', 'Detection', 'Discrimination', 'Drops', 'Early Diagnosis', 'Early Intervention', 'Future', 'Gold', 'Healthcare', 'Healthcare Systems', 'Hour', 'Image', 'Immune response', 'Institution', 'Knowledge', 'Learning', 'Length', 'Machine Learning', 'Medical', 'Methods', 'Multicenter Studies', 'Nature', 'Patient-Focused Outcomes', 'Patients', 'Performance', 'Psychological Transfer', 'Receiver Operating Characteristics', 'Research', 'Residual state', 'Risk', 'SCAP2 gene', 'Sensitivity and Specificity', 'Sepsis', 'Septic Shock', 'Severities', 'Side', 'Site', 'Small Business Innovation Research Grant', 'Source', 'Survival Rate', 'System', 'Techniques', 'Testing', 'Training', 'Validation', 'Work', 'base', 'clinical data warehouse', 'clinical decision support', 'clinical research site', 'cost', 'data acquisition', 'experimental study', 'improved', 'insight', 'learning strategy', 'mortality', 'performance site', 'portability', 'prospective', 'screening', 'septic', 'septic patients', 'success', 'support tools']",NCATS,"DASCENA, INC.",R43,2018,310782,0.019752258079263122
"WormBase: a core data resource for C. elegans and other nematodes Project Summary WormBase is the major publicly available database of information related to Caenorhabditis elegans, an important organism for basic biomedical research, and other nematodes of medical and agricultural signficance. Although a crucial daily resource for members of the C. elegans research field, our users extend to the larger parasitology, biomedical, and bioinformatics research communities. WormBase acts as a central forum through which every research group can contribute to the global effort to comprehend nematode genomes and biology. Most users access WormBase via the Internet (www.wormbase.org); some install the database locally. WormBase offers extensive coverage of C. elegans core genomic, genetic, anatomical and functional information, allowing the biomedical community to fully utilize the results of intensive molecular genetic analyses and functional genomic studies of this organism in the study of human disease. These data include all available nematode genomic data (such as genome sequence, transcripts and cis-regulatory sites prioritized by species), large-scale functional genomic datasets, the function and interactions of genes and gene products as they relate to development, physiology and behavior, and biological reagents and their source information. WormBase comprises a set of databases storing a wide range of biological information; a website that allows users to access stored information and precomputed analyses based on these data; and tools for programmatic access such as an application programming interface, a data mining platform, and bulk downloads. Curation activities include extraction and integration of information from the literature (assisted by the use of information retrieval tools), incorporation of large-scale datasets from a range of research projects, and gene model verification from experimental data. We will curate many nematode genome sequences, along with their annotations and core genetic information, as well as data on gene function, pathways and transcriptional regulatory networks for C. elegans and select other species. We will expand tools available for data mining, workflow management, visualization, and community annotation, and integrate, store and distribute data in a maintainable, interoperable and scalable system. The project team involves three sites: Caltech primarily curates functional information and develops ontologies; EBI carries out sequence-based curation and builds databases for public release; and OICR develops and supports the web presence and visualization. The three sites work closely together and share tasks to ensure timely incorporation, storage and display of information, as well as user outreach and education. Project Narrative Nematodes (roundworms) are major parasites of humans, livestock and crops, and understanding how to control them is a major world health and economic challenge. One species of nematode, C. elegans, is extensively used for basic biomedical research to elucidate how networks of genes affect cells, organs, and whole anima development, physiology and behavior to understand human disease. WormBase collects, stores and displays information about the genomes and genes of C. elegans and other nematodes to facilitate research about this diverse and important group of animals.",WormBase: a core data resource for C. elegans and other nematodes,9750325,U24HG002223,"['Affect', 'Agriculture', 'Anatomy', 'Animals', 'Architecture', 'Base Sequence', 'Behavior', 'Bioinformatics', 'Biological', 'Biology', 'Biomedical Research', 'Caenorhabditis', 'Caenorhabditis elegans', 'Cells', 'ChIP-seq', 'Clustered Regularly Interspaced Short Palindromic Repeats', 'Collection', 'Communities', 'Complex', 'Data', 'Data Set', 'Data Storage and Retrieval', 'Databases', 'Dependence', 'Development', 'Disease', 'Disease model', 'Documentation', 'Education and Outreach', 'Educational workshop', 'Electronic Mail', 'Elements', 'Ensure', 'FAIR principles', 'Gene Expression', 'Genes', 'Genetic', 'Genetic Transcription', 'Genome', 'Genomics', 'Gold', 'Graph', 'Health', 'Human', 'Imagery', 'Incentives', 'Information Resources', 'Information Retrieval', 'Internet', 'Laboratories', 'Leadership', 'Literature', 'Livestock', 'Maintenance', 'Maps', 'Medical', 'Modeling', 'Molecular Genetics', 'Nematoda', 'Network-based', 'Ontology', 'Organ', 'Organism', 'Parasites', 'Parasitology', 'Pathway interactions', 'Persons', 'Phenotype', 'Physiology', 'Play', 'Publications', 'Reagent', 'Reference Standards', 'Regulation', 'Regulatory Element', 'Regulatory Pathway', 'Research', 'Research Infrastructure', 'Research Personnel', 'Research Project Grants', 'Research Support', 'Resources', 'Role', 'Scientist', 'Services', 'Site', 'Source', 'System', 'Techniques', 'Time', 'Training', 'Transcript', 'Validation', 'Variant', 'Visit', 'Work', 'Workplace', 'World Health', 'application programming interface', 'base', 'cloud based', 'comparative', 'data mining', 'data resource', 'data visualization', 'design', 'distributed data', 'functional genomics', 'gene function', 'gene interaction', 'gene product', 'genetic analysis', 'genetic information', 'genome-wide', 'genomic data', 'health economics', 'human disease', 'information display', 'interest', 'interoperability', 'light weight', 'member', 'novel', 'outreach', 'reference genome', 'relational database', 'social media', 'symposium', 'system architecture', 'text searching', 'tool', 'tool development', 'transcriptome sequencing', 'web site']",NHGRI,CALIFORNIA INSTITUTE OF TECHNOLOGY,U24,2018,1194375,0.06738798272564757
"WormBase: a core data resource for C. elegans and other nematodes Project Summary WormBase is the major publicly available database of information related to Caenorhabditis elegans, an important organism for basic biomedical research, and other nematodes of medical and agricultural signficance. Although a crucial daily resource for members of the C. elegans research field, our users extend to the larger parasitology, biomedical, and bioinformatics research communities. WormBase acts as a central forum through which every research group can contribute to the global effort to comprehend nematode genomes and biology. Most users access WormBase via the Internet (www.wormbase.org); some install the database locally. WormBase offers extensive coverage of C. elegans core genomic, genetic, anatomical and functional information, allowing the biomedical community to fully utilize the results of intensive molecular genetic analyses and functional genomic studies of this organism in the study of human disease. These data include all available nematode genomic data (such as genome sequence, transcripts and cis-regulatory sites prioritized by species), large-scale functional genomic datasets, the function and interactions of genes and gene products as they relate to development, physiology and behavior, and biological reagents and their source information. WormBase comprises a set of databases storing a wide range of biological information; a website that allows users to access stored information and precomputed analyses based on these data; and tools for programmatic access such as an application programming interface, a data mining platform, and bulk downloads. Curation activities include extraction and integration of information from the literature (assisted by the use of information retrieval tools), incorporation of large-scale datasets from a range of research projects, and gene model verification from experimental data. We will curate many nematode genome sequences, along with their annotations and core genetic information, as well as data on gene function, pathways and transcriptional regulatory networks for C. elegans and select other species. We will expand tools available for data mining, workflow management, visualization, and community annotation, and integrate, store and distribute data in a maintainable, interoperable and scalable system. The project team involves three sites: Caltech primarily curates functional information and develops ontologies; EBI carries out sequence-based curation and builds databases for public release; and OICR develops and supports the web presence and visualization. The three sites work closely together and share tasks to ensure timely incorporation, storage and display of information, as well as user outreach and education. Project Narrative Nematodes (roundworms) are major parasites of humans, livestock and crops, and understanding how to control them is a major world health and economic challenge. One species of nematode, C. elegans, is extensively used for basic biomedical research to elucidate how networks of genes affect cells, organs, and whole anima development, physiology and behavior to understand human disease. WormBase collects, stores and displays information about the genomes and genes of C. elegans and other nematodes to facilitate research about this diverse and important group of animals.",WormBase: a core data resource for C. elegans and other nematodes,9572165,U24HG002223,"['Affect', 'Agriculture', 'Anatomy', 'Animals', 'Architecture', 'Base Sequence', 'Behavior', 'Bioinformatics', 'Biological', 'Biology', 'Biomedical Research', 'Caenorhabditis', 'Caenorhabditis elegans', 'Cells', 'ChIP-seq', 'Clustered Regularly Interspaced Short Palindromic Repeats', 'Collection', 'Communities', 'Complex', 'Data', 'Data Set', 'Data Storage and Retrieval', 'Databases', 'Dependence', 'Development', 'Disease', 'Disease model', 'Documentation', 'Education and Outreach', 'Educational workshop', 'Electronic Mail', 'Elements', 'Ensure', 'FAIR principles', 'Gene Expression', 'Genes', 'Genetic', 'Genetic Transcription', 'Genome', 'Genomics', 'Gold', 'Graph', 'Health', 'Human', 'Imagery', 'Incentives', 'Information Resources', 'Information Retrieval', 'Internet', 'Laboratories', 'Leadership', 'Literature', 'Livestock', 'Maintenance', 'Maps', 'Medical', 'Modeling', 'Molecular Genetics', 'Nematoda', 'Network-based', 'Ontology', 'Organ', 'Organism', 'Parasites', 'Parasitology', 'Pathway interactions', 'Persons', 'Phenotype', 'Physiology', 'Play', 'Publications', 'Reagent', 'Reference Standards', 'Regulation', 'Regulatory Element', 'Regulatory Pathway', 'Research', 'Research Infrastructure', 'Research Personnel', 'Research Project Grants', 'Research Support', 'Resources', 'Role', 'Scientist', 'Services', 'Site', 'Source', 'System', 'Techniques', 'Time', 'Training', 'Transcript', 'Validation', 'Variant', 'Visit', 'Work', 'Workplace', 'World Health', 'application programming interface', 'base', 'cloud based', 'comparative', 'data mining', 'data resource', 'data visualization', 'design', 'distributed data', 'functional genomics', 'gene function', 'gene interaction', 'gene product', 'genetic analysis', 'genetic information', 'genome-wide', 'genomic data', 'health economics', 'human disease', 'information display', 'interest', 'interoperability', 'light weight', 'member', 'novel', 'outreach', 'reference genome', 'relational database', 'social media', 'symposium', 'system architecture', 'text searching', 'tool', 'tool development', 'transcriptome sequencing', 'web site']",NHGRI,CALIFORNIA INSTITUTE OF TECHNOLOGY,U24,2018,2493700,0.06738798272564757
"WormBase:  a core data resource for C. elegans and other nematodes DESCRIPTION (provided by applicant): WormBase Is the major publicly available database of information related to Caenorhabditis elegans, an important organism for basic biomedical research, and other nematodes of medical and agricultural importance. Although a crucial daily resource for members of the C. elegans research field, our users extend to the larger parasitology, biomedical, and bioinformatics research communities. WormBase acts as a central forum through which every research group can contribute to the global effort to comprehend nematode genomes. Most users access WormBase via the Internet (www.wormbase.orq). While some install the database locally. WormBase offers extensive coverage of C. elegans core genomic, genetic, anatomical and functional information, allowing the biomedical community to fully utilize the results of intensive molecular genetic analyses and functional genomic studies of this organism in the study of human disease. These data include all available nematode genomic data (such as genome sequence, transcripts and cis-regulatory sites prioritized by species), large-scale functional genomic datasets, the function and interactions of genes and gene products as they relate to development, physiology and behavior, and biological reagents and their source information. WormBase comprises a set of databases storing a wide range of biological information; a website that allows users to access stored information and precomputed analyses based on these data; and tools for programmatic access such as an application programming interface, a data mining platform, and bulk downloads. Curation activities include extraction and integration of information from the literature (assisted by the use of information retrieval tools), incorporation of large-scale datasets from a range of research projects, and gene model verification from experimental data. We will curate hundreds of nematode genome sequences, annotations and core genetic information as well as data on gene function, pathways and transcriptional regulatory networks for C. elegans and select other species. We will expand tools available for data mining, workflow management, visualization, and community annotation, and integrate, store and distribute data in a maintainable, interoperable and scalable system. The project team involves three sites: Caltech primarily curates functional information; EBI carries out sequence-based curation and builds databases for public release; and OICR develops and supports the web presence and visualization. The three sites work closely together and share tasks to ensure timely incorporation, storage and display of information.         RELEVANCE Nematodes (roundworms) are major parasites of humans, livestock and crops, and understanding how to control them is a major world health and economic challenge. One species of nematode, C. elegans, is extensively used for basic biomedical research to elucidate how networks of genes affect cells, organs and a whole animal's development, physiology and behavior. WormBase collects, stores and displays information about the genomes and genes of C. elegans and other nematodes to facilitate research about this numerous and important group of animals. n/a",WormBase:  a core data resource for C. elegans and other nematodes,9330882,U41HG002223,"['Affect', 'Agriculture', 'Anatomy', 'Animals', 'Architecture', 'Base Sequence', 'Behavior', 'Bioinformatics', 'Biological', 'Biomedical Research', 'Caenorhabditis elegans', 'Cells', 'Collaborations', 'Communities', 'Controlled Vocabulary', 'Custom', 'Data', 'Data Analyses', 'Data Set', 'Data Sources', 'Databases', 'Dependency', 'Development', 'Elements', 'Ensure', 'Galaxy', 'Gene Expression', 'Gene Proteins', 'Genes', 'Genetic', 'Genetic Transcription', 'Genome', 'Genomics', 'Human', 'Imagery', 'Incentives', 'Information Retrieval', 'Internet', 'Literature', 'Livestock', 'Maintenance', 'Maps', 'Medical', 'Modeling', 'Modernization', 'Molecular Genetics', 'Nematoda', 'Network-based', 'Online Systems', 'Ontology', 'Organ', 'Organism', 'Parasites', 'Parasitology', 'Pathway interactions', 'Phenotype', 'Physiology', 'Proteins', 'RNA', 'RNA immunoprecipitation sequencing', 'Reagent', 'Regulation', 'Reproducibility', 'Research', 'Research Project Grants', 'Resources', 'Set protein', 'Site', 'Source', 'System', 'Systems Biology', 'Technology', 'Terminology', 'Time', 'Transcript', 'Update', 'Workplace', 'World Health', 'application programming interface', 'base', 'biological research', 'comparative', 'data integration', 'data mining', 'data resource', 'distributed data', 'drug development', 'experimental study', 'functional genomics', 'gene function', 'gene interaction', 'gene product', 'genetic analysis', 'genetic information', 'genome-wide', 'genomic data', 'health economics', 'human disease', 'information display', 'interoperability', 'light weight', 'member', 'non-genomic', 'novel', 'reference genome', 'text searching', 'tool', 'transcriptome sequencing', 'web site', 'web-based tool']",NHGRI,CALIFORNIA INSTITUTE OF TECHNOLOGY,U41,2017,4178190,0.0733472774530306
"WormBase: a core data resource for C. elegans and other nematodes Project Summary WormBase is the major publicly available database of information related to Caenorhabditis elegans, an important organism for basic biomedical research, and other nematodes of medical and agricultural signficance. Although a crucial daily resource for members of the C. elegans research field, our users extend to the larger parasitology, biomedical, and bioinformatics research communities. WormBase acts as a central forum through which every research group can contribute to the global effort to comprehend nematode genomes and biology. Most users access WormBase via the Internet (www.wormbase.org); some install the database locally. WormBase offers extensive coverage of C. elegans core genomic, genetic, anatomical and functional information, allowing the biomedical community to fully utilize the results of intensive molecular genetic analyses and functional genomic studies of this organism in the study of human disease. These data include all available nematode genomic data (such as genome sequence, transcripts and cis-regulatory sites prioritized by species), large-scale functional genomic datasets, the function and interactions of genes and gene products as they relate to development, physiology and behavior, and biological reagents and their source information. WormBase comprises a set of databases storing a wide range of biological information; a website that allows users to access stored information and precomputed analyses based on these data; and tools for programmatic access such as an application programming interface, a data mining platform, and bulk downloads. Curation activities include extraction and integration of information from the literature (assisted by the use of information retrieval tools), incorporation of large-scale datasets from a range of research projects, and gene model verification from experimental data. We will curate many nematode genome sequences, along with their annotations and core genetic information, as well as data on gene function, pathways and transcriptional regulatory networks for C. elegans and select other species. We will expand tools available for data mining, workflow management, visualization, and community annotation, and integrate, store and distribute data in a maintainable, interoperable and scalable system. The project team involves three sites: Caltech primarily curates functional information and develops ontologies; EBI carries out sequence-based curation and builds databases for public release; and OICR develops and supports the web presence and visualization. The three sites work closely together and share tasks to ensure timely incorporation, storage and display of information, as well as user outreach and education. Project Narrative Nematodes (roundworms) are major parasites of humans, livestock and crops, and understanding how to control them is a major world health and economic challenge. One species of nematode, C. elegans, is extensively used for basic biomedical research to elucidate how networks of genes affect cells, organs, and whole anima development, physiology and behavior to understand human disease. WormBase collects, stores and displays information about the genomes and genes of C. elegans and other nematodes to facilitate research about this diverse and important group of animals.",WormBase: a core data resource for C. elegans and other nematodes,9976564,U24HG002223,"['Affect', 'Agriculture', 'Anatomy', 'Animals', 'Architecture', 'Base Sequence', 'Behavior', 'Bioinformatics', 'Biological', 'Biology', 'Biomedical Research', 'Caenorhabditis', 'Caenorhabditis elegans', 'Cells', 'ChIP-seq', 'Clustered Regularly Interspaced Short Palindromic Repeats', 'Collection', 'Communities', 'Data', 'Data Storage and Retrieval', 'Database Management Systems', 'Databases', 'Dependence', 'Development', 'Disease', 'Disease model', 'Documentation', 'Education and Outreach', 'Educational workshop', 'Electronic Mail', 'Elements', 'Ensure', 'FAIR principles', 'Gene Expression', 'Genes', 'Genetic', 'Genetic Transcription', 'Genome', 'Genomics', 'Gold', 'Graph', 'Health', 'Human', 'Incentives', 'Information Resources', 'Information Retrieval', 'Infrastructure', 'Internet', 'Laboratories', 'Leadership', 'Literature', 'Livestock', 'Maintenance', 'Maps', 'Medical', 'Modeling', 'Molecular Genetics', 'Nematoda', 'Network-based', 'Ontology', 'Organ', 'Organism', 'Parasites', 'Parasitology', 'Pathway interactions', 'Persons', 'Phenotype', 'Physiology', 'Play', 'Publications', 'Reagent', 'Reference Standards', 'Regulation', 'Regulatory Element', 'Regulatory Pathway', 'Research', 'Research Personnel', 'Research Project Grants', 'Research Support', 'Resources', 'Role', 'Scientist', 'Services', 'Site', 'Source', 'System', 'Techniques', 'Time', 'Training', 'Transcript', 'Validation', 'Variant', 'Visit', 'Visualization', 'Work', 'Workplace', 'World Health', 'WormBase', 'application programming interface', 'base', 'cloud based', 'comparative', 'complex data ', 'data mining', 'data resource', 'data tools', 'data visualization', 'design', 'distributed data', 'functional genomics', 'gene function', 'gene interaction', 'gene product', 'genetic analysis', 'genetic information', 'genome resource', 'genome-wide', 'genomic data', 'health economics', 'human disease', 'information display', 'interest', 'interoperability', 'large scale data', 'light weight', 'member', 'novel', 'outreach', 'reference genome', 'relational database', 'social media', 'symposium', 'system architecture', 'text searching', 'tool', 'tool development', 'transcriptome sequencing', 'web site']",NHGRI,CALIFORNIA INSTITUTE OF TECHNOLOGY,U24,2020,2200324,0.06738798272564757
"WormBase: a core data resource for C. elegans and other nematodes Project Summary WormBase is the major publicly available database of information related to Caenorhabditis elegans, an important organism for basic biomedical research, and other nematodes of medical and agricultural signficance. Although a crucial daily resource for members of the C. elegans research field, our users extend to the larger parasitology, biomedical, and bioinformatics research communities. WormBase acts as a central forum through which every research group can contribute to the global effort to comprehend nematode genomes and biology. Most users access WormBase via the Internet (www.wormbase.org); some install the database locally. WormBase offers extensive coverage of C. elegans core genomic, genetic, anatomical and functional information, allowing the biomedical community to fully utilize the results of intensive molecular genetic analyses and functional genomic studies of this organism in the study of human disease. These data include all available nematode genomic data (such as genome sequence, transcripts and cis-regulatory sites prioritized by species), large-scale functional genomic datasets, the function and interactions of genes and gene products as they relate to development, physiology and behavior, and biological reagents and their source information. WormBase comprises a set of databases storing a wide range of biological information; a website that allows users to access stored information and precomputed analyses based on these data; and tools for programmatic access such as an application programming interface, a data mining platform, and bulk downloads. Curation activities include extraction and integration of information from the literature (assisted by the use of information retrieval tools), incorporation of large-scale datasets from a range of research projects, and gene model verification from experimental data. We will curate many nematode genome sequences, along with their annotations and core genetic information, as well as data on gene function, pathways and transcriptional regulatory networks for C. elegans and select other species. We will expand tools available for data mining, workflow management, visualization, and community annotation, and integrate, store and distribute data in a maintainable, interoperable and scalable system. The project team involves three sites: Caltech primarily curates functional information and develops ontologies; EBI carries out sequence-based curation and builds databases for public release; and OICR develops and supports the web presence and visualization. The three sites work closely together and share tasks to ensure timely incorporation, storage and display of information, as well as user outreach and education. Project Narrative Nematodes (roundworms) are major parasites of humans, livestock and crops, and understanding how to control them is a major world health and economic challenge. One species of nematode, C. elegans, is extensively used for basic biomedical research to elucidate how networks of genes affect cells, organs, and whole anima development, physiology and behavior to understand human disease. WormBase collects, stores and displays information about the genomes and genes of C. elegans and other nematodes to facilitate research about this diverse and important group of animals.",WormBase: a core data resource for C. elegans and other nematodes,9776601,U24HG002223,"['Affect', 'Agriculture', 'Anatomy', 'Animals', 'Architecture', 'Base Sequence', 'Behavior', 'Bioinformatics', 'Biological', 'Biology', 'Biomedical Research', 'Caenorhabditis', 'Caenorhabditis elegans', 'Cells', 'ChIP-seq', 'Clustered Regularly Interspaced Short Palindromic Repeats', 'Collection', 'Communities', 'Complex', 'Data', 'Data Set', 'Data Storage and Retrieval', 'Database Management Systems', 'Databases', 'Dependence', 'Development', 'Disease', 'Disease model', 'Documentation', 'Education and Outreach', 'Educational workshop', 'Electronic Mail', 'Elements', 'Ensure', 'FAIR principles', 'Gene Expression', 'Genes', 'Genetic', 'Genetic Transcription', 'Genome', 'Genomics', 'Gold', 'Graph', 'Health', 'Human', 'Imagery', 'Incentives', 'Information Resources', 'Information Retrieval', 'Infrastructure', 'Internet', 'Laboratories', 'Leadership', 'Literature', 'Livestock', 'Maintenance', 'Maps', 'Medical', 'Modeling', 'Molecular Genetics', 'Nematoda', 'Network-based', 'Ontology', 'Organ', 'Organism', 'Parasites', 'Parasitology', 'Pathway interactions', 'Persons', 'Phenotype', 'Physiology', 'Play', 'Publications', 'Reagent', 'Reference Standards', 'Regulation', 'Regulatory Element', 'Regulatory Pathway', 'Research', 'Research Personnel', 'Research Project Grants', 'Research Support', 'Resources', 'Role', 'Scientist', 'Services', 'Site', 'Source', 'System', 'Techniques', 'Time', 'Training', 'Transcript', 'Validation', 'Variant', 'Visit', 'Work', 'Workplace', 'World Health', 'application programming interface', 'base', 'cloud based', 'comparative', 'data mining', 'data resource', 'data visualization', 'design', 'distributed data', 'functional genomics', 'gene function', 'gene interaction', 'gene product', 'genetic analysis', 'genetic information', 'genome-wide', 'genomic data', 'health economics', 'human disease', 'information display', 'interest', 'interoperability', 'light weight', 'member', 'novel', 'outreach', 'reference genome', 'relational database', 'social media', 'symposium', 'system architecture', 'text searching', 'tool', 'tool development', 'transcriptome sequencing', 'web site']",NHGRI,CALIFORNIA INSTITUTE OF TECHNOLOGY,U24,2019,2347011,0.06738798272564757
"WormBase:  a core data resource for C. elegans and other nematodes     DESCRIPTION (provided by applicant): WormBase Is the major publicly available database of information related to Caenorhabditis elegans, an important organism for basic biomedical research, and other nematodes of medical and agricultural importance. Although a crucial daily resource for members of the C. elegans research field, our users extend to the larger parasitology, biomedical, and bioinformatics research communities. WormBase acts as a central forum through which every research group can contribute to the global effort to comprehend nematode genomes. Most users access WormBase via the Internet (www.wormbase.orq). While some install the database locally. WormBase offers extensive coverage of C. elegans core genomic, genetic, anatomical and functional information, allowing the biomedical community to fully utilize the results of intensive molecular genetic analyses and functional genomic studies of this organism in the study of human disease. These data include all available nematode genomic data (such as genome sequence, transcripts and cis-regulatory sites prioritized by species), large-scale functional genomic datasets, the function and interactions of genes and gene products as they relate to development, physiology and behavior, and biological reagents and their source information. WormBase comprises a set of databases storing a wide range of biological information; a website that allows users to access stored information and precomputed analyses based on these data; and tools for programmatic access such as an application programming interface, a data mining platform, and bulk downloads. Curation activities include extraction and integration of information from the literature (assisted by the use of information retrieval tools), incorporation of large-scale datasets from a range of research projects, and gene model verification from experimental data. We will curate hundreds of nematode genome sequences, annotations and core genetic information as well as data on gene function, pathways and transcriptional regulatory networks for C. elegans and select other species. We will expand tools available for data mining, workflow management, visualization, and community annotation, and integrate, store and distribute data in a maintainable, interoperable and scalable system. The project team involves three sites: Caltech primarily curates functional information; EBI carries out sequence-based curation and builds databases for public release; and OICR develops and supports the web presence and visualization. The three sites work closely together and share tasks to ensure timely incorporation, storage and display of information.         RELEVANCE Nematodes (roundworms) are major parasites of humans, livestock and crops, and understanding how to control them is a major world health and economic challenge. One species of nematode, C. elegans, is extensively used for basic biomedical research to elucidate how networks of genes affect cells, organs and a whole animal's development, physiology and behavior. WormBase collects, stores and displays information about the genomes and genes of C. elegans and other nematodes to facilitate research about this numerous and important group of animals.                  n/a",WormBase:  a core data resource for C. elegans and other nematodes,9130596,U41HG002223,"['Affect', 'Agriculture', 'Animals', 'Architecture', 'Base Sequence', 'Behavior', 'Bioinformatics', 'Biological', 'Biomedical Research', 'Caenorhabditis elegans', 'Cells', 'Collaborations', 'Communities', 'Controlled Vocabulary', 'Custom', 'Data', 'Data Analyses', 'Data Set', 'Data Sources', 'Databases', 'Dependency', 'Development', 'Elements', 'Ensure', 'Galaxy', 'Gene Expression', 'Gene Proteins', 'Genes', 'Genetic', 'Genome', 'Genomics', 'Housing', 'Human', 'Imagery', 'Information Retrieval', 'Internet', 'Literature', 'Livestock', 'Maintenance', 'Maps', 'Medical', 'Modeling', 'Molecular Genetics', 'Nematoda', 'Network-based', 'Online Systems', 'Ontology', 'Organ', 'Organism', 'Parasites', 'Parasitology', 'Pathway interactions', 'Phenotype', 'Physiology', 'Proteins', 'RNA', 'RNA immunoprecipitation sequencing', 'Reagent', 'Regulation', 'Regulator Genes', 'Research', 'Research Project Grants', 'Resources', 'Set protein', 'Site', 'Source', 'System', 'Systems Biology', 'Technology', 'Terminology', 'Transcript', 'Update', 'Workplace', 'World Health', 'application programming interface', 'base', 'biological research', 'comparative', 'data integration', 'data mining', 'distributed data', 'drug development', 'functional genomics', 'gene function', 'gene interaction', 'gene product', 'genetic analysis', 'genetic information', 'genome annotation', 'genome sequencing', 'genome-wide', 'genomic data', 'health economics', 'human disease', 'information display', 'interoperability', 'light weight', 'member', 'non-genomic', 'novel', 'reference genome', 'research study', 'text searching', 'tool', 'transcriptome sequencing', 'web site']",NHGRI,CALIFORNIA INSTITUTE OF TECHNOLOGY,U41,2016,2939165,0.0733472774530306
"WormBase:  a core data resource for C. elegans and other nematodes DESCRIPTION (provided by applicant): WormBase Is the major publicly available database of information related to Caenorhabditis elegans, an important organism for basic biomedical research, and other nematodes of medical and agricultural importance. Although a crucial daily resource for members of the C. elegans research field, our users extend to the larger parasitology, biomedical, and bioinformatics research communities. WormBase acts as a central forum through which every research group can contribute to the global effort to comprehend nematode genomes. Most users access WormBase via the Internet (www.wormbase.orq). While some install the database locally. WormBase offers extensive coverage of C. elegans core genomic, genetic, anatomical and functional information, allowing the biomedical community to fully utilize the results of intensive molecular genetic analyses and functional genomic studies of this organism in the study of human disease. These data include all available nematode genomic data (such as genome sequence, transcripts and cis-regulatory sites prioritized by species), large-scale functional genomic datasets, the function and interactions of genes and gene products as they relate to development, physiology and behavior, and biological reagents and their source information. WormBase comprises a set of databases storing a wide range of biological information; a website that allows users to access stored information and precomputed analyses based on these data; and tools for programmatic access such as an application programming interface, a data mining platform, and bulk downloads. Curation activities include extraction and integration of information from the literature (assisted by the use of information retrieval tools), incorporation of large-scale datasets from a range of research projects, and gene model verification from experimental data. We will curate hundreds of nematode genome sequences, annotations and core genetic information as well as data on gene function, pathways and transcriptional regulatory networks for C. elegans and select other species. We will expand tools available for data mining, workflow management, visualization, and community annotation, and integrate, store and distribute data in a maintainable, interoperable and scalable system. The project team involves three sites: Caltech primarily curates functional information; EBI carries out sequence-based curation and builds databases for public release; and OICR develops and supports the web presence and visualization. The three sites work closely together and share tasks to ensure timely incorporation, storage and display of information.         RELEVANCE Nematodes (roundworms) are major parasites of humans, livestock and crops, and understanding how to control them is a major world health and economic challenge. One species of nematode, C. elegans, is extensively used for basic biomedical research to elucidate how networks of genes affect cells, organs and a whole animal's development, physiology and behavior. WormBase collects, stores and displays information about the genomes and genes of C. elegans and other nematodes to facilitate research about this numerous and important group of animals. n/a",WormBase:  a core data resource for C. elegans and other nematodes,9336007,U41HG002223,"['Affect', 'Agriculture', 'Animals', 'Architecture', 'Base Sequence', 'Behavior', 'Bioinformatics', 'Biological', 'Biomedical Research', 'Caenorhabditis elegans', 'Cells', 'Collaborations', 'Communities', 'Controlled Vocabulary', 'Custom', 'Data', 'Data Analyses', 'Data Set', 'Data Sources', 'Databases', 'Dependency', 'Development', 'Elements', 'Ensure', 'Galaxy', 'Gene Expression', 'Gene Proteins', 'Genes', 'Genetic', 'Genome', 'Genomics', 'Housing', 'Human', 'Imagery', 'Information Retrieval', 'Internet', 'Literature', 'Livestock', 'Maintenance', 'Maps', 'Medical', 'Modeling', 'Molecular Genetics', 'Nematoda', 'Network-based', 'Online Systems', 'Ontology', 'Organ', 'Organism', 'Parasites', 'Parasitology', 'Pathway interactions', 'Phenotype', 'Physiology', 'Proteins', 'RNA', 'RNA immunoprecipitation sequencing', 'Reagent', 'Regulation', 'Regulator Genes', 'Research', 'Research Project Grants', 'Resources', 'Set protein', 'Site', 'Source', 'System', 'Systems Biology', 'Technology', 'Terminology', 'Transcript', 'Update', 'Workplace', 'World Health', 'application programming interface', 'base', 'biological research', 'comparative', 'data integration', 'data mining', 'distributed data', 'drug development', 'functional genomics', 'gene function', 'gene interaction', 'gene product', 'genetic analysis', 'genetic information', 'genome annotation', 'genome sequencing', 'genome-wide', 'genomic data', 'health economics', 'human disease', 'information display', 'interoperability', 'light weight', 'member', 'non-genomic', 'novel', 'reference genome', 'research study', 'text searching', 'tool', 'transcriptome sequencing', 'web site']",NHGRI,CALIFORNIA INSTITUTE OF TECHNOLOGY,U41,2016,83000,0.0733472774530306
"WormBase:  a core data resource for C. elegans and other nematodes DESCRIPTION (provided by applicant): WormBase Is the major publicly available database of information related to Caenorhabditis elegans, an important organism for basic biomedical research, and other nematodes of medical and agricultural importance. Although a crucial daily resource for members of the C. elegans research field, our users extend to the larger parasitology, biomedical, and bioinformatics research communities. WormBase acts as a central forum through which every research group can contribute to the global effort to comprehend nematode genomes. Most users access WormBase via the Internet (www.wormbase.orq). While some install the database locally. WormBase offers extensive coverage of C. elegans core genomic, genetic, anatomical and functional information, allowing the biomedical community to fully utilize the results of intensive molecular genetic analyses and functional genomic studies of this organism in the study of human disease. These data include all available nematode genomic data (such as genome sequence, transcripts and cis-regulatory sites prioritized by species), large-scale functional genomic datasets, the function and interactions of genes and gene products as they relate to development, physiology and behavior, and biological reagents and their source information. WormBase comprises a set of databases storing a wide range of biological information; a website that allows users to access stored information and precomputed analyses based on these data; and tools for programmatic access such as an application programming interface, a data mining platform, and bulk downloads. Curation activities include extraction and integration of information from the literature (assisted by the use of information retrieval tools), incorporation of large-scale datasets from a range of research projects, and gene model verification from experimental data. We will curate hundreds of nematode genome sequences, annotations and core genetic information as well as data on gene function, pathways and transcriptional regulatory networks for C. elegans and select other species. We will expand tools available for data mining, workflow management, visualization, and community annotation, and integrate, store and distribute data in a maintainable, interoperable and scalable system. The project team involves three sites: Caltech primarily curates functional information; EBI carries out sequence-based curation and builds databases for public release; and OICR develops and supports the web presence and visualization. The three sites work closely together and share tasks to ensure timely incorporation, storage and display of information.         RELEVANCE Nematodes (roundworms) are major parasites of humans, livestock and crops, and understanding how to control them is a major world health and economic challenge. One species of nematode, C. elegans, is extensively used for basic biomedical research to elucidate how networks of genes affect cells, organs and a whole animal's development, physiology and behavior. WormBase collects, stores and displays information about the genomes and genes of C. elegans and other nematodes to facilitate research about this numerous and important group of animals. n/a",WormBase:  a core data resource for C. elegans and other nematodes,9137332,U41HG002223,"['Affect', 'Agriculture', 'Animals', 'Architecture', 'Base Sequence', 'Behavior', 'Bioinformatics', 'Biological', 'Biomedical Research', 'Caenorhabditis elegans', 'Cells', 'Collaborations', 'Communities', 'Controlled Vocabulary', 'Custom', 'Data', 'Data Analyses', 'Data Set', 'Data Sources', 'Databases', 'Dependency', 'Development', 'Elements', 'Ensure', 'Galaxy', 'Gene Expression', 'Gene Proteins', 'Genes', 'Genetic', 'Genome', 'Genomics', 'Housing', 'Human', 'Imagery', 'Information Retrieval', 'Internet', 'Literature', 'Livestock', 'Maintenance', 'Maps', 'Medical', 'Modeling', 'Molecular Genetics', 'Nematoda', 'Network-based', 'Online Systems', 'Ontology', 'Organ', 'Organism', 'Parasites', 'Parasitology', 'Pathway interactions', 'Phenotype', 'Physiology', 'Proteins', 'RNA', 'RNA immunoprecipitation sequencing', 'Reagent', 'Regulation', 'Regulator Genes', 'Research', 'Research Project Grants', 'Resources', 'Set protein', 'Site', 'Source', 'System', 'Systems Biology', 'Technology', 'Terminology', 'Transcript', 'Update', 'Workplace', 'World Health', 'base', 'biological research', 'comparative', 'data integration', 'data mining', 'distributed data', 'drug development', 'functional genomics', 'gene function', 'gene interaction', 'genetic analysis', 'genetic information', 'genome annotation', 'genome sequencing', 'genome-wide', 'health economics', 'human disease', 'information display', 'interoperability', 'member', 'non-genomic', 'novel', 'programs', 'research study', 'text searching', 'tool', 'transcriptome sequencing', 'web site']",NHGRI,CALIFORNIA INSTITUTE OF TECHNOLOGY,U41,2015,451148,0.0733472774530306
"WormBase:  a core data resource for C. elegans and other nematodes DESCRIPTION (provided by applicant): WormBase Is the major publicly available database of information related to Caenorhabditis elegans, an important organism for basic biomedical research, and other nematodes of medical and agricultural importance. Although a crucial daily resource for members of the C. elegans research field, our users extend to the larger parasitology, biomedical, and bioinformatics research communities. WormBase acts as a central forum through which every research group can contribute to the global effort to comprehend nematode genomes. Most users access WormBase via the Internet (www.wormbase.orq). While some install the database locally. WormBase offers extensive coverage of C. elegans core genomic, genetic, anatomical and functional information, allowing the biomedical community to fully utilize the results of intensive molecular genetic analyses and functional genomic studies of this organism in the study of human disease. These data include all available nematode genomic data (such as genome sequence, transcripts and cis-regulatory sites prioritized by species), large-scale functional genomic datasets, the function and interactions of genes and gene products as they relate to development, physiology and behavior, and biological reagents and their source information. WormBase comprises a set of databases storing a wide range of biological information; a website that allows users to access stored information and precomputed analyses based on these data; and tools for programmatic access such as an application programming interface, a data mining platform, and bulk downloads. Curation activities include extraction and integration of information from the literature (assisted by the use of information retrieval tools), incorporation of large-scale datasets from a range of research projects, and gene model verification from experimental data. We will curate hundreds of nematode genome sequences, annotations and core genetic information as well as data on gene function, pathways and transcriptional regulatory networks for C. elegans and select other species. We will expand tools available for data mining, workflow management, visualization, and community annotation, and integrate, store and distribute data in a maintainable, interoperable and scalable system. The project team involves three sites: Caltech primarily curates functional information; EBI carries out sequence-based curation and builds databases for public release; and OICR develops and supports the web presence and visualization. The three sites work closely together and share tasks to ensure timely incorporation, storage and display of information.         RELEVANCE Nematodes (roundworms) are major parasites of humans, livestock and crops, and understanding how to control them is a major world health and economic challenge. One species of nematode, C. elegans, is extensively used for basic biomedical research to elucidate how networks of genes affect cells, organs and a whole animal's development, physiology and behavior. WormBase collects, stores and displays information about the genomes and genes of C. elegans and other nematodes to facilitate research about this numerous and important group of animals. n/a",WormBase:  a core data resource for C. elegans and other nematodes,9137322,U41HG002223,"['Affect', 'Agriculture', 'Animals', 'Architecture', 'Base Sequence', 'Behavior', 'Bioinformatics', 'Biological', 'Biomedical Research', 'Caenorhabditis elegans', 'Cells', 'Collaborations', 'Communities', 'Controlled Vocabulary', 'Custom', 'Data', 'Data Analyses', 'Data Set', 'Data Sources', 'Databases', 'Dependency', 'Development', 'Elements', 'Ensure', 'Galaxy', 'Gene Expression', 'Gene Proteins', 'Genes', 'Genetic', 'Genome', 'Genomics', 'Housing', 'Human', 'Imagery', 'Information Retrieval', 'Internet', 'Literature', 'Livestock', 'Maintenance', 'Maps', 'Medical', 'Modeling', 'Molecular Genetics', 'Nematoda', 'Network-based', 'Online Systems', 'Ontology', 'Organ', 'Organism', 'Parasites', 'Parasitology', 'Pathway interactions', 'Phenotype', 'Physiology', 'Proteins', 'RNA', 'RNA immunoprecipitation sequencing', 'Reagent', 'Regulation', 'Regulator Genes', 'Research', 'Research Project Grants', 'Resources', 'Set protein', 'Site', 'Source', 'System', 'Systems Biology', 'Technology', 'Terminology', 'Transcript', 'Update', 'Workplace', 'World Health', 'base', 'biological research', 'comparative', 'data integration', 'data mining', 'distributed data', 'drug development', 'functional genomics', 'gene function', 'gene interaction', 'genetic analysis', 'genetic information', 'genome annotation', 'genome sequencing', 'genome-wide', 'health economics', 'human disease', 'information display', 'interoperability', 'member', 'non-genomic', 'novel', 'programs', 'research study', 'text searching', 'tool', 'transcriptome sequencing', 'web site']",NHGRI,CALIFORNIA INSTITUTE OF TECHNOLOGY,U41,2015,206128,0.0733472774530306
"WormBase:  a core data resource for C. elegans and other nematodes     DESCRIPTION (provided by applicant): WormBase Is the major publicly available database of information related to Caenorhabditis elegans, an important organism for basic biomedical research, and other nematodes of medical and agricultural importance. Although a crucial daily resource for members of the C. elegans research field, our users extend to the larger parasitology, biomedical, and bioinformatics research communities. WormBase acts as a central forum through which every research group can contribute to the global effort to comprehend nematode genomes. Most users access WormBase via the Internet (www.wormbase.orq). While some install the database locally. WormBase offers extensive coverage of C. elegans core genomic, genetic, anatomical and functional information, allowing the biomedical community to fully utilize the results of intensive molecular genetic analyses and functional genomic studies of this organism in the study of human disease. These data include all available nematode genomic data (such as genome sequence, transcripts and cis-regulatory sites prioritized by species), large-scale functional genomic datasets, the function and interactions of genes and gene products as they relate to development, physiology and behavior, and biological reagents and their source information. WormBase comprises a set of databases storing a wide range of biological information; a website that allows users to access stored information and precomputed analyses based on these data; and tools for programmatic access such as an application programming interface, a data mining platform, and bulk downloads. Curation activities include extraction and integration of information from the literature (assisted by the use of information retrieval tools), incorporation of large-scale datasets from a range of research projects, and gene model verification from experimental data. We will curate hundreds of nematode genome sequences, annotations and core genetic information as well as data on gene function, pathways and transcriptional regulatory networks for C. elegans and select other species. We will expand tools available for data mining, workflow management, visualization, and community annotation, and integrate, store and distribute data in a maintainable, interoperable and scalable system. The project team involves three sites: Caltech primarily curates functional information; EBI carries out sequence-based curation and builds databases for public release; and OICR develops and supports the web presence and visualization. The three sites work closely together and share tasks to ensure timely incorporation, storage and display of information.         RELEVANCE Nematodes (roundworms) are major parasites of humans, livestock and crops, and understanding how to control them is a major world health and economic challenge. One species of nematode, C. elegans, is extensively used for basic biomedical research to elucidate how networks of genes affect cells, organs and a whole animal's development, physiology and behavior. WormBase collects, stores and displays information about the genomes and genes of C. elegans and other nematodes to facilitate research about this numerous and important group of animals.                  n/a",WormBase:  a core data resource for C. elegans and other nematodes,8886973,U41HG002223,"['Affect', 'Agriculture', 'Animals', 'Architecture', 'Base Sequence', 'Behavior', 'Bioinformatics', 'Biological', 'Biomedical Research', 'Caenorhabditis elegans', 'Cells', 'Collaborations', 'Communities', 'Controlled Vocabulary', 'Custom', 'Data', 'Data Analyses', 'Data Set', 'Data Sources', 'Databases', 'Dependency', 'Development', 'Elements', 'Ensure', 'Galaxy', 'Gene Expression', 'Gene Proteins', 'Genes', 'Genetic', 'Genome', 'Genomics', 'Housing', 'Human', 'Imagery', 'Information Retrieval', 'Internet', 'Literature', 'Livestock', 'Maintenance', 'Maps', 'Medical', 'Modeling', 'Molecular Genetics', 'Nematoda', 'Network-based', 'Online Systems', 'Ontology', 'Organ', 'Organism', 'Parasites', 'Parasitology', 'Pathway interactions', 'Phenotype', 'Physiology', 'Proteins', 'RNA', 'RNA immunoprecipitation sequencing', 'Reagent', 'Regulation', 'Regulator Genes', 'Research', 'Research Project Grants', 'Resources', 'Set protein', 'Site', 'Source', 'System', 'Systems Biology', 'Technology', 'Terminology', 'Transcript', 'Update', 'Workplace', 'World Health', 'base', 'biological research', 'comparative', 'data integration', 'data mining', 'distributed data', 'drug development', 'functional genomics', 'gene function', 'gene interaction', 'genetic analysis', 'genetic information', 'genome annotation', 'genome sequencing', 'genome-wide', 'health economics', 'human disease', 'information display', 'interoperability', 'member', 'non-genomic', 'novel', 'programs', 'research study', 'text searching', 'tool', 'transcriptome sequencing', 'web site']",NHGRI,CALIFORNIA INSTITUTE OF TECHNOLOGY,U41,2015,2864345,0.0733472774530306
"WormBase:  a core data resource for C. elegans and other nematodes     DESCRIPTION (provided by applicant): WormBase Is the major publicly available database of information related to Caenorhabditis elegans, an important organism for basic biomedical research, and other nematodes of medical and agricultural importance. Although a crucial daily resource for members of the C. elegans research field, our users extend to the larger parasitology, biomedical, and bioinformatics research communities. WormBase acts as a central forum through which every research group can contribute to the global effort to comprehend nematode genomes. Most users access WormBase via the Internet (www.wormbase.orq). While some install the database locally. WormBase offers extensive coverage of C. elegans core genomic, genetic, anatomical and functional information, allowing the biomedical community to fully utilize the results of intensive molecular genetic analyses and functional genomic studies of this organism in the study of human disease. These data include all available nematode genomic data (such as genome sequence, transcripts and cis-regulatory sites prioritized by species), large-scale functional genomic datasets, the function and interactions of genes and gene products as they relate to development, physiology and behavior, and biological reagents and their source information. WormBase comprises a set of databases storing a wide range of biological information; a website that allows users to access stored information and precomputed analyses based on these data; and tools for programmatic access such as an application programming interface, a data mining platform, and bulk downloads. Curation activities include extraction and integration of information from the literature (assisted by the use of information retrieval tools), incorporation of large-scale datasets from a range of research projects, and gene model verification from experimental data. We will curate hundreds of nematode genome sequences, annotations and core genetic information as well as data on gene function, pathways and transcriptional regulatory networks for C. elegans and select other species. We will expand tools available for data mining, workflow management, visualization, and community annotation, and integrate, store and distribute data in a maintainable, interoperable and scalable system. The project team involves three sites: Caltech primarily curates functional information; EBI carries out sequence-based curation and builds databases for public release; and OICR develops and supports the web presence and visualization. The three sites work closely together and share tasks to ensure timely incorporation, storage and display of information.         RELEVANCE Nematodes (roundworms) are major parasites of humans, livestock and crops, and understanding how to control them is a major world health and economic challenge. One species of nematode, C. elegans, is extensively used for basic biomedical research to elucidate how networks of genes affect cells, organs and a whole animal's development, physiology and behavior. WormBase collects, stores and displays information about the genomes and genes of C. elegans and other nematodes to facilitate research about this numerous and important group of animals.                  n/a",WormBase:  a core data resource for C. elegans and other nematodes,8735175,U41HG002223,"['Affect', 'Agriculture', 'Animals', 'Architecture', 'Base Sequence', 'Behavior', 'Bioinformatics', 'Biological', 'Biomedical Research', 'Caenorhabditis elegans', 'Cells', 'Collaborations', 'Communities', 'Controlled Vocabulary', 'Custom', 'Data', 'Data Analyses', 'Data Set', 'Data Sources', 'Databases', 'Dependency', 'Development', 'Elements', 'Ensure', 'Galaxy', 'Gene Expression', 'Gene Proteins', 'Genes', 'Genetic', 'Genome', 'Genomics', 'Housing', 'Human', 'Imagery', 'Information Retrieval', 'Internet', 'Literature', 'Livestock', 'Maintenance', 'Maps', 'Medical', 'Modeling', 'Molecular Genetics', 'Nematoda', 'Network-based', 'Online Systems', 'Ontology', 'Organ', 'Organism', 'Parasites', 'Parasitology', 'Pathway interactions', 'Phenotype', 'Physiology', 'Proteins', 'RNA', 'Reagent', 'Regulation', 'Regulator Genes', 'Research', 'Research Project Grants', 'Resources', 'Set protein', 'Site', 'Source', 'System', 'Systems Biology', 'Technology', 'Terminology', 'Transcript', 'Update', 'Workplace', 'World Health', 'base', 'biological research', 'comparative', 'data integration', 'data mining', 'distributed data', 'drug development', 'functional genomics', 'gene function', 'gene interaction', 'genetic analysis', 'genome annotation', 'genome sequencing', 'health economics', 'human disease', 'information display', 'interoperability', 'member', 'non-genomic', 'novel', 'programs', 'research study', 'text searching', 'tool', 'transcriptome sequencing', 'web site']",NHGRI,CALIFORNIA INSTITUTE OF TECHNOLOGY,U41,2014,2891903,0.0733472774530306
"WormBase:  a core data resource for C. elegans and other nematodes     DESCRIPTION (provided by applicant): WormBase Is the major publicly available database of information related to Caenorhabditis elegans, an important organism for basic biomedical research, and other nematodes of medical and agricultural importance. Although a crucial daily resource for members of the C. elegans research field, our users extend to the larger parasitology, biomedical, and bioinformatics research communities. WormBase acts as a central forum through which every research group can contribute to the global effort to comprehend nematode genomes. Most users access WormBase via the Internet (www.wormbase.orq). While some install the database locally. WormBase offers extensive coverage of C. elegans core genomic, genetic, anatomical and functional information, allowing the biomedical community to fully utilize the results of intensive molecular genetic analyses and functional genomic studies of this organism in the study of human disease. These data include all available nematode genomic data (such as genome sequence, transcripts and cis-regulatory sites prioritized by species), large-scale functional genomic datasets, the function and interactions of genes and gene products as they relate to development, physiology and behavior, and biological reagents and their source information. WormBase comprises a set of databases storing a wide range of biological information; a website that allows users to access stored information and precomputed analyses based on these data; and tools for programmatic access such as an application programming interface, a data mining platform, and bulk downloads. Curation activities include extraction and integration of information from the literature (assisted by the use of information retrieval tools), incorporation of large-scale datasets from a range of research projects, and gene model verification from experimental data. We will curate hundreds of nematode genome sequences, annotations and core genetic information as well as data on gene function, pathways and transcriptional regulatory networks for C. elegans and select other species. We will expand tools available for data mining, workflow management, visualization, and community annotation, and integrate, store and distribute data in a maintainable, interoperable and scalable system. The project team involves three sites: Caltech primarily curates functional information; EBI carries out sequence-based curation and builds databases for public release; and OICR develops and supports the web presence and visualization. The three sites work closely together and share tasks to ensure timely incorporation, storage and display of information.         RELEVANCE Nematodes (roundworms) are major parasites of humans, livestock and crops, and understanding how to control them is a major world health and economic challenge. One species of nematode, C. elegans, is extensively used for basic biomedical research to elucidate how networks of genes affect cells, organs and a whole animal's development, physiology and behavior. WormBase collects, stores and displays information about the genomes and genes of C. elegans and other nematodes to facilitate research about this numerous and important group of animals.                  n/a",WormBase:  a core data resource for C. elegans and other nematodes,8554533,U41HG002223,"['Affect', 'Agriculture', 'Animals', 'Architecture', 'Base Sequence', 'Behavior', 'Bioinformatics', 'Biological', 'Biomedical Research', 'Caenorhabditis elegans', 'Cells', 'Collaborations', 'Communities', 'Controlled Vocabulary', 'Custom', 'Data', 'Data Analyses', 'Data Set', 'Data Sources', 'Databases', 'Dependency', 'Development', 'Elements', 'Ensure', 'Galaxy', 'Gene Expression', 'Gene Proteins', 'Genes', 'Genetic', 'Genome', 'Genomics', 'Housing', 'Human', 'Imagery', 'Information Retrieval', 'Internet', 'Literature', 'Livestock', 'Maintenance', 'Maps', 'Medical', 'Modeling', 'Molecular Genetics', 'Nematoda', 'Network-based', 'Online Systems', 'Ontology', 'Organ', 'Organism', 'Parasites', 'Parasitology', 'Pathway interactions', 'Phenotype', 'Physiology', 'Proteins', 'RNA', 'Reagent', 'Regulation', 'Regulator Genes', 'Research', 'Research Project Grants', 'Resources', 'Set protein', 'Site', 'Source', 'System', 'Systems Biology', 'Technology', 'Terminology', 'Transcript', 'Update', 'Workplace', 'World Health', 'base', 'biological research', 'comparative', 'data integration', 'data mining', 'distributed data', 'drug development', 'functional genomics', 'gene function', 'gene interaction', 'genetic analysis', 'genome annotation', 'genome sequencing', 'health economics', 'human disease', 'information display', 'interoperability', 'member', 'non-genomic', 'novel', 'programs', 'research study', 'text searching', 'tool', 'transcriptome sequencing', 'web site']",NHGRI,CALIFORNIA INSTITUTE OF TECHNOLOGY,U41,2013,3106203,0.0733472774530306
"Identification of Transcriptional Factor Binding Sites in Human Promoters    DESCRIPTION (provided by applicant):   Transcriptional regulation is a highly coordinated process in the human genome. A significant component of transcriptional regulation is the interaction between transcriptional factor proteins (TFs) and cis-regulatory DNA elements. The goal of this project is to computationally predict and experimentally validate DNA sequence motifs that explain promoter function. The results of this project will be direct functional measurements of sequence motifs at base-pair resolution. This will yield extremely valuable information to assess the sensitivity and specificity of algorithms that can be immediately applied to the whole genome. These results will also help to identify the proportion of functionally relevant transcription factor binding events. The three aims of our project are: Aim 1: We will use two machine learning algorithms (support vector machines and random forest) to determine a subset of known transcription factor binding motifs that are the most predictive of promoter activities. Aim 2: We will then use Bayesian networks to select the most predictive motif features. These features are the strengths of the motif using PSSM and the positions of individual sites relative to each other and the transcription start site. Aim 3: We will then perform mutagenesis of the informative positions within the 900 sites identified in Aim 2, and measure their promoter activities by using transient transfection assays. We also plan to test 100 lower ranking sites to determine the sensitivity and specificity of our algorithms. We will also develop an oligo competition assay as a new approach to increase the throughput of experimental motif analysis for the rest of the genome. The data generated in this project will be the first systematic functional analysis of TF binding sites at base-pair resolution.              n/a",Identification of Transcriptional Factor Binding Sites in Human Promoters,8132645,U01HG004561,"['Accounting', 'Algorithms', 'Amino Acid Motifs', 'Antibodies', 'Base Pairing', 'Base Sequence', 'Binding', 'Binding Sites', 'Biological Assay', 'Cell Line', 'Cells', 'Chromatin', 'Collection', 'DNA', 'DNA Sequence', 'Data', 'Data Set', 'Databases', 'Elements', 'Event', 'Genome', 'Genomics', 'Goals', 'Human', 'Human Genome', 'Individual', 'Informatics', 'Life', 'Machine Learning', 'Measurement', 'Measures', 'Methods', 'Mutagenesis', 'Mutation', 'Oligonucleotides', 'Policies', 'Positioning Attribute', 'Process', 'Promoter Regions', 'Protein Binding', 'Proteins', 'Relative (related person)', 'Reporter', 'Research Personnel', 'Resolution', 'Rest', 'Sensitivity and Specificity', 'Single Nucleotide Polymorphism', 'Site', 'Techniques', 'Testing', 'Transcription Initiation Site', 'Transcriptional Regulation', 'Transfection', 'base', 'chromatin immunoprecipitation', 'computer based statistical methods', 'cost', 'forest', 'member', 'novel strategies', 'promoter', 'research study', 'transcription factor']",NHGRI,UNIV OF MASSACHUSETTS MED SCH WORCESTER,U01,2010,430000,-0.014701797551537313
"Identification of Transcriptional Factor Binding Sites in Human Promoters    DESCRIPTION (provided by applicant):   Transcriptional regulation is a highly coordinated process in the human genome. A significant component of transcriptional regulation is the interaction between transcriptional factor proteins (TFs) and cis-regulatory DNA elements. The goal of this project is to computationally predict and experimentally validate DNA sequence motifs that explain promoter function. The results of this project will be direct functional measurements of sequence motifs at base-pair resolution. This will yield extremely valuable information to assess the sensitivity and specificity of algorithms that can be immediately applied to the whole genome. These results will also help to identify the proportion of functionally relevant transcription factor binding events. The three aims of our project are: Aim 1: We will use two machine learning algorithms (support vector machines and random forest) to determine a subset of known transcription factor binding motifs that are the most predictive of promoter activities. Aim 2: We will then use Bayesian networks to select the most predictive motif features. These features are the strengths of the motif using PSSM and the positions of individual sites relative to each other and the transcription start site. Aim 3: We will then perform mutagenesis of the informative positions within the 900 sites identified in Aim 2, and measure their promoter activities by using transient transfection assays. We also plan to test 100 lower ranking sites to determine the sensitivity and specificity of our algorithms. We will also develop an oligo competition assay as a new approach to increase the throughput of experimental motif analysis for the rest of the genome. The data generated in this project will be the first systematic functional analysis of TF binding sites at base-pair resolution.              n/a",Identification of Transcriptional Factor Binding Sites in Human Promoters,7684267,U01HG004561,"['Accounting', 'Algorithms', 'Amino Acid Motifs', 'Antibodies', 'Base Pairing', 'Base Sequence', 'Binding', 'Binding Sites', 'Biological Assay', 'Cell Line', 'Cells', 'Chromatin', 'Classification', 'Collection', 'DNA', 'DNA Sequence', 'Data', 'Data Set', 'Databases', 'Elements', 'Event', 'Genome', 'Genomics', 'Goals', 'Human', 'Human Genome', 'Individual', 'Informatics', 'Life', 'Machine Learning', 'Measurement', 'Measures', 'Methods', 'Mutagenesis', 'Mutation', 'Oligonucleotides', 'Policies', 'Positioning Attribute', 'Process', 'Promoter Regions', 'Protein Binding', 'Proteins', 'Relative (related person)', 'Reporter', 'Research Personnel', 'Resolution', 'Rest', 'Sensitivity and Specificity', 'Single Nucleotide Polymorphism', 'Site', 'Techniques', 'Testing', 'Transcription Initiation Site', 'Transcriptional Regulation', 'Transfection', 'base', 'chromatin immunoprecipitation', 'computer based statistical methods', 'cost', 'forest', 'member', 'novel strategies', 'promoter', 'research study', 'transcription factor']",NHGRI,UNIV OF MASSACHUSETTS MED SCH WORCESTER,U01,2009,430878,-0.014701797551537313
"Identification of Transcriptional Factor Binding Sites in Human Promoters    DESCRIPTION (provided by applicant):   Transcriptional regulation is a highly coordinated process in the human genome. A significant component of transcriptional regulation is the interaction between transcriptional factor proteins (TFs) and cis-regulatory DNA elements. The goal of this project is to computationally predict and experimentally validate DNA sequence motifs that explain promoter function. The results of this project will be direct functional measurements of sequence motifs at base-pair resolution. This will yield extremely valuable information to assess the sensitivity and specificity of algorithms that can be immediately applied to the whole genome. These results will also help to identify the proportion of functionally relevant transcription factor binding events. The three aims of our project are: Aim 1: We will use two machine learning algorithms (support vector machines and random forest) to determine a subset of known transcription factor binding motifs that are the most predictive of promoter activities. Aim 2: We will then use Bayesian networks to select the most predictive motif features. These features are the strengths of the motif using PSSM and the positions of individual sites relative to each other and the transcription start site. Aim 3: We will then perform mutagenesis of the informative positions within the 900 sites identified in Aim 2, and measure their promoter activities by using transient transfection assays. We also plan to test 100 lower ranking sites to determine the sensitivity and specificity of our algorithms. We will also develop an oligo competition assay as a new approach to increase the throughput of experimental motif analysis for the rest of the genome. The data generated in this project will be the first systematic functional analysis of TF binding sites at base-pair resolution.              n/a",Identification of Transcriptional Factor Binding Sites in Human Promoters,7502766,U01HG004561,"['Accounting', 'Algorithms', 'Amino Acid Motifs', 'Antibodies', 'Base Pairing', 'Base Sequence', 'Binding', 'Binding Sites', 'Biological Assay', 'Cell Line', 'Cells', 'Chromatin', 'Classification', 'Collection', 'DNA', 'DNA Sequence', 'Data', 'Data Set', 'Databases', 'Elements', 'Event', 'Genome', 'Genomics', 'Goals', 'Human', 'Human Genome', 'Individual', 'Informatics', 'Life', 'Localized', 'Machine Learning', 'Measurement', 'Measures', 'Methods', 'Mutagenesis', 'Mutation', 'Oligonucleotides', 'Policies', 'Positioning Attribute', 'Process', 'Promoter Regions', 'Protein Binding', 'Proteins', 'Range', 'Relative (related person)', 'Reporter', 'Research Personnel', 'Resolution', 'Rest', 'Score', 'Sensitivity and Specificity', 'Single Nucleotide Polymorphism', 'Site', 'Techniques', 'Testing', 'Transcription Initiation Site', 'Transcriptional Regulation', 'Transfection', 'base', 'chromatin immunoprecipitation', 'computer based statistical methods', 'cost', 'forest', 'member', 'novel strategies', 'promoter', 'research study', 'transcription factor']",NHGRI,UNIV OF MASSACHUSETTS MED SCH WORCESTER,U01,2008,418301,-0.014701797551537313
"Identification of Transcriptional Factor Binding Sites in Human Promoters    DESCRIPTION (provided by applicant):   Transcriptional regulation is a highly coordinated process in the human genome. A significant component of transcriptional regulation is the interaction between transcriptional factor proteins (TFs) and cis-regulatory DNA elements. The goal of this project is to computationally predict and experimentally validate DNA sequence motifs that explain promoter function. The results of this project will be direct functional measurements of sequence motifs at base-pair resolution. This will yield extremely valuable information to assess the sensitivity and specificity of algorithms that can be immediately applied to the whole genome. These results will also help to identify the proportion of functionally relevant transcription factor binding events. The three aims of our project are: Aim 1: We will use two machine learning algorithms (support vector machines and random forest) to determine a subset of known transcription factor binding motifs that are the most predictive of promoter activities. Aim 2: We will then use Bayesian networks to select the most predictive motif features. These features are the strengths of the motif using PSSM and the positions of individual sites relative to each other and the transcription start site. Aim 3: We will then perform mutagenesis of the informative positions within the 900 sites identified in Aim 2, and measure their promoter activities by using transient transfection assays. We also plan to test 100 lower ranking sites to determine the sensitivity and specificity of our algorithms. We will also develop an oligo competition assay as a new approach to increase the throughput of experimental motif analysis for the rest of the genome. The data generated in this project will be the first systematic functional analysis of TF binding sites at base-pair resolution.              n/a",Identification of Transcriptional Factor Binding Sites in Human Promoters,7615950,U01HG004561,"['Accounting', 'Algorithms', 'Amino Acid Motifs', 'Antibodies', 'Base Pairing', 'Base Sequence', 'Binding', 'Binding Sites', 'Biological Assay', 'Cell Line', 'Cells', 'Chromatin', 'Classification', 'Collection', 'DNA', 'DNA Sequence', 'Data', 'Data Set', 'Databases', 'Elements', 'Event', 'Genome', 'Genomics', 'Goals', 'Human', 'Human Genome', 'Individual', 'Informatics', 'Life', 'Localized', 'Machine Learning', 'Measurement', 'Measures', 'Methods', 'Mutagenesis', 'Mutation', 'Oligonucleotides', 'Policies', 'Positioning Attribute', 'Process', 'Promoter Regions', 'Protein Binding', 'Proteins', 'Range', 'Relative (related person)', 'Reporter', 'Resolution', 'Rest', 'Score', 'Sensitivity and Specificity', 'Single Nucleotide Polymorphism', 'Site', 'Techniques', 'Testing', 'Transcription Initiation Site', 'Transcriptional Regulation', 'Transfection', 'base', 'chromatin immunoprecipitation', 'computer based statistical methods', 'cost', 'forest', 'member', 'novel strategies', 'promoter', 'research study', 'transcription factor']",NHGRI,UNIV OF MASSACHUSETTS MED SCH WORCESTER,U01,2007,495625,-0.014701797551537313
"Identification of Transcriptional Factor Binding Sites in Human Promoters    DESCRIPTION (provided by applicant):   Transcriptional regulation is a highly coordinated process in the human genome. A significant component of transcriptional regulation is the interaction between transcriptional factor proteins (TFs) and cis-regulatory DNA elements. The goal of this project is to computationally predict and experimentally validate DNA sequence motifs that explain promoter function. The results of this project will be direct functional measurements of sequence motifs at base-pair resolution. This will yield extremely valuable information to assess the sensitivity and specificity of algorithms that can be immediately applied to the whole genome. These results will also help to identify the proportion of functionally relevant transcription factor binding events. The three aims of our project are: Aim 1: We will use two machine learning algorithms (support vector machines and random forest) to determine a subset of known transcription factor binding motifs that are the most predictive of promoter activities. Aim 2: We will then use Bayesian networks to select the most predictive motif features. These features are the strengths of the motif using PSSM and the positions of individual sites relative to each other and the transcription start site. Aim 3: We will then perform mutagenesis of the informative positions within the 900 sites identified in Aim 2, and measure their promoter activities by using transient transfection assays. We also plan to test 100 lower ranking sites to determine the sensitivity and specificity of our algorithms. We will also develop an oligo competition assay as a new approach to increase the throughput of experimental motif analysis for the rest of the genome. The data generated in this project will be the first systematic functional analysis of TF binding sites at base-pair resolution.              n/a",Identification of Transcriptional Factor Binding Sites in Human Promoters,7392500,U01HG004561,"['Accounting', 'Algorithms', 'Amino Acid Motifs', 'Antibodies', 'Base Pairing', 'Base Sequence', 'Binding', 'Binding Sites', 'Biological Assay', 'Cell Line', 'Cells', 'Chromatin', 'Classification', 'Collection', 'DNA', 'DNA Sequence', 'Data', 'Data Set', 'Databases', 'Elements', 'Event', 'Genome', 'Genomics', 'Goals', 'Human', 'Human Genome', 'Individual', 'Informatics', 'Life', 'Localized', 'Machine Learning', 'Measurement', 'Measures', 'Methods', 'Mutagenesis', 'Mutation', 'Oligonucleotides', 'Policies', 'Positioning Attribute', 'Process', 'Promoter Regions', 'Protein Binding', 'Proteins', 'Range', 'Relative (related person)', 'Reporter', 'Research Personnel', 'Resolution', 'Rest', 'Score', 'Sensitivity and Specificity', 'Single Nucleotide Polymorphism', 'Site', 'Techniques', 'Testing', 'Transcription Initiation Site', 'Transcriptional Regulation', 'Transfection', 'base', 'chromatin immunoprecipitation', 'computer based statistical methods', 'cost', 'forest', 'member', 'novel strategies', 'promoter', 'research study', 'transcription factor']",NHGRI,BOSTON UNIVERSITY (CHARLES RIVER CAMPUS),U01,2007,80452,-0.014701797551537313
"A Comprehensive catalog of human DNasel hypersensitive sites The overall aim of this proposal is to establish a comprehensive, high-quality catalogue of human DNasel hypersensitive sites (DHSs) spanning all major tissue lineages. We plan to map DNasel hypersensitive sites at physiological resolution across the genome with high sensitivity and specificity. The major focus of our production effort will be on data quality, a strategy that served the Human Genome Project well. Accordingly, samples will be rigorously screened in a pipeline fashion, with only a select set advancing to whole-genome data collection (Specific Aim 1). To ensure the broadest possible coverage of both unique and non-unique genomic territories, a synergistic combination of three technologies (DNase-array, digital mapping of DNAasel cleave site sequences, and Quantitative Chromatin Profiling) will be applied (Specific Aim 2). This combination will enable mapping of >95% of the DHSs in the genome of each cell type. Independent validation provides the ultimate quality standard. We therefore plan to validate the DHS catalogue in a statistically rigorous fashion using hypersensitivity Southerns, a well-established, gold standard assay (Specific Aim 3). Since DNAasel hypersensitive sites are generic markers of a broad spectrum of human cis-regulatory sequences, the utility of the catalogue will be greatly enhanced by the classification of DHSs into major functional categories including promoters, distal elements (enhancers, LCRs), and insulators (Specific Aim 4). Validation of DHS functional classes will be accomplished using well-tested cell and transgenic assays of biological function (Specific Aim 5). n/a",A Comprehensive catalog of human DNasel hypersensitive sites,8321717,U54HG004592,"['Algorithms', 'Biological', 'Biological Assay', 'Biological Process', 'Biological Testing', 'Biology', 'Boundary Elements', 'Cataloging', 'Catalogs', 'Categories', 'Cell Nucleus', 'Cells', 'Chromatin', 'Classification', 'Cleaved cell', 'Communities', 'Custom', 'Data', 'Data Collection', 'Data Quality', 'Deoxyribonucleases', 'Detection', 'Digestion', 'Distal', 'Distal Enhancer Elements', 'Elements', 'Employee Strikes', 'Enhancers', 'Ensure', 'Environment', 'Exhibits', 'Generations', 'Generic Drugs', 'Genes', 'Genome', 'Genomics', 'Goals', 'Gold', 'Human', 'Human Genome', 'Human Genome Project', 'Hypersensitivity', 'Individual', 'Informatics', 'Insulator Elements', 'Laboratories', 'Locales', 'Locus Control Region', 'Machine Learning', 'Maps', 'Methods', 'Metric', 'Molecular', 'Noise', 'Physiological', 'Pilot Projects', 'Plague', 'Positioning Attribute', 'Predictive Value', 'Preparation', 'Production', 'Public Domains', 'Regulation', 'Research Infrastructure', 'Resolution', 'Sample Size', 'Sampling', 'Sensitivity and Specificity', 'Signal Transduction', 'Site', 'Staging', 'Surveys', 'System', 'Technology', 'Testing', 'Time', 'Tissues', 'Transgenic Mice', 'Transgenic Organisms', 'Validation', 'base', 'cell type', 'cost', 'cost effective', 'density', 'design', 'digital', 'experience', 'functional genomics', 'genome-wide', 'high standard', 'high throughput screening', 'histone modification', 'human tissue', 'in vivo', 'insight', 'meetings', 'promoter']",NHGRI,UNIVERSITY OF WASHINGTON,U54,2011,342218,0.12156472871507237
"A Comprehensive catalog of human DNasel hypersensitive sites The overall aim of this proposal is to establish a comprehensive, high-quality catalogue of human DNasel hypersensitive sites (DHSs) spanning all major tissue lineages. We plan to map DNasel hypersensitive sites at physiological resolution across the genome with high sensitivity and specificity. The major focus of our production effort will be on data quality, a strategy that served the Human Genome Project well. Accordingly, samples will be rigorously screened in a pipeline fashion, with only a select set advancing to whole-genome data collection (Specific Aim 1). To ensure the broadest possible coverage of both unique and non-unique genomic territories, a synergistic combination of three technologies (DNase-array, digital mapping of DNAasel cleave site sequences, and Quantitative Chromatin Profiling) will be applied (Specific Aim 2). This combination will enable mapping of >95% of the DHSs in the genome of each cell type. Independent validation provides the ultimate quality standard. We therefore plan to validate the DHS catalogue in a statistically rigorous fashion using hypersensitivity Southerns, a well-established, gold standard assay (Specific Aim 3). Since DNAasel hypersensitive sites are generic markers of a broad spectrum of human cis-regulatory sequences, the utility of the catalogue will be greatly enhanced by the classification of DHSs into major functional categories including promoters, distal elements (enhancers, LCRs), and insulators (Specific Aim 4). Validation of DHS functional classes will be accomplished using well-tested cell and transgenic assays of biological function (Specific Aim 5). n/a",A Comprehensive catalog of human DNasel hypersensitive sites,8320051,U54HG004592,"['Algorithms', 'Biological', 'Biological Assay', 'Biological Process', 'Biological Testing', 'Biology', 'Boundary Elements', 'Cataloging', 'Catalogs', 'Categories', 'Cell Nucleus', 'Cells', 'Chromatin', 'Classification', 'Cleaved cell', 'Communities', 'Custom', 'Data', 'Data Collection', 'Data Quality', 'Deoxyribonucleases', 'Detection', 'Digestion', 'Distal', 'Distal Enhancer Elements', 'Elements', 'Employee Strikes', 'Enhancers', 'Ensure', 'Environment', 'Exhibits', 'Generations', 'Generic Drugs', 'Genes', 'Genome', 'Genomics', 'Goals', 'Gold', 'Human', 'Human Genome', 'Human Genome Project', 'Hypersensitivity', 'Individual', 'Informatics', 'Insulator Elements', 'Laboratories', 'Locales', 'Locus Control Region', 'Machine Learning', 'Maps', 'Methods', 'Metric', 'Molecular', 'Noise', 'Physiological', 'Pilot Projects', 'Plague', 'Positioning Attribute', 'Predictive Value', 'Preparation', 'Production', 'Public Domains', 'Regulation', 'Research Infrastructure', 'Resolution', 'Sample Size', 'Sampling', 'Sensitivity and Specificity', 'Signal Transduction', 'Site', 'Staging', 'Surveys', 'System', 'Technology', 'Testing', 'Time', 'Tissues', 'Transgenic Mice', 'Transgenic Organisms', 'Validation', 'base', 'cell type', 'cost', 'cost effective', 'density', 'design', 'digital', 'experience', 'functional genomics', 'genome-wide', 'high standard', 'high throughput screening', 'histone modification', 'human tissue', 'in vivo', 'insight', 'meetings', 'promoter']",NHGRI,UNIVERSITY OF WASHINGTON,U54,2011,2615448,0.12156472871507237
"A Comprehensive catalog of human DNasel hypersensitive sites    DESCRIPTION (provided by applicant):   The overall aim of this proposal is to establish a comprehensive, high-quality catalogue of human DNaseI hypersensitive sites (DHSs) spanning all major tissue lineages. We plan to map DNaseI hypersensitive sites at physiological resolution across the genome with high sensitivity and specificity. The major focus of our production effort will be on data quality, a strategy that served the Human Genome Project well. Accordingly, samples will be rigorously screened in a pipeline fashion, with only a select set advancing to whole-genome data collection (Specific Aim 1). To ensure the broadest possible coverage of both unique and non-unique genomic territories, a synergistic combination of three technologies (DNase-array, digital mapping of DNAasel cleave site sequences, and Quantitative Chromatin Profiling) will be applied (Specific Aim 2). This combination will enable mapping of >95% of the DHSs in the genome of each cell type. Independent validation provides the ultimate quality standard. We therefore plan to validate the DHS catalogue in a statistically rigorous fashion using hypersensitivity Southerns, a well-established, gold standard assay (Specific Aim 3). Since DNAasel hypersensitive sites are generic markers of a broad spectrum of human cis-regulatory sequences, the utility of the catalogue will be greatly enhanced by the classification of DHSs into major functional categories including promoters, distal elements (enhancers, LCRs), and insulators (Specific Aim 4). Validation of DHS functional classes will be accomplished using well-tested cell and transgenic assays of biological function (Specific Aim 5).           n/a",A Comprehensive catalog of human DNasel hypersensitive sites,7410206,U54HG004592,"['Algorithms', 'Biological', 'Biological Assay', 'Biological Process', 'Biological Testing', 'Biology', 'Boundary Elements', 'Cataloging', 'Catalogs', 'Categories', 'Cell Nucleus', 'Cells', 'Chromatin', 'Class', 'Classification', 'Cleaved cell', 'Communities', 'Custom', 'Data', 'Data Collection', 'Data Quality', 'Deoxyribonuclease I', 'Deoxyribonucleases', 'Detection', 'Digestion', 'Distal', 'Distal Enhancer Elements', 'Elements', 'Employee Strikes', 'Enhancers', 'Ensure', 'Environment', 'Exhibits', 'Generations', 'Generic Drugs', 'Genes', 'Genome', 'Genomics', 'Goals', 'Gold', 'Histones', 'Human', 'Human Genome', 'Human Genome Project', 'Hypersensitivity', 'Individual', 'Informatics', 'Laboratories', 'Locales', 'Locus Control Region', 'Machine Learning', 'Maps', 'Methods', 'Metric', 'Modification', 'Molecular', 'Noise', 'Numbers', 'Physiological', 'Pilot Projects', 'Plague', 'Positioning Attribute', 'Preparation', 'Production', 'Public Domains', 'Range', 'Rate', 'Regulation', 'Research Infrastructure', 'Resolution', 'Sample Size', 'Sampling', 'Score', 'Sensitivity and Specificity', 'Signal Transduction', 'Site', 'Staging', 'Standards of Weights and Measures', 'Surveys', 'System', 'Technology', 'Testing', 'Time', 'Tissues', 'Transgenic Mice', 'Transgenic Organisms', 'Validation', 'base', 'cell type', 'cost', 'density', 'design', 'digital', 'experience', 'functional genomics', 'high throughput screening', 'human tissue', 'in vivo', 'insight', 'promoter']",NHGRI,UNIVERSITY OF WASHINGTON,U54,2007,3114596,0.12156472871507237
"RESOURCE CENTER FOR BIOMEDICAL COMPLEX CARBOHYDRATES The need for improved analytical methods inc complex carbohydrate science grows unabated by impressive gains in our knowledge of the structures and functions of these fascinating molecules. The pressure for more powerful technologies is fueled by the many physiologically important recognition events mediated by protein-carbohydrate interactions and by the roles of carbohydrate interactions and by the roles of carbohydrates in such important biomedical functions as inflammatory reactions, hormone action, cancer viral infections, and cell differentiation.. The two proposed Technological Research and Development Projects of this Resource Center are tightly integrated around the central theme of developing technologies for studies of complex carbohydrates. The resulting technologies are disseminated to the scientific community through publications; many internal and external collaborative workshops, seminars, and lectures at scientific meetings; through interactions with many corporations; and through analyses of samples submitted to the Center's service personnel. One of the proposed Technological Research and Development Projects is entitled, ""Using Integrated Technologies to Study Oligosacharide-Protein Interactions."" This Project, proposed by six senior investigators and their research items, utilizes techniques of molecular biology, biochemistry, analytical chemistry, synthetic chemistry, physical chemistry and computational chemistry to improve our ability to determine the three-dimensional shapes of oligosaccharide binding sites of proteins and of oligosacharides when they occupy the binding sites. The other proposed Technological Research and Development Project is entitled ""Glycoscience Bioinformatics,"" which integrates the technologies of three senior investigators and their research teams to design and build NMR, mass spectrometric, and infrared spectral databases with artificial neural network pattern recognition search engines. Currently,, five databases and their search engines are located on this center's Web site (www.ccrc.uga.edu). The goal of this project is to allow researchers to submit spectra of complex carbohydrates to the databases and have the search program identify the structure of the carbohydrate defined by the spectrum. The databases, although only a few months in operation and very incomplete, have already been searched several thousand times.  n/a",RESOURCE CENTER FOR BIOMEDICAL COMPLEX CARBOHYDRATES,6653168,P41RR005351,"['analytical method', ' biomedical resource', ' carbohydrate structure', ' technology /technique development']",NCRR,UNIVERSITY OF GEORGIA (UGA),P41,2003,1823683,0.011059032995914327
"RESOURCE CENTER FOR BIOMEDICAL COMPLEX CARBOHYDRATES The need for improved analytical methods inc complex carbohydrate science grows unabated by impressive gains in our knowledge of the structures and functions of these fascinating molecules. The pressure for more powerful technologies is fueled by the many physiologically important recognition events mediated by protein-carbohydrate interactions and by the roles of carbohydrate interactions and by the roles of carbohydrates in such important biomedical functions as inflammatory reactions, hormone action, cancer viral infections, and cell differentiation.. The two proposed Technological Research and Development Projects of this Resource Center are tightly integrated around the central theme of developing technologies for studies of complex carbohydrates. The resulting technologies are disseminated to the scientific community through publications; many internal and external collaborative workshops, seminars, and lectures at scientific meetings; through interactions with many corporations; and through analyses of samples submitted to the Center's service personnel. One of the proposed Technological Research and Development Projects is entitled, ""Using Integrated Technologies to Study Oligosacharide-Protein Interactions."" This Project, proposed by six senior investigators and their research items, utilizes techniques of molecular biology, biochemistry, analytical chemistry, synthetic chemistry, physical chemistry and computational chemistry to improve our ability to determine the three-dimensional shapes of oligosaccharide binding sites of proteins and of oligosacharides when they occupy the binding sites. The other proposed Technological Research and Development Project is entitled ""Glycoscience Bioinformatics,"" which integrates the technologies of three senior investigators and their research teams to design and build NMR, mass spectrometric, and infrared spectral databases with artificial neural network pattern recognition search engines. Currently,, five databases and their search engines are located on this center's Web site (www.ccrc.uga.edu). The goal of this project is to allow researchers to submit spectra of complex carbohydrates to the databases and have the search program identify the structure of the carbohydrate defined by the spectrum. The databases, although only a few months in operation and very incomplete, have already been searched several thousand times.  n/a",RESOURCE CENTER FOR BIOMEDICAL COMPLEX CARBOHYDRATES,6530045,P41RR005351,"['analytical method', ' biomedical resource', ' carbohydrate structure', ' technology /technique development']",NCRR,UNIVERSITY OF GEORGIA (UGA),P41,2002,897075,0.011059032995914327
"RESOURCE CENTER FOR BIOMEDICAL COMPLEX CARBOHYDRATES The need for improved analytical methods inc complex carbohydrate science grows unabated by impressive gains in our knowledge of the structures and functions of these fascinating molecules. The pressure for more powerful technologies is fueled by the many physiologically important recognition events mediated by protein-carbohydrate interactions and by the roles of carbohydrate interactions and by the roles of carbohydrates in such important biomedical functions as inflammatory reactions, hormone action, cancer viral infections, and cell differentiation.. The two proposed Technological Research and Development Projects of this Resource Center are tightly integrated around the central theme of developing technologies for studies of complex carbohydrates. The resulting technologies are disseminated to the scientific community through publications; many internal and external collaborative workshops, seminars, and lectures at scientific meetings; through interactions with many corporations; and through analyses of samples submitted to the Center's service personnel. One of the proposed Technological Research and Development Projects is entitled, ""Using Integrated Technologies to Study Oligosacharide-Protein Interactions."" This Project, proposed by six senior investigators and their research items, utilizes techniques of molecular biology, biochemistry, analytical chemistry, synthetic chemistry, physical chemistry and computational chemistry to improve our ability to determine the three-dimensional shapes of oligosaccharide binding sites of proteins and of oligosacharides when they occupy the binding sites. The other proposed Technological Research and Development Project is entitled ""Glycoscience Bioinformatics,"" which integrates the technologies of three senior investigators and their research teams to design and build NMR, mass spectrometric, and infrared spectral databases with artificial neural network pattern recognition search engines. Currently,, five databases and their search engines are located on this center's Web site (www.ccrc.uga.edu). The goal of this project is to allow researchers to submit spectra of complex carbohydrates to the databases and have the search program identify the structure of the carbohydrate defined by the spectrum. The databases, although only a few months in operation and very incomplete, have already been searched several thousand times.  n/a",RESOURCE CENTER FOR BIOMEDICAL COMPLEX CARBOHYDRATES,6394600,P41RR005351,"['analytical method', ' biomedical resource', ' carbohydrate structure', ' technology /technique development']",NCRR,UNIVERSITY OF GEORGIA (UGA),P41,2001,897075,0.011059032995914327
"RESOURCE CENTER FOR BIOMEDICAL COMPLEX CARBOHYDRATES The need for improved analytical methods inc complex carbohydrate science grows unabated by impressive gains in our knowledge of the structures and functions of these fascinating molecules. The pressure for more powerful technologies is fueled by the many physiologically important recognition events mediated by protein-carbohydrate interactions and by the roles of carbohydrate interactions and by the roles of carbohydrates in such important biomedical functions as inflammatory reactions, hormone action, cancer viral infections, and cell differentiation.. The two proposed Technological Research and Development Projects of this Resource Center are tightly integrated around the central theme of developing technologies for studies of complex carbohydrates. The resulting technologies are disseminated to the scientific community through publications; many internal and external collaborative workshops, seminars, and lectures at scientific meetings; through interactions with many corporations; and through analyses of samples submitted to the Center's service personnel. One of the proposed Technological Research and Development Projects is entitled, ""Using Integrated Technologies to Study Oligosacharide-Protein Interactions."" This Project, proposed by six senior investigators and their research items, utilizes techniques of molecular biology, biochemistry, analytical chemistry, synthetic chemistry, physical chemistry and computational chemistry to improve our ability to determine the three-dimensional shapes of oligosaccharide binding sites of proteins and of oligosacharides when they occupy the binding sites. The other proposed Technological Research and Development Project is entitled ""Glycoscience Bioinformatics,"" which integrates the technologies of three senior investigators and their research teams to design and build NMR, mass spectrometric, and infrared spectral databases with artificial neural network pattern recognition search engines. Currently,, five databases and their search engines are located on this center's Web site (www.ccrc.uga.edu). The goal of this project is to allow researchers to submit spectra of complex carbohydrates to the databases and have the search program identify the structure of the carbohydrate defined by the spectrum. The databases, although only a few months in operation and very incomplete, have already been searched several thousand times.  n/a",RESOURCE CENTER FOR BIOMEDICAL COMPLEX CARBOHYDRATES,6188344,P41RR005351,"['analytical method', ' biomedical resource', ' carbohydrate structure', ' technology /technique development']",NCRR,UNIVERSITY OF GEORGIA (UGA),P41,2000,972075,0.011059032995914327
"RESOURCE CENTER FOR BIOMEDICAL COMPLEX CARBOHYDRATES The need for improved analytical methods inc complex carbohydrate science grows unabated by impressive gains in our knowledge of the structures and functions of these fascinating molecules. The pressure for more powerful technologies is fueled by the many physiologically important recognition events mediated by protein-carbohydrate interactions and by the roles of carbohydrate interactions and by the roles of carbohydrates in such important biomedical functions as inflammatory reactions, hormone action, cancer viral infections, and cell differentiation.. The two proposed Technological Research and Development Projects of this Resource Center are tightly integrated around the central theme of developing technologies for studies of complex carbohydrates. The resulting technologies are disseminated to the scientific community through publications; many internal and external collaborative workshops, seminars, and lectures at scientific meetings; through interactions with many corporations; and through analyses of samples submitted to the Center's service personnel. One of the proposed Technological Research and Development Projects is entitled, ""Using Integrated Technologies to Study Oligosacharide-Protein Interactions."" This Project, proposed by six senior investigators and their research items, utilizes techniques of molecular biology, biochemistry, analytical chemistry, synthetic chemistry, physical chemistry and computational chemistry to improve our ability to determine the three-dimensional shapes of oligosaccharide binding sites of proteins and of oligosacharides when they occupy the binding sites. The other proposed Technological Research and Development Project is entitled ""Glycoscience Bioinformatics,"" which integrates the technologies of three senior investigators and their research teams to design and build NMR, mass spectrometric, and infrared spectral databases with artificial neural network pattern recognition search engines. Currently,, five databases and their search engines are located on this center's Web site (www.ccrc.uga.edu). The goal of this project is to allow researchers to submit spectra of complex carbohydrates to the databases and have the search program identify the structure of the carbohydrate defined by the spectrum. The databases, although only a few months in operation and very incomplete, have already been searched several thousand times.  n/a",RESOURCE CENTER FOR BIOMEDICAL COMPLEX CARBOHYDRATES,2903636,P41RR005351,"['analytical method', ' biomedical resource', ' carbohydrate structure', ' technology /technique development']",NCRR,UNIVERSITY OF GEORGIA (UGA),P41,1999,1221311,0.011059032995914327
"Annotating Functional Sites in 3D Biological Structures    DESCRIPTION (provided by applicant):       Project Summary/Abstract Dramatic advances in our understanding of molecular structure and function promise to accelerate the creation of new diagnostics and therapeutics. However the link between the structure of a biological macromolecule and its function is usually not obvious: fundamental to understanding how a molecule functions is an understanding of how its structure behaves over time. Recent advances in molecular dynamics simulations now allow the rapid collection of information about structural motion. These data sets are huge, and require statistical machine learning algorithms to characterize and recognize patterns relevant to function. The National Library of Medicine's new long-range plan calls for research in the use of advanced simulation and machine learning algorithms in support of biomedical research.       This proposal focuses on annotating molecular structures with missing or incomplete functional information. We are particularly interested in identifying binding sites and active sites in proteins. We bring together simulation and machine learning, and hypothesize that the performance of structure- based function annotation methods will dramatically improve with the addition of information about dynamics. Thus, our specific aims are (1) to develop methods for recognizing function from structural dynamics and diversity, (2) to develop capabilities for large scale clustering and analysis tools for the discovery of novel functions, and (3) to apply our tools to challenging and important biological systems, while disseminating our software, data and capabilities to the biomedical research community. In particular, we will focus our new capabilities on three difficult function annotation challenges: ATP binding sites, phosphorylation sites, and metabolizing enzyme active sites.            Project Narrative The explosion in data related to molecular biology has created great opportunities for new disease diagnostics and therapies. One source of data is the three-dimensional (3D) structure of biological molecules such as proteins, DNA and RNA. This work focuses on using computational technologies to understand how these structures perform their function, so we have a better understanding of both normal and disease processes.",Annotating Functional Sites in 3D Biological Structures,8528717,R01LM005652,"['Active Sites', 'Address', 'Algorithms', 'Automobile Driving', 'Binding', 'Binding Sites', 'Biological', 'Biomedical Research', 'Calcium Binding', 'Cell physiology', 'Cells', 'Chemicals', 'Clinical', 'Cluster Analysis', 'Code', 'Collaborations', 'Collection', 'Communities', 'Computer software', 'Computing Methodologies', 'Crystallography', 'DNA', 'Data', 'Data Set', 'Data Sources', 'Databases', 'Diagnostic', 'Disease', 'Drug Binding Site', 'Environment', 'Enzymes', 'Explosion', 'Genetic Polymorphism', 'Genomics', 'Grant', 'High Performance Computing', 'Human', 'Informatics', 'Investments', 'Knowledge', 'Korea', 'Label', 'Learning', 'Libraries', 'Link', 'Machine Learning', 'Maps', 'Methods', 'Mining', 'Molecular', 'Molecular Biology', 'Molecular Medicine', 'Molecular Structure', 'Morphologic artifacts', 'Motion', 'Pathologic', 'Pattern', 'Performance', 'Phenotype', 'Phosphorylation', 'Phosphorylation Site', 'Physics', 'Physiological', 'Process', 'Property', 'Proteins', 'Publishing', 'RNA', 'Research', 'Resources', 'Rest', 'Retrieval', 'San Francisco', 'Signal Transduction', 'Site', 'Software Engineering', 'Source', 'Source Code', 'Specialist', 'Structure', 'Technology', 'Time', 'Training', 'United States National Institutes of Health', 'United States National Library of Medicine', 'Universities', 'Work', 'abstracting', 'advanced simulation', 'base', 'biological systems', 'cost', 'data reduction', 'design', 'improved', 'indexing', 'innovation', 'interest', 'macromolecule', 'molecular dynamics', 'novel', 'novel diagnostics', 'novel therapeutics', 'programs', 'protein function', 'protein structure', 'simulation', 'simulation software', 'structural genomics', 'three dimensional structure', 'tool']",NLM,STANFORD UNIVERSITY,R01,2013,292222,0.09545694653162495
"Annotating Functional Sites in 3D Biological Structures    DESCRIPTION (provided by applicant):       Project Summary/Abstract Dramatic advances in our understanding of molecular structure and function promise to accelerate the creation of new diagnostics and therapeutics. However the link between the structure of a biological macromolecule and its function is usually not obvious: fundamental to understanding how a molecule functions is an understanding of how its structure behaves over time. Recent advances in molecular dynamics simulations now allow the rapid collection of information about structural motion. These data sets are huge, and require statistical machine learning algorithms to characterize and recognize patterns relevant to function. The National Library of Medicine's new long-range plan calls for research in the use of advanced simulation and machine learning algorithms in support of biomedical research.       This proposal focuses on annotating molecular structures with missing or incomplete functional information. We are particularly interested in identifying binding sites and active sites in proteins. We bring together simulation and machine learning, and hypothesize that the performance of structure- based function annotation methods will dramatically improve with the addition of information about dynamics. Thus, our specific aims are (1) to develop methods for recognizing function from structural dynamics and diversity, (2) to develop capabilities for large scale clustering and analysis tools for the discovery of novel functions, and (3) to apply our tools to challenging and important biological systems, while disseminating our software, data and capabilities to the biomedical research community. In particular, we will focus our new capabilities on three difficult function annotation challenges: ATP binding sites, phosphorylation sites, and metabolizing enzyme active sites.            Project Narrative The explosion in data related to molecular biology has created great opportunities for new disease diagnostics and therapies. One source of data is the three-dimensional (3D) structure of biological molecules such as proteins, DNA and RNA. This work focuses on using computational technologies to understand how these structures perform their function, so we have a better understanding of both normal and disease processes.",Annotating Functional Sites in 3D Biological Structures,8324017,R01LM005652,"['Active Sites', 'Address', 'Algorithms', 'Automobile Driving', 'Binding', 'Binding Sites', 'Biological', 'Biomedical Research', 'Calcium Binding', 'Cell physiology', 'Cells', 'Chemicals', 'Clinical', 'Cluster Analysis', 'Code', 'Collaborations', 'Collection', 'Communities', 'Computer software', 'Computing Methodologies', 'Crystallography', 'DNA', 'Data', 'Data Set', 'Data Sources', 'Databases', 'Diagnostic', 'Disease', 'Drug Binding Site', 'Environment', 'Enzymes', 'Explosion', 'Genetic Polymorphism', 'Genomics', 'Grant', 'High Performance Computing', 'Human', 'Informatics', 'Investments', 'Knowledge', 'Korea', 'Label', 'Learning', 'Libraries', 'Link', 'Machine Learning', 'Maps', 'Methods', 'Mining', 'Molecular', 'Molecular Biology', 'Molecular Medicine', 'Molecular Structure', 'Morphologic artifacts', 'Motion', 'Pathologic', 'Pattern', 'Performance', 'Phenotype', 'Phosphorylation', 'Phosphorylation Site', 'Physics', 'Physiological', 'Process', 'Property', 'Proteins', 'Publishing', 'RNA', 'Research', 'Resources', 'Rest', 'Retrieval', 'San Francisco', 'Signal Transduction', 'Site', 'Software Engineering', 'Source', 'Source Code', 'Specialist', 'Structure', 'Technology', 'Time', 'Training', 'United States National Institutes of Health', 'United States National Library of Medicine', 'Universities', 'Work', 'abstracting', 'advanced simulation', 'base', 'biological systems', 'cost', 'data reduction', 'design', 'improved', 'indexing', 'innovation', 'interest', 'macromolecule', 'molecular dynamics', 'novel', 'novel diagnostics', 'novel therapeutics', 'programs', 'protein function', 'protein structure', 'simulation', 'simulation software', 'structural genomics', 'three dimensional structure', 'tool']",NLM,STANFORD UNIVERSITY,R01,2012,314573,0.09545694653162495
"Annotating Functional Sites in 3D Biological Structures    DESCRIPTION (provided by applicant):       Project Summary/Abstract Dramatic advances in our understanding of molecular structure and function promise to accelerate the creation of new diagnostics and therapeutics. However the link between the structure of a biological macromolecule and its function is usually not obvious: fundamental to understanding how a molecule functions is an understanding of how its structure behaves over time. Recent advances in molecular dynamics simulations now allow the rapid collection of information about structural motion. These data sets are huge, and require statistical machine learning algorithms to characterize and recognize patterns relevant to function. The National Library of Medicine's new long-range plan calls for research in the use of advanced simulation and machine learning algorithms in support of biomedical research.       This proposal focuses on annotating molecular structures with missing or incomplete functional information. We are particularly interested in identifying binding sites and active sites in proteins. We bring together simulation and machine learning, and hypothesize that the performance of structure- based function annotation methods will dramatically improve with the addition of information about dynamics. Thus, our specific aims are (1) to develop methods for recognizing function from structural dynamics and diversity, (2) to develop capabilities for large scale clustering and analysis tools for the discovery of novel functions, and (3) to apply our tools to challenging and important biological systems, while disseminating our software, data and capabilities to the biomedical research community. In particular, we will focus our new capabilities on three difficult function annotation challenges: ATP binding sites, phosphorylation sites, and metabolizing enzyme active sites.            Project Narrative The explosion in data related to molecular biology has created great opportunities for new disease diagnostics and therapies. One source of data is the three-dimensional (3D) structure of biological molecules such as proteins, DNA and RNA. This work focuses on using computational technologies to understand how these structures perform their function, so we have a better understanding of both normal and disease processes.",Annotating Functional Sites in 3D Biological Structures,8142219,R01LM005652,"['Active Sites', 'Address', 'Algorithms', 'Automobile Driving', 'Binding', 'Binding Sites', 'Biological', 'Biomedical Research', 'Calcium Binding', 'Cell physiology', 'Cells', 'Chemicals', 'Clinical', 'Cluster Analysis', 'Code', 'Collaborations', 'Collection', 'Communities', 'Computer software', 'Computing Methodologies', 'Crystallography', 'DNA', 'Data', 'Data Set', 'Data Sources', 'Databases', 'Diagnostic', 'Disease', 'Drug Binding Site', 'Environment', 'Enzymes', 'Explosion', 'Genetic Polymorphism', 'Genomics', 'Grant', 'High Performance Computing', 'Human', 'Informatics', 'Investments', 'Knowledge', 'Korea', 'Label', 'Learning', 'Libraries', 'Link', 'Machine Learning', 'Maps', 'Methods', 'Mining', 'Molecular', 'Molecular Biology', 'Molecular Medicine', 'Molecular Structure', 'Morphologic artifacts', 'Motion', 'Pathologic', 'Pattern', 'Performance', 'Phenotype', 'Phosphorylation', 'Phosphorylation Site', 'Physics', 'Physiological', 'Process', 'Property', 'Proteins', 'Publishing', 'RNA', 'Research', 'Resources', 'Rest', 'Retrieval', 'San Francisco', 'Signal Transduction', 'Site', 'Software Engineering', 'Source', 'Source Code', 'Specialist', 'Structure', 'Technology', 'Time', 'Training', 'United States National Institutes of Health', 'United States National Library of Medicine', 'Universities', 'Work', 'abstracting', 'advanced simulation', 'base', 'biological systems', 'cost', 'data reduction', 'design', 'improved', 'indexing', 'innovation', 'interest', 'macromolecule', 'molecular dynamics', 'novel', 'novel diagnostics', 'novel therapeutics', 'programs', 'protein function', 'protein structure', 'simulation', 'simulation software', 'structural genomics', 'three dimensional structure', 'tool']",NLM,STANFORD UNIVERSITY,R01,2011,317920,0.09545694653162495
"Annotating functional sites in 3D biological structures DESCRIPTION:    High-throughput data collection methods have revolutionized many areas of biology and medicine. The National Library of Medicine has targeted the representation, management, and manipulation of biological structure as a key element of its mission. Following upon the success of genome sequencing and functional genomics projects, the structural biology community is creating technologies to streamline the process of determining three-dimensional biological structures--with efforts in structural genomics. Like other high-throughput efforts, a major challenge for these efforts is the appropriate annotation and indexing of structures for retrieval and analysis by biologists who are trying to understand molecular function at an atomic detail: Where are the important functional sites, and how confident are we in their location?      In this proposal, we plan to develop and apply methods for annotating biological structures, so that active sites, binding sites and interaction sites in biological structures can be automatically identified and annotated. Our novel computational representation of functional sites has been successful in characterizing these sites, and recognizing them based on their biochemical and biophysical signature--a 3D motif. We propose to improve the performance of our method with basic research in the representations and algorithms used for our site models. Because our site models are manually created, our library of available models has grown slowly. We therefore further propose to accelerate the growth of our model library using a combination of supervised and unsupervised machine learning methods. First, we will use known 1D sequence motifs as ""seeds"" to create corresponding 3D motifs. Second, we will develop techniques for discovering entirely new motifs using cluster techniques. We will evaluate our models and resulting predictions through analysis of known structural sites, follow-up and dissemination of predictions with the structural genomics community, and large-scale evaluation on decoy and predicted structures. We will make the resulting models available on the Web for real-time structural annotation, and will distribute the software for open source development. n/a",Annotating functional sites in 3D biological structures,7477279,R01LM005652,"['Active Sites', 'Algorithms', 'Appendix', 'Area', 'Basic Science', 'Binding', 'Binding Sites', 'Biochemical', 'Biological', 'Biology', 'Catalysis', 'Communities', 'Computer software', 'Crystallography', 'Data', 'Data Collection', 'Databases', 'Development', 'Elements', 'Engineering', 'Evaluation', 'Failure', 'Growth', 'Informatics', 'Internet', 'Libraries', 'Location', 'Machine Learning', 'Manuals', 'Maps', 'Medicine', 'Methodology', 'Methods', 'Mission', 'Modeling', 'Molecular', 'Neighborhoods', 'Online Systems', 'Performance', 'Pharmaceutical Preparations', 'Process', 'Property', 'Proteins', 'Proteomics', 'Resolution', 'Retrieval', 'Seeds', 'Site', 'Speed', 'Statistical Methods', 'Structure', 'Techniques', 'Technology', 'Testing', 'Time', 'United States National Institutes of Health', 'United States National Library of Medicine', 'Validation', 'Work', 'base', 'design', 'follow-up', 'functional genomics', 'genome sequencing', 'high throughput technology', 'improved', 'indexing', 'macromolecule', 'novel', 'open source', 'programs', 'size', 'structural biology', 'structural genomics', 'success', 'technology development', 'three dimensional structure', 'three-dimensional modeling', 'tool', 'vector']",NLM,STANFORD UNIVERSITY,R01,2008,338976,0.18691091624364722
"Annotating Functional Sites in 3D Biological Structures    DESCRIPTION (provided by applicant):       Project Summary/Abstract Dramatic advances in our understanding of molecular structure and function promise to accelerate the creation of new diagnostics and therapeutics. However the link between the structure of a biological macromolecule and its function is usually not obvious: fundamental to understanding how a molecule functions is an understanding of how its structure behaves over time. Recent advances in molecular dynamics simulations now allow the rapid collection of information about structural motion. These data sets are huge, and require statistical machine learning algorithms to characterize and recognize patterns relevant to function. The National Library of Medicine's new long-range plan calls for research in the use of advanced simulation and machine learning algorithms in support of biomedical research.       This proposal focuses on annotating molecular structures with missing or incomplete functional information. We are particularly interested in identifying binding sites and active sites in proteins. We bring together simulation and machine learning, and hypothesize that the performance of structure- based function annotation methods will dramatically improve with the addition of information about dynamics. Thus, our specific aims are (1) to develop methods for recognizing function from structural dynamics and diversity, (2) to develop capabilities for large scale clustering and analysis tools for the discovery of novel functions, and (3) to apply our tools to challenging and important biological systems, while disseminating our software, data and capabilities to the biomedical research community. In particular, we will focus our new capabilities on three difficult function annotation challenges: ATP binding sites, phosphorylation sites, and metabolizing enzyme active sites.            Project Narrative The explosion in data related to molecular biology has created great opportunities for new disease diagnostics and therapies. One source of data is the three-dimensional (3D) structure of biological molecules such as proteins, DNA and RNA. This work focuses on using computational technologies to understand how these structures perform their function, so we have a better understanding of both normal and disease processes.",Annotating Functional Sites in 3D Biological Structures,7797639,R01LM005652,"['Active Sites', 'Address', 'Algorithms', 'Automobile Driving', 'Binding', 'Binding Sites', 'Biological', 'Biomedical Research', 'Calcium Binding', 'Cell physiology', 'Cells', 'Chemicals', 'Clinical', 'Cluster Analysis', 'Code', 'Collaborations', 'Collection', 'Communities', 'Computer software', 'Computing Methodologies', 'Crystallography', 'DNA', 'Data', 'Data Set', 'Data Sources', 'Databases', 'Diagnostic', 'Disease', 'Drug Binding Site', 'Environment', 'Enzymes', 'Explosion', 'Genetic Polymorphism', 'Genomics', 'Grant', 'High Performance Computing', 'Human', 'Informatics', 'Investments', 'Knowledge', 'Korea', 'Label', 'Learning', 'Libraries', 'Link', 'Machine Learning', 'Maps', 'Methods', 'Mining', 'Molecular', 'Molecular Biology', 'Molecular Medicine', 'Molecular Structure', 'Morphologic artifacts', 'Motion', 'Pathologic', 'Pattern', 'Performance', 'Phenotype', 'Phosphorylation', 'Phosphorylation Site', 'Physics', 'Physiological', 'Process', 'Property', 'Proteins', 'Publishing', 'RNA', 'Research', 'Research Proposals', 'Resources', 'Rest', 'Retrieval', 'San Francisco', 'Signal Transduction', 'Site', 'Software Engineering', 'Source', 'Source Code', 'Specialist', 'Structure', 'Technology', 'Therapeutic', 'Time', 'Training', 'United States National Institutes of Health', 'United States National Library of Medicine', 'Universities', 'Work', 'abstracting', 'advanced simulation', 'base', 'biological systems', 'cost', 'design', 'improved', 'indexing', 'innovation', 'interest', 'macromolecule', 'molecular dynamics', 'novel', 'novel diagnostics', 'programs', 'protein function', 'protein structure', 'simulation', 'simulation software', 'structural genomics', 'three dimensional structure', 'tool']",NLM,STANFORD UNIVERSITY,R01,2010,328016,0.09545694653162495
"Annotating Functional Sites in 3D Biological Structures    DESCRIPTION (provided by applicant):       Project Summary/Abstract Dramatic advances in our understanding of molecular structure and function promise to accelerate the creation of new diagnostics and therapeutics. However the link between the structure of a biological macromolecule and its function is usually not obvious: fundamental to understanding how a molecule functions is an understanding of how its structure behaves over time. Recent advances in molecular dynamics simulations now allow the rapid collection of information about structural motion. These data sets are huge, and require statistical machine learning algorithms to characterize and recognize patterns relevant to function. The National Library of Medicine's new long-range plan calls for research in the use of advanced simulation and machine learning algorithms in support of biomedical research.       This proposal focuses on annotating molecular structures with missing or incomplete functional information. We are particularly interested in identifying binding sites and active sites in proteins. We bring together simulation and machine learning, and hypothesize that the performance of structure- based function annotation methods will dramatically improve with the addition of information about dynamics. Thus, our specific aims are (1) to develop methods for recognizing function from structural dynamics and diversity, (2) to develop capabilities for large scale clustering and analysis tools for the discovery of novel functions, and (3) to apply our tools to challenging and important biological systems, while disseminating our software, data and capabilities to the biomedical research community. In particular, we will focus our new capabilities on three difficult function annotation challenges: ATP binding sites, phosphorylation sites, and metabolizing enzyme active sites.            Project Narrative The explosion in data related to molecular biology has created great opportunities for new disease diagnostics and therapies. One source of data is the three-dimensional (3D) structure of biological molecules such as proteins, DNA and RNA. This work focuses on using computational technologies to understand how these structures perform their function, so we have a better understanding of both normal and disease processes.",Annotating Functional Sites in 3D Biological Structures,8076140,R01LM005652,"['Active Sites', 'Address', 'Algorithms', 'Automobile Driving', 'Binding', 'Binding Sites', 'Biological', 'Biomedical Research', 'Calcium Binding', 'Cell physiology', 'Cells', 'Chemicals', 'Clinical', 'Cluster Analysis', 'Code', 'Collaborations', 'Collection', 'Communities', 'Computer software', 'Computing Methodologies', 'Crystallography', 'DNA', 'Data', 'Data Set', 'Data Sources', 'Databases', 'Diagnostic', 'Disease', 'Drug Binding Site', 'Environment', 'Enzymes', 'Explosion', 'Genetic Polymorphism', 'Genomics', 'Grant', 'High Performance Computing', 'Human', 'Informatics', 'Investments', 'Knowledge', 'Korea', 'Label', 'Learning', 'Libraries', 'Link', 'Machine Learning', 'Maps', 'Methods', 'Mining', 'Molecular', 'Molecular Biology', 'Molecular Medicine', 'Molecular Structure', 'Morphologic artifacts', 'Motion', 'Pathologic', 'Pattern', 'Performance', 'Phenotype', 'Phosphorylation', 'Phosphorylation Site', 'Physics', 'Physiological', 'Process', 'Property', 'Proteins', 'Publishing', 'RNA', 'Research', 'Research Proposals', 'Resources', 'Rest', 'Retrieval', 'San Francisco', 'Signal Transduction', 'Site', 'Software Engineering', 'Source', 'Source Code', 'Specialist', 'Structure', 'Technology', 'Therapeutic', 'Time', 'Training', 'United States National Institutes of Health', 'United States National Library of Medicine', 'Universities', 'Work', 'abstracting', 'advanced simulation', 'base', 'biological systems', 'cost', 'design', 'improved', 'indexing', 'innovation', 'interest', 'macromolecule', 'molecular dynamics', 'novel', 'novel diagnostics', 'programs', 'protein function', 'protein structure', 'simulation', 'simulation software', 'structural genomics', 'three dimensional structure', 'tool']",NLM,STANFORD UNIVERSITY,R01,2010,18266,0.09545694653162495
"Annotating Functional Sites in 3D Biological Structures    DESCRIPTION (provided by applicant):       Project Summary/Abstract Dramatic advances in our understanding of molecular structure and function promise to accelerate the creation of new diagnostics and therapeutics. However the link between the structure of a biological macromolecule and its function is usually not obvious: fundamental to understanding how a molecule functions is an understanding of how its structure behaves over time. Recent advances in molecular dynamics simulations now allow the rapid collection of information about structural motion. These data sets are huge, and require statistical machine learning algorithms to characterize and recognize patterns relevant to function. The National Library of Medicine's new long-range plan calls for research in the use of advanced simulation and machine learning algorithms in support of biomedical research.       This proposal focuses on annotating molecular structures with missing or incomplete functional information. We are particularly interested in identifying binding sites and active sites in proteins. We bring together simulation and machine learning, and hypothesize that the performance of structure- based function annotation methods will dramatically improve with the addition of information about dynamics. Thus, our specific aims are (1) to develop methods for recognizing function from structural dynamics and diversity, (2) to develop capabilities for large scale clustering and analysis tools for the discovery of novel functions, and (3) to apply our tools to challenging and important biological systems, while disseminating our software, data and capabilities to the biomedical research community. In particular, we will focus our new capabilities on three difficult function annotation challenges: ATP binding sites, phosphorylation sites, and metabolizing enzyme active sites.            Project Narrative The explosion in data related to molecular biology has created great opportunities for new disease diagnostics and therapies. One source of data is the three-dimensional (3D) structure of biological molecules such as proteins, DNA and RNA. This work focuses on using computational technologies to understand how these structures perform their function, so we have a better understanding of both normal and disease processes.",Annotating Functional Sites in 3D Biological Structures,7917165,R01LM005652,"['Active Sites', 'Address', 'Algorithms', 'Automobile Driving', 'Binding', 'Binding Sites', 'Biological', 'Biomedical Research', 'Calcium Binding', 'Cell physiology', 'Cells', 'Chemicals', 'Clinical', 'Cluster Analysis', 'Code', 'Collaborations', 'Collection', 'Communities', 'Computer software', 'Computing Methodologies', 'Crystallography', 'DNA', 'Data', 'Data Set', 'Data Sources', 'Databases', 'Diagnostic', 'Disease', 'Drug Binding Site', 'Environment', 'Enzymes', 'Explosion', 'Genetic Polymorphism', 'Genomics', 'Grant', 'High Performance Computing', 'Human', 'Informatics', 'Investments', 'Knowledge', 'Korea', 'Label', 'Learning', 'Libraries', 'Link', 'Machine Learning', 'Maps', 'Methods', 'Mining', 'Molecular', 'Molecular Biology', 'Molecular Medicine', 'Molecular Structure', 'Morphologic artifacts', 'Motion', 'Pathologic', 'Pattern', 'Performance', 'Phenotype', 'Phosphorylation', 'Phosphorylation Site', 'Physics', 'Physiological', 'Process', 'Property', 'Proteins', 'Publishing', 'RNA', 'Research', 'Research Proposals', 'Resources', 'Rest', 'Retrieval', 'San Francisco', 'Signal Transduction', 'Site', 'Software Engineering', 'Source', 'Source Code', 'Specialist', 'Structure', 'Technology', 'Therapeutic', 'Time', 'Training', 'United States National Institutes of Health', 'United States National Library of Medicine', 'Universities', 'Work', 'abstracting', 'advanced simulation', 'base', 'biological systems', 'cost', 'design', 'improved', 'indexing', 'innovation', 'interest', 'macromolecule', 'molecular dynamics', 'novel', 'novel diagnostics', 'programs', 'protein function', 'protein structure', 'simulation', 'structural genomics', 'three dimensional structure', 'tool']",NLM,STANFORD UNIVERSITY,R01,2009,163560,0.09545694653162495
"Annotating Functional Sites in 3D Biological Structures    DESCRIPTION (provided by applicant):       Project Summary/Abstract Dramatic advances in our understanding of molecular structure and function promise to accelerate the creation of new diagnostics and therapeutics. However the link between the structure of a biological macromolecule and its function is usually not obvious: fundamental to understanding how a molecule functions is an understanding of how its structure behaves over time. Recent advances in molecular dynamics simulations now allow the rapid collection of information about structural motion. These data sets are huge, and require statistical machine learning algorithms to characterize and recognize patterns relevant to function. The National Library of Medicine's new long-range plan calls for research in the use of advanced simulation and machine learning algorithms in support of biomedical research.       This proposal focuses on annotating molecular structures with missing or incomplete functional information. We are particularly interested in identifying binding sites and active sites in proteins. We bring together simulation and machine learning, and hypothesize that the performance of structure- based function annotation methods will dramatically improve with the addition of information about dynamics. Thus, our specific aims are (1) to develop methods for recognizing function from structural dynamics and diversity, (2) to develop capabilities for large scale clustering and analysis tools for the discovery of novel functions, and (3) to apply our tools to challenging and important biological systems, while disseminating our software, data and capabilities to the biomedical research community. In particular, we will focus our new capabilities on three difficult function annotation challenges: ATP binding sites, phosphorylation sites, and metabolizing enzyme active sites.            Project Narrative The explosion in data related to molecular biology has created great opportunities for new disease diagnostics and therapies. One source of data is the three-dimensional (3D) structure of biological molecules such as proteins, DNA and RNA. This work focuses on using computational technologies to understand how these structures perform their function, so we have a better understanding of both normal and disease processes.",Annotating Functional Sites in 3D Biological Structures,7652033,R01LM005652,"['Active Sites', 'Address', 'Algorithms', 'Automobile Driving', 'Binding', 'Binding Sites', 'Biological', 'Biomedical Research', 'Calcium Binding', 'Cell physiology', 'Cells', 'Chemicals', 'Clinical', 'Cluster Analysis', 'Code', 'Collaborations', 'Collection', 'Communities', 'Computer software', 'Computing Methodologies', 'Crystallography', 'DNA', 'Data', 'Data Set', 'Data Sources', 'Databases', 'Diagnostic', 'Disease', 'Drug Binding Site', 'Environment', 'Enzymes', 'Explosion', 'Genetic Polymorphism', 'Genomics', 'Grant', 'High Performance Computing', 'Human', 'Informatics', 'Investments', 'Knowledge', 'Korea', 'Label', 'Learning', 'Libraries', 'Link', 'Machine Learning', 'Maps', 'Methods', 'Mining', 'Molecular', 'Molecular Biology', 'Molecular Medicine', 'Molecular Structure', 'Morphologic artifacts', 'Motion', 'Pathologic', 'Pattern', 'Performance', 'Phenotype', 'Phosphorylation', 'Phosphorylation Site', 'Physics', 'Physiological', 'Process', 'Property', 'Proteins', 'Publishing', 'RNA', 'Research', 'Research Proposals', 'Resources', 'Rest', 'Retrieval', 'San Francisco', 'Signal Transduction', 'Site', 'Software Engineering', 'Source', 'Source Code', 'Specialist', 'Structure', 'Technology', 'Therapeutic', 'Time', 'Training', 'United States National Institutes of Health', 'United States National Library of Medicine', 'Universities', 'Work', 'abstracting', 'advanced simulation', 'base', 'biological systems', 'cost', 'design', 'improved', 'indexing', 'innovation', 'interest', 'macromolecule', 'molecular dynamics', 'novel', 'novel diagnostics', 'programs', 'protein function', 'protein structure', 'simulation', 'structural genomics', 'three dimensional structure', 'tool']",NLM,STANFORD UNIVERSITY,R01,2009,327122,0.09545694653162495
"Annotating functional sites in 3D biological structures DESCRIPTION:    High-throughput data collection methods have revolutionized many areas of biology and medicine. The National Library of Medicine has targeted the representation, management, and manipulation of biological structure as a key element of its mission. Following upon the success of genome sequencing and functional genomics projects, the structural biology community is creating technologies to streamline the process of determining three-dimensional biological structures--with efforts in structural genomics. Like other high-throughput efforts, a major challenge for these efforts is the appropriate annotation and indexing of structures for retrieval and analysis by biologists who are trying to understand molecular function at an atomic detail: Where are the important functional sites, and how confident are we in their location?      In this proposal, we plan to develop and apply methods for annotating biological structures, so that active sites, binding sites and interaction sites in biological structures can be automatically identified and annotated. Our novel computational representation of functional sites has been successful in characterizing these sites, and recognizing them based on their biochemical and biophysical signature--a 3D motif. We propose to improve the performance of our method with basic research in the representations and algorithms used for our site models. Because our site models are manually created, our library of available models has grown slowly. We therefore further propose to accelerate the growth of our model library using a combination of supervised and unsupervised machine learning methods. First, we will use known 1D sequence motifs as ""seeds"" to create corresponding 3D motifs. Second, we will develop techniques for discovering entirely new motifs using cluster techniques. We will evaluate our models and resulting predictions through analysis of known structural sites, follow-up and dissemination of predictions with the structural genomics community, and large-scale evaluation on decoy and predicted structures. We will make the resulting models available on the Web for real-time structural annotation, and will distribute the software for open source development. n/a",Annotating functional sites in 3D biological structures,7282065,R01LM005652,"['Active Sites', 'Algorithms', 'Appendix', 'Area', 'Basic Science', 'Binding', 'Binding Sites', 'Biochemical', 'Biological', 'Biology', 'Catalysis', 'Communities', 'Computer software', 'Crystallography', 'Data', 'Data Collection', 'Databases', 'Development', 'Elements', 'Engineering', 'Evaluation', 'Failure', 'Growth', 'Informatics', 'Internet', 'Libraries', 'Location', 'Machine Learning', 'Manuals', 'Maps', 'Medicine', 'Methodology', 'Methods', 'Mission', 'Modeling', 'Molecular', 'Neighborhoods', 'Online Systems', 'Performance', 'Pharmaceutical Preparations', 'Process', 'Property', 'Proteins', 'Proteomics', 'Resolution', 'Retrieval', 'Seeds', 'Site', 'Speed', 'Statistical Methods', 'Structure', 'Techniques', 'Technology', 'Testing', 'Time', 'United States National Institutes of Health', 'United States National Library of Medicine', 'Validation', 'Work', 'base', 'design', 'follow-up', 'functional genomics', 'genome sequencing', 'high throughput technology', 'improved', 'indexing', 'macromolecule', 'novel', 'open source', 'programs', 'size', 'structural biology', 'structural genomics', 'success', 'technology development', 'three dimensional structure', 'three-dimensional modeling', 'tool', 'vector']",NLM,STANFORD UNIVERSITY,R01,2007,355458,0.18691091624364722
"Annotating functional sites in 3D biological structures DESCRIPTION:    High-throughput data collection methods have revolutionized many areas of biology and medicine. The National Library of Medicine has targeted the representation, management, and manipulation of biological structure as a key element of its mission. Following upon the success of genome sequencing and functional genomics projects, the structural biology community is creating technologies to streamline the process of determining three-dimensional biological structures--with efforts in structural genomics. Like other high-throughput efforts, a major challenge for these efforts is the appropriate annotation and indexing of structures for retrieval and analysis by biologists who are trying to understand molecular function at an atomic detail: Where are the important functional sites, and how confident are we in their location?      In this proposal, we plan to develop and apply methods for annotating biological structures, so that active sites, binding sites and interaction sites in biological structures can be automatically identified and annotated. Our novel computational representation of functional sites has been successful in characterizing these sites, and recognizing them based on their biochemical and biophysical signature--a 3D motif. We propose to improve the performance of our method with basic research in the representations and algorithms used for our site models. Because our site models are manually created, our library of available models has grown slowly. We therefore further propose to accelerate the growth of our model library using a combination of supervised and unsupervised machine learning methods. First, we will use known 1D sequence motifs as ""seeds"" to create corresponding 3D motifs. Second, we will develop techniques for discovering entirely new motifs using cluster techniques. We will evaluate our models and resulting predictions through analysis of known structural sites, follow-up and dissemination of predictions with the structural genomics community, and large-scale evaluation on decoy and predicted structures. We will make the resulting models available on the Web for real-time structural annotation, and will distribute the software for open source development. n/a",Annotating functional sites in 3D biological structures,7117852,R01LM005652,"['active sites', 'binding sites', 'computer simulation', 'macromolecule', 'model design /development', 'physical model', 'structural biology']",NLM,STANFORD UNIVERSITY,R01,2006,326259,0.18691091624364722
"Annotating functional sites in 3D biological structures DESCRIPTION:    High-throughput data collection methods have revolutionized many areas of biology and medicine. The National Library of Medicine has targeted the representation, management, and manipulation of biological structure as a key element of its mission. Following upon the success of genome sequencing and functional genomics projects, the structural biology community is creating technologies to streamline the process of determining three-dimensional biological structures--with efforts in structural genomics. Like other high-throughput efforts, a major challenge for these efforts is the appropriate annotation and indexing of structures for retrieval and analysis by biologists who are trying to understand molecular function at an atomic detail: Where are the important functional sites, and how confident are we in their location?      In this proposal, we plan to develop and apply methods for annotating biological structures, so that active sites, binding sites and interaction sites in biological structures can be automatically identified and annotated. Our novel computational representation of functional sites has been successful in characterizing these sites, and recognizing them based on their biochemical and biophysical signature--a 3D motif. We propose to improve the performance of our method with basic research in the representations and algorithms used for our site models. Because our site models are manually created, our library of available models has grown slowly. We therefore further propose to accelerate the growth of our model library using a combination of supervised and unsupervised machine learning methods. First, we will use known 1D sequence motifs as ""seeds"" to create corresponding 3D motifs. Second, we will develop techniques for discovering entirely new motifs using cluster techniques. We will evaluate our models and resulting predictions through analysis of known structural sites, follow-up and dissemination of predictions with the structural genomics community, and large-scale evaluation on decoy and predicted structures. We will make the resulting models available on the Web for real-time structural annotation, and will distribute the software for open source development. n/a",Annotating functional sites in 3D biological structures,6942980,R01LM005652,"['active sites', 'binding sites', 'computer simulation', 'macromolecule', 'model design /development', 'physical model', 'structural biology']",NLM,STANFORD UNIVERSITY,R01,2005,324673,0.18691091624364722
"Annotating functional sites in 3D biological structures DESCRIPTION:    High-throughput data collection methods have revolutionized many areas of biology and medicine. The National Library of Medicine has targeted the representation, management, and manipulation of biological structure as a key element of its mission. Following upon the success of genome sequencing and functional genomics projects, the structural biology community is creating technologies to streamline the process of determining three-dimensional biological structures--with efforts in structural genomics. Like other high-throughput efforts, a major challenge for these efforts is the appropriate annotation and indexing of structures for retrieval and analysis by biologists who are trying to understand molecular function at an atomic detail: Where are the important functional sites, and how confident are we in their location?      In this proposal, we plan to develop and apply methods for annotating biological structures, so that active sites, binding sites and interaction sites in biological structures can be automatically identified and annotated. Our novel computational representation of functional sites has been successful in characterizing these sites, and recognizing them based on their biochemical and biophysical signature--a 3D motif. We propose to improve the performance of our method with basic research in the representations and algorithms used for our site models. Because our site models are manually created, our library of available models has grown slowly. We therefore further propose to accelerate the growth of our model library using a combination of supervised and unsupervised machine learning methods. First, we will use known 1D sequence motifs as ""seeds"" to create corresponding 3D motifs. Second, we will develop techniques for discovering entirely new motifs using cluster techniques. We will evaluate our models and resulting predictions through analysis of known structural sites, follow-up and dissemination of predictions with the structural genomics community, and large-scale evaluation on decoy and predicted structures. We will make the resulting models available on the Web for real-time structural annotation, and will distribute the software for open source development. n/a",Annotating functional sites in 3D biological structures,6825272,R01LM005652,"['active sites', 'binding sites', 'computer simulation', 'macromolecule', 'model design /development', 'physical model', 'structural biology']",NLM,STANFORD UNIVERSITY,R01,2004,396367,0.18691091624364722
"Predicting Impact of Genetic Variation on Splicing ï»¿    DESCRIPTION (provided by applicant): The genetic code not only determines protein amino acid residue sequence but also defines the 'splicing code' of cis- and trans-acting regulatory elements that control pre-mRNA splicing. Single nucleotide variant (SNV) changes at key regions in pre-mRNA may disrupt splicing resulting in disease [1, 2]. Understanding which SNVs cause aberrant splicing and which are benign is important for understanding disease pathogenesis. SNVs at consensus splice sites, at exon-intron junctions, are known to cause aberrant splicing and contribute to at least 10% of inherited diseases [2]. However, SNVs outside consensus splice sites can still disrupt splicing [3]. Current, bioinformatics tools limit analysis to SNVs at or near consensus splice sites and lack the ability to generalize to SNVs beyond the consensus splice site [4-7]. In this application, I propose to substantially improve the ability to interpret the consequences of mutations on pre-mRNA splicing. This goal will be achieved by: 1) developing novel features, useful in predicting the impact of variation on cis- splicing regulation; 2) training a supervised machine learning algorithm that uses the novel features to predict the impact of SNVs; 3) sharing the algorithm in a publically available software package; and 4) comparing algorithm predictions to the relationships between SNVs and splicing patterns derived from matched DNA- and RNA-sequencing studies.         PUBLIC HEALTH RELEVANCE: Genetic sequences not only encode the amino acids of proteins but also regulate many critical biological functions, including pre-mRNA splicing. The impact of genetic variation on splicing is not well understood. The goal of this research project i to computationally identify features of variants useful in predicting aberrant splicing, then incorporate the features into a machine learning algorithm and test the utility of the predictions using publically available sequencing studies. 1            ",Predicting Impact of Genetic Variation on Splicing,8991662,F31HG007804,"['Algorithms', 'Amino Acids', 'Benign', 'Bioinformatics', 'Biological', 'Biological Process', 'Cell physiology', 'Characteristics', 'Code', 'Comparative Study', 'Computational algorithm', 'Computer software', 'Computing Methodologies', 'Consensus', 'DNA', 'DNA Sequence', 'Data', 'Development', 'Disease', 'Exons', 'Genetic', 'Genetic Code', 'Genetic Variation', 'Genomics', 'Goals', 'Inherited', 'Introns', 'Label', 'Location', 'Machine Learning', 'Methods', 'Mutation', 'Nucleotides', 'Pathogenesis', 'Pattern', 'Performance', 'Play', 'Proteins', 'RNA Splicing', 'Regulation', 'Regulatory Element', 'Research Project Grants', 'Role', 'Site', 'Structure', 'Testing', 'Training', 'Transcript', 'Variant', 'base', 'improved', 'interest', 'learning strategy', 'mRNA Precursor', 'novel', 'prediction algorithm', 'public health relevance', 'tool', 'transcriptome sequencing']",NHGRI,JOHNS HOPKINS UNIVERSITY,F31,2016,43576,0.009615727764187867
"Predicting Impact of Genetic Variation on Splicing ï»¿    DESCRIPTION (provided by applicant): The genetic code not only determines protein amino acid residue sequence but also defines the 'splicing code' of cis- and trans-acting regulatory elements that control pre-mRNA splicing. Single nucleotide variant (SNV) changes at key regions in pre-mRNA may disrupt splicing resulting in disease [1, 2]. Understanding which SNVs cause aberrant splicing and which are benign is important for understanding disease pathogenesis. SNVs at consensus splice sites, at exon-intron junctions, are known to cause aberrant splicing and contribute to at least 10% of inherited diseases [2]. However, SNVs outside consensus splice sites can still disrupt splicing [3]. Current, bioinformatics tools limit analysis to SNVs at or near consensus splice sites and lack the ability to generalize to SNVs beyond the consensus splice site [4-7]. In this application, I propose to substantially improve the ability to interpret the consequences of mutations on pre-mRNA splicing. This goal will be achieved by: 1) developing novel features, useful in predicting the impact of variation on cis- splicing regulation; 2) training a supervised machine learning algorithm that uses the novel features to predict the impact of SNVs; 3) sharing the algorithm in a publically available software package; and 4) comparing algorithm predictions to the relationships between SNVs and splicing patterns derived from matched DNA- and RNA-sequencing studies.         PUBLIC HEALTH RELEVANCE: Genetic sequences not only encode the amino acids of proteins but also regulate many critical biological functions, including pre-mRNA splicing. The impact of genetic variation on splicing is not well understood. The goal of this research project i to computationally identify features of variants useful in predicting aberrant splicing, then incorporate the features into a machine learning algorithm and test the utility of the predictions using publically available sequencing studies. 1            ",Predicting Impact of Genetic Variation on Splicing,8833507,F31HG007804,"['Algorithms', 'Amino Acids', 'Benign', 'Bioinformatics', 'Biological', 'Biological Process', 'Cell physiology', 'Characteristics', 'Code', 'Comparative Study', 'Computational algorithm', 'Computer software', 'Computing Methodologies', 'Consensus', 'DNA', 'DNA Sequence', 'Data', 'Development', 'Disease', 'Exons', 'Genetic', 'Genetic Code', 'Genetic Variation', 'Genomics', 'Goals', 'Inherited', 'Introns', 'Label', 'Location', 'Machine Learning', 'Methods', 'Mutation', 'Nucleotides', 'Pathogenesis', 'Pattern', 'Performance', 'Play', 'Proteins', 'RNA Sequences', 'RNA Splicing', 'Regulation', 'Regulatory Element', 'Research Project Grants', 'Role', 'Site', 'Structure', 'Testing', 'Training', 'Transcript', 'Variant', 'base', 'improved', 'interest', 'mRNA Precursor', 'novel', 'public health relevance', 'tool', 'transcriptome sequencing']",NHGRI,JOHNS HOPKINS UNIVERSITY,F31,2015,43120,0.009615727764187867
"Predicting Impact of Genetic Variation on Splicing ï»¿    DESCRIPTION (provided by applicant): The genetic code not only determines protein amino acid residue sequence but also defines the 'splicing code' of cis- and trans-acting regulatory elements that control pre-mRNA splicing. Single nucleotide variant (SNV) changes at key regions in pre-mRNA may disrupt splicing resulting in disease [1, 2]. Understanding which SNVs cause aberrant splicing and which are benign is important for understanding disease pathogenesis. SNVs at consensus splice sites, at exon-intron junctions, are known to cause aberrant splicing and contribute to at least 10% of inherited diseases [2]. However, SNVs outside consensus splice sites can still disrupt splicing [3]. Current, bioinformatics tools limit analysis to SNVs at or near consensus splice sites and lack the ability to generalize to SNVs beyond the consensus splice site [4-7]. In this application, I propose to substantially improve the ability to interpret the consequences of mutations on pre-mRNA splicing. This goal will be achieved by: 1) developing novel features, useful in predicting the impact of variation on cis- splicing regulation; 2) training a supervised machine learning algorithm that uses the novel features to predict the impact of SNVs; 3) sharing the algorithm in a publically available software package; and 4) comparing algorithm predictions to the relationships between SNVs and splicing patterns derived from matched DNA- and RNA-sequencing studies.         PUBLIC HEALTH RELEVANCE: Genetic sequences not only encode the amino acids of proteins but also regulate many critical biological functions, including pre-mRNA splicing. The impact of genetic variation on splicing is not well understood. The goal of this research project i to computationally identify features of variants useful in predicting aberrant splicing, then incorporate the features into a machine learning algorithm and test the utility of the predictions using publically available sequencing studies. 1            ",Predicting Impact of Genetic Variation on Splicing,9213314,F31HG007804,"['Algorithms', 'Amino Acids', 'Benign', 'Bioinformatics', 'Biological', 'Biological Process', 'Cell physiology', 'Characteristics', 'Code', 'Comparative Study', 'Computational algorithm', 'Computer software', 'Computing Methodologies', 'Consensus', 'DNA', 'DNA Sequence', 'DNA sequencing', 'Data', 'Development', 'Disease', 'Exons', 'Genetic', 'Genetic Code', 'Genetic Variation', 'Genomics', 'Goals', 'Inherited', 'Introns', 'Label', 'Location', 'Machine Learning', 'Methods', 'Mutation', 'Nucleotides', 'Pathogenesis', 'Pattern', 'Performance', 'Play', 'Proteins', 'RNA Splicing', 'Regulation', 'Regulatory Element', 'Research Project Grants', 'Role', 'Site', 'Structure', 'Supervision', 'Testing', 'Training', 'Transcript', 'Variant', 'base', 'improved', 'interest', 'learning strategy', 'mRNA Precursor', 'novel', 'prediction algorithm', 'public health relevance', 'tool', 'transcriptome sequencing']",NHGRI,JOHNS HOPKINS UNIVERSITY,F31,2017,17892,0.009615727764187867
"BECKON - Block Estimate Chain: creating Knowledge ON demand & protecting privacy Project Summary/Abstract Artificial intelligence on genomic/healthcare data that is performed jointly between multiple collaborating institutions relies on a trust model but can accelerate genomic medicine research and facilitate quality improvement. To conduct such machine learning while protecting patient privacy and reducing security risks, we are developing blockchain-based privacy-preserving learning methods in a K99/R00 study supported by the National Human Genome Research Institute (NHGRI). However, our previous design of privacy-preserving learning on private blockchain assumed â€œsemi-honestyâ€ as the underlying adversary assumption. That is, we assume that each participating site is curious yet very careful and honest, such that it would only submit correct predictive models. Nevertheless, in real world this assumption may be too optimistic; the models submitted could be an old one due to network latency or malicious users may try to create fake models, which can in turn lead to bioethical concerns and reduce the incentives for genomic/clinical institutions to participate in the collaborative predictive modeling. Therefore, the capability to detect, assess and prevent â€œmodel misconductsâ€ is critical to increase the integrity/reliability of machine learning. To address this issue, we consider the following 3 types of model misconducts: (1) model plagiarism, of which a site becomes a free-rider and just submits a copy of a model from the other sites, trying to hide their own information and inspect models from other sites; (2) model fabrication, of which a site mocks up a model, trying to hide information and disturb the machine learning process; and (3) model falsification, of which a site tweaks its model a bit, trying to just disturb the learning process. For each type of the model misconducts, we are interest in how to detect these misconducts of another site, how to assess the losses of machine learning results due to misconducts, and how to prevent these model misconducts. Our aims include (a) detecting model misconducts using model properties, (b) assessing model misconducts losses via model simulation, and (c) preventing model misconducts based on whole model history. The innovative components to our proposed project include (i) summarizing various types of model misconduct, (ii) developing a complete strategy to handle the model misconduct, and (iii) providing a generalizable approach to mitigate bioethical concerns for collaborative machine learning. Project Narrative Artificial intelligence performed jointly between multiple collaborating institutions can accelerate genomic medicine research and facilitate quality improvement, but relies on a trust model which may be too optimistic in real-world setting. In this project, we plan to develop a comprehensive detection, assessment and prevention mechanism to address the potential bioethical risks brought by misconducts of model plagiarism, fabrication, and falsification. The proposed study can supplement the considerations of model misconducts for our original project of privacy-preserving learning on blockchain.",BECKON - Block Estimate Chain: creating Knowledge ON demand & protecting privacy,10130868,R00HG009680,"['Address', 'Artificial Intelligence', 'Bioethics', 'Budgets', 'Calibration', 'Clinical', 'Data', 'Data Set', 'Detection', 'Digit structure', 'Discrimination', 'Event', 'Genomic medicine', 'Genomics', 'Healthcare', 'Incentives', 'Institution', 'Knowledge', 'Lead', 'Learning', 'Machine Learning', 'Measurement', 'Methods', 'Modeling', 'National Human Genome Research Institute', 'Pattern', 'Plagiarism', 'Prevention', 'Privacy', 'Privatization', 'Process', 'Property', 'Randomized', 'Recording of previous events', 'Research', 'Risk', 'Security', 'Site', 'Sum', 'Testing', 'Time', 'Trust', 'base', 'blockchain', 'design', 'distributed ledger', 'innovation', 'interest', 'learning strategy', 'models and simulation', 'patient privacy', 'predictive modeling', 'prevent', 'privacy preservation', 'statistics']",NHGRI,"UNIVERSITY OF CALIFORNIA, SAN DIEGO",R00,2020,102049,0.1256293768671344
"CUTANEOUS PATTERN PERCEPTION The proposed research will investigate the perception of tactile patterns by human subjects.  The tactile patterns will be generated on arrays of stimulators that fit against the subject's fingertips.  Each array consists of 144 stimulators arranged in a matrix 6 columns by 24 rows.  Sets of patterns differing along such dimensions as location, intensity, number of line segments, and so forth will be generated and presented to subjects. Response measures will include identification, discrimination, reaction time, and pattern matching.  Three aspects of tactile pattern perception will be examined:  masking, interactions among multiple sites of stimulation, and the role of experience.  A temporal masking paradigm will be used to see how the perception of tactile patterns is interfered with by tactile maskers and how the nature of the interference changes with changes in the type of masker and in the temporal separation between target and masker.  In the studies of interaction among multiple sites, patterns will be presented to as many as three sites on the fingertips and palm.  This paradigm will be used to assess the role of attention in tactile information processing. The role of short-term experience will be examined by measuring changes in pattern perception as subjects learn to identify and discriminate tactile patterns.  The effect of long-term experience will be evaluated by comparing the performance of groups of subjects who differ in the amount and nature of their experience with complex tactile patterns.  One group will be Optacon users, blind individuals who can read by means of a tactile array.  The other groups will be blind individuals without Optacon experience and several groups of sighted subjects with varying amounts of tactile experience.  The proposed research will be concerned with drawing parallels between tactile processing and visual and auditory processing, with developing measures relevant to understanding the neural coding of tactile patterns, and with improving cutaneous communication systems for the blind, deaf, and deaf-blind.  n/a",CUTANEOUS PATTERN PERCEPTION,3394044,R01NS009783,"['artificial intelligence', ' attention', ' blindness', ' cutaneous sensory nerve', ' fingers', ' form /pattern perception', ' human subject', ' mechanoreceptors', ' neural information processing', ' neurophysiology', ' perceptual maskings', ' psychometrics', ' psychophysics', ' sensory discrimination', ' sensory disorders', ' sensory thresholds', ' sequential perception', ' skin', ' somesthesis', ' space perception', ' stimulus /response', ' stimulus interval', ' substitute sight', ' touch', ' vibration perception']",NINDS,INDIANA UNIVERSITY BLOOMINGTON,R01,1988,173421,0.08533801347310618
"CUTANEOUS PATERN PERCEPTION The proposed research will investigate the perception of tactile patterns by human subjects.  The tactile patterns will be generated on arrays of stimulators that fit against the subject's fingertips.  Each array consists of 144 stimulators arranged in a matrix 6 columns by 24 rows.  Sets of patterns differing along such dimensions as location, intensity, number of line segments, and so forth will be generated and presented to subjects. Response measures will include identification, discrimination, reaction time, and pattern matching.  Three aspects of tactile pattern perception will be examined:  masking, interactions among multiple sites of stimulation, and the role of experience.  A temporal masking paradigm will be used to see how the perception of tactile patterns is interfered with by tactile maskers and how the nature of the interference changes with changes in the type of masker and in the temporal separation between target and masker.  In the studies of interaction among multiple sites, patterns will be presented to as many as three sites on the fingertips and palm.  This paradigm will be used to assess the role of attention in tactile information processing. The role of short-term experience will be examined by measuring changes in pattern perception as subjects learn to identify and discriminate tactile patterns.  The effect of long-term experience will be evaluated by comparing the performance of groups of subjects who differ in the amount and nature of their experience with complex tactile patterns.  One group will be Optacon users, blind individuals who can read by means of a tactile array.  The other groups will be blind individuals without Optacon experience and several groups of sighted subjects with varying amounts of tactile experience.  The proposed research will be concerned with drawing parallels between tactile processing and visual and auditory processing, with developing measures relevant to understanding the neural coding of tactile patterns, and with improving cutaneous communication systems for the blind, deaf, and deaf-blind.  n/a",CUTANEOUS PATERN PERCEPTION,3394043,R01NS009783,"['artificial intelligence', ' attention', ' blindness', ' cutaneous sensory nerve', ' fingers', ' form /pattern perception', ' human subject', ' mechanoreceptors', ' neural information processing', ' neurophysiology', ' perceptual maskings', ' psychometrics', ' psychophysics', ' sensory discrimination', ' sensory disorders', ' sensory thresholds', ' sequential perception', ' skin', ' somesthesis', ' space perception', ' stimulus /response', ' stimulus interval', ' substitute sight', ' touch', ' vibration perception']",NINDS,INDIANA UNIVERSITY BLOOMINGTON,R01,1987,184022,0.08533801347310618
"CUTANEOUS PATERN PERCEPTION The proposed research will investigate the perception of tactile patterns by human subjects.  The tactile patterns will be generated on arrays of stimulators that fit against the subject's fingertips.  Each array consists of 144 stimulators arranged in a matrix 6 columns by 24 rows.  Sets of patterns differing along such dimensions as location, intensity, number of line segments, and so forth will be generated and presented to subjects. Response measures will include identification, discrimination, reaction time, and pattern matching.  Three aspects of tactile pattern perception will be examined:  masking, interactions among multiple sites of stimulation, and the role of experience.  A temporal masking paradigm will be used to see how the perception of tactile patterns is interfered with by tactile maskers and how the nature of the interference changes with changes in the type of masker and in the temporal separation between target and masker.  In the studies of interaction among multiple sites, patterns will be presented to as many as three sites on the fingertips and palm.  This paradigm will be used to assess the role of attention in tactile information processing. The role of short-term experience will be examined by measuring changes in pattern perception as subjects learn to identify and discriminate tactile patterns.  The effect of long-term experience will be evaluated by comparing the performance of groups of subjects who differ in the amount and nature of their experience with complex tactile patterns.  One group will be Optacon users, blind individuals who can read by means of a tactile array.  The other groups will be blind individuals without Optacon experience and several groups of sighted subjects with varying amounts of tactile experience.  The proposed research will be concerned with drawing parallels between tactile processing and visual and auditory processing, with developing measures relevant to understanding the neural coding of tactile patterns, and with improving cutaneous communication systems for the blind, deaf, and deaf-blind.  n/a",CUTANEOUS PATERN PERCEPTION,3394041,R01NS009783,"['artificial intelligence', ' attention', ' blindness', ' cutaneous sensory nerve', ' fingers', ' form /pattern perception', ' human subject', ' mechanoreceptors', ' neural information processing', ' neurophysiology', ' perceptual maskings', ' psychometrics', ' psychophysics', ' sensory discrimination', ' sensory disorders', ' sensory thresholds', ' sequential perception', ' skin', ' somesthesis', ' space perception', ' stimulus /response', ' stimulus interval', ' substitute sight', ' touch', ' vibration perception']",NINDS,INDIANA UNIVERSITY BLOOMINGTON,R01,1986,160677,0.08533801347310618
"Hypothesis Web Development for Neuropsychiatric Phenomics A major obstacle to translational research is the formulation of hypotheses that span multiple levels of biomedical research. This is particularly true for complex neuropsychiatric disorders, which involve aspects of many scientific disciplines at many physical scales. Combined efforts involving multiple disciplines are needed in order to make any substantial progress. We propose development of a software platform called the Hypothesis Web that permits collaborative formulation of complex scientific hypotheses. It represents a novel approach to the way scientific hypotheses are conceived and tested, in which: (1) hypotheses are the focus of collaboration; (2) literature, data, and annotations are organized in a usable interface; (3) translational research groups work together to develop a web site for the hypothesis that contains accumulated evidence; (4) hypotheses that span multiple levels are represented as hierarchical graphs; (5) hypotheses can be inspected analytically with tools like meta-analysis; (6) resulting hypothesis web sites can be shared, modularized, and published. We propose to develop this platform as an extension of existing open-source systems for web-based collaboration, data management, modeling, and access of online scientific literature. Specifically: a wiki-like platform augmented for collaborative refinement of hypotheses. The Hypothesis Web represents hypotheses visually as labeled graph models that identify the relevant concepts and associations. This graphical approach permits visual specification of hypothesized models of different kinds, including pathway diagrams, measurement models, and structural equation models. The graphs can then be represented in 2D cartographic displays that we refer to as Hypothesis Maps. Our design for the Hypothesis Web builds on many results for phenotype analysis developed under our P20 planning grant (P20RR020750). The system will be used to record hypotheses developed by Consortium Projects. It will be developed as an extension of existing open-source systems, and be made freely available as it evolves over the duration of this project. We also propose development of a platform for producing a Phenomic Atlas, using the Hypothesis Web as a foundation, but extended with knowledge-based capabilities for exploration. Conceptually a related set of Hypothesis Webs can be bundled together to form an Atlas. Thus the Atlas is a medium for publication that permits dissemination of a collection of related Maps (hypotheses). In collaboration with Consortium Research Projects we will construct Phenomic Atlases. n/a",Hypothesis Web Development for Neuropsychiatric Phenomics,7467668,RL1LM009833,"['Adopted', 'Affect', 'Atlases', 'Attention', 'Attention deficit hyperactivity disorder', 'Bibliography', 'Biomedical Research', 'Bipolar Disorder', 'Brain', 'Brain region', 'Characteristics', 'Cognitive', 'Collaborations', 'Collection', 'Complement', 'Complex', 'Computer software', 'DRD4 gene', 'Data', 'Development', 'Diagnostic and Statistical Manual', 'Discipline', 'Disease', 'Drug Formulations', 'Equation', 'Foundations', 'Generations', 'Genes', 'Genetic Polymorphism', 'Genome', 'Genomics', 'Grant', 'Graph', 'Hippocampus (Brain)', 'Informatics', 'Internet', 'Knowledge', 'Label', 'Light', 'Link', 'Literature', 'Maps', 'MeSH Thesaurus', 'Measurable', 'Measurement', 'Measures', 'Memory', 'Meta-Analysis', 'Methodology', 'Modeling', 'Nature', 'Online Systems', 'Ontology', 'Output', 'Paper', 'Pathway interactions', 'Phase', 'Phenotype', 'Population', 'Prefrontal Cortex', 'Process', 'Proteomics', 'PubMed', 'Publications', 'Publishing', 'Range', 'Relative (related person)', 'Research', 'Research Infrastructure', 'Research Project Grants', 'Resource Informatics', 'Resources', 'Sample Size', 'Sampling Studies', 'Scanning', 'Schizophrenia', 'Schizotypal Personality Disorder', 'Scientist', 'Seeds', 'Semantics', 'Services', 'Short-Term Memory', 'Site', 'Slice', 'Standards of Weights and Measures', 'Structural Models', 'Structure', 'Surveys', 'Syndrome', 'System', 'Taxonomy', 'Techniques', 'Testing', 'Thick', 'Time', 'Title', 'Translational Research', 'Translational Research Working Group', 'Translations', 'Visual', 'Vocabulary', 'Week', 'Weight', 'Work', 'abstracting', 'concept', 'data management', 'data mining', 'design', 'experience', 'improved', 'knowledge base', 'memory process', 'neuropsychiatry', 'novel strategies', 'open source', 'programs', 'response', 'size', 'software development', 'study characteristics', 'text searching', 'tool', 'treatment effect', 'web-accessible', 'wiki']",NLM,UNIVERSITY OF CALIFORNIA LOS ANGELES,RL1,2007,303654,0.037652987601702166
"WASHINGTON UNIVERSITY SCHOOL OF MEDICINE UNDIAGNOSED DISEASES NETWORK CLINICAL SITE 1.0 PROJECT SUMMARY The scientific premise of this application is that the individualized translational research process of the Undiagnosed Diseases Network (UDN) developed during Phase I is scalable and that its impact on patients, families, and disease discovery can be advanced and sustained by addition of a Clinical Site at Washington University School of Medicine (WUSM). WUSM represents a large academic medical center that is fully integrated with world-renowned basic science capabilities and demonstrated expertise in a gene first approach for patients with undiagnosed diseases. The highly collaborative clinical and biomedical research culture at WUSM promotes interactions within and across Departments, with institutional genomic, clinical, computational, and model system experts, and with colleagues regionally, nationally, and internationally. These interactions support recruitment, selection, evaluation, diagnosis discovery, and follow up of pediatric and adult patients with undiagnosed diseases through both established networks and individual referrals. Building on this infrastructure, WUSM faculty and staff will advance the success of the UDN in diagnosing and managing disease in undiagnosed patients by, first, using, refining, and improving protocols designed during Phase I of the UDN for comprehensive, timely clinical evaluations of 30 undiagnosed patients annually. Secondly, we will collect, securely store, and share standardized, high-quality clinical and laboratory data including genotyping, phenotyping, and documentation of environmental exposures and promote an integrated and collaborative community across the UDN and among laboratory and clinical investigators focused on defining the pathophysiology, cell biologic, and molecular mechanisms that cause these difficult to diagnose diseases. Thirdly, the WUSM UDN Clinical Site will propose a bioinformatics plan for leveraging institutional infrastructure and expertise to develop innovative strategies to improve discovery of pathogenic variants. Fourthly, the assessment, dissemination, outreach, and training plan will accelerate assessment and dissemination of data, protocols, consent materials, and methods, availability of educational and outreach materials for participants, clinicians, and other researchers, engagement of underrepresented minorities, and training for students, fellows, staff, and faculty in collaboration with WUSMâ€™s Clinical and Translational Science Award infrastructure. Finally, WUSM will make a clear institutional commitment to maintain its Clinical Site, to adapt UDN Phase I practices for sustainability, to contribute to formation of a sustainable national UDN resource, and to adapt to unique needs and unexpected circumstances that may arise once Common Fund support ends in fiscal year 2022. 2.0 PROJECT NARRATIVE Undiagnosed diseases in children and adults represent frustrating and costly challenges for patients, families, physicians, and society. Building on established institutional infrastructure similar to the Undiagnosed Diseases Network (UDN), Washington University School of Medicine (WUSM) will establish a UDN Clinical Site to improve the level of diagnosis and care for patients with undiagnosed diseases, facilitate research into the etiology of undiagnosed diseases, and promote an integrated and collaborative community across multiple UDN Clinical Sites, Sequencing Cores, Model Organisms Screening Centers, and among laboratory and clinical investigators. Specifically, the WUSM UDN Clinical Site will annually recruit, select, evaluate, and follow 30 participants with disorders in any clinical specialty, adult and pediatric, provide comprehensive clinical evaluations that require <5 days and follow up, and participate in all UDN protocols, data management and sharing, and sustainability planning.",WASHINGTON UNIVERSITY SCHOOL OF MEDICINE UNDIAGNOSED DISEASES NETWORK CLINICAL SITE,10124937,U01HG010215,"['Academic Medical Centers', 'Accreditation', 'Adult', 'Animal Model', 'Basic Science', 'Bioinformatics', 'Biological', 'Biomedical Research', 'Businesses', 'Cells', 'Child', 'Childhood', 'Classification', 'Clinical', 'Clinical Investigator', 'Clinical Research', 'Clinical Sciences', 'Clinical and Translational Science Awards', 'Collaborations', 'Communities', 'Computer Models', 'Consent', 'DNA Sequencing Facility', 'Data', 'Development', 'Diagnosis', 'Diagnostic', 'Disease', 'Disease Management', 'Documentation', 'Environmental Exposure', 'Etiology', 'Evaluation', 'Expert Systems', 'Faculty', 'Family', 'Family Physicians', 'Functional disorder', 'Funding', 'Genes', 'Genomics', 'Genotype', 'Geographic Locations', 'Individual', 'Infrastructure', 'Institutes', 'International', 'Laboratories', 'Methods', 'Molecular', 'Monitor', 'Network-based', 'Participant', 'Pathogenicity', 'Patient Care', 'Patients', 'Phase', 'Phase I Clinical Trials', 'Phenotype', 'Process', 'Protocols documentation', 'Research', 'Research Personnel', 'Resources', 'Review Committee', 'Secure', 'Societies', 'Standardization', 'Time', 'Training', 'Translational Research', 'Underrepresented Minority', 'Universities', 'Variant', 'Washington', 'clinical practice', 'clinical research site', 'cost', 'data dissemination', 'data management', 'data sharing', 'deep learning', 'design', 'disease diagnosis', 'exome sequencing', 'experience', 'follow-up', 'genetic variant', 'genome sequencing', 'improved', 'innovation', 'medical schools', 'medical specialties', 'network models', 'operation', 'outreach', 'recruit', 'research clinical testing', 'screening', 'sequencing platform', 'student training', 'success', 'transcriptome sequencing']",NHGRI,WASHINGTON UNIVERSITY,U01,2020,150000,0.07085468040883595
"Washington University School of Medicine Undiagnosed Diseases Network Clinical Site 1.0 PROJECT SUMMARY The scientific premise of this application is that the individualized translational research process of the Undiagnosed Diseases Network (UDN) developed during Phase I is scalable and that its impact on patients, families, and disease discovery can be advanced and sustained by addition of a Clinical Site at Washington University School of Medicine (WUSM). WUSM represents a large academic medical center that is fully integrated with world-renowned basic science capabilities and demonstrated expertise in a gene first approach for patients with undiagnosed diseases. The highly collaborative clinical and biomedical research culture at WUSM promotes interactions within and across Departments, with institutional genomic, clinical, computational, and model system experts, and with colleagues regionally, nationally, and internationally. These interactions support recruitment, selection, evaluation, diagnosis discovery, and follow up of pediatric and adult patients with undiagnosed diseases through both established networks and individual referrals. Building on this infrastructure, WUSM faculty and staff will advance the success of the UDN in diagnosing and managing disease in undiagnosed patients by, first, using, refining, and improving protocols designed during Phase I of the UDN for comprehensive, timely clinical evaluations of 30 undiagnosed patients annually. Secondly, we will collect, securely store, and share standardized, high-quality clinical and laboratory data including genotyping, phenotyping, and documentation of environmental exposures and promote an integrated and collaborative community across the UDN and among laboratory and clinical investigators focused on defining the pathophysiology, cell biologic, and molecular mechanisms that cause these difficult to diagnose diseases. Thirdly, the WUSM UDN Clinical Site will propose a bioinformatics plan for leveraging institutional infrastructure and expertise to develop innovative strategies to improve discovery of pathogenic variants. Fourthly, the assessment, dissemination, outreach, and training plan will accelerate assessment and dissemination of data, protocols, consent materials, and methods, availability of educational and outreach materials for participants, clinicians, and other researchers, engagement of underrepresented minorities, and training for students, fellows, staff, and faculty in collaboration with WUSMâ€™s Clinical and Translational Science Award infrastructure. Finally, WUSM will make a clear institutional commitment to maintain its Clinical Site, to adapt UDN Phase I practices for sustainability, to contribute to formation of a sustainable national UDN resource, and to adapt to unique needs and unexpected circumstances that may arise once Common Fund support ends in fiscal year 2022. 2.0 PROJECT NARRATIVE Undiagnosed diseases in children and adults represent frustrating and costly challenges for patients, families, physicians, and society. Building on established institutional infrastructure similar to the Undiagnosed Diseases Network (UDN), Washington University School of Medicine (WUSM) will establish a UDN Clinical Site to improve the level of diagnosis and care for patients with undiagnosed diseases, facilitate research into the etiology of undiagnosed diseases, and promote an integrated and collaborative community across multiple UDN Clinical Sites, Sequencing Cores, Model Organisms Screening Centers, and among laboratory and clinical investigators. Specifically, the WUSM UDN Clinical Site will annually recruit, select, evaluate, and follow 30 participants with disorders in any clinical specialty, adult and pediatric, provide comprehensive clinical evaluations that require <5 days and follow up, and participate in all UDN protocols, data management and sharing, and sustainability planning.",Washington University School of Medicine Undiagnosed Diseases Network Clinical Site,9977220,U01HG010215,"['Academic Medical Centers', 'Accreditation', 'Adult', 'Animal Model', 'Basic Science', 'Bioinformatics', 'Biological', 'Biomedical Research', 'Businesses', 'Cells', 'Child', 'Childhood', 'Classification', 'Clinical', 'Clinical Investigator', 'Clinical Research', 'Clinical Sciences', 'Clinical and Translational Science Awards', 'Collaborations', 'Communities', 'Computer Models', 'Consent', 'DNA Sequencing Facility', 'Data', 'Development', 'Diagnosis', 'Diagnostic', 'Disease', 'Disease Management', 'Documentation', 'Environmental Exposure', 'Etiology', 'Evaluation', 'Expert Systems', 'Faculty', 'Family', 'Family Physicians', 'Functional disorder', 'Funding', 'Genes', 'Genomics', 'Genotype', 'Geographic Locations', 'Individual', 'Infrastructure', 'Institutes', 'International', 'Laboratories', 'Methods', 'Molecular', 'Monitor', 'Network-based', 'Participant', 'Pathogenicity', 'Patient Care', 'Patients', 'Phase', 'Phase I Clinical Trials', 'Phenotype', 'Process', 'Protocols documentation', 'Research', 'Research Personnel', 'Resources', 'Review Committee', 'Secure', 'Societies', 'Standardization', 'Time', 'Training', 'Translational Research', 'Underrepresented Minority', 'Universities', 'Variant', 'Washington', 'clinical practice', 'clinical research site', 'cost', 'data dissemination', 'data management', 'data sharing', 'deep learning', 'design', 'disease diagnosis', 'exome sequencing', 'experience', 'follow-up', 'genetic variant', 'genome sequencing', 'improved', 'innovation', 'medical schools', 'medical specialties', 'network models', 'operation', 'outreach', 'recruit', 'research clinical testing', 'screening', 'sequencing platform', 'student training', 'success', 'transcriptome sequencing']",NHGRI,WASHINGTON UNIVERSITY,U01,2020,550000,0.07085468040883595
"Washington University School of Medicine Undiagnosed Diseases Network Clinical Site 1.0 PROJECT SUMMARY The scientific premise of this application is that the individualized translational research process of the Undiagnosed Diseases Network (UDN) developed during Phase I is scalable and that its impact on patients, families, and disease discovery can be advanced and sustained by addition of a Clinical Site at Washington University School of Medicine (WUSM). WUSM represents a large academic medical center that is fully integrated with world-renowned basic science capabilities and demonstrated expertise in a gene first approach for patients with undiagnosed diseases. The highly collaborative clinical and biomedical research culture at WUSM promotes interactions within and across Departments, with institutional genomic, clinical, computational, and model system experts, and with colleagues regionally, nationally, and internationally. These interactions support recruitment, selection, evaluation, diagnosis discovery, and follow up of pediatric and adult patients with undiagnosed diseases through both established networks and individual referrals. Building on this infrastructure, WUSM faculty and staff will advance the success of the UDN in diagnosing and managing disease in undiagnosed patients by, first, using, refining, and improving protocols designed during Phase I of the UDN for comprehensive, timely clinical evaluations of 30 undiagnosed patients annually. Secondly, we will collect, securely store, and share standardized, high-quality clinical and laboratory data including genotyping, phenotyping, and documentation of environmental exposures and promote an integrated and collaborative community across the UDN and among laboratory and clinical investigators focused on defining the pathophysiology, cell biologic, and molecular mechanisms that cause these difficult to diagnose diseases. Thirdly, the WUSM UDN Clinical Site will propose a bioinformatics plan for leveraging institutional infrastructure and expertise to develop innovative strategies to improve discovery of pathogenic variants. Fourthly, the assessment, dissemination, outreach, and training plan will accelerate assessment and dissemination of data, protocols, consent materials, and methods, availability of educational and outreach materials for participants, clinicians, and other researchers, engagement of underrepresented minorities, and training for students, fellows, staff, and faculty in collaboration with WUSMâ€™s Clinical and Translational Science Award infrastructure. Finally, WUSM will make a clear institutional commitment to maintain its Clinical Site, to adapt UDN Phase I practices for sustainability, to contribute to formation of a sustainable national UDN resource, and to adapt to unique needs and unexpected circumstances that may arise once Common Fund support ends in fiscal year 2022. 2.0 PROJECT NARRATIVE Undiagnosed diseases in children and adults represent frustrating and costly challenges for patients, families, physicians, and society. Building on established institutional infrastructure similar to the Undiagnosed Diseases Network (UDN), Washington University School of Medicine (WUSM) will establish a UDN Clinical Site to improve the level of diagnosis and care for patients with undiagnosed diseases, facilitate research into the etiology of undiagnosed diseases, and promote an integrated and collaborative community across multiple UDN Clinical Sites, Sequencing Cores, Model Organisms Screening Centers, and among laboratory and clinical investigators. Specifically, the WUSM UDN Clinical Site will annually recruit, select, evaluate, and follow 30 participants with disorders in any clinical specialty, adult and pediatric, provide comprehensive clinical evaluations that require <5 days and follow up, and participate in all UDN protocols, data management and sharing, and sustainability planning.",Washington University School of Medicine Undiagnosed Diseases Network Clinical Site,9789913,U01HG010215,"['Academic Medical Centers', 'Accreditation', 'Adult', 'Animal Model', 'Basic Science', 'Bioinformatics', 'Biological', 'Biomedical Research', 'Businesses', 'Cells', 'Child', 'Childhood', 'Classification', 'Clinical', 'Clinical Investigator', 'Clinical Research', 'Clinical Sciences', 'Clinical and Translational Science Awards', 'Collaborations', 'Communities', 'Computer Simulation', 'Consent', 'DNA Sequencing Facility', 'Data', 'Development', 'Diagnosis', 'Diagnostic', 'Disease', 'Disease Management', 'Documentation', 'Environmental Exposure', 'Etiology', 'Evaluation', 'Expert Systems', 'Faculty', 'Family', 'Family Physicians', 'Functional disorder', 'Funding', 'Genes', 'Genomics', 'Genotype', 'Geographic Locations', 'Individual', 'Infrastructure', 'Institutes', 'International', 'Laboratories', 'Methods', 'Molecular', 'Monitor', 'Network-based', 'Participant', 'Pathogenicity', 'Patient Care', 'Patients', 'Phase', 'Phase I Clinical Trials', 'Phenotype', 'Process', 'Protocols documentation', 'Research', 'Research Personnel', 'Resources', 'Review Committee', 'Secure', 'Societies', 'Standardization', 'Time', 'Training', 'Translational Research', 'Underrepresented Minority', 'Universities', 'Variant', 'Washington', 'clinical practice', 'clinical research site', 'cost', 'data management', 'data sharing', 'deep learning', 'design', 'disease diagnosis', 'exome sequencing', 'experience', 'follow-up', 'genetic variant', 'genome sequencing', 'improved', 'innovation', 'medical schools', 'medical specialties', 'network models', 'operation', 'outreach', 'recruit', 'research clinical testing', 'screening', 'sequencing platform', 'student training', 'success', 'transcriptome sequencing']",NHGRI,WASHINGTON UNIVERSITY,U01,2019,750000,0.07085468040883595
"Washington University School of Medicine Undiagnosed Diseases Network Clinical Site 1.0 PROJECT SUMMARY The scientific premise of this application is that the individualized translational research process of the Undiagnosed Diseases Network (UDN) developed during Phase I is scalable and that its impact on patients, families, and disease discovery can be advanced and sustained by addition of a Clinical Site at Washington University School of Medicine (WUSM). WUSM represents a large academic medical center that is fully integrated with world-renowned basic science capabilities and demonstrated expertise in a gene first approach for patients with undiagnosed diseases. The highly collaborative clinical and biomedical research culture at WUSM promotes interactions within and across Departments, with institutional genomic, clinical, computational, and model system experts, and with colleagues regionally, nationally, and internationally. These interactions support recruitment, selection, evaluation, diagnosis discovery, and follow up of pediatric and adult patients with undiagnosed diseases through both established networks and individual referrals. Building on this infrastructure, WUSM faculty and staff will advance the success of the UDN in diagnosing and managing disease in undiagnosed patients by, first, using, refining, and improving protocols designed during Phase I of the UDN for comprehensive, timely clinical evaluations of 30 undiagnosed patients annually. Secondly, we will collect, securely store, and share standardized, high-quality clinical and laboratory data including genotyping, phenotyping, and documentation of environmental exposures and promote an integrated and collaborative community across the UDN and among laboratory and clinical investigators focused on defining the pathophysiology, cell biologic, and molecular mechanisms that cause these difficult to diagnose diseases. Thirdly, the WUSM UDN Clinical Site will propose a bioinformatics plan for leveraging institutional infrastructure and expertise to develop innovative strategies to improve discovery of pathogenic variants. Fourthly, the assessment, dissemination, outreach, and training plan will accelerate assessment and dissemination of data, protocols, consent materials, and methods, availability of educational and outreach materials for participants, clinicians, and other researchers, engagement of underrepresented minorities, and training for students, fellows, staff, and faculty in collaboration with WUSMâ€™s Clinical and Translational Science Award infrastructure. Finally, WUSM will make a clear institutional commitment to maintain its Clinical Site, to adapt UDN Phase I practices for sustainability, to contribute to formation of a sustainable national UDN resource, and to adapt to unique needs and unexpected circumstances that may arise once Common Fund support ends in fiscal year 2022. 2.0 PROJECT NARRATIVE Undiagnosed diseases in children and adults represent frustrating and costly challenges for patients, families, physicians, and society. Building on established institutional infrastructure similar to the Undiagnosed Diseases Network (UDN), Washington University School of Medicine (WUSM) will establish a UDN Clinical Site to improve the level of diagnosis and care for patients with undiagnosed diseases, facilitate research into the etiology of undiagnosed diseases, and promote an integrated and collaborative community across multiple UDN Clinical Sites, Sequencing Cores, Model Organisms Screening Centers, and among laboratory and clinical investigators. Specifically, the WUSM UDN Clinical Site will annually recruit, select, evaluate, and follow 30 participants with disorders in any clinical specialty, adult and pediatric, provide comprehensive clinical evaluations that require <5 days and follow up, and participate in all UDN protocols, data management and sharing, and sustainability planning.",Washington University School of Medicine Undiagnosed Diseases Network Clinical Site,9593059,U01HG010215,"['Academic Medical Centers', 'Accreditation', 'Adult', 'Animal Model', 'Basic Science', 'Bioinformatics', 'Biomedical Research', 'Businesses', 'Cells', 'Child', 'Childhood', 'Classification', 'Clinical', 'Clinical Investigator', 'Clinical Research', 'Clinical Sciences', 'Clinical and Translational Science Awards', 'Collaborations', 'Communities', 'Computer Simulation', 'Consent', 'DNA Sequencing Facility', 'Data', 'Development', 'Diagnosis', 'Diagnostic', 'Disease', 'Disease Management', 'Documentation', 'Environmental Exposure', 'Etiology', 'Evaluation', 'Expert Systems', 'Faculty', 'Family', 'Family Physicians', 'Functional disorder', 'Funding', 'Genes', 'Genomics', 'Genotype', 'Geographic Locations', 'Individual', 'Institutes', 'International', 'Laboratories', 'Methods', 'Molecular', 'Monitor', 'Network-based', 'Participant', 'Pathogenicity', 'Patient Care', 'Patients', 'Phase', 'Phase I Clinical Trials', 'Phenotype', 'Process', 'Protocols documentation', 'Research', 'Research Infrastructure', 'Research Personnel', 'Resources', 'Review Committee', 'Secure', 'Societies', 'Standardization', 'Time', 'Training', 'Translational Research', 'Underrepresented Minority', 'Universities', 'Variant', 'Washington', 'clinical practice', 'clinical research site', 'cost', 'data management', 'deep learning', 'design', 'disease diagnosis', 'exome sequencing', 'experience', 'follow-up', 'genetic variant', 'genome sequencing', 'improved', 'innovation', 'medical schools', 'medical specialties', 'network models', 'operation', 'outreach', 'recruit', 'research clinical testing', 'screening', 'sequencing platform', 'student training', 'success', 'transcriptome sequencing']",NHGRI,WASHINGTON UNIVERSITY,U01,2018,750000,0.07085468040883595
"COMPUTATIONAL APPROACH TO NEUROPEPTIDES AND DRUG ABUSE    DESCRIPTION (provided by applicant): The identification of novel neuropeptides that act as the endogenous ligand for orphan G Protein Coupled Receptors (GPCRs) has been a slow and costly process that required the purification of an unstable peptide from a brain homogenate. This process can be improved upon using newly developed computational methodologies. A neuropeptide prohormone profile based upon species comparison has been produced. This profile includes a signal sequence, a region of dissimilarity between the species, a splicing site (double basic residues), a region of similarity between the species, and another splicing site. This profile can be modeled computationally using newly developed Match Profile Hidden Markov Model (MPHMM) methodology. The MPHMM computational profile will be used to identify putative novel prohormones and hormones from a dataset of all known and proposed or hypothetical proteins obtained from either the Celera Discovery System (CDS) or from public sources (GenBank). Software tools will be improved upon to enable discriminative training of match modules and to control ranking via visualization of matches. Once putative peptide hormones are proposed, their transcripts will be identified by quantitative rtPCR and localized using in situ hybridization. To identify which of these might be involved in drug abuse, transcript levels will be determined in brain after acute and chronic treatment of mice with morphine, cocaine, and nicotine or after withdrawal from the drug. Any transcript that changes subsequent to treatment with drugs of abuse will be highest priority in the ensuing purification and identification of the proposed neuropeptide. These studies should lead to the identification of novel neuropeptides that could be involved in the drug abuse process.         n/a",COMPUTATIONAL APPROACH TO NEUROPEPTIDES AND DRUG ABUSE,6719648,R21DA016629,"['G protein', 'G protein coupled receptor kinase', 'behavioral /social science research tag', 'biological signal transduction', 'cocaine', 'computer program /software', 'drug abuse', 'drug withdrawal', 'enzyme activity', 'in situ hybridization', 'laboratory mouse', 'mathematical model', 'messenger RNA', 'morphine', 'neuropeptides', 'neuroregulation', 'nicotine', 'northern blottings', 'pathologic process', 'peptide hormone', 'peptide hormone biosynthesis', 'polymerase chain reaction', 'protein localization', 'protein sequence', 'receptor coupling', 'tissue /cell culture']",NIDA,SRI INTERNATIONAL,R21,2004,194985,0.03207691651126568
"COMPUTATIONAL APPROACH TO NEUROPEPTIDES AND DRUG ABUSE    DESCRIPTION (provided by applicant): The identification of novel neuropeptides that act as the endogenous ligand for orphan G Protein Coupled Receptors (GPCRs) has been a slow and costly process that required the purification of an unstable peptide from a brain homogenate. This process can be improved upon using newly developed computational methodologies. A neuropeptide prohormone profile based upon species comparison has been produced. This profile includes a signal sequence, a region of dissimilarity between the species, a splicing site (double basic residues), a region of similarity between the species, and another splicing site. This profile can be modeled computationally using newly developed Match Profile Hidden Markov Model (MPHMM) methodology. The MPHMM computational profile will be used to identify putative novel prohormones and hormones from a dataset of all known and proposed or hypothetical proteins obtained from either the Celera Discovery System (CDS) or from public sources (GenBank). Software tools will be improved upon to enable discriminative training of match modules and to control ranking via visualization of matches. Once putative peptide hormones are proposed, their transcripts will be identified by quantitative rtPCR and localized using in situ hybridization. To identify which of these might be involved in drug abuse, transcript levels will be determined in brain after acute and chronic treatment of mice with morphine, cocaine, and nicotine or after withdrawal from the drug. Any transcript that changes subsequent to treatment with drugs of abuse will be highest priority in the ensuing purification and identification of the proposed neuropeptide. These studies should lead to the identification of novel neuropeptides that could be involved in the drug abuse process.         n/a",COMPUTATIONAL APPROACH TO NEUROPEPTIDES AND DRUG ABUSE,6671639,R21DA016629,"['G protein', ' G protein coupled receptor kinase', ' behavioral /social science research tag', ' biological signal transduction', ' cocaine', ' computer program /software', ' drug abuse', ' drug withdrawal', ' enzyme activity', ' in situ hybridization', ' laboratory mouse', ' mathematical model', ' messenger RNA', ' morphine', ' neuropeptides', ' neuroregulation', ' nicotine', ' northern blottings', ' pathologic process', ' peptide hormone', ' peptide hormone biosynthesis', ' polymerase chain reaction', ' protein localization', ' protein sequence', ' receptor coupling', ' tissue /cell culture']",NIDA,SRI INTERNATIONAL,R21,2003,195376,0.03207691651126568
"COMPUTERIZED DENSITOMETRY OF NEUROCHEMICALS Techniques of quantitative autoradiography have been employed to gain insights to chemical mechanisms involved in the regulation of brain function.  We will refine the method of quantitative autoradiography to allow more precise assessments of neurotransmitter receptors and drug binding sites in the central nervous system (CNS).  Particular attention will be directed to the problem of quenching of tritium emissions by white matter, and we will establish criteria for introducing quench corrections in studies involving human tissue.  We will extend studies on the quantitative autoradiography of monoamine uptake sites, utilizing the antidepressant compounds desmethylimipramine and imipramine to identify, respectively, uptake sites for norepinephrine (NE) and serotonin (5-HT). Studies will be conducted to examine the ontogeny of monoamine uptake sites, possible sex differences, regulation of these sites and their distribution in post-mortem human brain.  Further studies will examine monoamine receptors, and compare the distribution of monoamine uptake sites and receptors.  The ontogeny of betal and beta2 adrenergic receptors will be examined, as will the cellular location of these selective subtypes, using the selective neurotoxin ibotenic acid.  The location of putative internalized beta adrenergic receptors will also be studied.  A major new emphasis of the present proposal will be studies of possible differences in neurotransmitter receptors in post-mortem brain tissue from patients with Huntington's disease, schizophrenia and manic-depressive illness. Extensive studies will be conducted of alterations in thyrotropin releasing hormone (TRH) and receptors for TRH in spinal tissue of patients with amyotrophic lateral sclerosis (ALS).  The results of these experiments should provide important new basic information about the location and regulation of neurotransmitter receptors in rat brain, and important new clinical information about possible changes in neurotransmitter receptors in neurological and psychiatric diseases.  n/a",COMPUTERIZED DENSITOMETRY OF NEUROCHEMICALS,3399715,R01NS019597,"[""Huntington's disease"", ' antidepressants', ' artificial intelligence', ' autoradiography', ' beta adrenergic receptor', ' biochemical evolution', ' bipolar depression', ' brain disorder diagnosis', ' brain metabolism', ' degenerative motor system disease', ' diagnosis design /evaluation', ' hormone receptor', ' human tissue', ' imipramine', ' laboratory rat', ' nervous system disorder diagnosis', ' neural information processing', ' neurochemistry', ' neuropharmacology', ' neurotoxins', ' neurotransmitter receptor', ' norepinephrine', ' postmortem', ' schizophrenia', ' serotonin', ' thyrotropin releasing hormone', ' tritium']",NINDS,UNIVERSITY OF PENNSYLVANIA,R01,1988,70243,0.04230080535160494
"COMPUTERIZED DENSITOMETRY OF NEUROCHEMICALS Techniques of quantitative autoradiography have been employed to gain insights to chemical mechanisms involved in the regulation of brain function.  We will refine the method of quantitative autoradiography to allow more precise assessments of neurotransmitter receptors and drug binding sites in the central nervous system (CNS).  Particular attention will be directed to the problem of quenching of tritium emissions by white matter, and we will establish criteria for introducing quench corrections in studies involving human tissue.  We will extend studies on the quantitative autoradiography of monoamine uptake sites, utilizing the antidepressant compounds desmethylimipramine and imipramine to identify, respectively, uptake sites for norepinephrine (NE) and serotonin (5-HT). Studies will be conducted to examine the ontogeny of monoamine uptake sites, possible sex differences, regulation of these sites and their distribution in post-mortem human brain.  Further studies will examine monoamine receptors, and compare the distribution of monoamine uptake sites and receptors.  The ontogeny of betal and beta2 adrenergic receptors will be examined, as will the cellular location of these selective subtypes, using the selective neurotoxin ibotenic acid.  The location of putative internalized beta adrenergic receptors will also be studied.  A major new emphasis of the present proposal will be studies of possible differences in neurotransmitter receptors in post-mortem brain tissue from patients with Huntington's disease, schizophrenia and manic-depressive illness. Extensive studies will be conducted of alterations in thyrotropin releasing hormone (TRH) and receptors for TRH in spinal tissue of patients with amyotrophic lateral sclerosis (ALS).  The results of these experiments should provide important new basic information about the location and regulation of neurotransmitter receptors in rat brain, and important new clinical information about possible changes in neurotransmitter receptors in neurological and psychiatric diseases.  n/a",COMPUTERIZED DENSITOMETRY OF NEUROCHEMICALS,3399714,R01NS019597,"[""Huntington's disease"", ' antidepressants', ' artificial intelligence', ' autoradiography', ' biochemical evolution', ' brain disorder diagnosis', ' brain metabolism', ' degenerative motor system disease', ' human tissue', ' imipramine', ' nervous system disorder diagnosis', ' neural information processing', ' neurochemistry', ' neuropharmacology', ' neurotoxins', ' norepinephrine', ' postmortem', ' schizophrenia', ' serotonin', ' thyrotropin releasing hormone', ' tritium']",NINDS,UNIVERSITY OF PENNSYLVANIA,R01,1987,73141,0.04230080535160494
"COMPUTERIZED DENSITOMETRY OF NEUROCHEMICALS Techniques of quantitative autoradiography have been employed to gain insights to chemical mechanisms involved in the regulation of brain function.  We will refine the method of quantitative autoradiography to allow more precise assessments of neurotransmitter receptors and drug binding sites in the central nervous system (CNS).  Particular attention will be directed to the problem of quenching of tritium emissions by white matter, and we will establish criteria for introducing quench corrections in studies involving human tissue.  We will extend studies on the quantitative autoradiography of monoamine uptake sites, utilizing the antidepressant compounds desmethylimipramine and imipramine to identify, respectively, uptake sites for norepinephrine (NE) and serotonin (5-HT). Studies will be conducted to examine the ontogeny of monoamine uptake sites, possible sex differences, regulation of these sites and their distribution in post-mortem human brain.  Further studies will examine monoamine receptors, and compare the distribution of monoamine uptake sites and receptors.  The ontogeny of betal and beta2 adrenergic receptors will be examined, as will the cellular location of these selective subtypes, using the selective neurotoxin ibotenic acid.  The location of putative internalized beta adrenergic receptors will also be studied.  A major new emphasis of the present proposal will be studies of possible differences in neurotransmitter receptors in post-mortem brain tissue from patients with Huntington's disease, schizophrenia and manic-depressive illness. Extensive studies will be conducted of alterations in thyrotropin releasing hormone (TRH) and receptors for TRH in spinal tissue of patients with amyotrophic lateral sclerosis (ALS).  The results of these experiments should provide important new basic information about the location and regulation of neurotransmitter receptors in rat brain, and important new clinical information about possible changes in neurotransmitter receptors in neurological and psychiatric diseases.  n/a",COMPUTERIZED DENSITOMETRY OF NEUROCHEMICALS,3399711,R01NS019597,"[""Huntington's disease"", ' antidepressants', ' artificial intelligence', ' autoradiography', ' biochemical evolution', ' brain disorder diagnosis', ' brain metabolism', ' degenerative motor system disease', ' human tissue', ' imipramine', ' nervous system disorder diagnosis', ' neural information processing', ' neurochemistry', ' neuropharmacology', ' neurotoxins', ' norepinephrine', ' postmortem', ' schizophrenia', ' serotonin', ' thyrotropin releasing hormone']",NINDS,UNIVERSITY OF PENNSYLVANIA,R01,1986,65571,0.04230080535160494
"Morphometry Biomedical Informatics Research Network    DESCRIPTION (provided by applicant):     Technological advances in imaging have revolutionized the biomedical investigation of illness. The tremendous potential that this methodology brings to advancing diagnostic and prognostic capabilities and in treatment of illnesses has as yet remained largely an unfulfilled promise. This potential has been limited by a number of technological impediments that could be in large part overcome by the availability of a federated imaging database and the attendant infrastructure. Specifically, the ability to conduct clinical imaging studies across multiple sites, to analyze imaging data with the most powerful software regardless of development site, and to test new hypotheses on large collections of subjects with well characterized image and clinical data would have a demonstrable and positive impact on progress in this field. The Morphometry BIRN (mBIRN), established in October 2001, has made substantial progress in the development of this national infrastructure to develop a data and computational network based on a federated data acquisition and database across seven sites in the service of facilitating multi-site neuroanatomic analysis. Standardized structural MRI image acquisition protocols have been developed and implemented that demonstrably reduce initial sources of inter-site variance. Data structure, transmission, storage and querying aspects of the federated database have been implemented. In this continuation of the mBIRN efforts, we propose three broad areas of work:   1) continuing structural MRI acquisition optimization, calibration and validation to include T2 and DTI; 2) translation of site specific state-of-the-art image analysis, visualization and machine learning technologies to work in the federated, multi-site BIRN environment; and 3) extension of data management and database query capabilities to include additional imaging modalities, clinical disorders and individualized human genetic covariates. These broad areas of work will come together in through key collaborations that will ensure utilization promotion by facilitating data entry into the federated database and creation of database incentive functionality. Our participating sites include MGH (PI), BWH, UCI, Duke, UCLA, UCSD, John Hopkins, and newly added Washington University and MIT. We have made a concerted effort to bridge the gap that can exist between biomedical and computational sciences by recruiting to our group leaders in both of these domains. Our efforts will be coordinated with those of the entire BIRN consortium in order to insure that acquisition and database functionality, and application-based disorder queries are interoperable across sites and designed to advance the capabilities to further knowledge and understanding of health and disease.         n/a",Morphometry Biomedical Informatics Research Network,7467385,U24RR021382,[' '],NCRR,MASSACHUSETTS GENERAL HOSPITAL,U24,2008,5140823,0.1354233895395745
"Morphometry Biomedical Informatics Research Network    DESCRIPTION (provided by applicant):     Technological advances in imaging have revolutionized the biomedical investigation of illness. The tremendous potential that this methodology brings to advancing diagnostic and prognostic capabilities and in treatment of illnesses has as yet remained largely an unfulfilled promise. This potential has been limited by a number of technological impediments that could be in large part overcome by the availability of a federated imaging database and the attendant infrastructure. Specifically, the ability to conduct clinical imaging studies across multiple sites, to analyze imaging data with the most powerful software regardless of development site, and to test new hypotheses on large collections of subjects with well characterized image and clinical data would have a demonstrable and positive impact on progress in this field. The Morphometry BIRN (mBIRN), established in October 2001, has made substantial progress in the development of this national infrastructure to develop a data and computational network based on a federated data acquisition and database across seven sites in the service of facilitating multi-site neuroanatomic analysis. Standardized structural MRI image acquisition protocols have been developed and implemented that demonstrably reduce initial sources of inter-site variance. Data structure, transmission, storage and querying aspects of the federated database have been implemented. In this continuation of the mBIRN efforts, we propose three broad areas of work:   1) continuing structural MRI acquisition optimization, calibration and validation to include T2 and DTI; 2) translation of site specific state-of-the-art image analysis, visualization and machine learning technologies to work in the federated, multi-site BIRN environment; and 3) extension of data management and database query capabilities to include additional imaging modalities, clinical disorders and individualized human genetic covariates. These broad areas of work will come together in through key collaborations that will ensure utilization promotion by facilitating data entry into the federated database and creation of database incentive functionality. Our participating sites include MGH (PI), BWH, UCI, Duke, UCLA, UCSD, John Hopkins, and newly added Washington University and MIT. We have made a concerted effort to bridge the gap that can exist between biomedical and computational sciences by recruiting to our group leaders in both of these domains. Our efforts will be coordinated with those of the entire BIRN consortium in order to insure that acquisition and database functionality, and application-based disorder queries are interoperable across sites and designed to advance the capabilities to further knowledge and understanding of health and disease.         n/a",Morphometry Biomedical Informatics Research Network,7253351,U24RR021382,[' '],NCRR,MASSACHUSETTS GENERAL HOSP,U24,2007,5123449,0.1354233895395745
"Morphometry Biomedical Informatics Research Network    DESCRIPTION (provided by applicant):     Technological advances in imaging have revolutionized the biomedical investigation of illness. The tremendous potential that this methodology brings to advancing diagnostic and prognostic capabilities and in treatment of illnesses has as yet remained largely an unfulfilled promise. This potential has been limited by a number of technological impediments that could be in large part overcome by the availability of a federated imaging database and the attendant infrastructure. Specifically, the ability to conduct clinical imaging studies across multiple sites, to analyze imaging data with the most powerful software regardless of development site, and to test new hypotheses on large collections of subjects with well characterized image and clinical data would have a demonstrable and positive impact on progress in this field. The Morphometry BIRN (mBIRN), established in October 2001, has made substantial progress in the development of this national infrastructure to develop a data and computational network based on a federated data acquisition and database across seven sites in the service of facilitating multi-site neuroanatomic analysis. Standardized structural MRI image acquisition protocols have been developed and implemented that demonstrably reduce initial sources of inter-site variance. Data structure, transmission, storage and querying aspects of the federated database have been implemented. In this continuation of the mBIRN efforts, we propose three broad areas of work:   1) continuing structural MRI acquisition optimization, calibration and validation to include T2 and DTI; 2) translation of site specific state-of-the-art image analysis, visualization and machine learning technologies to work in the federated, multi-site BIRN environment; and 3) extension of data management and database query capabilities to include additional imaging modalities, clinical disorders and individualized human genetic covariates. These broad areas of work will come together in through key collaborations that will ensure utilization promotion by facilitating data entry into the federated database and creation of database incentive functionality. Our participating sites include MGH (PI), BWH, UCI, Duke, UCLA, UCSD, John Hopkins, and newly added Washington University and MIT. We have made a concerted effort to bridge the gap that can exist between biomedical and computational sciences by recruiting to our group leaders in both of these domains. Our efforts will be coordinated with those of the entire BIRN consortium in order to insure that acquisition and database functionality, and application-based disorder queries are interoperable across sites and designed to advance the capabilities to further knowledge and understanding of health and disease.         n/a",Morphometry Biomedical Informatics Research Network,7078667,U24RR021382,"['bioimaging /biomedical imaging', 'bioinformatics', 'clinical research', 'computational biology', 'computer data analysis', 'computer program /software', 'computer system design /evaluation', 'cooperative study', 'data management', 'human subject', 'imaging /visualization /scanning', 'information systems', 'magnetic resonance imaging', 'method development', 'molecular biology information system', 'morphometry', 'neurogenetics', 'neuroimaging', 'neuropsychology']",NCRR,MASSACHUSETTS GENERAL HOSPITAL,U24,2006,5010926,0.1354233895395745
"Morphometry Biomedical Informatics Research Network    DESCRIPTION (provided by applicant):     Technological advances in imaging have revolutionized the biomedical investigation of illness. The tremendous potential that this methodology brings to advancing diagnostic and prognostic capabilities and in treatment of illnesses has as yet remained largely an unfulfilled promise. This potential has been limited by a number of technological impediments that could be in large part overcome by the availability of a federated imaging database and the attendant infrastructure. Specifically, the ability to conduct clinical imaging studies across multiple sites, to analyze imaging data with the most powerful software regardless of development site, and to test new hypotheses on large collections of subjects with well characterized image and clinical data would have a demonstrable and positive impact on progress in this field. The Morphometry BIRN (mBIRN), established in October 2001, has made substantial progress in the development of this national infrastructure to develop a data and computational network based on a federated data acquisition and database across seven sites in the service of facilitating multi-site neuroanatomic analysis. Standardized structural MRI image acquisition protocols have been developed and implemented that demonstrably reduce initial sources of inter-site variance. Data structure, transmission, storage and querying aspects of the federated database have been implemented. In this continuation of the mBIRN efforts, we propose three broad areas of work:   1) continuing structural MRI acquisition optimization, calibration and validation to include T2 and DTI; 2) translation of site specific state-of-the-art image analysis, visualization and machine learning technologies to work in the federated, multi-site BIRN environment; and 3) extension of data management and database query capabilities to include additional imaging modalities, clinical disorders and individualized human genetic covariates. These broad areas of work will come together in through key collaborations that will ensure utilization promotion by facilitating data entry into the federated database and creation of database incentive functionality. Our participating sites include MGH (PI), BWH, UCI, Duke, UCLA, UCSD, John Hopkins, and newly added Washington University and MIT. We have made a concerted effort to bridge the gap that can exist between biomedical and computational sciences by recruiting to our group leaders in both of these domains. Our efforts will be coordinated with those of the entire BIRN consortium in order to insure that acquisition and database functionality, and application-based disorder queries are interoperable across sites and designed to advance the capabilities to further knowledge and understanding of health and disease.         n/a",Morphometry Biomedical Informatics Research Network,6952714,U24RR021382,"['bioimaging /biomedical imaging', 'bioinformatics', 'clinical research', 'computational biology', 'computer data analysis', 'computer program /software', 'computer system design /evaluation', 'cooperative study', 'data management', 'human subject', 'imaging /visualization /scanning', 'information systems', 'magnetic resonance imaging', 'method development', 'molecular biology information system', 'morphometry', 'neurogenetics', 'neuroimaging', 'neuropsychology']",NCRR,MASSACHUSETTS GENERAL HOSPITAL,U24,2005,5013536,0.1354233895395745
"Morphometry Biomedical Informatics Research Network    DESCRIPTION (provided by applicant):     Technological advances in imaging have revolutionized the biomedical investigation of illness. The tremendous potential that this methodology brings to advancing diagnostic and prognostic capabilities and in treatment of illnesses has as yet remained largely an unfulfilled promise. This potential has been limited by a number of technological impediments that could be in large part overcome by the availability of a federated imaging database and the attendant infrastructure. Specifically, the ability to conduct clinical imaging studies across multiple sites, to analyze imaging data with the most powerful software regardless of development site, and to test new hypotheses on large collections of subjects with well characterized image and clinical data would have a demonstrable and positive impact on progress in this field. The Morphometry BIRN (mBIRN), established in October 2001, has made substantial progress in the development of this national infrastructure to develop a data and computational network based on a federated data acquisition and database across seven sites in the service of facilitating multi-site neuroanatomic analysis. Standardized structural MRI image acquisition protocols have been developed and implemented that demonstrably reduce initial sources of inter-site variance. Data structure, transmission, storage and querying aspects of the federated database have been implemented. In this continuation of the mBIRN efforts, we propose three broad areas of work:   1) continuing structural MRI acquisition optimization, calibration and validation to include T2 and DTI; 2) translation of site specific state-of-the-art image analysis, visualization and machine learning technologies to work in the federated, multi-site BIRN environment; and 3) extension of data management and database query capabilities to include additional imaging modalities, clinical disorders and individualized human genetic covariates. These broad areas of work will come together in through key collaborations that will ensure utilization promotion by facilitating data entry into the federated database and creation of database incentive functionality. Our participating sites include MGH (PI), BWH, UCI, Duke, UCLA, UCSD, John Hopkins, and newly added Washington University and MIT. We have made a concerted effort to bridge the gap that can exist between biomedical and computational sciences by recruiting to our group leaders in both of these domains. Our efforts will be coordinated with those of the entire BIRN consortium in order to insure that acquisition and database functionality, and application-based disorder queries are interoperable across sites and designed to advance the capabilities to further knowledge and understanding of health and disease.         n/a",Morphometry Biomedical Informatics Research Network,6909355,U24RR021382,"['bioimaging /biomedical imaging', 'bioinformatics', 'clinical research', 'computational biology', 'computer data analysis', 'computer program /software', 'computer system design /evaluation', 'cooperative study', 'data management', 'human subject', 'imaging /visualization /scanning', 'information systems', 'magnetic resonance imaging', 'method development', 'molecular biology information system', 'morphometry', 'neurogenetics', 'neuroimaging', 'neuropsychology']",NCRR,MASSACHUSETTS GENERAL HOSPITAL,U24,2004,3821536,0.1354233895395745
"COMPUTER ANALYSIS & PREDICTION OF PROTEIN STRUCTURE The amino acid sequence of a protein uniquely determines its tertiary            structure. Deciphering this relationship, the protein folding problem has        become increasingly important to molecular biologists. DNA sequencing has        become routine, but structural experiments remain very difficult.                Computational strategies are needed to help address this problem.                                                                                                 This proposal describes a strategy to identify the location of alpha-            helices and beta-strands throughout the sequence. A method for using off-        lattice simulations of a polypeptide chain to identify secondary structure       preferences in the ensemble average is proposed. Once secondary structure        is located, computational methods exist for generating plausible tertiary        structures. However, these combinatorial strategies give rise to a large         number of alternative structures which are difficult to distinguish from         the correct fold. Experimental and theoretical methods for clarifying the        distinction between correctly folded structures and their misfolded              counterparts will be considered.                                                                                                                                  In a new direction, we propose to develop a multiple sequence analysis           strategy to relate sequence and structure to function. In particular, we         will focus on identifying the binding sites on the G-alpha family of             GTPases for the relevant G-protein coupled receptors, G-beta-gamma and           downstream effectors. We plan to continue to develop a genetic algorithm         for the construction of polypeptide loops subject to a series of                 constraints. This method will be used to model the loop regions of G-            protein coupled receptors involved in the interaction with peptide ligands       and the hetero-trimeric G-protein complex.                                                                                                                        Finally, we propose to develop a new method to compare structures based on       the area of the minimal ""soap film"" that could join them following the           appropriate rotation and translation of one structure relative to another.       This provides a natural way to circumvent the gap penalty problem that           plagues current structure alignment algorithms.                                   n/a",COMPUTER ANALYSIS & PREDICTION OF PROTEIN STRUCTURE,2838542,R01GM039900,"['G protein', ' active sites', ' artificial intelligence', ' computer program /software', ' computer simulation', ' conformation', ' guanosinetriphosphatases', ' intermolecular interaction', ' peptides', ' physical model', ' protein engineering', ' protein folding', ' protein sequence', ' protein structure function', ' receptor coupling', ' thrombin', ' transcription factor']",NIGMS,UNIVERSITY OF CALIFORNIA SAN FRANCISCO,R01,1999,298431,-0.025986758783688436
"COMPUTER ANALYSIS & PREDICTION OF PROTEIN STRUCTURE The amino acid sequence of a protein uniquely determines its tertiary            structure. Deciphering this relationship, the protein folding problem has        become increasingly important to molecular biologists. DNA sequencing has        become routine, but structural experiments remain very difficult.                Computational strategies are needed to help address this problem.                                                                                                 This proposal describes a strategy to identify the location of alpha-            helices and beta-strands throughout the sequence. A method for using off-        lattice simulations of a polypeptide chain to identify secondary structure       preferences in the ensemble average is proposed. Once secondary structure        is located, computational methods exist for generating plausible tertiary        structures. However, these combinatorial strategies give rise to a large         number of alternative structures which are difficult to distinguish from         the correct fold. Experimental and theoretical methods for clarifying the        distinction between correctly folded structures and their misfolded              counterparts will be considered.                                                                                                                                  In a new direction, we propose to develop a multiple sequence analysis           strategy to relate sequence and structure to function. In particular, we         will focus on identifying the binding sites on the G-alpha family of             GTPases for the relevant G-protein coupled receptors, G-beta-gamma and           downstream effectors. We plan to continue to develop a genetic algorithm         for the construction of polypeptide loops subject to a series of                 constraints. This method will be used to model the loop regions of G-            protein coupled receptors involved in the interaction with peptide ligands       and the hetero-trimeric G-protein complex.                                                                                                                        Finally, we propose to develop a new method to compare structures based on       the area of the minimal ""soap film"" that could join them following the           appropriate rotation and translation of one structure relative to another.       This provides a natural way to circumvent the gap penalty problem that           plagues current structure alignment algorithms.                                   n/a",COMPUTER ANALYSIS & PREDICTION OF PROTEIN STRUCTURE,2608876,R01GM039900,"['G protein', ' active sites', ' artificial intelligence', ' computer program /software', ' computer simulation', ' conformation', ' guanosinetriphosphatases', ' intermolecular interaction', ' peptides', ' physical model', ' protein engineering', ' protein folding', ' protein sequence', ' protein structure function', ' receptor coupling', ' thrombin', ' transcription factor']",NIGMS,UNIVERSITY OF CALIFORNIA SAN FRANCISCO,R01,1998,289568,-0.025986758783688436
"COMPUTER ANALYSIS & PREDICTION OF PROTEIN STRUCTURE The amino acid sequence of a protein uniquely determines its tertiary            structure. Deciphering this relationship, the protein folding problem has        become increasingly important to molecular biologists. DNA sequencing has        become routine, but structural experiments remain very difficult.                Computational strategies are needed to help address this problem.                                                                                                 This proposal describes a strategy to identify the location of alpha-            helices and beta-strands throughout the sequence. A method for using off-        lattice simulations of a polypeptide chain to identify secondary structure       preferences in the ensemble average is proposed. Once secondary structure        is located, computational methods exist for generating plausible tertiary        structures. However, these combinatorial strategies give rise to a large         number of alternative structures which are difficult to distinguish from         the correct fold. Experimental and theoretical methods for clarifying the        distinction between correctly folded structures and their misfolded              counterparts will be considered.                                                                                                                                  In a new direction, we propose to develop a multiple sequence analysis           strategy to relate sequence and structure to function. In particular, we         will focus on identifying the binding sites on the G-alpha family of             GTPases for the relevant G-protein coupled receptors, G-beta-gamma and           downstream effectors. We plan to continue to develop a genetic algorithm         for the construction of polypeptide loops subject to a series of                 constraints. This method will be used to model the loop regions of G-            protein coupled receptors involved in the interaction with peptide ligands       and the hetero-trimeric G-protein complex.                                                                                                                        Finally, we propose to develop a new method to compare structures based on       the area of the minimal ""soap film"" that could join them following the           appropriate rotation and translation of one structure relative to another.       This provides a natural way to circumvent the gap penalty problem that           plagues current structure alignment algorithms.                                   n/a",COMPUTER ANALYSIS & PREDICTION OF PROTEIN STRUCTURE,2022214,R01GM039900,"['G protein', ' active sites', ' artificial intelligence', ' computer program /software', ' computer simulation', ' conformation', ' guanosinetriphosphatases', ' intermolecular interaction', ' peptides', ' physical model', ' protein engineering', ' protein folding', ' protein sequence', ' protein structure function', ' receptor coupling', ' thrombin', ' transcription factor']",NIGMS,UNIVERSITY OF CALIFORNIA SAN FRANCISCO,R01,1997,279111,-0.025986758783688436
"COMPUTER ANALYSIS AND PREDICTION OF PROTEIN STRUCTURE      The amino acid sequence of a protein uniquely determines its tertiary  structure.  Deciphering this relationship, the protein folding problem, has  become increasingly important to molecular biologists.  DNA sequencing has  become routine, but structural experiments remain very difficult.  Computational strategies are needed to help address this problem.         This proposal describes a strategy to identify the location of  alpha-helices and beta-strands throughout the sequence.  A rationale is  offered for employing neural networks and pattern based algorithms to  address the secondary structure prediction problem.  Once secondary  structure is located, computational methods exist for generating plausible  tertiary structures.  However, these combinatorial strategies give rise to  a large number of alternative structures which are difficult to distinguish  from the correct fold.  Simplified potential functions are proposed as a  method for overcoming this structure evaluation problem.  The properties of  a non-lattice based simplified representation of a polypeptide chain will  be explored to aid in the construction of an appropriate simplified  potential function. Collaborative ventures are planned to experimentally  test the merits of existing algorithms for predicting protein structure.         In collaboration with Dr. Bunn at Harvard, the relationship of the  erythropoietin sequence to its structure and function will be explored.  In  collaboration with Dr.  Wang at UCSF, the merits of a proposed structure of  hypoxanthine guanine phosphoribosyl transferase will be studied using site  directed mutagenesis.  An exploration of the possibility of grafting the  active site of one enzyme onto the structural scaffold provided by another  protein will be studied in collaboration with Dr. Craik at UCSF and Dr.  Wells at Genentech.  n/a",COMPUTER ANALYSIS AND PREDICTION OF PROTEIN STRUCTURE,2180085,R01GM039900,"['active sites', ' artificial intelligence', ' computer graphics /printing', ' computer program /software', ' computer simulation', ' conformation', ' enzyme structure', ' erythropoietin', ' globular protein', ' hypoxanthine phosphoribosyltransferase', ' intermolecular interaction', ' molecular dynamics', ' parallel processing', ' physical model', ' protein engineering', ' protein folding', ' protein sequence', ' protein structure function', ' site directed mutagenesis']",NIGMS,UNIVERSITY OF CALIFORNIA SAN FRANCISCO,R01,1995,253389,0.06064951965394561
"COMPUTER ANALYSIS AND PREDICTION OF PROTEIN STRUCTURE      The amino acid sequence of a protein uniquely determines its tertiary structure.  Deciphering this relationship, the protein folding problem, has become increasingly important to molecular biologists.  DNA sequencing has become routine, but structural experiments remain very difficult. Computational strategies are needed to help address this problem.       This proposal describes a strategy to identify the location of alpha-helices and beta-strands throughout the sequence.  A rationale is offered for employing neural networks and pattern based algorithms to address the secondary structure prediction problem.  Once secondary structure is located, computational methods exist for generating plausible tertiary structures.  However, these combinatorial strategies give rise to a large number of alternative structures which are difficult to distinguish from the correct fold.  Simplified potential functions are proposed as a method for overcoming this structure evaluation problem.  The properties of a non-lattice based simplified representation of a polypeptide chain will be explored to aid in the construction of an appropriate simplified potential function. Collaborative ventures are planned to experimentally test the merits of existing algorithms for predicting protein structure.       In collaboration with Dr. Bunn at Harvard, the relationship of the erythropoietin sequence to its structure and function will be explored.  In collaboration with Dr.  Wang at UCSF, the merits of a proposed structure of hypoxanthine guanine phosphoribosyl transferase will be studied using site directed mutagenesis.  An exploration of the possibility of grafting the active site of one enzyme onto the structural scaffold provided by another protein will be studied in collaboration with Dr. Craik at UCSF and Dr. Wells at Genentech.  n/a",COMPUTER ANALYSIS AND PREDICTION OF PROTEIN STRUCTURE,2180084,R01GM039900,"['active sites', ' artificial intelligence', ' computer graphics /printing', ' computer program /software', ' computer simulation', ' conformation', ' enzyme structure', ' erythropoietin', ' globular protein', ' hypoxanthine phosphoribosyltransferase', ' intermolecular interaction', ' molecular dynamics', ' parallel processing', ' physical model', ' protein engineering', ' protein folding', ' protein sequence', ' protein structure function', ' site directed mutagenesis']",NIGMS,UNIVERSITY OF CALIFORNIA SAN FRANCISCO,R01,1994,206550,0.06064951965394561
"COMPUTER ANALYSIS AND PREDICTION OF PROTEIN STRUCTURE      The amino acid sequence of a protein uniquely determines its tertiary structure.  Deciphering this relationship, the protein folding problem, has become increasingly important to molecular biologists.  DNA sequencing has become routine, but structural experiments remain very difficult. Computational strategies are needed to help address this problem.       This proposal describes a strategy to identify the location of alpha-helices and beta-strands throughout the sequence.  A rationale is offered for employing neural networks and pattern based algorithms to address the secondary structure prediction problem.  Once secondary structure is located, computational methods exist for generating plausible tertiary structures.  However, these combinatorial strategies give rise to a large number of alternative structures which are difficult to distinguish from the correct fold.  Simplified potential functions are proposed as a method for overcoming this structure evaluation problem.  The properties of a non-lattice based simplified representation of a polypeptide chain will be explored to aid in the construction of an appropriate simplified potential function. Collaborative ventures are planned to experimentally test the merits of existing algorithms for predicting protein structure.       In collaboration with Dr. Bunn at Harvard, the relationship of the erythropoietin sequence to its structure and function will be explored.  In collaboration with Dr.  Wang at UCSF, the merits of a proposed structure of hypoxanthine guanine phosphoribosyl transferase will be studied using site directed mutagenesis.  An exploration of the possibility of grafting the active site of one enzyme onto the structural scaffold provided by another protein will be studied in collaboration with Dr. Craik at UCSF and Dr. Wells at Genentech.  n/a",COMPUTER ANALYSIS AND PREDICTION OF PROTEIN STRUCTURE,3297168,R01GM039900,"['active sites', ' artificial intelligence', ' computer graphics /printing', ' computer program /software', ' computer simulation', ' conformation', ' enzyme structure', ' erythropoietin', ' globular protein', ' hypoxanthine phosphoribosyltransferase', ' intermolecular interaction', ' molecular dynamics', ' parallel processing', ' physical model', ' protein engineering', ' protein folding', ' protein sequence', ' protein structure function', ' site directed mutagenesis']",NIGMS,UNIVERSITY OF CALIFORNIA SAN FRANCISCO,R01,1993,184222,0.06064951965394561
"COMPUTER ANALYSIS AND PREDICTION OF PROTEIN STRUCTURE      The amino acid sequence of a protein uniquely determines its tertiary structure.  Deciphering this relationship, the protein folding problem, has become increasingly important to molecular biologists.  DNA sequencing has become routine, but structural experiments remain very difficult. Computational strategies are needed to help address this problem.       This proposal describes a strategy to identify the location of alpha-helices and beta-strands throughout the sequence.  A rationale is offered for employing neural networks and pattern based algorithms to address the secondary structure prediction problem.  Once secondary structure is located, computational methods exist for generating plausible tertiary structures.  However, these combinatorial strategies give rise to a large number of alternative structures which are difficult to distinguish from the correct fold.  Simplified potential functions are proposed as a method for overcoming this structure evaluation problem.  The properties of a non-lattice based simplified representation of a polypeptide chain will be explored to aid in the construction of an appropriate simplified potential function. Collaborative ventures are planned to experimentally test the merits of existing algorithms for predicting protein structure.       In collaboration with Dr. Bunn at Harvard, the relationship of the erythropoietin sequence to its structure and function will be explored.  In collaboration with Dr.  Wang at UCSF, the merits of a proposed structure of hypoxanthine guanine phosphoribosyl transferase will be studied using site directed mutagenesis.  An exploration of the possibility of grafting the active site of one enzyme onto the structural scaffold provided by another protein will be studied in collaboration with Dr. Craik at UCSF and Dr. Wells at Genentech.  n/a",COMPUTER ANALYSIS AND PREDICTION OF PROTEIN STRUCTURE,3297165,R01GM039900,"['active sites', ' artificial intelligence', ' computer graphics /printing', ' computer program /software', ' computer simulation', ' conformation', ' enzyme structure', ' erythropoietin', ' globular protein', ' hypoxanthine phosphoribosyltransferase', ' intermolecular interaction', ' molecular dynamics', ' parallel processing', ' physical model', ' protein engineering', ' protein folding', ' protein sequence', ' protein structure function', ' site directed mutagenesis']",NIGMS,UNIVERSITY OF CALIFORNIA SAN FRANCISCO,R01,1992,171704,0.06064951965394561
"SPEECH RECOGNITION FOR CLINICAL TRIALS IN HYPERTENSION The overall aim of this effort is to develop a fully functional voice- activated computer system for clinical trials of hypertension to optimize data collection and reporting. This system will      1) facilitate data collection;      2) improve accuracy;      3) improve reliability and completeness;      4) improve timeliness. A randomized controlled study is proposed to demonstrate that this is an easier to use, more efficient, cost effective, complete and accurate method for clinical trials of hypertension than current systems.  The specific aims for Phase Il are:      1. Software engineering: refinement and expansion of actual system           a.   Inward database connections with coding databases (ICD-9,                WHO-ART, COSTART).           b.   Outward database connections, allowing electronic transfer                of data.           c.   Implementation of an audit trail           d.   Generalization of the knowledge base           e.   Refinement of the user interface      2. Testing and evaluation -- test site specific activities           a.   Collection of ergonomic information and user feedback for                multiple test sites           b.   Beta testing at multiple sites           c.   Evaluation of the system in a randomized controlled study      3. Transition to commercial development           a.   Market survey of hypertension clinical trial sites           b.   Development of a business and marketing plan         for the commercialization phase  n/a",SPEECH RECOGNITION FOR CLINICAL TRIALS IN HYPERTENSION,2224013,R44HL047965,"['artificial intelligence', ' automated medical record system', ' computer human interaction', ' computer system design /evaluation', ' questionnaires']",NHLBI,"DEGGE GROUP, LTD.",R44,1994,262795,0.06544917167734039
"Enhancer-mediated mechanisms of pattern formation ï»¿    DESCRIPTION (provided by applicant): Gene regulatory networks establish the body plans of complex multicellular animals. The main components of these networks are transcription factors and cis-regulatory elements (CREs) that contain unique combinations of transcription factor binding sites. Transgenic experiments have shown that CREs control spatial and temporal patterns of gene expression, but how binding events at the CRE level are converted into these patterns is still poorly understood. In humans, mutations that disrupt transcription factor activit or CRE DNA sequences can cause birth defects and disease states, including cancer. Here we propose to study CRE- mediated embryo patterning in the early Drosophila embryo, with a specific focus on CREs that respond to the maternal transcription factor Bicoid (Bcd). In previous work, we identified 66 Bcd-dependent CREs, which were validated by reporter genes in transgenic embryos. All 66 are directly activated by Bcd, but each contains a unique set of transcription factor-binding sites, and drives an expression pattern that appears as a band(s) or stripe(s) at a specific position(s) along the anterior-posterior (AP) axis. Expression pattern boundaries represent positions where genes make on/off decisions, and foreshadow boundaries between cells of different fates later in development. The work proposed here will focus on two major goals. First, we want to perform a deep, quantitative analysis of transcriptional activation by a single ""model"" CRE (hunchback P2E) that is activated by BCD. Two specific questions will be addressed: 1. how do individual binding sites, groups of binding sites, and combinations of sites for different factors contribute to transcriptional activation? We will combine DNA-binding data of different types to better define functional motifs, extensively mutate the CRE, and assay three specific output parameters using live imaging in close collaboration with Thomas Gregor's lab. 2. How does this Bcd-dependent CRE ""choose"" its specific basal promoter? We will use a split reporter system and single molecule FISH to identify basal promoter sequences that allow or prevent activation by Bcd, and CRISPR/Cas9 gene editing to test the importance of promoter choice in vivo. The second major goal will be to gain a conceptually complete understanding of the regulatory network that creates Bcd-dependent gene expression patterns. We have identified three proteins that function in broad activation, and nine candidate repressors expressed in discrete domains that together cover the entire embryonic region where activation can occur. We will use reporter gene manipulations and single molecule FISH to test how repressor gradients shape boundaries of gene expression, and genetics and reporter genes to test the roles of several newly identified repressors that prevent activation in anterior regions. Our hypothesis is that the expression patterns driven by all Bcd-dependent CREs are ""computed"" by specific combinations of binding sites for these twelve factors. These experiments will make significant contributions to our general understanding of how CREs functions in activation and repression events, and how embryos establish body plans. PUBLIC HEALTH RELEVANCE: Animal body plans are established by hundreds of DNA-binding factors that bind thousands of cis-regulatory elements (CREs). Our goals are to carry out the deepest analysis of gene activation by a single CRE in higher eukaryotes, and to understand how multiple CREs integrates activation and repression to pattern the embryo.",Enhancer-mediated mechanisms of pattern formation,9667439,R01GM051946,"['Address', 'Affinity', 'Animals', 'Anterior', 'Binding', 'Binding Proteins', 'Binding Sites', 'Biological Assay', 'Biological Models', 'Body Patterning', 'CRISPR/Cas technology', 'Cell Nucleus', 'Cells', 'Characteristics', 'Collaborations', 'Complement', 'Complex', 'Congenital Abnormality', 'DNA Binding', 'DNA Sequence', 'Data', 'Defect', 'Development', 'Disease', 'Dissection', 'Drosophila genus', 'Elements', 'Embryo', 'Enhancers', 'Eukaryota', 'Event', 'Funding', 'Gene Activation', 'Gene Expression', 'Gene Expression Profile', 'Gene Order', 'Genes', 'Genetic', 'Genetic Transcription', 'Goals', 'Homeodomain Proteins', 'Human', 'Image', 'Individual', 'Lead', 'Length', 'Link', 'Logic', 'Malignant Neoplasms', 'Measurement', 'Measures', 'Mediating', 'Modeling', 'Molecular', 'Mutate', 'Mutation', 'Output', 'Pattern', 'Pattern Formation', 'Play', 'Positioning Attribute', 'Proteins', 'RNA', 'Regulator Genes', 'Regulatory Element', 'Reporter', 'Reporter Genes', 'Repression', 'Role', 'Shapes', 'Site', 'System', 'Tertiary Protein Structure', 'Testing', 'Transact', 'Transcriptional Activation', 'Transgenic Organisms', 'Work', 'Zinc Fingers', 'bZIP Protein', 'base', 'cofactor', 'experimental study', 'fly', 'in vitro Assay', 'in vivo', 'loss of function mutation', 'machine learning algorithm', 'morphogens', 'prevent', 'promoter', 'protein function', 'public health relevance', 'single molecule', 'transcription factor']",NIGMS,NEW YORK UNIVERSITY,R01,2019,362238,-0.018382950601256966
"Enhancer-mediated mechanisms of pattern formation ï»¿    DESCRIPTION (provided by applicant): Gene regulatory networks establish the body plans of complex multicellular animals. The main components of these networks are transcription factors and cis-regulatory elements (CREs) that contain unique combinations of transcription factor binding sites. Transgenic experiments have shown that CREs control spatial and temporal patterns of gene expression, but how binding events at the CRE level are converted into these patterns is still poorly understood. In humans, mutations that disrupt transcription factor activit or CRE DNA sequences can cause birth defects and disease states, including cancer. Here we propose to study CRE- mediated embryo patterning in the early Drosophila embryo, with a specific focus on CREs that respond to the maternal transcription factor Bicoid (Bcd). In previous work, we identified 66 Bcd-dependent CREs, which were validated by reporter genes in transgenic embryos. All 66 are directly activated by Bcd, but each contains a unique set of transcription factor-binding sites, and drives an expression pattern that appears as a band(s) or stripe(s) at a specific position(s) along the anterior-posterior (AP) axis. Expression pattern boundaries represent positions where genes make on/off decisions, and foreshadow boundaries between cells of different fates later in development. The work proposed here will focus on two major goals. First, we want to perform a deep, quantitative analysis of transcriptional activation by a single ""model"" CRE (hunchback P2E) that is activated by BCD. Two specific questions will be addressed: 1. how do individual binding sites, groups of binding sites, and combinations of sites for different factors contribute to transcriptional activation? We will combine DNA-binding data of different types to better define functional motifs, extensively mutate the CRE, and assay three specific output parameters using live imaging in close collaboration with Thomas Gregor's lab. 2. How does this Bcd-dependent CRE ""choose"" its specific basal promoter? We will use a split reporter system and single molecule FISH to identify basal promoter sequences that allow or prevent activation by Bcd, and CRISPR/Cas9 gene editing to test the importance of promoter choice in vivo. The second major goal will be to gain a conceptually complete understanding of the regulatory network that creates Bcd-dependent gene expression patterns. We have identified three proteins that function in broad activation, and nine candidate repressors expressed in discrete domains that together cover the entire embryonic region where activation can occur. We will use reporter gene manipulations and single molecule FISH to test how repressor gradients shape boundaries of gene expression, and genetics and reporter genes to test the roles of several newly identified repressors that prevent activation in anterior regions. Our hypothesis is that the expression patterns driven by all Bcd-dependent CREs are ""computed"" by specific combinations of binding sites for these twelve factors. These experiments will make significant contributions to our general understanding of how CREs functions in activation and repression events, and how embryos establish body plans. PUBLIC HEALTH RELEVANCE: Animal body plans are established by hundreds of DNA-binding factors that bind thousands of cis-regulatory elements (CREs). Our goals are to carry out the deepest analysis of gene activation by a single CRE in higher eukaryotes, and to understand how multiple CREs integrates activation and repression to pattern the embryo.",Enhancer-mediated mechanisms of pattern formation,9450518,R01GM051946,"['Address', 'Affinity', 'Algorithms', 'Animals', 'Anterior', 'Binding', 'Binding Proteins', 'Binding Sites', 'Biological Assay', 'Biological Models', 'Body Patterning', 'CRISPR/Cas technology', 'Cell Nucleus', 'Cells', 'Characteristics', 'Collaborations', 'Complement', 'Complex', 'Congenital Abnormality', 'DNA Binding', 'DNA Sequence', 'Data', 'Defect', 'Development', 'Disease', 'Dissection', 'Drosophila genus', 'Elements', 'Embryo', 'Enhancers', 'Eukaryota', 'Event', 'Funding', 'Gene Activation', 'Gene Expression', 'Gene Expression Profile', 'Gene Order', 'Gene Targeting', 'Genes', 'Genetic', 'Genetic Transcription', 'Goals', 'Homeodomain Proteins', 'Human', 'Image', 'Individual', 'Lead', 'Length', 'Link', 'Logic', 'Machine Learning', 'Malignant Neoplasms', 'Measurement', 'Measures', 'Mediating', 'Modeling', 'Molecular', 'Mutate', 'Mutation', 'Output', 'Pattern', 'Pattern Formation', 'Play', 'Positioning Attribute', 'Proteins', 'RNA', 'Regulator Genes', 'Regulatory Element', 'Reporter', 'Reporter Genes', 'Repression', 'Role', 'Shapes', 'Site', 'System', 'Tertiary Protein Structure', 'Testing', 'Transact', 'Transcriptional Activation', 'Transgenic Organisms', 'Work', 'Zinc Fingers', 'bZIP Protein', 'base', 'cofactor', 'experimental study', 'fly', 'in vitro Assay', 'in vivo', 'loss of function mutation', 'morphogens', 'prevent', 'promoter', 'protein function', 'public health relevance', 'single molecule', 'transcription factor']",NIGMS,NEW YORK UNIVERSITY,R01,2018,362333,-0.018382950601256966
"Enhancer-mediated mechanisms of pattern formation ï»¿    DESCRIPTION (provided by applicant): Gene regulatory networks establish the body plans of complex multicellular animals. The main components of these networks are transcription factors and cis-regulatory elements (CREs) that contain unique combinations of transcription factor binding sites. Transgenic experiments have shown that CREs control spatial and temporal patterns of gene expression, but how binding events at the CRE level are converted into these patterns is still poorly understood. In humans, mutations that disrupt transcription factor activit or CRE DNA sequences can cause birth defects and disease states, including cancer. Here we propose to study CRE- mediated embryo patterning in the early Drosophila embryo, with a specific focus on CREs that respond to the maternal transcription factor Bicoid (Bcd). In previous work, we identified 66 Bcd-dependent CREs, which were validated by reporter genes in transgenic embryos. All 66 are directly activated by Bcd, but each contains a unique set of transcription factor-binding sites, and drives an expression pattern that appears as a band(s) or stripe(s) at a specific position(s) along the anterior-posterior (AP) axis. Expression pattern boundaries represent positions where genes make on/off decisions, and foreshadow boundaries between cells of different fates later in development. The work proposed here will focus on two major goals. First, we want to perform a deep, quantitative analysis of transcriptional activation by a single ""model"" CRE (hunchback P2E) that is activated by BCD. Two specific questions will be addressed: 1. how do individual binding sites, groups of binding sites, and combinations of sites for different factors contribute to transcriptional activation? We will combine DNA-binding data of different types to better define functional motifs, extensively mutate the CRE, and assay three specific output parameters using live imaging in close collaboration with Thomas Gregor's lab. 2. How does this Bcd-dependent CRE ""choose"" its specific basal promoter? We will use a split reporter system and single molecule FISH to identify basal promoter sequences that allow or prevent activation by Bcd, and CRISPR/Cas9 gene editing to test the importance of promoter choice in vivo. The second major goal will be to gain a conceptually complete understanding of the regulatory network that creates Bcd-dependent gene expression patterns. We have identified three proteins that function in broad activation, and nine candidate repressors expressed in discrete domains that together cover the entire embryonic region where activation can occur. We will use reporter gene manipulations and single molecule FISH to test how repressor gradients shape boundaries of gene expression, and genetics and reporter genes to test the roles of several newly identified repressors that prevent activation in anterior regions. Our hypothesis is that the expression patterns driven by all Bcd-dependent CREs are ""computed"" by specific combinations of binding sites for these twelve factors. These experiments will make significant contributions to our general understanding of how CREs functions in activation and repression events, and how embryos establish body plans. PUBLIC HEALTH RELEVANCE: Animal body plans are established by hundreds of DNA-binding factors that bind thousands of cis-regulatory elements (CREs). Our goals are to carry out the deepest analysis of gene activation by a single CRE in higher eukaryotes, and to understand how multiple CREs integrates activation and repression to pattern the embryo.",Enhancer-mediated mechanisms of pattern formation,9276695,R01GM051946,"['Address', 'Affinity', 'Algorithms', 'Animals', 'Anterior', 'Binding', 'Binding Proteins', 'Binding Sites', 'Biological Assay', 'Biological Models', 'Body Patterning', 'CRISPR/Cas technology', 'Cell Nucleus', 'Cells', 'Characteristics', 'Collaborations', 'Complement', 'Complex', 'Congenital Abnormality', 'DNA Binding', 'DNA Sequence', 'Data', 'Defect', 'Development', 'Disease', 'Dissection', 'Drosophila genus', 'Elements', 'Embryo', 'Enhancers', 'Eukaryota', 'Event', 'Funding', 'Gene Activation', 'Gene Expression', 'Gene Expression Profile', 'Gene Order', 'Gene Targeting', 'Genes', 'Genetic', 'Genetic Transcription', 'Goals', 'Homeodomain Proteins', 'Human', 'Image', 'Individual', 'Lead', 'Length', 'Link', 'Logic', 'Machine Learning', 'Malignant Neoplasms', 'Measurement', 'Measures', 'Mediating', 'Modeling', 'Molecular', 'Mutate', 'Mutation', 'Output', 'Pattern', 'Pattern Formation', 'Play', 'Positioning Attribute', 'Proteins', 'RNA', 'Regulator Genes', 'Regulatory Element', 'Reporter', 'Reporter Genes', 'Repression', 'Role', 'Shapes', 'Site', 'System', 'Tertiary Protein Structure', 'Testing', 'Transact', 'Transcriptional Activation', 'Transgenic Organisms', 'Work', 'Zinc Fingers', 'bZIP Protein', 'base', 'cofactor', 'experimental study', 'fly', 'in vitro Assay', 'in vivo', 'loss of function mutation', 'morphogens', 'prevent', 'promoter', 'protein function', 'public health relevance', 'single molecule', 'transcription factor']",NIGMS,NEW YORK UNIVERSITY,R01,2017,356861,-0.018382950601256966
"Enhancer-mediated mechanisms of pattern formation ï»¿    DESCRIPTION (provided by applicant): Gene regulatory networks establish the body plans of complex multicellular animals. The main components of these networks are transcription factors and cis-regulatory elements (CREs) that contain unique combinations of transcription factor binding sites. Transgenic experiments have shown that CREs control spatial and temporal patterns of gene expression, but how binding events at the CRE level are converted into these patterns is still poorly understood. In humans, mutations that disrupt transcription factor activit or CRE DNA sequences can cause birth defects and disease states, including cancer. Here we propose to study CRE- mediated embryo patterning in the early Drosophila embryo, with a specific focus on CREs that respond to the maternal transcription factor Bicoid (Bcd). In previous work, we identified 66 Bcd-dependent CREs, which were validated by reporter genes in transgenic embryos. All 66 are directly activated by Bcd, but each contains a unique set of transcription factor-binding sites, and drives an expression pattern that appears as a band(s) or stripe(s) at a specific position(s) along the anterior-posterior (AP) axis. Expression pattern boundaries represent positions where genes make on/off decisions, and foreshadow boundaries between cells of different fates later in development. The work proposed here will focus on two major goals. First, we want to perform a deep, quantitative analysis of transcriptional activation by a single ""model"" CRE (hunchback P2E) that is activated by BCD. Two specific questions will be addressed: 1. how do individual binding sites, groups of binding sites, and combinations of sites for different factors contribute to transcriptional activation? We will combine DNA-binding data of different types to better define functional motifs, extensively mutate the CRE, and assay three specific output parameters using live imaging in close collaboration with Thomas Gregor's lab. 2. How does this Bcd-dependent CRE ""choose"" its specific basal promoter? We will use a split reporter system and single molecule FISH to identify basal promoter sequences that allow or prevent activation by Bcd, and CRISPR/Cas9 gene editing to test the importance of promoter choice in vivo. The second major goal will be to gain a conceptually complete understanding of the regulatory network that creates Bcd-dependent gene expression patterns. We have identified three proteins that function in broad activation, and nine candidate repressors expressed in discrete domains that together cover the entire embryonic region where activation can occur. We will use reporter gene manipulations and single molecule FISH to test how repressor gradients shape boundaries of gene expression, and genetics and reporter genes to test the roles of several newly identified repressors that prevent activation in anterior regions. Our hypothesis is that the expression patterns driven by all Bcd-dependent CREs are ""computed"" by specific combinations of binding sites for these twelve factors. These experiments will make significant contributions to our general understanding of how CREs functions in activation and repression events, and how embryos establish body plans.         PUBLIC HEALTH RELEVANCE: Animal body plans are established by hundreds of DNA-binding factors that bind thousands of cis-regulatory elements (CREs). Our goals are to carry out the deepest analysis of gene activation by a single CRE in higher eukaryotes, and to understand how multiple CREs integrates activation and repression to pattern the embryo.            ",Enhancer-mediated mechanisms of pattern formation,9106490,R01GM051946,"['Address', 'Affinity', 'Algorithms', 'Animals', 'Anterior', 'Binding', 'Binding Proteins', 'Binding Sites', 'Biological Assay', 'Biological Models', 'Body Patterning', 'CRISPR/Cas technology', 'Cell Nucleus', 'Cells', 'Characteristics', 'Collaborations', 'Complement', 'Complex', 'Congenital Abnormality', 'DNA Binding', 'DNA Sequence', 'Data', 'Defect', 'Development', 'Developmental Gene', 'Disease', 'Dissection', 'Drosophila genus', 'Elements', 'Embryo', 'Enhancers', 'Eukaryota', 'Event', 'Funding', 'Gene Activation', 'Gene Expression', 'Gene Expression Profile', 'Gene Order', 'Gene Targeting', 'Genes', 'Genetic', 'Genetic Transcription', 'Goals', 'Homeodomain Proteins', 'Human', 'Image', 'Individual', 'Lead', 'Length', 'Life', 'Link', 'Logic', 'Machine Learning', 'Malignant Neoplasms', 'Measurement', 'Measures', 'Mediating', 'Modeling', 'Molecular', 'Mutate', 'Mutation', 'Output', 'Pattern', 'Pattern Formation', 'Play', 'Positioning Attribute', 'Proteins', 'RNA', 'Regulator Genes', 'Regulatory Element', 'Reporter', 'Reporter Genes', 'Repression', 'Role', 'Shapes', 'Site', 'System', 'Tertiary Protein Structure', 'Testing', 'Transact', 'Transcriptional Activation', 'Transgenic Organisms', 'Work', 'Zinc Fingers', 'base', 'cofactor', 'fly', 'in vitro Assay', 'in vivo', 'loss of function mutation', 'morphogens', 'prevent', 'promoter', 'protein function', 'public health relevance', 'research study', 'single molecule', 'transcription factor']",NIGMS,NEW YORK UNIVERSITY,R01,2016,360706,-0.018382950601256966
"ROBUST 3D FLUORESCENCE CONFOCAL MICROSCOPY DEBLURRING The objective of this research is the wide accessibility of 3D                   deconvolution (computational deblurring and visual clarification of 3D           image data) for the neuroscientific community and other life-science             communities. Long-term aims are to provide the most reliable, robust and         quantitatively accurate system for 3D visualization and morphometry, and         to provide neuroscientists and other life-scientists with easy-to-use            tools for studying the structure and function of normal and pathologic           tissue. The focus of this project is on neuroscientific applications. The        commercial objective is a profitable software product, which, owing to           innovations, well outperforms competitive products in reliability,               robustness, quantitative accuracy, speed and ease of usage. The specific         aims of this project are: (1) To develop and test variations of the              algorithm for a broader range of widely used confocal microscope types,          including the slit-scan and array-detector geomeries; (2) To improve (and        test) the robustness of the algorithm under a number of common adverse           conditions; (3) To further validate the correctness of the image                 reconstructions by using fabricated test objects of known geometry; (4) To       demonstrate the system on two of the most suitable computer platforms for        wide usage. These are the Silicon Graphics unix-based platform and the           IBM-PC compatible platform; (5) To beta test prototypes of the product at        several potential customer sites. Innovations introduced by us in this           research include: (1), a blind deconvolution approach, which obviates the        need to measure the point spread function, (2), a maximum likelihood             optimization approach, which makes the methodology robust against                photodetector noise and other adverse conditions, and (3), a unified             underlying mathematical model, which makes the algorithm easily adaptable        among confocal geometries.                                                                                                                                        PROPOSED COMMERCIAL APPLICATION:                                                 We estimate on the order of 800 biological pinhole confocal microscopes          and 150 biological slit scan confocal microscopes to exist worldwide. We         expect these numbers to increase to 8,000 confocal microscopes over 10           years. We expect that 1/2 of these potentIal sites will purchase                 deconvolution software. We should secure at least 1/3rd of this potentIal        market and thereby (conservatively) Bell at,least 100 units per year over        10 years. Numerous nonblologlcal spin-off markets (e.g., pharmeceuticals,        chemicals) exist as well.                                                         n/a",ROBUST 3D FLUORESCENCE CONFOCAL MICROSCOPY DEBLURRING,2675305,R44MH053692,"['artificial intelligence', ' computer program /software', ' computer system design /evaluation', ' confocal scanning microscopy', ' dendrites', ' digital imaging', ' fluorescence microscopy', ' glia', ' image enhancement', ' laboratory rat', ' sectioning', ' tissue /cell preparation']",NIMH,"LICKENBROCK TECHNOLOGIES, LLC",R44,1998,345000,0.002717314075495421
"ROBUST 3D FLUORESCENCE CONFOCAL MICROSCOPY DEBLURRING The objective of this research is the wide accessibility of 3D                   deconvolution (computational deblurring and visual clarification of 3D           image data) for the neuroscientific community and other life-science             communities. Long-term aims are to provide the most reliable, robust and         quantitatively accurate system for 3D visualization and morphometry, and         to provide neuroscientists and other life-scientists with easy-to-use            tools for studying the structure and function of normal and pathologic           tissue. The focus of this project is on neuroscientific applications. The        commercial objective is a profitable software product, which, owing to           innovations, well outperforms competitive products in reliability,               robustness, quantitative accuracy, speed and ease of usage. The specific         aims of this project are: (1) To develop and test variations of the              algorithm for a broader range of widely used confocal microscope types,          including the slit-scan and array-detector geomeries; (2) To improve (and        test) the robustness of the algorithm under a number of common adverse           conditions; (3) To further validate the correctness of the image                 reconstructions by using fabricated test objects of known geometry; (4) To       demonstrate the system on two of the most suitable computer platforms for        wide usage. These are the Silicon Graphics unix-based platform and the           IBM-PC compatible platform; (5) To beta test prototypes of the product at        several potential customer sites. Innovations introduced by us in this           research include: (1), a blind deconvolution approach, which obviates the        need to measure the point spread function, (2), a maximum likelihood             optimization approach, which makes the methodology robust against                photodetector noise and other adverse conditions, and (3), a unified             underlying mathematical model, which makes the algorithm easily adaptable        among confocal geometries.                                                                                                                                        PROPOSED COMMERCIAL APPLICATION:                                                 We estimate on the order of 800 biological pinhole confocal microscopes          and 150 biological slit scan confocal microscopes to exist worldwide. We         expect these numbers to increase to 8,000 confocal microscopes over 10           years. We expect that 1/2 of these potentIal sites will purchase                 deconvolution software. We should secure at least 1/3rd of this potentIal        market and thereby (conservatively) Bell at,least 100 units per year over        10 years. Numerous nonblologlcal spin-off markets (e.g., pharmeceuticals,        chemicals) exist as well.                                                         n/a",ROBUST 3D FLUORESCENCE CONFOCAL MICROSCOPY DEBLURRING,2034269,R44MH053692,"['artificial intelligence', ' computer program /software', ' computer system design /evaluation', ' confocal scanning microscopy', ' dendrites', ' digital imaging', ' fluorescence microscopy', ' glia', ' image enhancement', ' laboratory rat', ' sectioning', ' tissue /cell preparation']",NIMH,"LICKENBROCK TECHNOLOGIES, LLC",R44,1997,405000,0.002717314075495421
"Mechanism of Dioxygen Reduction by Heme-Copper Oxidases The primary objective of this research is to elucidate the mechanism of electron and proton transfer during the reduction of dioxygen to water by heme-copper oxidases. Our specific aims will focus on four problems: 1. The mechanism of the reduction of dioxygen to water by bacterial heme-copper oxidases will be studied by the CO flow-flash method. Time-resolved multichannel optical absorption spectroscopy, in conjunction with singular value decomposition (SVD) and global exponential fitting analysis, will be used to follow the kinetics of electron and proton transfer and to deduce the UV-Vis spectra of the transient intermediates. These studies should provide new insight into the mechanism of the dioxygen reduction reaction by heme-copper oxidases. 2. We will investigate the reaction of dioxygen with bovine heart and bacterial oxidases in different oxidation states using dioxygen which is produced in situ by photodissociating synthetic dioxygen carriers. We will also extend this approach to rapid dioxygen binding and activation in ribonucleotide reductase (RNR), in which the reactions occur too rapidly to be monitored by conventional stopped-flow methods. 3. The intramolecular electron transfer in the bacterial oxidases, bo3 from E. coil, aa3 from Rhodobacter sphaeroides and ba3 from Thermus thermophilus will be investigated using a photoactivatable dye, thiouredopyrene-trisulfonate (TUPS), covalently linked to single reactive cysteine residues on the oxidases. Time-resolved optical absorption spectroscopy, in conjunction with SVD and global exponential fitting, will be used to determine the spectra of the intermediates present and the rate constants of individual electron transfer steps. By varying the distance between the labeled cysteine and the initial electron acceptor and by introducing breaks into presumed electron transfer pathways by site-directed mutagenesis, detailed information regarding intramolecular electron transfer pathways in heme-copper oxidases will be obtained. 4. We propose to make chemical analogs of the active site of cytochrome oxidase, including the His-Tyr cross-linked dipeptide and the cyclic pentapeptide (His-Pro-Glu-Val-Tyr) with and without Cu-ligands incorporated. The analogs will be studied using a multispectroscopic approach, including steady-state and time-resolved UV-Vis spectroscopy, FTIR and ESR.  n/a",Mechanism of Dioxygen Reduction by Heme-Copper Oxidases,6706298,R01GM053788,"['bioenergetics', 'carbon monoxide', 'cytochrome oxidase', 'electron spin resonance spectroscopy', 'enzyme activity', 'infrared spectrometry', 'interferometry', 'membrane model', 'oxidation reduction reaction', 'oxygen', 'photochemistry', 'site directed mutagenesis', 'stop flow technique', 'ultraviolet spectrometry']",NIGMS,UNIVERSITY OF CALIFORNIA SANTA CRUZ,R01,2004,260915,0.004589249916803928
"Mechanism of Dioxygen Reduction by Heme-Copper Oxidases The primary objective of this research is to elucidate the mechanism of electron and proton transfer during the reduction of dioxygen to water by heme-copper oxidases. Our specific aims will focus on four problems: 1. The mechanism of the reduction of dioxygen to water by bacterial heme-copper oxidases will be studied by the CO flow-flash method. Time-resolved multichannel optical absorption spectroscopy, in conjunction with singular value decomposition (SVD) and global exponential fitting analysis, will be used to follow the kinetics of electron and proton transfer and to deduce the UV-Vis spectra of the transient intermediates. These studies should provide new insight into the mechanism of the dioxygen reduction reaction by heme-copper oxidases. 2. We will investigate the reaction of dioxygen with bovine heart and bacterial oxidases in different oxidation states using dioxygen which is produced in situ by photodissociating synthetic dioxygen carriers. We will also extend this approach to rapid dioxygen binding and activation in ribonucleotide reductase (RNR), in which the reactions occur too rapidly to be monitored by conventional stopped-flow methods. 3. The intramolecular electron transfer in the bacterial oxidases, bo3 from E. coil, aa3 from Rhodobacter sphaeroides and ba3 from Thermus thermophilus will be investigated using a photoactivatable dye, thiouredopyrene-trisulfonate (TUPS), covalently linked to single reactive cysteine residues on the oxidases. Time-resolved optical absorption spectroscopy, in conjunction with SVD and global exponential fitting, will be used to determine the spectra of the intermediates present and the rate constants of individual electron transfer steps. By varying the distance between the labeled cysteine and the initial electron acceptor and by introducing breaks into presumed electron transfer pathways by site-directed mutagenesis, detailed information regarding intramolecular electron transfer pathways in heme-copper oxidases will be obtained. 4. We propose to make chemical analogs of the active site of cytochrome oxidase, including the His-Tyr cross-linked dipeptide and the cyclic pentapeptide (His-Pro-Glu-Val-Tyr) with and without Cu-ligands incorporated. The analogs will be studied using a multispectroscopic approach, including steady-state and time-resolved UV-Vis spectroscopy, FTIR and ESR.  n/a",Mechanism of Dioxygen Reduction by Heme-Copper Oxidases,6636160,R01GM053788,"['bioenergetics', ' carbon monoxide', ' cytochrome oxidase', ' electron spin resonance spectroscopy', ' enzyme activity', ' infrared spectrometry', ' interferometry', ' membrane model', ' oxidation reduction reaction', ' oxygen', ' photochemistry', ' site directed mutagenesis', ' stop flow technique', ' ultraviolet spectrometry']",NIGMS,UNIVERSITY OF CALIFORNIA SANTA CRUZ,R01,2003,260915,0.004589249916803928
"Mechanism of Dioxygen Reduction by Heme-Copper Oxidases The primary objective of this research is to elucidate the mechanism of electron and proton transfer during the reduction of dioxygen to water by heme-copper oxidases. Our specific aims will focus on four problems: 1. The mechanism of the reduction of dioxygen to water by bacterial heme-copper oxidases will be studied by the CO flow-flash method. Time-resolved multichannel optical absorption spectroscopy, in conjunction with singular value decomposition (SVD) and global exponential fitting analysis, will be used to follow the kinetics of electron and proton transfer and to deduce the UV-Vis spectra of the transient intermediates. These studies should provide new insight into the mechanism of the dioxygen reduction reaction by heme-copper oxidases. 2. We will investigate the reaction of dioxygen with bovine heart and bacterial oxidases in different oxidation states using dioxygen which is produced in situ by photodissociating synthetic dioxygen carriers. We will also extend this approach to rapid dioxygen binding and activation in ribonucleotide reductase (RNR), in which the reactions occur too rapidly to be monitored by conventional stopped-flow methods. 3. The intramolecular electron transfer in the bacterial oxidases, bo3 from E. coil, aa3 from Rhodobacter sphaeroides and ba3 from Thermus thermophilus will be investigated using a photoactivatable dye, thiouredopyrene-trisulfonate (TUPS), covalently linked to single reactive cysteine residues on the oxidases. Time-resolved optical absorption spectroscopy, in conjunction with SVD and global exponential fitting, will be used to determine the spectra of the intermediates present and the rate constants of individual electron transfer steps. By varying the distance between the labeled cysteine and the initial electron acceptor and by introducing breaks into presumed electron transfer pathways by site-directed mutagenesis, detailed information regarding intramolecular electron transfer pathways in heme-copper oxidases will be obtained. 4. We propose to make chemical analogs of the active site of cytochrome oxidase, including the His-Tyr cross-linked dipeptide and the cyclic pentapeptide (His-Pro-Glu-Val-Tyr) with and without Cu-ligands incorporated. The analogs will be studied using a multispectroscopic approach, including steady-state and time-resolved UV-Vis spectroscopy, FTIR and ESR.  n/a",Mechanism of Dioxygen Reduction by Heme-Copper Oxidases,6519704,R01GM053788,"['bioenergetics', ' carbon monoxide', ' cytochrome oxidase', ' electron spin resonance spectroscopy', ' enzyme activity', ' infrared spectrometry', ' interferometry', ' membrane model', ' oxidation reduction reaction', ' oxygen', ' photochemistry', ' site directed mutagenesis', ' stop flow technique', ' ultraviolet spectrometry']",NIGMS,UNIVERSITY OF CALIFORNIA SANTA CRUZ,R01,2002,260915,0.004589249916803928
"Mechanism of Dioxygen Reduction by Heme-Copper Oxidases The primary objective of this research is to elucidate the mechanism of electron and proton transfer during the reduction of dioxygen to water by heme-copper oxidases. Our specific aims will focus on four problems: 1. The mechanism of the reduction of dioxygen to water by bacterial heme-copper oxidases will be studied by the CO flow-flash method. Time-resolved multichannel optical absorption spectroscopy, in conjunction with singular value decomposition (SVD) and global exponential fitting analysis, will be used to follow the kinetics of electron and proton transfer and to deduce the UV-Vis spectra of the transient intermediates. These studies should provide new insight into the mechanism of the dioxygen reduction reaction by heme-copper oxidases. 2. We will investigate the reaction of dioxygen with bovine heart and bacterial oxidases in different oxidation states using dioxygen which is produced in situ by photodissociating synthetic dioxygen carriers. We will also extend this approach to rapid dioxygen binding and activation in ribonucleotide reductase (RNR), in which the reactions occur too rapidly to be monitored by conventional stopped-flow methods. 3. The intramolecular electron transfer in the bacterial oxidases, bo3 from E. coil, aa3 from Rhodobacter sphaeroides and ba3 from Thermus thermophilus will be investigated using a photoactivatable dye, thiouredopyrene-trisulfonate (TUPS), covalently linked to single reactive cysteine residues on the oxidases. Time-resolved optical absorption spectroscopy, in conjunction with SVD and global exponential fitting, will be used to determine the spectra of the intermediates present and the rate constants of individual electron transfer steps. By varying the distance between the labeled cysteine and the initial electron acceptor and by introducing breaks into presumed electron transfer pathways by site-directed mutagenesis, detailed information regarding intramolecular electron transfer pathways in heme-copper oxidases will be obtained. 4. We propose to make chemical analogs of the active site of cytochrome oxidase, including the His-Tyr cross-linked dipeptide and the cyclic pentapeptide (His-Pro-Glu-Val-Tyr) with and without Cu-ligands incorporated. The analogs will be studied using a multispectroscopic approach, including steady-state and time-resolved UV-Vis spectroscopy, FTIR and ESR.  n/a",Mechanism of Dioxygen Reduction by Heme-Copper Oxidases,6330772,R01GM053788,"['bioenergetics', ' carbon monoxide', ' cytochrome oxidase', ' electron spin resonance spectroscopy', ' enzyme activity', ' infrared spectrometry', ' interferometry', ' membrane model', ' oxidation reduction reaction', ' oxygen', ' photochemistry', ' site directed mutagenesis', ' stop flow technique', ' ultraviolet spectrometry']",NIGMS,UNIVERSITY OF CALIFORNIA SANTA CRUZ,R01,2001,269955,0.004589249916803928
"ELECTRON TRANSFER/PROTON PUMPING IN CYTOCHROME OXIDATION DESCRIPTION:  The proposed research will focus on the mechanisms of electron     transfer and proton pumping in respiration.  Special emphasis will be on         cytochrome oxidase, the primary site of coupling between the two processes.      Our goals include the following:  1) The mechanism of the reduction of           dixoygen to water by cytochrome oxidase will be studied under a variety of       conditions with the flow-flash method, which uses the photolability of the       CO complex to initiate the redox activity with O2.  Time-resolved                multichannel optical absorption spectroscopy will be used to follow the          kinetics of electron and proton transfer on time scales of nanoseconds to        milliseconds.  Singular value decomposition and global exponential fitting       methods will be applied to analyze the kinetics and determine the UV-Vis         spectra of the transient intermediates.  These studies should provide new        insight into the mechanism of the dioxygen reduction by cytochrome oxidase.      2) Alternatives to CO photodissociation will be used to investigate the          reaction of O2 with cytochrome oxidase.  The reaction of unliganded reduced      cytochrome oxidase with oxygen will be studied using a superfast direct          mixing method, pulsed-accelerated-flow (PAF).  The reaction of oxygen with       the unliganded enzyme will also be investigated using O2 which is produced       in situ on any relevant time scale by photodissociating synthetic dioxygen       carriers such as dicobalt u-peroxo polyaine complexes.  Both the PAF method      and the photodissociation of the dicobalt u-peroxo and u-superoxo polyamine      complexes represent new approaches to study the fast dioxygen reactions of       cytochrome oxidase and both avoid the mechanistic ambiguities associated         with the fate of photodissociated CO in transitional flow-flash experiments.     3) The mechanism of the redox-linked proton pump in cytochrome oxidase will      be investigated.  The kinetics of electron transfer and proton pumping upon      flash-induced oxidation of cytochrome oxidase reconstituted into                 phospholipid vesicles will be monitored using time-resolved optical              absorption spectroscopy.  The proton pumping reactions will be probed by pH      indicators located int he extra-vesicular space, trapped inside the              vesicles, or covalently bound to the lipid or protein.  These studies will       allow us to correlate proton pumping events with individual steps in the         dioxygen/cytochrome oxidase redox cycle and will provide a foundation for a      structural model of the energy transduction mechanism in cytochrome oxidase.      n/a",ELECTRON TRANSFER/PROTON PUMPING IN CYTOCHROME OXIDATION,6151028,R01GM053788,"['bioenergetics', ' carbon monoxide', ' cytochrome oxidase', ' electron transport', ' enzyme mechanism', ' enzyme reconstitution', ' flash photolysis', ' membrane model', ' membrane transport proteins', ' oxidation reduction reaction', ' oxygen', ' photochemistry', ' spectrometry', ' time resolved data']",NIGMS,UNIVERSITY OF CALIFORNIA SANTA CRUZ,R01,2000,151029,0.06463674561223395
"ELECTRON TRANSFER/PROTON PUMPING IN CYTOCHROME OXIDATION DESCRIPTION:  The proposed research will focus on the mechanisms of electron     transfer and proton pumping in respiration.  Special emphasis will be on         cytochrome oxidase, the primary site of coupling between the two processes.      Our goals include the following:  1) The mechanism of the reduction of           dixoygen to water by cytochrome oxidase will be studied under a variety of       conditions with the flow-flash method, which uses the photolability of the       CO complex to initiate the redox activity with O2.  Time-resolved                multichannel optical absorption spectroscopy will be used to follow the          kinetics of electron and proton transfer on time scales of nanoseconds to        milliseconds.  Singular value decomposition and global exponential fitting       methods will be applied to analyze the kinetics and determine the UV-Vis         spectra of the transient intermediates.  These studies should provide new        insight into the mechanism of the dioxygen reduction by cytochrome oxidase.      2) Alternatives to CO photodissociation will be used to investigate the          reaction of O2 with cytochrome oxidase.  The reaction of unliganded reduced      cytochrome oxidase with oxygen will be studied using a superfast direct          mixing method, pulsed-accelerated-flow (PAF).  The reaction of oxygen with       the unliganded enzyme will also be investigated using O2 which is produced       in situ on any relevant time scale by photodissociating synthetic dioxygen       carriers such as dicobalt u-peroxo polyaine complexes.  Both the PAF method      and the photodissociation of the dicobalt u-peroxo and u-superoxo polyamine      complexes represent new approaches to study the fast dioxygen reactions of       cytochrome oxidase and both avoid the mechanistic ambiguities associated         with the fate of photodissociated CO in transitional flow-flash experiments.     3) The mechanism of the redox-linked proton pump in cytochrome oxidase will      be investigated.  The kinetics of electron transfer and proton pumping upon      flash-induced oxidation of cytochrome oxidase reconstituted into                 phospholipid vesicles will be monitored using time-resolved optical              absorption spectroscopy.  The proton pumping reactions will be probed by pH      indicators located int he extra-vesicular space, trapped inside the              vesicles, or covalently bound to the lipid or protein.  These studies will       allow us to correlate proton pumping events with individual steps in the         dioxygen/cytochrome oxidase redox cycle and will provide a foundation for a      structural model of the energy transduction mechanism in cytochrome oxidase.      n/a",ELECTRON TRANSFER/PROTON PUMPING IN CYTOCHROME OXIDATION,2872706,R01GM053788,"['bioenergetics', ' carbon monoxide', ' cytochrome oxidase', ' electron transport', ' enzyme mechanism', ' enzyme reconstitution', ' flash photolysis', ' membrane model', ' membrane transport proteins', ' oxidation reduction reaction', ' oxygen', ' photochemistry', ' spectrometry', ' time resolved data']",NIGMS,UNIVERSITY OF CALIFORNIA SANTA CRUZ,R01,1999,147171,0.06463674561223395
"ELECTRON TRANSFER/PROTON PUMPING IN CYTOCHROME OXIDATION DESCRIPTION:  The proposed research will focus on the mechanisms of electron     transfer and proton pumping in respiration.  Special emphasis will be on         cytochrome oxidase, the primary site of coupling between the two processes.      Our goals include the following:  1) The mechanism of the reduction of           dixoygen to water by cytochrome oxidase will be studied under a variety of       conditions with the flow-flash method, which uses the photolability of the       CO complex to initiate the redox activity with O2.  Time-resolved                multichannel optical absorption spectroscopy will be used to follow the          kinetics of electron and proton transfer on time scales of nanoseconds to        milliseconds.  Singular value decomposition and global exponential fitting       methods will be applied to analyze the kinetics and determine the UV-Vis         spectra of the transient intermediates.  These studies should provide new        insight into the mechanism of the dioxygen reduction by cytochrome oxidase.      2) Alternatives to CO photodissociation will be used to investigate the          reaction of O2 with cytochrome oxidase.  The reaction of unliganded reduced      cytochrome oxidase with oxygen will be studied using a superfast direct          mixing method, pulsed-accelerated-flow (PAF).  The reaction of oxygen with       the unliganded enzyme will also be investigated using O2 which is produced       in situ on any relevant time scale by photodissociating synthetic dioxygen       carriers such as dicobalt u-peroxo polyaine complexes.  Both the PAF method      and the photodissociation of the dicobalt u-peroxo and u-superoxo polyamine      complexes represent new approaches to study the fast dioxygen reactions of       cytochrome oxidase and both avoid the mechanistic ambiguities associated         with the fate of photodissociated CO in transitional flow-flash experiments.     3) The mechanism of the redox-linked proton pump in cytochrome oxidase will      be investigated.  The kinetics of electron transfer and proton pumping upon      flash-induced oxidation of cytochrome oxidase reconstituted into                 phospholipid vesicles will be monitored using time-resolved optical              absorption spectroscopy.  The proton pumping reactions will be probed by pH      indicators located int he extra-vesicular space, trapped inside the              vesicles, or covalently bound to the lipid or protein.  These studies will       allow us to correlate proton pumping events with individual steps in the         dioxygen/cytochrome oxidase redox cycle and will provide a foundation for a      structural model of the energy transduction mechanism in cytochrome oxidase.      n/a",ELECTRON TRANSFER/PROTON PUMPING IN CYTOCHROME OXIDATION,2655009,R01GM053788,"['bioenergetics', ' carbon monoxide', ' cytochrome oxidase', ' electron transport', ' enzyme mechanism', ' enzyme reconstitution', ' flash photolysis', ' membrane model', ' membrane transport proteins', ' oxidation reduction reaction', ' oxygen', ' photochemistry', ' spectrometry', ' time resolved data']",NIGMS,UNIVERSITY OF CALIFORNIA SANTA CRUZ,R01,1998,143427,0.06463674561223395
"ELECTRON TRANSFER/PROTON PUMPING IN CYTOCHROME OXIDATION DESCRIPTION:  The proposed research will focus on the mechanisms of electron     transfer and proton pumping in respiration.  Special emphasis will be on         cytochrome oxidase, the primary site of coupling between the two processes.      Our goals include the following:  1) The mechanism of the reduction of           dixoygen to water by cytochrome oxidase will be studied under a variety of       conditions with the flow-flash method, which uses the photolability of the       CO complex to initiate the redox activity with O2.  Time-resolved                multichannel optical absorption spectroscopy will be used to follow the          kinetics of electron and proton transfer on time scales of nanoseconds to        milliseconds.  Singular value decomposition and global exponential fitting       methods will be applied to analyze the kinetics and determine the UV-Vis         spectra of the transient intermediates.  These studies should provide new        insight into the mechanism of the dioxygen reduction by cytochrome oxidase.      2) Alternatives to CO photodissociation will be used to investigate the          reaction of O2 with cytochrome oxidase.  The reaction of unliganded reduced      cytochrome oxidase with oxygen will be studied using a superfast direct          mixing method, pulsed-accelerated-flow (PAF).  The reaction of oxygen with       the unliganded enzyme will also be investigated using O2 which is produced       in situ on any relevant time scale by photodissociating synthetic dioxygen       carriers such as dicobalt u-peroxo polyaine complexes.  Both the PAF method      and the photodissociation of the dicobalt u-peroxo and u-superoxo polyamine      complexes represent new approaches to study the fast dioxygen reactions of       cytochrome oxidase and both avoid the mechanistic ambiguities associated         with the fate of photodissociated CO in transitional flow-flash experiments.     3) The mechanism of the redox-linked proton pump in cytochrome oxidase will      be investigated.  The kinetics of electron transfer and proton pumping upon      flash-induced oxidation of cytochrome oxidase reconstituted into                 phospholipid vesicles will be monitored using time-resolved optical              absorption spectroscopy.  The proton pumping reactions will be probed by pH      indicators located int he extra-vesicular space, trapped inside the              vesicles, or covalently bound to the lipid or protein.  These studies will       allow us to correlate proton pumping events with individual steps in the         dioxygen/cytochrome oxidase redox cycle and will provide a foundation for a      structural model of the energy transduction mechanism in cytochrome oxidase.      n/a",ELECTRON TRANSFER/PROTON PUMPING IN CYTOCHROME OXIDATION,2023200,R01GM053788,"['bioenergetics', ' carbon monoxide', ' cytochrome oxidase', ' electron transport', ' enzyme mechanism', ' enzyme reconstitution', ' flash photolysis', ' membrane model', ' membrane transport proteins', ' oxidation reduction reaction', ' oxygen', ' photochemistry', ' spectrometry', ' time resolved data']",NIGMS,UNIVERSITY OF CALIFORNIA SANTA CRUZ,R01,1997,155636,0.06463674561223395
"Novel Inhibitors to DHPS to Probe Catalytic Mechanism & Therapeutic Potential    DESCRIPTION (provided by applicant): Folate biosynthesis is an essential bacterial pathway that is absent in higher animals, and it has been an effective target of antibacterial agents for over 70 years. The sulfonamide drugs inhibit a key enzyme in the pathway, dihydropteroate synthase (DHPS), by acting as non-productive substrate analogs of paminobenzoic acid (pABA). However, the flexible pABA binding site is structurally susceptible to resistance mutations, and the sulfonamides are rapidly becoming therapeutically ineffective. In contrast, the binding site of the second DHPS substrate, pterin-pyrophosphate, is buried in a conserved pocket that is less likely to tolerate mutations. We propose to generate new classes of potent DHPS inhibitors that specifically engage this pocket. These inhibitors have the potential of being developed into novel therapeutic agents that still target folate synthesis but which avoid the problems of resistance. To generate effective inhibitors of any enzyme, it is crucial to understand the structure and mechanism of its active site. This information is largely absent for DHPS, and understanding how DHPS performs catalysis at the molecular level will be a central goal of the application.      This comprehensive project will encompass biochemistry, structural biology, medicinal chemistry, computational biology, and microbiology, and will be performed in two laboratories at neighboring institutions in Memphis. The central focus of the project is the design and synthesis of novel small molecules that can be used to probe the DHPS mechanism and also be evaluated as DHPS inhibitors. Promising inhibitor scaffolds will then be tested for their potential as anti-microbials by direct screening of select organisms. The more potent inhibitors will be used to create derivative libraries for further screening and evaluation. The use of state-of-the-art drug discovery software, library synthesis, high-throughput screening and X-ray crystallography are central features of the research. Our goal is to provide a solid platform for the development of new, desperately-needed, broad-spectrum anti-infectives agents. However, we are also focused on developing specific therapies for the category A biowarfare agents B. anthracis, Y. pestis and F. tularensis, as well as for pathogenic protozoa and fungi.          n/a",Novel Inhibitors to DHPS to Probe Catalytic Mechanism & Therapeutic Potential,7617662,R01AI070721,"['4-Aminobenzoic Acid', 'Acids', 'Active Sites', 'Affinity', 'Amino Acids', 'Animals', 'Anti-Bacterial Agents', 'Anti-Infective Agents', 'Antibiotics', 'Arts', 'Bacillus anthracis', 'Binding', 'Binding Sites', 'Biochemistry', 'Biological Warfare', 'Candida albicans', 'Catalysis', 'Categories', 'Collaborations', 'Computational Biology', 'Computer software', 'Data', 'Development', 'Dihydropteroate Synthase', 'Diphosphates', 'Disease', 'Drug Design', 'Drug resistance', 'Enzymes', 'Escherichia coli', 'Evaluation', 'Folate', 'Folate Biosynthesis Pathway', 'Folic Acid Antagonists', 'Francisella tularensis', 'Funding', 'Genes', 'Genomics', 'Goals', 'Immunocompromised Host', 'Individual', 'Infection', 'Institution', 'Laboratories', 'Libraries', 'Ligands', 'Locales', 'Methods', 'Microbiology', 'Modeling', 'Molecular', 'Molecular Conformation', 'Mutation', 'Mycobacterium tuberculosis', 'Organism', 'Orthologous Gene', 'Pathway interactions', 'Pharmaceutical Chemistry', 'Pharmaceutical Preparations', 'Proteins', 'Protozoa', 'Protozoan Infections', 'Pseudomonas aeruginosa', 'Pterins', 'Quantitative Structure-Activity Relationship', 'Research', 'Research Personnel', 'Resistance', 'Role', 'Salmonella', 'Screening procedure', 'Serum', 'Site', 'Site-Directed Mutagenesis', 'Solid', 'Specificity', 'Staphylococcus aureus', 'Streptococcus pneumoniae', 'Structure', 'Sulfonamides', 'Techniques', 'Testing', 'Therapeutic', 'Therapeutic Agents', 'X-Ray Crystallography', 'Yersinia pestis', 'analog', 'antimicrobial', 'bacterial resistance', 'base', 'biodefense', 'chemical synthesis', 'cytotoxicity', 'design', 'dihydropteroate', 'drug discovery', 'enzyme mechanism', 'flexibility', 'fungus', 'high throughput screening', 'in vivo', 'inhibitor/antagonist', 'insight', 'interest', 'methicillin resistant Staphylococcus aureus', 'microorganism', 'molecular dynamics', 'novel', 'novel therapeutics', 'programs', 'resistance mutation', 'resistant strain', 'scaffold', 'small molecule', 'structural biology', 'text searching', 'virtual']",NIAID,ST. JUDE CHILDREN'S RESEARCH HOSPITAL,R01,2009,614066,0.003217440558774634
"Novel Inhibitors to DHPS to Probe Catalytic Mechanism & Therapeutic Potential    DESCRIPTION (provided by applicant): Folate biosynthesis is an essential bacterial pathway that is absent in higher animals, and it has been an effective target of antibacterial agents for over 70 years. The sulfonamide drugs inhibit a key enzyme in the pathway, dihydropteroate synthase (DHPS), by acting as non-productive substrate analogs of paminobenzoic acid (pABA). However, the flexible pABA binding site is structurally susceptible to resistance mutations, and the sulfonamides are rapidly becoming therapeutically ineffective. In contrast, the binding site of the second DHPS substrate, pterin-pyrophosphate, is buried in a conserved pocket that is less likely to tolerate mutations. We propose to generate new classes of potent DHPS inhibitors that specifically engage this pocket. These inhibitors have the potential of being developed into novel therapeutic agents that still target folate synthesis but which avoid the problems of resistance. To generate effective inhibitors of any enzyme, it is crucial to understand the structure and mechanism of its active site. This information is largely absent for DHPS, and understanding how DHPS performs catalysis at the molecular level will be a central goal of the application.      This comprehensive project will encompass biochemistry, structural biology, medicinal chemistry, computational biology, and microbiology, and will be performed in two laboratories at neighboring institutions in Memphis. The central focus of the project is the design and synthesis of novel small molecules that can be used to probe the DHPS mechanism and also be evaluated as DHPS inhibitors. Promising inhibitor scaffolds will then be tested for their potential as anti-microbials by direct screening of select organisms. The more potent inhibitors will be used to create derivative libraries for further screening and evaluation. The use of state-of-the-art drug discovery software, library synthesis, high-throughput screening and X-ray crystallography are central features of the research. Our goal is to provide a solid platform for the development of new, desperately-needed, broad-spectrum anti-infectives agents. However, we are also focused on developing specific therapies for the category A biowarfare agents B. anthracis, Y. pestis and F. tularensis, as well as for pathogenic protozoa and fungi.          n/a",Novel Inhibitors to DHPS to Probe Catalytic Mechanism & Therapeutic Potential,7422359,R01AI070721,"['4-Aminobenzoic Acid', 'Acids', 'Active Sites', 'Affinity', 'Amino Acids', 'Animals', 'Anti-Bacterial Agents', 'Anti-Infective Agents', 'Antibiotics', 'Arts', 'Bacillus anthracis', 'Binding', 'Binding Sites', 'Biochemistry', 'Biological Warfare', 'Candida albicans', 'Catalysis', 'Categories', 'Class', 'Collaborations', 'Computational Biology', 'Computer software', 'Data', 'Development', 'Dihydropteroate Synthase', 'Diphosphates', 'Disease', 'Drug Design', 'Drug resistance', 'Enzymes', 'Escherichia coli', 'Evaluation', 'Folate', 'Folate Biosynthesis Pathway', 'Folic Acid Antagonists', 'Francisella tularensis', 'Funding', 'Genes', 'Genomics', 'Goals', 'Immunocompromised Host', 'Individual', 'Infection', 'Institution', 'Laboratories', 'Libraries', 'Ligands', 'Locales', 'Methods', 'Microbiology', 'Modeling', 'Molecular', 'Molecular Conformation', 'Mutation', 'Mycobacterium tuberculosis', 'Numbers', 'Organism', 'Orthologous Gene', 'Pathway interactions', 'Pharmaceutical Chemistry', 'Pharmaceutical Preparations', 'Proteins', 'Protozoa', 'Protozoan Infections', 'Pseudomonas aeruginosa', 'Pterins', 'Quantitative Structure-Activity Relationship', 'Rate', 'Research', 'Research Personnel', 'Resistance', 'Role', 'Salmonella', 'Screening procedure', 'Serum', 'Site', 'Site-Directed Mutagenesis', 'Solid', 'Specificity', 'Staphylococcus aureus', 'Streptococcus pneumoniae', 'Structure', 'Sulfonamides', 'Techniques', 'Testing', 'Therapeutic', 'Therapeutic Agents', 'X-Ray Crystallography', 'Yersinia pestis', 'analog', 'antimicrobial', 'bacterial resistance', 'base', 'biodefense', 'chemical synthesis', 'cytotoxicity', 'design', 'dihydropteroate', 'drug discovery', 'enzyme mechanism', 'fungus', 'high throughput screening', 'in vivo', 'inhibitor/antagonist', 'insight', 'interest', 'mecarzole', 'methicillin resistant Staphylococcus aureus', 'microorganism', 'molecular dynamics', 'novel', 'novel therapeutics', 'programs', 'scaffold', 'small molecule', 'structural biology', 'text searching', 'virtual']",NIAID,ST. JUDE CHILDREN'S RESEARCH HOSPITAL,R01,2008,598667,0.003217440558774634
"Novel Inhibitors to DHPS to Probe Catalytic Mechanism & Therapeutic Potential    DESCRIPTION (provided by applicant): Folate biosynthesis is an essential bacterial pathway that is absent in higher animals, and it has been an effective target of antibacterial agents for over 70 years. The sulfonamide drugs inhibit a key enzyme in the pathway, dihydropteroate synthase (DHPS), by acting as non-productive substrate analogs of paminobenzoic acid (pABA). However, the flexible pABA binding site is structurally susceptible to resistance mutations, and the sulfonamides are rapidly becoming therapeutically ineffective. In contrast, the binding site of the second DHPS substrate, pterin-pyrophosphate, is buried in a conserved pocket that is less likely to tolerate mutations. We propose to generate new classes of potent DHPS inhibitors that specifically engage this pocket. These inhibitors have the potential of being developed into novel therapeutic agents that still target folate synthesis but which avoid the problems of resistance. To generate effective inhibitors of any enzyme, it is crucial to understand the structure and mechanism of its active site. This information is largely absent for DHPS, and understanding how DHPS performs catalysis at the molecular level will be a central goal of the application.      This comprehensive project will encompass biochemistry, structural biology, medicinal chemistry, computational biology, and microbiology, and will be performed in two laboratories at neighboring institutions in Memphis. The central focus of the project is the design and synthesis of novel small molecules that can be used to probe the DHPS mechanism and also be evaluated as DHPS inhibitors. Promising inhibitor scaffolds will then be tested for their potential as anti-microbials by direct screening of select organisms. The more potent inhibitors will be used to create derivative libraries for further screening and evaluation. The use of state-of-the-art drug discovery software, library synthesis, high-throughput screening and X-ray crystallography are central features of the research. Our goal is to provide a solid platform for the development of new, desperately-needed, broad-spectrum anti-infectives agents. However, we are also focused on developing specific therapies for the category A biowarfare agents B. anthracis, Y. pestis and F. tularensis, as well as for pathogenic protozoa and fungi.          n/a",Novel Inhibitors to DHPS to Probe Catalytic Mechanism & Therapeutic Potential,7848340,R01AI070721,"['4-Aminobenzoic Acid', 'Acids', 'Active Sites', 'Affinity', 'Amino Acids', 'Animals', 'Anti-Bacterial Agents', 'Anti-Infective Agents', 'Antibiotics', 'Arts', 'Bacillus anthracis', 'Binding', 'Binding Sites', 'Biochemistry', 'Biological Warfare', 'Candida albicans', 'Catalysis', 'Categories', 'Collaborations', 'Computational Biology', 'Computer software', 'Data', 'Development', 'Dihydropteroate Synthase', 'Diphosphates', 'Disease', 'Drug Design', 'Drug resistance', 'Enzymes', 'Escherichia coli', 'Evaluation', 'Folate', 'Folate Biosynthesis Pathway', 'Folic Acid Antagonists', 'Francisella tularensis', 'Funding', 'Genes', 'Genomics', 'Goals', 'Immunocompromised Host', 'Individual', 'Infection', 'Institution', 'Laboratories', 'Libraries', 'Ligands', 'Locales', 'Methods', 'Microbiology', 'Modeling', 'Molecular', 'Molecular Conformation', 'Mutation', 'Mycobacterium tuberculosis', 'Organism', 'Orthologous Gene', 'Pathway interactions', 'Pharmaceutical Chemistry', 'Pharmaceutical Preparations', 'Proteins', 'Protozoa', 'Protozoan Infections', 'Pseudomonas aeruginosa', 'Pterins', 'Quantitative Structure-Activity Relationship', 'Research', 'Research Personnel', 'Resistance', 'Role', 'Salmonella', 'Screening procedure', 'Serum', 'Site', 'Site-Directed Mutagenesis', 'Solid', 'Specificity', 'Staphylococcus aureus', 'Streptococcus pneumoniae', 'Structure', 'Sulfonamides', 'Techniques', 'Testing', 'Therapeutic', 'Therapeutic Agents', 'X-Ray Crystallography', 'Yersinia pestis', 'analog', 'antimicrobial', 'bacterial resistance', 'base', 'biodefense', 'chemical synthesis', 'cytotoxicity', 'design', 'dihydropteroate', 'drug discovery', 'enzyme mechanism', 'flexibility', 'fungus', 'high throughput screening', 'in vivo', 'inhibitor/antagonist', 'insight', 'interest', 'methicillin resistant Staphylococcus aureus', 'microorganism', 'molecular dynamics', 'novel', 'novel therapeutics', 'programs', 'resistance mutation', 'resistant strain', 'scaffold', 'small molecule', 'structural biology', 'text searching', 'virtual']",NIAID,ST. JUDE CHILDREN'S RESEARCH HOSPITAL,R01,2010,623075,0.003217440558774634
"Novel Inhibitors to DHPS to Probe Catalytic Mechanism & Therapeutic Potential    DESCRIPTION (provided by applicant): Folate biosynthesis is an essential bacterial pathway that is absent in higher animals, and it has been an effective target of antibacterial agents for over 70 years. The sulfonamide drugs inhibit a key enzyme in the pathway, dihydropteroate synthase (DHPS), by acting as non-productive substrate analogs of paminobenzoic acid (pABA). However, the flexible pABA binding site is structurally susceptible to resistance mutations, and the sulfonamides are rapidly becoming therapeutically ineffective. In contrast, the binding site of the second DHPS substrate, pterin-pyrophosphate, is buried in a conserved pocket that is less likely to tolerate mutations. We propose to generate new classes of potent DHPS inhibitors that specifically engage this pocket. These inhibitors have the potential of being developed into novel therapeutic agents that still target folate synthesis but which avoid the problems of resistance. To generate effective inhibitors of any enzyme, it is crucial to understand the structure and mechanism of its active site. This information is largely absent for DHPS, and understanding how DHPS performs catalysis at the molecular level will be a central goal of the application.      This comprehensive project will encompass biochemistry, structural biology, medicinal chemistry, computational biology, and microbiology, and will be performed in two laboratories at neighboring institutions in Memphis. The central focus of the project is the design and synthesis of novel small molecules that can be used to probe the DHPS mechanism and also be evaluated as DHPS inhibitors. Promising inhibitor scaffolds will then be tested for their potential as anti-microbials by direct screening of select organisms. The more potent inhibitors will be used to create derivative libraries for further screening and evaluation. The use of state-of-the-art drug discovery software, library synthesis, high-throughput screening and X-ray crystallography are central features of the research. Our goal is to provide a solid platform for the development of new, desperately-needed, broad-spectrum anti-infectives agents. However, we are also focused on developing specific therapies for the category A biowarfare agents B. anthracis, Y. pestis and F. tularensis, as well as for pathogenic protozoa and fungi.          n/a",Novel Inhibitors to DHPS to Probe Catalytic Mechanism & Therapeutic Potential,7236066,R01AI070721,"['4-Aminobenzoic Acid', 'Acids', 'Active Sites', 'Affinity', 'Amino Acids', 'Animals', 'Anti-Bacterial Agents', 'Anti-Infective Agents', 'Antibiotics', 'Arts', 'Bacillus anthracis', 'Binding', 'Binding Sites', 'Biochemistry', 'Biological Warfare', 'Candida albicans', 'Catalysis', 'Categories', 'Class', 'Collaborations', 'Computational Biology', 'Computer software', 'Data', 'Development', 'Dihydropteroate Synthase', 'Diphosphates', 'Disease', 'Drug Design', 'Drug resistance', 'Enzymes', 'Escherichia coli', 'Evaluation', 'Folate', 'Folate Biosynthesis Pathway', 'Folic Acid Antagonists', 'Francisella tularensis', 'Funding', 'Genes', 'Genomics', 'Goals', 'Immunocompromised Host', 'Individual', 'Infection', 'Institution', 'Laboratories', 'Libraries', 'Ligands', 'Locales', 'Methods', 'Microbiology', 'Modeling', 'Molecular', 'Molecular Conformation', 'Mutation', 'Mycobacterium tuberculosis', 'Numbers', 'Organism', 'Orthologous Gene', 'Pathway interactions', 'Pharmaceutical Chemistry', 'Pharmaceutical Preparations', 'Proteins', 'Protozoa', 'Protozoan Infections', 'Pseudomonas aeruginosa', 'Pterins', 'Quantitative Structure-Activity Relationship', 'Rate', 'Research', 'Research Personnel', 'Resistance', 'Role', 'Salmonella', 'Screening procedure', 'Serum', 'Site', 'Site-Directed Mutagenesis', 'Solid', 'Specificity', 'Staphylococcus aureus', 'Streptococcus pneumoniae', 'Structure', 'Sulfonamides', 'Techniques', 'Testing', 'Therapeutic', 'Therapeutic Agents', 'X-Ray Crystallography', 'Yersinia pestis', 'analog', 'antimicrobial', 'bacterial resistance', 'base', 'biodefense', 'chemical synthesis', 'cytotoxicity', 'design', 'dihydropteroate', 'drug discovery', 'enzyme mechanism', 'fungus', 'high throughput screening', 'in vivo', 'inhibitor/antagonist', 'insight', 'interest', 'mecarzole', 'methicillin resistant Staphylococcus aureus', 'microorganism', 'molecular dynamics', 'novel', 'novel therapeutics', 'programs', 'scaffold', 'small molecule', 'structural biology', 'text searching', 'virtual']",NIAID,ST. JUDE CHILDREN'S RESEARCH HOSPITAL,R01,2007,589007,0.003217440558774634
"Computational discovery of cis-regulatory sequences DESCRIPTION (provided by applicant):  The overall aim of this research proposal is to combine computational and functional methodologies to develop a set of algorithms with high positive predictive value for identifying and classifying candidate cis-regulatory sequences sites in the vicinity of any gene of interest. The underlying hypothesis is that functional non-coding sequences - particularly those governing a set of tissue-specific genes - will evince common features at the sequence level that can be identified computationally and modeled with sufficient precision to enable accurate de novo predictions. However, it is expected that the overall predictive value of computational approaches alone will be comparatively low. Rather, employed as a screening tool in combination with a high throughput functional validation methodology, computational approaches of even low (10-20%) predictive potential would be of enormous value, enabling rapid culling of tens of thousands of cis-regulatory sequences from the human genome.  The strategy employed will commence with development of a catalogue of functional non-coding sequences for a set of tissue- and lineage-specific human genes. This will be achieved by precise localization of DNaseI hypersensitive sites (HSs) surrounding 100 erythroid-specific and 100 lymphoid lineage -restricted genes. Both tissues represent highly developed experimental systems, and a substantial amount of information has already come to light concerning both cis- and trans-regulatory mechanisms operative within these cell types. DNaseI hypersensitivity in vivo is the sine qua non of a diverse cast of transcriptional regulatory elements including enhancers, promoters, insulators, and locus control regions. The utility of the nuclease hypersensitivity assay for identification of in vivo-functional regulatory sequences is unmatched: it is a mature, functionally-based approach validated by a vast literature and decades of highly productive studies encompassing hundreds of human and other eukaryotic genes. A comprehensive catalogue of HSs surrounding any gene would therefore be expected to encompass the majority - if not all - of its cognate transcriptional control elements active in the tissues under study.  Next, a significant data mining effort will be undertaken. This phase will involve (i) structural comparisons among identified functional elements; (ii) identification of candidate transcription factor binding sites within HS sequences using motif analysis methodologies; (iii) identification of correlations with ancillary genomic features such as transcriptional start sites, CpG islands, and certain classes of repetitive sequences; and (iv) structural comparisons between in vivo functional sequences and evolutionarily conserved sequences within the study regions. A major focus will be application of model techniques such as hidden Markov models, technology from gene prediction programs, and classifier kernel methods such as support vector machines. Based on these analyses, initial models for prospective detection of cis-regulatory regions will be developed.  Finally, these models will be tested in and out of sample for sensitivity and specificity. Positive feedback from successfully confirmed sites will be utilized to refine the information collected above, thereby enhancing the basic model. Predictive techniques will then be applied systematically to discover cis-regulatory sequences surrounding erythroid, lymphoid, and diverse other classes of human genes.  The resulting database will be of incalculable value in furthering the study of the regulation of human genes and the computational methodologies employed therein. n/a",Computational discovery of cis-regulatory sequences,7281307,R01GM071923,"['Algorithms', 'Arts', 'Binding Sites', 'Biological Assay', 'Cataloging', 'Catalogs', 'Chromatin', 'Class', 'Classification', 'Complex', 'Computer Simulation', 'Computing Methodologies', 'Conserved Sequence', 'CpG Islands', 'Data Set', 'Databases', 'Deoxyribonuclease I', 'Deoxyribonucleases', 'Detection', 'Development', 'Economics', 'Elements', 'Enhancers', 'Erythroid', 'Feedback', 'Functional RNA', 'Gene Expression Regulation', 'Genes', 'Genome', 'Genomics', 'Goals', 'Grooming', 'Histocompatibility Testing', 'Human', 'Human Genome', 'Hypersensitivity', 'Light', 'Literature', 'Localized', 'Locus Control Region', 'Lymphoid', 'Machine Learning', 'Maps', 'Methodology', 'Methods', 'Modeling', 'Nucleic Acid Regulatory Sequences', 'Phase', 'Predictive Value', 'Regulation', 'Regulator Genes', 'Repetitive Sequence', 'Research Personnel', 'Research Proposals', 'Resolution', 'Sampling', 'Screening procedure', 'Sensitivity and Specificity', 'Site', 'Surveys', 'System', 'Techniques', 'Technology', 'Testing', 'Tissues', 'Transcriptional Regulation', 'Translations', 'Validation', 'base', 'cell type', 'computer studies', 'data mining', 'in vivo', 'interest', 'markov model', 'novel', 'nuclease', 'predictive modeling', 'programs', 'promoter', 'prospective', 'tool', 'transcription factor']",NIGMS,UNIVERSITY OF WASHINGTON,R01,2007,578070,0.04986890265024498
"Exon recognition during constitutive pre-mRNA splicing    DESCRIPTION (provided by applicant): The splicing together of exons during the transcription of most eukaryotic pre-mRNA molecules is a fundamental step in the transfer of information from DNA to protein. However, how the splice sites are recognized to initiate this fast and accurate process in not at all clear, since false sequences that resemble real sites outnumber the latter by 1 or 2 orders of magnitude yet are not used. We are searching for the additional information that specifies splice site recognition during pre-mRNA splicing in mammalian cells. In previous work we have used computational analysis to discover that: 1) that exon flanks 50 nt beyond the splice site consensuses can greatly influence splicing and contain sequences that stand out from the background; and 2) there are a large number of specific 8 mers that can act either as exonic splicing enhancers or splicing silencers. We will characterize both of these types of sequences, defining their base requirements, extent, position dependence, and specificity. With regard to the last, we will develop a novel exhaustive survey method that uses massively parallel solid state sequencing to identify every possible 8-mer that can be functional in a particular context, and we will compare this profile in different intronic, exonic and cellular contexts for constitutive and alternatively spliced exons. The flanking sequences fall into 2 distinct classes according to their G+C contents; we will test the idea that the rules governing exon definition differ for the two classes. To simplify the discovery of rules that govern exon definition, we will create designer exons made up of synthetic 8-mer modules we have identified as enhancers, silencers or neutral sequences. The numbers and spacing of these modules will reveal relationships that are hidden in the complexity of natural sequences. Finally, we will continue to use computation, including new machine learning algorithms, to better define intronic elements and to discover interactions between two or more features of a local sequence that define a splice site. We will also develop a Web-based exon-finding program that integrates all the information we have accumulated. Pre-mRNA splicing goes awry in a large proportion or human genetic disease cases. An understanding of the rules that govern the recognition of splice sites should help in the design of therapeutic intervention strategies to reverse such ill effects.                           n/a",Exon recognition during constitutive pre-mRNA splicing,7469442,R01GM072740,"['Algorithms', 'Alternative Splicing', 'Class', 'Computer Analysis', 'Consensus', 'DNA', 'Dependence', 'Elements', 'Enhancers', 'Exons', 'Genetic Transcription', 'Guanine + Cytosine Composition', 'Hereditary Disease', 'Heterogeneous Nuclear RNA', 'Human', 'Intervention', 'Introns', 'Machine Learning', 'Mammalian Cell', 'Numbers', 'Online Systems', 'Positioning Attribute', 'Process', 'Proteins', 'RNA Splicing', 'Role', 'Signal Transduction', 'Site', 'Specific qualifier value', 'Specificity', 'Structure', 'Survey Methodology', 'Surveys', 'Testing', 'Therapeutic Intervention', 'Work', 'base', 'design', 'falls', 'genetic selection', 'mRNA Precursor', 'novel', 'prevent', 'programs', 'size', 'solid state']",NIGMS,COLUMBIA UNIV NEW YORK MORNINGSIDE,R01,2008,291756,0.12873491630515388
"Exon recognition during constitutive pre-mRNA splicing    DESCRIPTION (provided by applicant): The splicing together of exons during the transcription of most eukaryotic pre-mRNA molecules is a fundamental step in the transfer of information from DNA to protein. However, how the splice sites are recognized to initiate this fast and accurate process in not at all clear, since false sequences that resemble real sites outnumber the latter by 1 or 2 orders of magnitude yet are not used. We are searching for the additional information that specifies splice site recognition during pre-mRNA splicing in mammalian cells. In previous work we have used computational analysis to discover that: 1) that exon flanks 50 nt beyond the splice site consensuses can greatly influence splicing and contain sequences that stand out from the background; and 2) there are a large number of specific 8 mers that can act either as exonic splicing enhancers or splicing silencers. We will characterize both of these types of sequences, defining their base requirements, extent, position dependence, and specificity. With regard to the last, we will develop a novel exhaustive survey method that uses massively parallel solid state sequencing to identify every possible 8-mer that can be functional in a particular context, and we will compare this profile in different intronic, exonic and cellular contexts for constitutive and alternatively spliced exons. The flanking sequences fall into 2 distinct classes according to their G+C contents; we will test the idea that the rules governing exon definition differ for the two classes. To simplify the discovery of rules that govern exon definition, we will create designer exons made up of synthetic 8-mer modules we have identified as enhancers, silencers or neutral sequences. The numbers and spacing of these modules will reveal relationships that are hidden in the complexity of natural sequences. Finally, we will continue to use computation, including new machine learning algorithms, to better define intronic elements and to discover interactions between two or more features of a local sequence that define a splice site. We will also develop a Web-based exon-finding program that integrates all the information we have accumulated. Pre-mRNA splicing goes awry in a large proportion or human genetic disease cases. An understanding of the rules that govern the recognition of splice sites should help in the design of therapeutic intervention strategies to reverse such ill effects.                           n/a",Exon recognition during constitutive pre-mRNA splicing,7261326,R01GM072740,[' '],NIGMS,COLUMBIA UNIV NEW YORK MORNINGSIDE,R01,2007,290853,0.12873491630515388
"Exon recognition during constitutive pre-mRNA splicing    DESCRIPTION (provided by applicant): The splicing together of exons during the transcription of most eukaryotic pre-mRNA molecules is a fundamental step in the transfer of information from DNA to protein. However, how the splice sites are recognized to initiate this fast and accurate process in not at all clear, since false sequences that resemble real sites outnumber the latter by 1 or 2 orders of magnitude yet are not used. We are searching for the additional information that specifies splice site recognition during pre-mRNA splicing in mammalian cells. In previous work we have used computational analysis to discover that: 1) that exon flanks 50 nt beyond the splice site consensuses can greatly influence splicing and contain sequences that stand out from the background; and 2) there are a large number of specific 8 mers that can act either as exonic splicing enhancers or splicing silencers. We will characterize both of these types of sequences, defining their base requirements, extent, position dependence, and specificity. With regard to the last, we will develop a novel exhaustive survey method that uses massively parallel solid state sequencing to identify every possible 8-mer that can be functional in a particular context, and we will compare this profile in different intronic, exonic and cellular contexts for constitutive and alternatively spliced exons. The flanking sequences fall into 2 distinct classes according to their G+C contents; we will test the idea that the rules governing exon definition differ for the two classes. To simplify the discovery of rules that govern exon definition, we will create designer exons made up of synthetic 8-mer modules we have identified as enhancers, silencers or neutral sequences. The numbers and spacing of these modules will reveal relationships that are hidden in the complexity of natural sequences. Finally, we will continue to use computation, including new machine learning algorithms, to better define intronic elements and to discover interactions between two or more features of a local sequence that define a splice site. We will also develop a Web-based exon-finding program that integrates all the information we have accumulated. Pre-mRNA splicing goes awry in a large proportion or human genetic disease cases. An understanding of the rules that govern the recognition of splice sites should help in the design of therapeutic intervention strategies to reverse such ill effects.                           n/a",Exon recognition during constitutive pre-mRNA splicing,7105514,R01GM072740,"['Internet', 'RNA splicing', 'binding sites', 'computational biology', 'computer system design /evaluation', 'genetic regulation', 'messenger RNA', 'molecular biology information system', 'molecular shape', 'nucleic acid sequence', 'polymerase chain reaction', 'serial analysis of gene expression', 'statistics /biometry']",NIGMS,COLUMBIA UNIV NEW YORK MORNINGSIDE,R01,2006,298611,0.12873491630515388
"Exon recognition during constitutive pre-mRNA splicing    DESCRIPTION (provided by applicant): The splicing together of exons during the transcription of most eukaryotic pre-mRNA molecules is a fundamental step in the transfer of information from DNA to protein. However, how the splice sites are recognized to initiate this fast and accurate process in not at all clear, since false sequences that resemble real sites outnumber the latter by 1 or 2 orders of magnitude yet are not used. We are searching for the additional information that specifies splice site recognition during pre-mRNA splicing in mammalian cells. In previous work we have used computational analysis to discover that: 1) that exon flanks 50 nt beyond the splice site consensuses can greatly influence splicing and contain sequences that stand out from the background; and 2) there are a large number of specific 8 mers that can act either as exonic splicing enhancers or splicing silencers. We will characterize both of these types of sequences, defining their base requirements, extent, position dependence, and specificity. With regard to the last, we will develop a novel exhaustive survey method that uses massively parallel solid state sequencing to identify every possible 8-mer that can be functional in a particular context, and we will compare this profile in different intronic, exonic and cellular contexts for constitutive and alternatively spliced exons. The flanking sequences fall into 2 distinct classes according to their G+C contents; we will test the idea that the rules governing exon definition differ for the two classes. To simplify the discovery of rules that govern exon definition, we will create designer exons made up of synthetic 8-mer modules we have identified as enhancers, silencers or neutral sequences. The numbers and spacing of these modules will reveal relationships that are hidden in the complexity of natural sequences. Finally, we will continue to use computation, including new machine learning algorithms, to better define intronic elements and to discover interactions between two or more features of a local sequence that define a splice site. We will also develop a Web-based exon-finding program that integrates all the information we have accumulated. Pre-mRNA splicing goes awry in a large proportion or human genetic disease cases. An understanding of the rules that govern the recognition of splice sites should help in the design of therapeutic intervention strategies to reverse such ill effects.                           n/a",Exon recognition during constitutive pre-mRNA splicing,6966860,R01GM072740,"['Internet', 'RNA splicing', 'binding sites', 'computational biology', 'computer system design /evaluation', 'genetic regulation', 'messenger RNA', 'molecular biology information system', 'molecular shape', 'nucleic acid sequence', 'polymerase chain reaction', 'serial analysis of gene expression', 'statistics /biometry']",NIGMS,COLUMBIA UNIV NEW YORK MORNINGSIDE,R01,2005,304845,0.12873491630515388
"DRUG MANAGEMENT SOFTWARE FOR NCI CLINICAL TRIALS DDOTS was awarded a Phase I SBIR contract to create an algorithmic computer model which inventories and tracks all investigational drugs used in NCI-sponsored clinical trials. DDOTS met all of the requirements of the project with the development of a stand-alone system for pharmacy use entitled ""Investigational Drug Environmental Accountability"" (IDEA). At the request of the NCI's CTEP informatics workgroup, the project was extended for a period of six months in order to allow DDOTS to create and align the IDEA drug accountability file submission format for inclusion in the Drug Authorization and Review Tracking System (DARTS) being developed for NCI's Pharmacy Management Branch. Having successfully accomplished the above, the primary specific aim of this Phase II proposal is the actual production of the IDEA software system. The IDEA software program will be installed and operationalized at two beta test sites: the Ann Arbor Regional CCOP in Ann Arbor, Ml and the Carle Cancer Center in Urbana, IL. There is no investigational drug management and auditing software program presently available in either the commercial market or from health care organizations. The IDEA software provides a state-of-the-art technologic tool which serves to meet both the needs of cancer research sites and the NCI for improved efficiency, reliability, and cost-effectiveness in the overall investigational drug management and inventory process. PROPOSED COMMERCIAL APPLICATIONS: Although the IDEA software is being developed for NCI-sponsored research programs, broad applicability exists for its use by all organizations conducting drug research, i.e., comprehensive cancer programs, university hospitals, and pharmaceutical companies.  n/a",DRUG MANAGEMENT SOFTWARE FOR NCI CLINICAL TRIALS,6071505,R44CA078105,"['artificial intelligence', ' clinical trials', ' computer assisted patient care', ' computer program /software', ' computer simulation', ' computer system design /evaluation', ' drug screening /evaluation', ' informatics']",NCI,"DDOTS, INC.",R44,2000,375000,0.0013029946778102658
"Comparative genomics of protein structure and function    DESCRIPTION (provided by applicant): This work aims to develop methods to identify functional sites in protein structures and to characterize protein function on a genomic scale. The approach is predicated on the Evolutionary Trace method (ET) to locate functional sites in structures. Preliminary studies enabled us to automate the basic steps towards a complete, automated functional annotation pipeline, namely, functional site analysis with ET; extraction from ET analysis of SD-templates that describe composition and conformation of key residues involved in binding or catalytic function; the search in other structures for geometric matches to these 3D-templates; and the analysis of which of those matched are most biologically relevant. We now seek to increase the sensitivity and specificity of the annotation pipeline by optimizing the definition of 3-D templates, by adding new template features to better judge whether molecular mimicry underlies functional similarity; and by developing novel strategies that use multiple templates to identify function. The result will reveal which regions of proteins are most biologically relevant, and hence logical targets for protein engineering and drug design, and it will extend to three dimensions a functional annotation strategy traditionally based on one- dimensional pattern matching in protein sequences. In so doing, this work addresses a fundamental NIH roadmap problem in ""post-genomic biology"": linking massive and exponentially growing amounts of raw sequence and structure data to the molecular basis of biological function.           n/a",Comparative genomics of protein structure and function,7786185,R01GM079656,"['3-Dimensional', 'Address', 'Algorithms', 'Amino Acid Sequence', 'Amino Acids', 'Benchmarking', 'Binding', 'Binding Sites', 'Biological', 'Biological Process', 'Biology', 'Catalysis', 'Collaborations', 'Data', 'Databases', 'Dimensions', 'Drug Design', 'Electrostatics', 'Enzymes', 'Failure', 'Genomics', 'Goals', 'Gold', 'Ligand Binding', 'Link', 'Machine Learning', 'Manuals', 'Maps', 'Measures', 'Methods', 'Molecular', 'Molecular Conformation', 'Molecular Mimicry', 'Mutation', 'Outcome', 'PAWR protein', 'Pattern', 'Peptide Sequence Determination', 'Performance', 'Pharmaceutical Preparations', 'Protein Binding', 'Protein Engineering', 'Protein Region', 'Protein Structure Initiative', 'Proteins', 'Research Personnel', 'Resources', 'Sampling', 'Sensitivity and Specificity', 'Site', 'Solutions', 'Solvents', 'Source', 'Source Code', 'Specificity', 'Structure', 'Surface', 'Testing', 'United States National Institutes of Health', 'Variant', 'Work', 'base', 'comparative genomics', 'computer studies', 'conformer', 'database structure', 'design', 'falls', 'flexibility', 'heuristics', 'inhibitor/antagonist', 'interest', 'mimetics', 'novel strategies', 'programs', 'protein function', 'protein structure', 'protein structure function', 'structural genomics', 'success', 'tool']",NIGMS,BAYLOR COLLEGE OF MEDICINE,R01,2010,278531,0.09156051218350095
"Comparative genomics of protein structure and function    DESCRIPTION (provided by applicant): This work aims to develop methods to identify functional sites in protein structures and to characterize protein function on a genomic scale. The approach is predicated on the Evolutionary Trace method (ET) to locate functional sites in structures. Preliminary studies enabled us to automate the basic steps towards a complete, automated functional annotation pipeline, namely, functional site analysis with ET; extraction from ET analysis of SD-templates that describe composition and conformation of key residues involved in binding or catalytic function; the search in other structures for geometric matches to these 3D-templates; and the analysis of which of those matched are most biologically relevant. We now seek to increase the sensitivity and specificity of the annotation pipeline by optimizing the definition of 3-D templates, by adding new template features to better judge whether molecular mimicry underlies functional similarity; and by developing novel strategies that use multiple templates to identify function. The result will reveal which regions of proteins are most biologically relevant, and hence logical targets for protein engineering and drug design, and it will extend to three dimensions a functional annotation strategy traditionally based on one- dimensional pattern matching in protein sequences. In so doing, this work addresses a fundamental NIH roadmap problem in ""post-genomic biology"": linking massive and exponentially growing amounts of raw sequence and structure data to the molecular basis of biological function.           n/a",Comparative genomics of protein structure and function,7586248,R01GM079656,"['3-Dimensional', 'Address', 'Algorithms', 'Amino Acid Sequence', 'Amino Acids', 'Benchmarking', 'Binding', 'Binding Sites', 'Biological', 'Biological Process', 'Biology', 'Catalysis', 'Collaborations', 'Data', 'Databases', 'Dimensions', 'Drug Design', 'Electrostatics', 'Enzymes', 'Failure', 'Genomics', 'Goals', 'Gold', 'Ligand Binding', 'Link', 'Machine Learning', 'Manuals', 'Maps', 'Measures', 'Methods', 'Molecular', 'Molecular Conformation', 'Molecular Mimicry', 'Mutation', 'Outcome', 'PAWR protein', 'Pattern', 'Peptide Sequence Determination', 'Performance', 'Pharmaceutical Preparations', 'Protein Binding', 'Protein Engineering', 'Protein Region', 'Protein Structure Initiative', 'Proteins', 'Research Personnel', 'Resources', 'Sampling', 'Sensitivity and Specificity', 'Site', 'Solutions', 'Solvents', 'Source', 'Source Code', 'Specificity', 'Structure', 'Surface', 'Testing', 'United States National Institutes of Health', 'Variant', 'Work', 'base', 'comparative', 'computer studies', 'conformer', 'database structure', 'design', 'falls', 'flexibility', 'heuristics', 'inhibitor/antagonist', 'interest', 'mimetics', 'novel strategies', 'programs', 'protein function', 'protein structure', 'protein structure function', 'structural genomics', 'success', 'tool']",NIGMS,BAYLOR COLLEGE OF MEDICINE,R01,2009,281344,0.09156051218350095
"Comparative genomics of protein structure and function    DESCRIPTION (provided by applicant): This work aims to develop methods to identify functional sites in protein structures and to characterize protein function on a genomic scale. The approach is predicated on the Evolutionary Trace method (ET) to locate functional sites in structures. Preliminary studies enabled us to automate the basic steps towards a complete, automated functional annotation pipeline, namely, functional site analysis with ET; extraction from ET analysis of SD-templates that describe composition and conformation of key residues involved in binding or catalytic function; the search in other structures for geometric matches to these 3D-templates; and the analysis of which of those matched are most biologically relevant. We now seek to increase the sensitivity and specificity of the annotation pipeline by optimizing the definition of 3-D templates, by adding new template features to better judge whether molecular mimicry underlies functional similarity; and by developing novel strategies that use multiple templates to identify function. The result will reveal which regions of proteins are most biologically relevant, and hence logical targets for protein engineering and drug design, and it will extend to three dimensions a functional annotation strategy traditionally based on one- dimensional pattern matching in protein sequences. In so doing, this work addresses a fundamental NIH roadmap problem in ""post-genomic biology"": linking massive and exponentially growing amounts of raw sequence and structure data to the molecular basis of biological function.           n/a",Comparative genomics of protein structure and function,7391818,R01GM079656,"['3-Dimensional', 'Address', 'Algorithms', 'Amino Acid Sequence', 'Amino Acids', 'Benchmarking', 'Binding', 'Binding Sites', 'Biological', 'Biological Process', 'Biology', 'Catalysis', 'Collaborations', 'Data', 'Databases', 'Dimensions', 'Drug Design', 'Electrostatics', 'Enzymes', 'Failure', 'Genomics', 'Goals', 'Gold', 'Ligand Binding', 'Link', 'Machine Learning', 'Manuals', 'Maps', 'Measures', 'Methods', 'Molecular', 'Molecular Conformation', 'Molecular Mimicry', 'Mutation', 'Numbers', 'Outcome', 'PAWR protein', 'Pattern', 'Peptide Sequence Determination', 'Performance', 'Pharmaceutical Preparations', 'Pliability', 'Protein Binding', 'Protein Engineering', 'Protein Region', 'Protein Structure Initiative', 'Proteins', 'Research Personnel', 'Resources', 'Sampling', 'Sensitivity and Specificity', 'Site', 'Solutions', 'Solvents', 'Source', 'Source Code', 'Specificity', 'Standards of Weights and Measures', 'Structure', 'Surface', 'Testing', 'United States National Institutes of Health', 'Variant', 'Work', 'base', 'comparative', 'computer studies', 'conformer', 'design', 'falls', 'heuristics', 'inhibitor/antagonist', 'interest', 'mimetics', 'novel strategies', 'programs', 'protein function', 'protein structure', 'protein structure function', 'structural genomics', 'success', 'tool']",NIGMS,BAYLOR COLLEGE OF MEDICINE,R01,2008,281344,0.09156051218350095
"Comparative genomics of protein structure and function    DESCRIPTION (provided by applicant): This work aims to develop methods to identify functional sites in protein structures and to characterize protein function on a genomic scale. The approach is predicated on the Evolutionary Trace method (ET) to locate functional sites in structures. Preliminary studies enabled us to automate the basic steps towards a complete, automated functional annotation pipeline, namely, functional site analysis with ET; extraction from ET analysis of SD-templates that describe composition and conformation of key residues involved in binding or catalytic function; the search in other structures for geometric matches to these 3D-templates; and the analysis of which of those matched are most biologically relevant. We now seek to increase the sensitivity and specificity of the annotation pipeline by optimizing the definition of 3-D templates, by adding new template features to better judge whether molecular mimicry underlies functional similarity; and by developing novel strategies that use multiple templates to identify function. The result will reveal which regions of proteins are most biologically relevant, and hence logical targets for protein engineering and drug design, and it will extend to three dimensions a functional annotation strategy traditionally based on one- dimensional pattern matching in protein sequences. In so doing, this work addresses a fundamental NIH roadmap problem in ""post-genomic biology"": linking massive and exponentially growing amounts of raw sequence and structure data to the molecular basis of biological function.           n/a",Comparative genomics of protein structure and function,7192957,R01GM079656,"['3-Dimensional', 'Address', 'Algorithms', 'Amino Acid Sequence', 'Amino Acids', 'Benchmarking', 'Binding', 'Binding Sites', 'Biological', 'Biological Process', 'Biology', 'Catalysis', 'Collaborations', 'Data', 'Databases', 'Dimensions', 'Drug Design', 'Electrostatics', 'Enzymes', 'Failure', 'Genomics', 'Goals', 'Gold', 'Ligand Binding', 'Link', 'Machine Learning', 'Manuals', 'Maps', 'Measures', 'Methods', 'Molecular', 'Molecular Conformation', 'Molecular Mimicry', 'Mutation', 'Numbers', 'Outcome', 'PAWR protein', 'Pattern', 'Peptide Sequence Determination', 'Performance', 'Pharmaceutical Preparations', 'Pliability', 'Protein Binding', 'Protein Engineering', 'Protein Region', 'Protein Structure Initiative', 'Proteins', 'Research Personnel', 'Resources', 'Sampling', 'Sensitivity and Specificity', 'Site', 'Solutions', 'Solvents', 'Source', 'Source Code', 'Specificity', 'Standards of Weights and Measures', 'Structure', 'Surface', 'Testing', 'United States National Institutes of Health', 'Variant', 'Work', 'base', 'comparative', 'computer studies', 'conformer', 'design', 'falls', 'heuristics', 'inhibitor/antagonist', 'interest', 'mimetics', 'novel strategies', 'programs', 'protein function', 'protein structure', 'protein structure function', 'structural genomics', 'success', 'tool']",NIGMS,BAYLOR COLLEGE OF MEDICINE,R01,2007,290844,0.09156051218350095
"Analysis of mRNA Polyadenylation across Species and Tissues    DESCRIPTION (provided by applicant): mRNA polyadenylation is an essential step for the maturation of almost all eukaryotic mRNAs. Altered polyadenylation activity caused by genetic mutation has been implicated in a growing number of human diseases. Over half of the human genes contain multiple polyadenylation sites [poly(A) sites] supported by cDNA/EST sequences. The polyadenylation pattern in the 3'- most exon defines the 3' UnTranslated Region (UTR), which contains various cis regulatory elements for mRNA metabolism, such as microRNA (miRNA) target sites and AU-rich elements (AUEs). In addition, a large fraction of human genes have polyadenylation events in introns, leading to mRNA variants with different protein coding sequence and indicating dynamic interplay between polyadenylation and splicing. Regulation of gene expression by polyadenylation has been characterized only for a handful of model genes, and its mechanism is poorly understood on the systems level. The long-term goal is to understand the mechanisms by which mRNA polyadenylation regulates gene expression in eukaryotic genomes. There are two specific aims in this project: 1) To accurately predict poly(A) sites across metazoan species using their corresponding cis elements; 2) To quantitatively model poly(A) site usage and selection across human and mouse tissues. We will combine computational and molecular biology techniques to address these issues. The results will improve gene annotation in metazoan species, uncover gene regulation events mediated by alternative polyadenylation, elucidate 3' UTR evolution, shed light on the mechanisms of polyadenylation, and provide valuable tools to examine human mutations and polymorphisms that affect poly(A) sites. NARRATIVE mRNA polyadenylation is an essential step for the maturation of almost all eukaryotic mRNAs. Altered polyadenylation activity caused by genetic mutation has been implicated in a growing number of human diseases. Over half of the human genes contain multiple polyadenylation sites [poly(A) sites] supported by cDNA/EST sequences. The polyadenylation pattern in the 3'- most exon defines the 3' UnTranslated Region (UTR), which contains various cis regulatory elements for mRNA metabolism, such as microRNA (miRNA) target sites and AU-rich elements (AUEs). In addition, a large fraction of human genes have polyadenylation events in introns, leading to mRNA variants with different protein coding sequence and indicating dynamic interplay between polyadenylation and splicing. Regulation of gene expression by polyadenylation has been characterized only for a handful of model genes, and its mechanism is poorly understood on the systems level. The long term goal is to understand the mechanisms by which mRNA polyadenylation regulates gene expression in eukaryotic genomes. There are two specific aims in this project: 1) To accurately predict poly(A) sites across metazoan species using their corresponding cis elements; 2) To quantitatively model poly(A) site usage and selection across human and mouse tissues. We will combine computational and molecular biology techniques to address these issues. The results will improve gene annotation in metazoan species, uncover gene regulation events mediated by alternative polyadenylation, elucidate 3' UTR evolution, shed light on the mechanisms of polyadenylation, and provide valuable tools to examine human mutations and polymorphisms that affect poly(A) sites.          n/a",Analysis of mRNA Polyadenylation across Species and Tissues,8257929,R01GM084089,"['3&apos', ' Untranslated Regions', 'Address', 'Affect', 'Biochemical', 'Biological', 'Biological Assay', 'Cell Line', 'Classification', 'Code', 'Complementary DNA', 'Computational Molecular Biology', 'DNA Microarray Chip', 'Data', 'Databases', 'Elements', 'Event', 'Evolution', 'Exons', 'Expressed Sequence Tags', 'Frequencies', 'Gene Expression', 'Gene Expression Regulation', 'Gene Mutation', 'Genes', 'Genetic Polymorphism', 'Genome', 'Goals', 'Human', 'Indium', 'Introns', 'Light', 'Machine Learning', 'Malignant Neoplasms', 'Mediating', 'Messenger RNA', 'Metabolism', 'MicroRNAs', 'Modeling', 'Molecular Biology', 'Molecular Biology Techniques', 'Mus', 'Mutagenesis', 'Mutation', 'Pattern', 'Phylogenetic Analysis', 'Poly A', 'Polyadenylation', 'Polyadenylation Pathway', 'Proteins', 'RNA', 'RNA Binding', 'RNA Interference', 'RNA Splicing', 'RNA-Binding Proteins', 'Regulation', 'Regulatory Element', 'Relative (related person)', 'Reporter', 'Site', 'Statistical Models', 'Structure', 'System', 'Technology', 'Tissues', 'Trees', 'Untranslated Regions', 'Validation', 'Variant', 'base', 'human disease', 'improved', 'preference', 'research study', 'serial analysis of gene expression', 'tool']",NIGMS,UNIV OF MED/DENT OF NJ-NJ MEDICAL SCHOOL,R01,2012,298147,0.11249555316619807
"Analysis of mRNA Polyadenylation across Species and Tissues    DESCRIPTION (provided by applicant): mRNA polyadenylation is an essential step for the maturation of almost all eukaryotic mRNAs. Altered polyadenylation activity caused by genetic mutation has been implicated in a growing number of human diseases. Over half of the human genes contain multiple polyadenylation sites [poly(A) sites] supported by cDNA/EST sequences. The polyadenylation pattern in the 3'- most exon defines the 3' UnTranslated Region (UTR), which contains various cis regulatory elements for mRNA metabolism, such as microRNA (miRNA) target sites and AU-rich elements (AUEs). In addition, a large fraction of human genes have polyadenylation events in introns, leading to mRNA variants with different protein coding sequence and indicating dynamic interplay between polyadenylation and splicing. Regulation of gene expression by polyadenylation has been characterized only for a handful of model genes, and its mechanism is poorly understood on the systems level. The long-term goal is to understand the mechanisms by which mRNA polyadenylation regulates gene expression in eukaryotic genomes. There are two specific aims in this project: 1) To accurately predict poly(A) sites across metazoan species using their corresponding cis elements; 2) To quantitatively model poly(A) site usage and selection across human and mouse tissues. We will combine computational and molecular biology techniques to address these issues. The results will improve gene annotation in metazoan species, uncover gene regulation events mediated by alternative polyadenylation, elucidate 3' UTR evolution, shed light on the mechanisms of polyadenylation, and provide valuable tools to examine human mutations and polymorphisms that affect poly(A) sites. NARRATIVE mRNA polyadenylation is an essential step for the maturation of almost all eukaryotic mRNAs. Altered polyadenylation activity caused by genetic mutation has been implicated in a growing number of human diseases. Over half of the human genes contain multiple polyadenylation sites [poly(A) sites] supported by cDNA/EST sequences. The polyadenylation pattern in the 3'- most exon defines the 3' UnTranslated Region (UTR), which contains various cis regulatory elements for mRNA metabolism, such as microRNA (miRNA) target sites and AU-rich elements (AUEs). In addition, a large fraction of human genes have polyadenylation events in introns, leading to mRNA variants with different protein coding sequence and indicating dynamic interplay between polyadenylation and splicing. Regulation of gene expression by polyadenylation has been characterized only for a handful of model genes, and its mechanism is poorly understood on the systems level. The long term goal is to understand the mechanisms by which mRNA polyadenylation regulates gene expression in eukaryotic genomes. There are two specific aims in this project: 1) To accurately predict poly(A) sites across metazoan species using their corresponding cis elements; 2) To quantitatively model poly(A) site usage and selection across human and mouse tissues. We will combine computational and molecular biology techniques to address these issues. The results will improve gene annotation in metazoan species, uncover gene regulation events mediated by alternative polyadenylation, elucidate 3' UTR evolution, shed light on the mechanisms of polyadenylation, and provide valuable tools to examine human mutations and polymorphisms that affect poly(A) sites.          n/a",Analysis of mRNA Polyadenylation across Species and Tissues,8068636,R01GM084089,"['3&apos', ' Untranslated Regions', 'Address', 'Affect', 'Biochemical', 'Biological', 'Biological Assay', 'Cell Line', 'Classification', 'Code', 'Complementary DNA', 'Computational Molecular Biology', 'DNA Microarray Chip', 'Data', 'Databases', 'Elements', 'Event', 'Evolution', 'Exons', 'Expressed Sequence Tags', 'Frequencies', 'Gene Expression', 'Gene Expression Regulation', 'Gene Mutation', 'Genes', 'Genetic Polymorphism', 'Genome', 'Goals', 'Human', 'Indium', 'Introns', 'Light', 'Machine Learning', 'Malignant Neoplasms', 'Mediating', 'Messenger RNA', 'Metabolism', 'MicroRNAs', 'Modeling', 'Molecular Biology', 'Molecular Biology Techniques', 'Mus', 'Mutagenesis', 'Mutation', 'Pattern', 'Phylogenetic Analysis', 'Poly A', 'Polyadenylation', 'Polyadenylation Pathway', 'Proteins', 'RNA', 'RNA Binding', 'RNA Interference', 'RNA Splicing', 'RNA-Binding Proteins', 'Regulation', 'Regulatory Element', 'Relative (related person)', 'Reporter', 'Site', 'Statistical Models', 'Structure', 'System', 'Technology', 'Tissues', 'Trees', 'Untranslated Regions', 'Validation', 'Variant', 'base', 'human disease', 'improved', 'preference', 'research study', 'serial analysis of gene expression', 'tool']",NIGMS,UNIV OF MED/DENT OF NJ-NJ MEDICAL SCHOOL,R01,2011,298147,0.11249555316619807
"Analysis of mRNA Polyadenylation across Species and Tissues    DESCRIPTION (provided by applicant): mRNA polyadenylation is an essential step for the maturation of almost all eukaryotic mRNAs. Altered polyadenylation activity caused by genetic mutation has been implicated in a growing number of human diseases. Over half of the human genes contain multiple polyadenylation sites [poly(A) sites] supported by cDNA/EST sequences. The polyadenylation pattern in the 3'- most exon defines the 3' UnTranslated Region (UTR), which contains various cis regulatory elements for mRNA metabolism, such as microRNA (miRNA) target sites and AU-rich elements (AUEs). In addition, a large fraction of human genes have polyadenylation events in introns, leading to mRNA variants with different protein coding sequence and indicating dynamic interplay between polyadenylation and splicing. Regulation of gene expression by polyadenylation has been characterized only for a handful of model genes, and its mechanism is poorly understood on the systems level. The long-term goal is to understand the mechanisms by which mRNA polyadenylation regulates gene expression in eukaryotic genomes. There are two specific aims in this project: 1) To accurately predict poly(A) sites across metazoan species using their corresponding cis elements; 2) To quantitatively model poly(A) site usage and selection across human and mouse tissues. We will combine computational and molecular biology techniques to address these issues. The results will improve gene annotation in metazoan species, uncover gene regulation events mediated by alternative polyadenylation, elucidate 3' UTR evolution, shed light on the mechanisms of polyadenylation, and provide valuable tools to examine human mutations and polymorphisms that affect poly(A) sites. NARRATIVE mRNA polyadenylation is an essential step for the maturation of almost all eukaryotic mRNAs. Altered polyadenylation activity caused by genetic mutation has been implicated in a growing number of human diseases. Over half of the human genes contain multiple polyadenylation sites [poly(A) sites] supported by cDNA/EST sequences. The polyadenylation pattern in the 3'- most exon defines the 3' UnTranslated Region (UTR), which contains various cis regulatory elements for mRNA metabolism, such as microRNA (miRNA) target sites and AU-rich elements (AUEs). In addition, a large fraction of human genes have polyadenylation events in introns, leading to mRNA variants with different protein coding sequence and indicating dynamic interplay between polyadenylation and splicing. Regulation of gene expression by polyadenylation has been characterized only for a handful of model genes, and its mechanism is poorly understood on the systems level. The long term goal is to understand the mechanisms by which mRNA polyadenylation regulates gene expression in eukaryotic genomes. There are two specific aims in this project: 1) To accurately predict poly(A) sites across metazoan species using their corresponding cis elements; 2) To quantitatively model poly(A) site usage and selection across human and mouse tissues. We will combine computational and molecular biology techniques to address these issues. The results will improve gene annotation in metazoan species, uncover gene regulation events mediated by alternative polyadenylation, elucidate 3' UTR evolution, shed light on the mechanisms of polyadenylation, and provide valuable tools to examine human mutations and polymorphisms that affect poly(A) sites.          n/a",Analysis of mRNA Polyadenylation across Species and Tissues,7810646,R01GM084089,"['3&apos', ' Untranslated Regions', 'Address', 'Affect', 'Biochemical', 'Biological', 'Biological Assay', 'Cell Line', 'Classification', 'Code', 'Complementary DNA', 'Computational Molecular Biology', 'DNA Microarray Chip', 'Data', 'Databases', 'Elements', 'Event', 'Evolution', 'Exons', 'Expressed Sequence Tags', 'Frequencies', 'Gene Expression', 'Gene Expression Regulation', 'Gene Mutation', 'Genes', 'Genetic Polymorphism', 'Genome', 'Goals', 'Human', 'Indium', 'Introns', 'Light', 'Machine Learning', 'Malignant Neoplasms', 'Mediating', 'Messenger RNA', 'Metabolism', 'MicroRNAs', 'Modeling', 'Molecular Biology', 'Molecular Biology Techniques', 'Mus', 'Mutagenesis', 'Mutation', 'Pattern', 'Phylogenetic Analysis', 'Poly A', 'Polyadenylation', 'Polyadenylation Pathway', 'Proteins', 'RNA', 'RNA Binding', 'RNA Interference', 'RNA Splicing', 'RNA-Binding Proteins', 'Regulation', 'Regulatory Element', 'Relative (related person)', 'Reporter', 'Site', 'Statistical Models', 'Structure', 'System', 'Technology', 'Tissues', 'Trees', 'Untranslated Regions', 'Validation', 'Variant', 'base', 'human disease', 'improved', 'preference', 'research study', 'serial analysis of gene expression', 'tool']",NIGMS,UNIV OF MED/DENT OF NJ-NJ MEDICAL SCHOOL,R01,2010,301158,0.11249555316619807
"Analysis of mRNA Polyadenylation across Species and Tissues    DESCRIPTION (provided by applicant): mRNA polyadenylation is an essential step for the maturation of almost all eukaryotic mRNAs. Altered polyadenylation activity caused by genetic mutation has been implicated in a growing number of human diseases. Over half of the human genes contain multiple polyadenylation sites [poly(A) sites] supported by cDNA/EST sequences. The polyadenylation pattern in the 3'- most exon defines the 3' UnTranslated Region (UTR), which contains various cis regulatory elements for mRNA metabolism, such as microRNA (miRNA) target sites and AU-rich elements (AUEs). In addition, a large fraction of human genes have polyadenylation events in introns, leading to mRNA variants with different protein coding sequence and indicating dynamic interplay between polyadenylation and splicing. Regulation of gene expression by polyadenylation has been characterized only for a handful of model genes, and its mechanism is poorly understood on the systems level. The long-term goal is to understand the mechanisms by which mRNA polyadenylation regulates gene expression in eukaryotic genomes. There are two specific aims in this project: 1) To accurately predict poly(A) sites across metazoan species using their corresponding cis elements; 2) To quantitatively model poly(A) site usage and selection across human and mouse tissues. We will combine computational and molecular biology techniques to address these issues. The results will improve gene annotation in metazoan species, uncover gene regulation events mediated by alternative polyadenylation, elucidate 3' UTR evolution, shed light on the mechanisms of polyadenylation, and provide valuable tools to examine human mutations and polymorphisms that affect poly(A) sites. NARRATIVE mRNA polyadenylation is an essential step for the maturation of almost all eukaryotic mRNAs. Altered polyadenylation activity caused by genetic mutation has been implicated in a growing number of human diseases. Over half of the human genes contain multiple polyadenylation sites [poly(A) sites] supported by cDNA/EST sequences. The polyadenylation pattern in the 3'- most exon defines the 3' UnTranslated Region (UTR), which contains various cis regulatory elements for mRNA metabolism, such as microRNA (miRNA) target sites and AU-rich elements (AUEs). In addition, a large fraction of human genes have polyadenylation events in introns, leading to mRNA variants with different protein coding sequence and indicating dynamic interplay between polyadenylation and splicing. Regulation of gene expression by polyadenylation has been characterized only for a handful of model genes, and its mechanism is poorly understood on the systems level. The long term goal is to understand the mechanisms by which mRNA polyadenylation regulates gene expression in eukaryotic genomes. There are two specific aims in this project: 1) To accurately predict poly(A) sites across metazoan species using their corresponding cis elements; 2) To quantitatively model poly(A) site usage and selection across human and mouse tissues. We will combine computational and molecular biology techniques to address these issues. The results will improve gene annotation in metazoan species, uncover gene regulation events mediated by alternative polyadenylation, elucidate 3' UTR evolution, shed light on the mechanisms of polyadenylation, and provide valuable tools to examine human mutations and polymorphisms that affect poly(A) sites.          n/a",Analysis of mRNA Polyadenylation across Species and Tissues,7616180,R01GM084089,"['3&apos', ' Untranslated Regions', 'Address', 'Affect', 'Biochemical', 'Biological', 'Biological Assay', 'Cell Line', 'Classification', 'Code', 'Complementary DNA', 'Computational Molecular Biology', 'DNA Microarray Chip', 'Data', 'Databases', 'Elements', 'Event', 'Evolution', 'Exons', 'Expressed Sequence Tags', 'Frequencies', 'Gene Expression', 'Gene Expression Regulation', 'Gene Mutation', 'Genes', 'Genetic Polymorphism', 'Genome', 'Goals', 'Human', 'Indium', 'Introns', 'Light', 'Machine Learning', 'Malignant Neoplasms', 'Mediating', 'Messenger RNA', 'Metabolism', 'MicroRNAs', 'Modeling', 'Molecular Biology', 'Molecular Biology Techniques', 'Mus', 'Mutagenesis', 'Mutation', 'Pattern', 'Phylogenetic Analysis', 'Poly A', 'Polyadenylation', 'Polyadenylation Pathway', 'Proteins', 'RNA', 'RNA Binding', 'RNA Interference', 'RNA Splicing', 'RNA-Binding Proteins', 'Regulation', 'Regulatory Element', 'Relative (related person)', 'Reporter', 'Site', 'Statistical Models', 'Structure', 'System', 'Technology', 'Tissues', 'Trees', 'Untranslated Regions', 'Validation', 'Variant', 'base', 'human disease', 'improved', 'preference', 'research study', 'serial analysis of gene expression', 'tool']",NIGMS,UNIV OF MED/DENT OF NJ-NJ MEDICAL SCHOOL,R01,2009,304200,0.11249555316619807
"Analysis of mRNA Polyadenylation across Species and Tissues    DESCRIPTION (provided by applicant): mRNA polyadenylation is an essential step for the maturation of almost all eukaryotic mRNAs. Altered polyadenylation activity caused by genetic mutation has been implicated in a growing number of human diseases. Over half of the human genes contain multiple polyadenylation sites [poly(A) sites] supported by cDNA/EST sequences. The polyadenylation pattern in the 3'- most exon defines the 3' UnTranslated Region (UTR), which contains various cis regulatory elements for mRNA metabolism, such as microRNA (miRNA) target sites and AU-rich elements (AUEs). In addition, a large fraction of human genes have polyadenylation events in introns, leading to mRNA variants with different protein coding sequence and indicating dynamic interplay between polyadenylation and splicing. Regulation of gene expression by polyadenylation has been characterized only for a handful of model genes, and its mechanism is poorly understood on the systems level. The long-term goal is to understand the mechanisms by which mRNA polyadenylation regulates gene expression in eukaryotic genomes. There are two specific aims in this project: 1) To accurately predict poly(A) sites across metazoan species using their corresponding cis elements; 2) To quantitatively model poly(A) site usage and selection across human and mouse tissues. We will combine computational and molecular biology techniques to address these issues. The results will improve gene annotation in metazoan species, uncover gene regulation events mediated by alternative polyadenylation, elucidate 3' UTR evolution, shed light on the mechanisms of polyadenylation, and provide valuable tools to examine human mutations and polymorphisms that affect poly(A) sites. NARRATIVE mRNA polyadenylation is an essential step for the maturation of almost all eukaryotic mRNAs. Altered polyadenylation activity caused by genetic mutation has been implicated in a growing number of human diseases. Over half of the human genes contain multiple polyadenylation sites [poly(A) sites] supported by cDNA/EST sequences. The polyadenylation pattern in the 3'- most exon defines the 3' UnTranslated Region (UTR), which contains various cis regulatory elements for mRNA metabolism, such as microRNA (miRNA) target sites and AU-rich elements (AUEs). In addition, a large fraction of human genes have polyadenylation events in introns, leading to mRNA variants with different protein coding sequence and indicating dynamic interplay between polyadenylation and splicing. Regulation of gene expression by polyadenylation has been characterized only for a handful of model genes, and its mechanism is poorly understood on the systems level. The long term goal is to understand the mechanisms by which mRNA polyadenylation regulates gene expression in eukaryotic genomes. There are two specific aims in this project: 1) To accurately predict poly(A) sites across metazoan species using their corresponding cis elements; 2) To quantitatively model poly(A) site usage and selection across human and mouse tissues. We will combine computational and molecular biology techniques to address these issues. The results will improve gene annotation in metazoan species, uncover gene regulation events mediated by alternative polyadenylation, elucidate 3' UTR evolution, shed light on the mechanisms of polyadenylation, and provide valuable tools to examine human mutations and polymorphisms that affect poly(A) sites.          n/a",Analysis of mRNA Polyadenylation across Species and Tissues,7883800,R01GM084089,"['3&apos', ' Untranslated Regions', 'Address', 'Affect', 'Biochemical', 'Biological', 'Biological Assay', 'Cell Line', 'Classification', 'Code', 'Complementary DNA', 'Computational Molecular Biology', 'DNA Microarray Chip', 'Data', 'Databases', 'Elements', 'Event', 'Evolution', 'Exons', 'Expressed Sequence Tags', 'Frequencies', 'Gene Expression', 'Gene Expression Regulation', 'Gene Mutation', 'Genes', 'Genetic Polymorphism', 'Genome', 'Goals', 'Human', 'Indium', 'Introns', 'Light', 'Machine Learning', 'Malignant Neoplasms', 'Mediating', 'Messenger RNA', 'Metabolism', 'MicroRNAs', 'Modeling', 'Molecular Biology', 'Molecular Biology Techniques', 'Mus', 'Mutagenesis', 'Mutation', 'Pattern', 'Phylogenetic Analysis', 'Poly A', 'Polyadenylation', 'Polyadenylation Pathway', 'Proteins', 'RNA', 'RNA Binding', 'RNA Interference', 'RNA Splicing', 'RNA-Binding Proteins', 'Regulation', 'Regulatory Element', 'Relative (related person)', 'Reporter', 'Site', 'Statistical Models', 'Structure', 'System', 'Technology', 'Tissues', 'Trees', 'Untranslated Regions', 'Validation', 'Variant', 'base', 'human disease', 'improved', 'preference', 'research study', 'serial analysis of gene expression', 'tool']",NIGMS,UNIV OF MED/DENT OF NJ-NJ MEDICAL SCHOOL,R01,2009,134431,0.11249555316619807
"Analysis of mRNA Polyadenylation across Species and Tissues    DESCRIPTION (provided by applicant): mRNA polyadenylation is an essential step for the maturation of almost all eukaryotic mRNAs. Altered polyadenylation activity caused by genetic mutation has been implicated in a growing number of human diseases. Over half of the human genes contain multiple polyadenylation sites [poly(A) sites] supported by cDNA/EST sequences. The polyadenylation pattern in the 3'- most exon defines the 3' UnTranslated Region (UTR), which contains various cis regulatory elements for mRNA metabolism, such as microRNA (miRNA) target sites and AU-rich elements (AUEs). In addition, a large fraction of human genes have polyadenylation events in introns, leading to mRNA variants with different protein coding sequence and indicating dynamic interplay between polyadenylation and splicing. Regulation of gene expression by polyadenylation has been characterized only for a handful of model genes, and its mechanism is poorly understood on the systems level. The long-term goal is to understand the mechanisms by which mRNA polyadenylation regulates gene expression in eukaryotic genomes. There are two specific aims in this project: 1) To accurately predict poly(A) sites across metazoan species using their corresponding cis elements; 2) To quantitatively model poly(A) site usage and selection across human and mouse tissues. We will combine computational and molecular biology techniques to address these issues. The results will improve gene annotation in metazoan species, uncover gene regulation events mediated by alternative polyadenylation, elucidate 3' UTR evolution, shed light on the mechanisms of polyadenylation, and provide valuable tools to examine human mutations and polymorphisms that affect poly(A) sites. NARRATIVE mRNA polyadenylation is an essential step for the maturation of almost all eukaryotic mRNAs. Altered polyadenylation activity caused by genetic mutation has been implicated in a growing number of human diseases. Over half of the human genes contain multiple polyadenylation sites [poly(A) sites] supported by cDNA/EST sequences. The polyadenylation pattern in the 3'- most exon defines the 3' UnTranslated Region (UTR), which contains various cis regulatory elements for mRNA metabolism, such as microRNA (miRNA) target sites and AU-rich elements (AUEs). In addition, a large fraction of human genes have polyadenylation events in introns, leading to mRNA variants with different protein coding sequence and indicating dynamic interplay between polyadenylation and splicing. Regulation of gene expression by polyadenylation has been characterized only for a handful of model genes, and its mechanism is poorly understood on the systems level. The long term goal is to understand the mechanisms by which mRNA polyadenylation regulates gene expression in eukaryotic genomes. There are two specific aims in this project: 1) To accurately predict poly(A) sites across metazoan species using their corresponding cis elements; 2) To quantitatively model poly(A) site usage and selection across human and mouse tissues. We will combine computational and molecular biology techniques to address these issues. The results will improve gene annotation in metazoan species, uncover gene regulation events mediated by alternative polyadenylation, elucidate 3' UTR evolution, shed light on the mechanisms of polyadenylation, and provide valuable tools to examine human mutations and polymorphisms that affect poly(A) sites.          n/a",Analysis of mRNA Polyadenylation across Species and Tissues,7432898,R01GM084089,"['3&apos', ' Untranslated Regions', 'Address', 'Affect', 'Biochemical', 'Biological', 'Biological Assay', 'Cell Line', 'Classification', 'Code', 'Complementary DNA', 'DNA Microarray Chip', 'DNA Microarray format', 'Data', 'Databases', 'Disease regression', 'Elements', 'Event', 'Evolution', 'Exons', 'Expressed Sequence Tags', 'Frequencies', 'Gene Expression', 'Gene Expression Regulation', 'Gene Mutation', 'Genes', 'Genetic Polymorphism', 'Genome', 'Goals', 'Human', 'Indium', 'Introns', 'Light', 'Machine Learning', 'Malignant Neoplasms', 'Mediating', 'Messenger RNA', 'Metabolism', 'MicroRNAs', 'Modeling', 'Molecular Biology', 'Molecular Biology Techniques', 'Mus', 'Mutagenesis', 'Mutation', 'Numbers', 'Pattern', 'Phylogenetic Analysis', 'Poly A', 'Polyadenylation', 'Polyadenylation Pathway', 'Polymerase Chain Reaction', 'Proteins', 'RNA', 'RNA Binding', 'RNA Interference', 'RNA Splicing', 'RNA-Binding Proteins', 'Regulation', 'Regulatory Element', 'Relative (related person)', 'Reporter', 'Site', 'Statistical Models', 'Structure', 'System', 'Technology', 'Tissues', 'Trees', 'Untranslated Regions', 'Validation', 'Variant', 'base', 'human disease', 'improved', 'preference', 'research study', 'serial analysis of gene expression', 'tool']",NIGMS,UNIV OF MED/DENT OF NJ-NJ MEDICAL SCHOOL,R01,2008,304200,0.11249555316619807
"Protein Design Using Physical Scoring Functions integrated with Site Couplings    DESCRIPTION (provided by applicant): Tremendous progress has been made in computational protein design in the last 10 years. Though most work has focused on redesign of existing proteins to enhance their stability, specificity or new functionality, successful designs of novel protein folds (not naturally occurring) have emerged. However, to make protein design useful in practical applications, many challenges still exist in the design of protein-protein and protein- DNA interface and the design of dynamic properties of proteins, etc. To conquer those challenges, a practical solution is to develop more accurate scoring functions. It has been proved both experimentally and theoretically that intra and intermolecular signaling between distant sites within one or among many proteins plays a significant role in many biological processes, such as signal transmission and allosteric regulation, etc. The main research goal of this R21 grant is to develop new algorithms and strategies to incorporate the site-site couplings into a protein design procedure. Specifically, in Aim 1, we propose to study the site-site couplings and cooperative interactions of a protein or protein system using both the sequence-based and the physics-based approaches. Critical assessment of the existing approaches will be conducted and a novel algorithm will be developed using the residue-residue interaction energies. In Aim 2, the best methods for site-site couplings prediction will be tailored and integrated to physical scoring functions of protein design. To guarantee the success of this research grant, we propose four schemes to incorporate/combine the site-site coupling into a protein design procedure. The first two schemes represent simple combinations of sequence-based and physics-based protein design approaches; on the other hand, the next two schemes represent a more advanced integration of site-site correlations and physical scoring functions. In the last protocol, we propose to develop a novel scheme and software package to conduct protein design using the residue-residue interaction energies as a template. This approach, which is referred to as correlation embedding (CE), is based on a hypothesis that the correlation information is intrinsically encoded in the interaction energy matrix. The success of this sub-aim will have a great impact on rational protein design, as it represents a perfect integration of site-site couplings into a physical scoring function and opens a new avenue to conduct protein design. All the designed promising PDZ proteins will be synthesized and tested in both folding and functional assays.        Protein Design Using Physical Scoring Functions integrated with Site Couplings In this proposal, we intend to develop novel approaches to conquer the challenges in protein design. The new protein design strategies can facilitate us to engineer dynamical controls into a novel protein so that it can undertake a dynamic function. The novel approaches could be used to develop more effective biomedicine.         ",Protein Design Using Physical Scoring Functions integrated with Site Couplings,8320949,R21GM097617,"['Accounting', 'Algorithms', 'Allosteric Regulation', 'Amino Acids', 'Base Sequence', 'Binding Sites', 'Biological Assay', 'Biological Process', 'Computer software', 'Coupled', 'Coupling', 'DNA', 'Distant', 'Engineering', 'Genetic Programming', 'Goals', 'Grant', 'Machine Learning', 'Measures', 'Methods', 'Modeling', 'Mutagenesis', 'NMR Spectroscopy', 'PDZ protein', 'Pattern', 'Physics', 'Play', 'Procedures', 'Property', 'Proteins', 'Protocols documentation', 'RNA Splicing', 'Research', 'Research Project Grants', 'Role', 'Scheme', 'Signal Transduction', 'Site', 'Solutions', 'Source Code', 'Specificity', 'System', 'Testing', 'Time', 'Work', 'base', 'comparative', 'design', 'fitness', 'model design', 'novel', 'novel strategies', 'practical application', 'protein folding', 'protein function', 'research study', 'simulation', 'success', 'transmission process']",NIGMS,UT SOUTHWESTERN MEDICAL CENTER,R21,2012,198750,0.018220167631848902
"Protein Design Using Physical Scoring Functions integrated with Site Couplings    DESCRIPTION (provided by applicant): Tremendous progress has been made in computational protein design in the last 10 years. Though most work has focused on redesign of existing proteins to enhance their stability, specificity or new functionality, successful designs of novel protein folds (not naturally occurring) have emerged. However, to make protein design useful in practical applications, many challenges still exist in the design of protein-protein and protein- DNA interface and the design of dynamic properties of proteins, etc. To conquer those challenges, a practical solution is to develop more accurate scoring functions. It has been proved both experimentally and theoretically that intra and intermolecular signaling between distant sites within one or among many proteins plays a significant role in many biological processes, such as signal transmission and allosteric regulation, etc. The main research goal of this R21 grant is to develop new algorithms and strategies to incorporate the site-site couplings into a protein design procedure. Specifically, in Aim 1, we propose to study the site-site couplings and cooperative interactions of a protein or protein system using both the sequence-based and the physics-based approaches. Critical assessment of the existing approaches will be conducted and a novel algorithm will be developed using the residue-residue interaction energies. In Aim 2, the best methods for site-site couplings prediction will be tailored and integrated to physical scoring functions of protein design. To guarantee the success of this research grant, we propose four schemes to incorporate/combine the site-site coupling into a protein design procedure. The first two schemes represent simple combinations of sequence-based and physics-based protein design approaches; on the other hand, the next two schemes represent a more advanced integration of site-site correlations and physical scoring functions. In the last protocol, we propose to develop a novel scheme and software package to conduct protein design using the residue-residue interaction energies as a template. This approach, which is referred to as correlation embedding (CE), is based on a hypothesis that the correlation information is intrinsically encoded in the interaction energy matrix. The success of this sub-aim will have a great impact on rational protein design, as it represents a perfect integration of site-site couplings into a physical scoring function and opens a new avenue to conduct protein design. All the designed promising PDZ proteins will be synthesized and tested in both folding and functional assays.      PUBLIC HEALTH RELEVANCE: Protein Design Using Physical Scoring Functions integrated with Site Couplings In this proposal, we intend to develop novel approaches to conquer the challenges in protein design. The new protein design strategies can facilitate us to engineer dynamical controls into a novel protein so that it can undertake a dynamic function. The novel approaches could be used to develop more effective biomedicine.           Protein Design Using Physical Scoring Functions integrated with Site Couplings In this proposal, we intend to develop novel approaches to conquer the challenges in protein design. The new protein design strategies can facilitate us to engineer dynamical controls into a novel protein so that it can undertake a dynamic function. The novel approaches could be used to develop more effective biomedicine.         ",Protein Design Using Physical Scoring Functions integrated with Site Couplings,8096396,R21GM097617,"['Accounting', 'Algorithms', 'Allosteric Regulation', 'Amino Acids', 'Base Sequence', 'Binding Sites', 'Biological Assay', 'Biological Process', 'Computer software', 'Coupled', 'Coupling', 'DNA', 'Distant', 'Engineering', 'Genetic Programming', 'Goals', 'Grant', 'Machine Learning', 'Measures', 'Methods', 'Modeling', 'Mutagenesis', 'NMR Spectroscopy', 'PDZ protein', 'Pattern', 'Physics', 'Play', 'Procedures', 'Property', 'Proteins', 'Protocols documentation', 'RNA Splicing', 'Research', 'Research Project Grants', 'Role', 'Scheme', 'Signal Transduction', 'Site', 'Solutions', 'Source Code', 'Specificity', 'System', 'Testing', 'Time', 'Work', 'base', 'comparative', 'design', 'fitness', 'model design', 'novel', 'novel strategies', 'practical application', 'protein folding', 'protein function', 'research study', 'simulation', 'success', 'transmission process']",NIGMS,UT SOUTHWESTERN MEDICAL CENTER,R21,2011,198125,0.0265514857810822
"Protein structural disorder and ubiquitination    DESCRIPTION (provided by applicant): Defects in the ubiquitin-proteasome system are implicated in the development of numerous human diseases. Some of the natural substrates for ubiquitination and degradation can induce malignant transformation if not properly removed from the cell. Despite the importance of the ubiquitination process, precise identification of ubiquitination (Ub) sites (i.e. acceptor lysine residues to which a ubiquitin molecule is attached) within substrates of ubiquitin ligases is still experimentally challenging. The development of computational approaches to predict Ub sites from a protein sequence provides an attractive alternative to the experimental methods. Here, we propose to develop a computational algorithm that could predict Ub sites with high precision. First, we will identify new protein Ub sites using a combination of multidimensional protein identification technology (MudPit) and mass spectrometry. Different environmental perturbations, such as heat shock, oxidative stress, DNA damage, and starvation for nutrients, will be introduced in order to increase the coverage of the ubiquitinated proteome. Second, we will use the dataset of new Ub sites to develop a ubiquitination sites predictor. A novel machine learning approach that includes co-training of two predictors having different data representations, and the usage of the unlabeled dataset to increase performance accuracy will be utilized. To our knowledge, this will be the first ubiquitination sites predictor developed to date. Finally, we will apply the predictor to the datasets of cell signaling and cancer-associated proteins to predict new ubiquitination sites and substrates among them. The prediction of intrinsic disorder (ID) will be carried out on the same datasets in order to test the hypothesis about preferential occurrence of Ub sites within ID regions. Annotated disease-related mutations will be extracted from three public databases (MutDB, SWISS-PROT and OMIM) and correlated with the predicted ubiquitination sites. The discovery of mutations in proximity to Ub sites or even those directly affecting Ub sites would lay the basis for formulating and testing biologically meaningful hypotheses about their role in cancer and other diseases. Proteins undergo a wide range of modifications that regulate their activity. One of such modification, ubiquitination, was shown to be involved in various human diseases including cancer, renal diseases (von Hippel-Lindau disease, Liddle syndrome, ischemic acute renal failure), several neurodegenerative diseases (Alzheimer, Parkinson, CAG- expansion disorders). The precise ubiquitination sites in proteins are difficult to detect. We propose to develop a computational approach that could identify such sites with high precision. This would help to develop better drugs that are directed either against the ubiquitinated proteins or against specific sites in these proteins.          n/a",Protein structural disorder and ubiquitination,7478711,R21CA113711,"['Acute Kidney Failure', 'Affect', 'Amino Acid Sequence', 'Cell physiology', 'Cells', 'Communities', 'Computational algorithm', 'DNA Damage', 'Data', 'Data Set', 'Databases', 'Defect', 'Development', 'Disease', 'Generations', 'Heat-Shock Response', 'Kidney Diseases', 'Knowledge', 'Lysine', 'Machine Learning', 'Malignant - descriptor', 'Malignant Neoplasms', 'Mass Spectrum Analysis', 'Methods', 'Modification', 'Mutation', 'Neurodegenerative Disorders', 'Numbers', 'Nutrient', 'Online Mendelian Inheritance In Man', 'Oxidative Stress', 'Parkinson Disease', 'Pathway interactions', 'Peptide Sequence Determination', 'Performance', 'Pharmaceutical Preparations', 'Play', 'Procedures', 'Process', 'Protein Region', 'Proteins', 'Proteome', 'Range', 'Role', 'Signal Transduction', 'Site', 'Starvation', 'Structural Protein', 'SwissProt', 'Syndrome', 'System', 'Technology', 'Testing', 'Training', 'Ubiquitin', 'Ubiquitination', 'Validation', 'Von Hippel-Lindau Syndrome', 'Yeasts', 'base', 'human disease', 'improved', 'multicatalytic endopeptidase complex', 'novel', 'ubiquitin ligase']",NCI,ROCKEFELLER UNIVERSITY,R21,2008,168000,0.17885167643239083
"Protein structural disorder and ubiquitination    DESCRIPTION (provided by applicant): Defects in the ubiquitin-proteasome system are implicated in the development of numerous human diseases. Some of the natural substrates for ubiquitination and degradation can induce malignant transformation if not properly removed from the cell. Despite the importance of the ubiquitination process, precise identification of ubiquitination (Ub) sites (i.e. acceptor lysine residues to which a ubiquitin molecule is attached) within substrates of ubiquitin ligases is still experimentally challenging. The development of computational approaches to predict Ub sites from a protein sequence provides an attractive alternative to the experimental methods. Here, we propose to develop a computational algorithm that could predict Ub sites with high precision. First, we will identify new protein Ub sites using a combination of multidimensional protein identification technology (MudPit) and mass spectrometry. Different environmental perturbations, such as heat shock, oxidative stress, DNA damage, and starvation for nutrients, will be introduced in order to increase the coverage of the ubiquitinated proteome. Second, we will use the dataset of new Ub sites to develop a ubiquitination sites predictor. A novel machine learning approach that includes co-training of two predictors having different data representations, and the usage of the unlabeled dataset to increase performance accuracy will be utilized. To our knowledge, this will be the first ubiquitination sites predictor developed to date. Finally, we will apply the predictor to the datasets of cell signaling and cancer-associated proteins to predict new ubiquitination sites and substrates among them. The prediction of intrinsic disorder (ID) will be carried out on the same datasets in order to test the hypothesis about preferential occurrence of Ub sites within ID regions. Annotated disease-related mutations will be extracted from three public databases (MutDB, SWISS-PROT and OMIM) and correlated with the predicted ubiquitination sites. The discovery of mutations in proximity to Ub sites or even those directly affecting Ub sites would lay the basis for formulating and testing biologically meaningful hypotheses about their role in cancer and other diseases. Proteins undergo a wide range of modifications that regulate their activity. One of such modification, ubiquitination, was shown to be involved in various human diseases including cancer, renal diseases (von Hippel-Lindau disease, Liddle syndrome, ischemic acute renal failure), several neurodegenerative diseases (Alzheimer, Parkinson, CAG- expansion disorders). The precise ubiquitination sites in proteins are difficult to detect. We propose to develop a computational approach that could identify such sites with high precision. This would help to develop better drugs that are directed either against the ubiquitinated proteins or against specific sites in these proteins.          n/a",Protein structural disorder and ubiquitination,7256169,R21CA113711,[' '],NCI,ROCKEFELLER UNIVERSITY,R21,2007,188000,0.17885167643239083
"Integrative approach to studying LncRNA functions ABSTRACT  Long non-coding RNAs (lncRNAs) play regulatory roles in biological cell process and disease development. It has been emerging as a key regulator of diverse cellular processes. Great efforts have been made towards investigation of lncRNA functions with both experimental determination and theoretical modeling, leading to a rudimentary understanding of this class of RNAs. However, all of these cannot keep pace with the fast growth of diverse genetic data and urgent request of individual lncRNA function annotation, which is inhibited by the tremendous amount of lncRNAs and expensive experimental cost. This propose aim to address this issue by providing efficient and user-friendly tools for key lncRNA discovery and lncRNA function annotation. To do so, we will develop a unique bioinformatics and Systems Biology integrated approach, ISSNLncFA system, which enables the integration of all sorts of omics data and a comprehensive understanding of lncRNA functions.  We propose three specific aims for the ultimate lncRNA function annotation: (1) To develop a novel Co- Modules-based LncRNA Function Annotation (CoMoLncFA) model to detect key lncRNAs and to annotate lncRNA functions at post transcription level as lncRNA-PCG co-modules, lncRNA-pathways association network and lncRNAâ€™s triplets (lncRNA-miRNA/TF-PCG) by considering the expression profiles of lncRNA, protein coding genes and miRNAs and transcript factors, and integrating the curated protein-protein interactions and biological pathways. (2) To develop a novel Structure-based LncRNA-protein Function Annotation (STRULncFA) model to characterize lncRNAs identified from Aim 1 by using their primary sequences and secondary structures for detecting lncRNA-protein functional relations; and to further reveal the regulatory roles and mechanism of these lncRNAs by determining the binding sites in both lncRNA and protein. (3) To experimentally validate the identified abnormal lncRNAs and their cellular products, to validate the identified lncRNA-protein interacting pairs and the predicted binding sites, and to develop software tools and an environment for functional annotation of lncRNAs, use these tools to evaluate the overall proposed approach, and apply them to identify lncRNA functions that may be involved in cell states, species, diseases and cancers and build lncRNA function databases.  We believe that we will build the models, tools and databases, and make them available to the public in a timely fashion. Our achievements will lead to a complete understanding of lncRNA functions and regulatory roles in cell and disease states. Moreover, our models and tools will be feasibly transformed to other function annotation tasks and disease studies with appropriate changes, and thus will move forward the general function annotation community and disease-related drug or therapy development. Project Narrative The ISSNLncFA software package will allow the investigators to characterize the LncRNA functions by integrating RNA-Seq, micorRNA-Seq, and together with protein and RNA structure data with systems biology approaches. As a prototype to test our system, we aim to use this system to study myelodysplastic syndromes (MDSs). Although MDS is used as the prototype of disease for this proposal, the system developed will be applicable to multiple diseases with complex phenotypes.",Integrative approach to studying LncRNA functions,9983714,R01GM123037,"['3-Dimensional', 'Achievement', 'Address', 'Architecture', 'Binding Sites', 'Bioinformatics', 'Biological', 'Biological Process', 'Breast', 'CD34 gene', 'Cell Proliferation', 'Cell physiology', 'Cells', 'Chromatin', 'Chronic Disease', 'Code', 'Colorectal', 'Communities', 'Complex', 'Computer software', 'Consumption', 'Data', 'Databases', 'Development', 'Disease', 'Dysmyelopoietic Syndromes', 'Embryonic Development', 'Environment', 'Enzymes', 'Evaluation', 'Expression Profiling', 'Gene Expression Regulation', 'Genes', 'Genetic', 'Genetic Transcription', 'Genome', 'Genomic Imprinting', 'Growth', 'Heart Diseases', 'Hematopoietic stem cells', 'Individual', 'Investigation', 'Liver', 'Malignant - descriptor', 'Malignant Neoplasms', 'Methods', 'MicroRNAs', 'Modeling', 'Modification', 'Neoplasm Metastasis', 'Network-based', 'Pathway interactions', 'Phenotype', 'Play', 'Process', 'Proteins', 'RNA', 'Regulator Genes', 'Research Personnel', 'Role', 'Signal Transduction', 'Software Tools', 'Source', 'Structure', 'System', 'Systems Biology', 'Testing', 'Theoretical model', 'Time', 'Transcript', 'Triplet Multiple Birth', 'Untranslated RNA', 'Validation', 'Work', 'X Chromosome', 'base', 'chromatin modification', 'chromatin remodeling', 'cost', 'deep learning', 'drug development', 'drug discovery', 'gene function', 'genomic data', 'high throughput technology', 'learning network', 'next generation', 'novel', 'outcome forecast', 'protein function', 'protein protein interaction', 'prototype', 'scaffold', 'software development', 'structured data', 'support vector machine', 'therapy development', 'tool', 'tool development', 'transcription factor', 'transcriptome', 'transcriptome sequencing', 'transcriptomics', 'user-friendly']",NIGMS,UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON,R01,2020,302225,-0.019451600179132392
"Integrative approach to studying LncRNA functions ABSTRACT  Long non-coding RNAs (lncRNAs) play regulatory roles in biological cell process and disease development. It has been emerging as a key regulator of diverse cellular processes. Great efforts have been made towards investigation of lncRNA functions with both experimental determination and theoretical modeling, leading to a rudimentary understanding of this class of RNAs. However, all of these cannot keep pace with the fast growth of diverse genetic data and urgent request of individual lncRNA function annotation, which is inhibited by the tremendous amount of lncRNAs and expensive experimental cost. This propose aim to address this issue by providing efficient and user-friendly tools for key lncRNA discovery and lncRNA function annotation. To do so, we will develop a unique bioinformatics and Systems Biology integrated approach, ISSNLncFA system, which enables the integration of all sorts of omics data and a comprehensive understanding of lncRNA functions.  We propose three specific aims for the ultimate lncRNA function annotation: (1) To develop a novel Co- Modules-based LncRNA Function Annotation (CoMoLncFA) model to detect key lncRNAs and to annotate lncRNA functions at post transcription level as lncRNA-PCG co-modules, lncRNA-pathways association network and lncRNAâ€™s triplets (lncRNA-miRNA/TF-PCG) by considering the expression profiles of lncRNA, protein coding genes and miRNAs and transcript factors, and integrating the curated protein-protein interactions and biological pathways. (2) To develop a novel Structure-based LncRNA-protein Function Annotation (STRULncFA) model to characterize lncRNAs identified from Aim 1 by using their primary sequences and secondary structures for detecting lncRNA-protein functional relations; and to further reveal the regulatory roles and mechanism of these lncRNAs by determining the binding sites in both lncRNA and protein. (3) To experimentally validate the identified abnormal lncRNAs and their cellular products, to validate the identified lncRNA-protein interacting pairs and the predicted binding sites, and to develop software tools and an environment for functional annotation of lncRNAs, use these tools to evaluate the overall proposed approach, and apply them to identify lncRNA functions that may be involved in cell states, species, diseases and cancers and build lncRNA function databases.  We believe that we will build the models, tools and databases, and make them available to the public in a timely fashion. Our achievements will lead to a complete understanding of lncRNA functions and regulatory roles in cell and disease states. Moreover, our models and tools will be feasibly transformed to other function annotation tasks and disease studies with appropriate changes, and thus will move forward the general function annotation community and disease-related drug or therapy development. Project Narrative The ISSNLncFA software package will allow the investigators to characterize the LncRNA functions by integrating RNA-Seq, micorRNA-Seq, and together with protein and RNA structure data with systems biology approaches. As a prototype to test our system, we aim to use this system to study myelodysplastic syndromes (MDSs). Although MDS is used as the prototype of disease for this proposal, the system developed will be applicable to multiple diseases with complex phenotypes.",Integrative approach to studying LncRNA functions,9751927,R01GM123037,"['Achievement', 'Address', 'Architecture', 'Binding Sites', 'Bioinformatics', 'Biological', 'Biological Process', 'Breast', 'CD34 gene', 'Cell Proliferation', 'Cell physiology', 'Cells', 'Chromatin', 'Chromosomes, Human, Pair 22', 'Chronic Disease', 'Code', 'Colorectal', 'Communities', 'Complex', 'Computer software', 'Consumption', 'Data', 'Databases', 'Development', 'Dimensions', 'Disease', 'Dysmyelopoietic Syndromes', 'Embryonic Development', 'Environment', 'Enzymes', 'Evaluation', 'Expression Profiling', 'Gene Expression Regulation', 'Genes', 'Genetic', 'Genetic Transcription', 'Genome', 'Genomic Imprinting', 'Growth', 'Heart Diseases', 'Hematopoietic stem cells', 'Individual', 'Investigation', 'Liver', 'Machine Learning', 'Malignant - descriptor', 'Malignant Neoplasms', 'Methods', 'MicroRNAs', 'Modeling', 'Modification', 'Neoplasm Metastasis', 'Network-based', 'Pathway interactions', 'Phenotype', 'Play', 'Process', 'Proteins', 'RNA', 'Regulator Genes', 'Research Personnel', 'Role', 'Signal Transduction', 'Software Tools', 'Source', 'Structure', 'System', 'Systems Biology', 'Testing', 'Theoretical model', 'Time', 'Transcript', 'Triplet Multiple Birth', 'Untranslated RNA', 'Validation', 'Work', 'X Chromosome', 'base', 'chromatin modification', 'chromatin remodeling', 'cost', 'deep learning', 'drug development', 'drug discovery', 'gene function', 'genomic data', 'high throughput technology', 'learning network', 'next generation', 'novel', 'outcome forecast', 'protein function', 'protein protein interaction', 'prototype', 'scaffold', 'software development', 'therapy development', 'tool', 'tool development', 'transcription factor', 'transcriptome', 'transcriptome sequencing', 'transcriptomics', 'user-friendly']",NIGMS,UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON,R01,2019,302225,-0.019451600179132392
"Integrative approach to studying LncRNA functions ABSTRACT  Long non-coding RNAs (lncRNAs) play regulatory roles in biological cell process and disease development. It has been emerging as a key regulator of diverse cellular processes. Great efforts have been made towards investigation of lncRNA functions with both experimental determination and theoretical modeling, leading to a rudimentary understanding of this class of RNAs. However, all of these cannot keep pace with the fast growth of diverse genetic data and urgent request of individual lncRNA function annotation, which is inhibited by the tremendous amount of lncRNAs and expensive experimental cost. This propose aim to address this issue by providing efficient and user-friendly tools for key lncRNA discovery and lncRNA function annotation. To do so, we will develop a unique bioinformatics and Systems Biology integrated approach, ISSNLncFA system, which enables the integration of all sorts of omics data and a comprehensive understanding of lncRNA functions.  We propose three specific aims for the ultimate lncRNA function annotation: (1) To develop a novel Co- Modules-based LncRNA Function Annotation (CoMoLncFA) model to detect key lncRNAs and to annotate lncRNA functions at post transcription level as lncRNA-PCG co-modules, lncRNA-pathways association network and lncRNAâ€™s triplets (lncRNA-miRNA/TF-PCG) by considering the expression profiles of lncRNA, protein coding genes and miRNAs and transcript factors, and integrating the curated protein-protein interactions and biological pathways. (2) To develop a novel Structure-based LncRNA-protein Function Annotation (STRULncFA) model to characterize lncRNAs identified from Aim 1 by using their primary sequences and secondary structures for detecting lncRNA-protein functional relations; and to further reveal the regulatory roles and mechanism of these lncRNAs by determining the binding sites in both lncRNA and protein. (3) To experimentally validate the identified abnormal lncRNAs and their cellular products, to validate the identified lncRNA-protein interacting pairs and the predicted binding sites, and to develop software tools and an environment for functional annotation of lncRNAs, use these tools to evaluate the overall proposed approach, and apply them to identify lncRNA functions that may be involved in cell states, species, diseases and cancers and build lncRNA function databases.  We believe that we will build the models, tools and databases, and make them available to the public in a timely fashion. Our achievements will lead to a complete understanding of lncRNA functions and regulatory roles in cell and disease states. Moreover, our models and tools will be feasibly transformed to other function annotation tasks and disease studies with appropriate changes, and thus will move forward the general function annotation community and disease-related drug or therapy development. Project Narrative The ISSNLncFA software package will allow the investigators to characterize the LncRNA functions by integrating RNA-Seq, micorRNA-Seq, and together with protein and RNA structure data with systems biology approaches. As a prototype to test our system, we aim to use this system to study myelodysplastic syndromes (MDSs). Although MDS is used as the prototype of disease for this proposal, the system developed will be applicable to multiple diseases with complex phenotypes.",Integrative approach to studying LncRNA functions,9565604,R01GM123037,"['Achievement', 'Address', 'Architecture', 'Binding Sites', 'Bioinformatics', 'Biological', 'Biological Process', 'Breast', 'CD34 gene', 'Cell Proliferation', 'Cell physiology', 'Cells', 'Chromatin', 'Chromosomes, Human, Pair 22', 'Chronic Disease', 'Code', 'Colorectal', 'Communities', 'Complex', 'Computer software', 'Data', 'Databases', 'Development', 'Dimensions', 'Disease', 'Dysmyelopoietic Syndromes', 'Embryonic Development', 'Environment', 'Enzymes', 'Evaluation', 'Expression Profiling', 'Gene Expression Regulation', 'Gene Targeting', 'Genes', 'Genetic', 'Genetic Transcription', 'Genome', 'Genomic Imprinting', 'Growth', 'Heart Diseases', 'Hematopoietic stem cells', 'Individual', 'Investigation', 'Liver', 'Machine Learning', 'Malignant - descriptor', 'Malignant Neoplasms', 'Methods', 'MicroRNAs', 'Modeling', 'Modification', 'Neoplasm Metastasis', 'Network-based', 'Pathway interactions', 'Phenotype', 'Play', 'Process', 'Proteins', 'RNA', 'Regulator Genes', 'Research Personnel', 'Role', 'Signal Transduction', 'Software Tools', 'Source', 'Structure', 'System', 'Systems Biology', 'Testing', 'Theoretical model', 'Time', 'Transcript', 'Triplet Multiple Birth', 'Untranslated RNA', 'Validation', 'Work', 'X Chromosome', 'base', 'chromatin modification', 'chromatin remodeling', 'cost', 'deep learning', 'drug development', 'drug discovery', 'gene function', 'genomic data', 'high throughput technology', 'learning network', 'next generation', 'novel', 'outcome forecast', 'protein function', 'protein protein interaction', 'prototype', 'scaffold', 'software development', 'therapy development', 'tool', 'tool development', 'transcription factor', 'transcriptome', 'transcriptome sequencing', 'transcriptomics', 'user-friendly']",NIGMS,UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON,R01,2018,302225,-0.019451600179132392
"Integrative approach to studying LncRNA functions ABSTRACT  Long non-coding RNAs (lncRNAs) play regulatory roles in biological cell process and disease development. It has been emerging as a key regulator of diverse cellular processes. Great efforts have been made towards investigation of lncRNA functions with both experimental determination and theoretical modeling, leading to a rudimentary understanding of this class of RNAs. However, all of these cannot keep pace with the fast growth of diverse genetic data and urgent request of individual lncRNA function annotation, which is inhibited by the tremendous amount of lncRNAs and expensive experimental cost. This propose aim to address this issue by providing efficient and user-friendly tools for key lncRNA discovery and lncRNA function annotation. To do so, we will develop a unique bioinformatics and Systems Biology integrated approach, ISSNLncFA system, which enables the integration of all sorts of omics data and a comprehensive understanding of lncRNA functions.  We propose three specific aims for the ultimate lncRNA function annotation: (1) To develop a novel Co- Modules-based LncRNA Function Annotation (CoMoLncFA) model to detect key lncRNAs and to annotate lncRNA functions at post transcription level as lncRNA-PCG co-modules, lncRNA-pathways association network and lncRNAâ€™s triplets (lncRNA-miRNA/TF-PCG) by considering the expression profiles of lncRNA, protein coding genes and miRNAs and transcript factors, and integrating the curated protein-protein interactions and biological pathways. (2) To develop a novel Structure-based LncRNA-protein Function Annotation (STRULncFA) model to characterize lncRNAs identified from Aim 1 by using their primary sequences and secondary structures for detecting lncRNA-protein functional relations; and to further reveal the regulatory roles and mechanism of these lncRNAs by determining the binding sites in both lncRNA and protein. (3) To experimentally validate the identified abnormal lncRNAs and their cellular products, to validate the identified lncRNA-protein interacting pairs and the predicted binding sites, and to develop software tools and an environment for functional annotation of lncRNAs, use these tools to evaluate the overall proposed approach, and apply them to identify lncRNA functions that may be involved in cell states, species, diseases and cancers and build lncRNA function databases.  We believe that we will build the models, tools and databases, and make them available to the public in a timely fashion. Our achievements will lead to a complete understanding of lncRNA functions and regulatory roles in cell and disease states. Moreover, our models and tools will be feasibly transformed to other function annotation tasks and disease studies with appropriate changes, and thus will move forward the general function annotation community and disease-related drug or therapy development. Project Narrative The ISSNLncFA software package will allow the investigators to characterize the LncRNA functions by integrating RNA-Seq, micorRNA-Seq, and together with protein and RNA structure data with systems biology approaches. As a prototype to test our system, we aim to use this system to study myelodysplastic syndromes (MDSs). Although MDS is used as the prototype of disease for this proposal, the system developed will be applicable to multiple diseases with complex phenotypes.",Integrative approach to studying LncRNA functions,9288292,R01GM123037,"['Achievement', 'Address', 'Architecture', 'Binding Sites', 'Bioinformatics', 'Biological', 'Biological Process', 'Breast', 'CD34 gene', 'Cell Proliferation', 'Cell physiology', 'Cells', 'Chromatin', 'Chromosomes, Human, Pair 22', 'Chronic Disease', 'Code', 'Colorectal', 'Communities', 'Complex', 'Computer software', 'Data', 'Databases', 'Development', 'Dimensions', 'Disease', 'Dysmyelopoietic Syndromes', 'Embryonic Development', 'Environment', 'Enzymes', 'Evaluation', 'Gene Expression Regulation', 'Gene Targeting', 'Genes', 'Genetic', 'Genetic Transcription', 'Genome', 'Genomic Imprinting', 'Growth', 'Heart Diseases', 'Hematopoietic stem cells', 'Individual', 'Investigation', 'Liver', 'Machine Learning', 'Malignant - descriptor', 'Malignant Neoplasms', 'Methods', 'MicroRNAs', 'Modeling', 'Modification', 'Molecular Profiling', 'Neoplasm Metastasis', 'Network-based', 'Pathway interactions', 'Phenotype', 'Play', 'Process', 'Proteins', 'RNA', 'Regulator Genes', 'Research Personnel', 'Role', 'Signal Transduction', 'Software Tools', 'Source', 'Structure', 'System', 'Systems Biology', 'Testing', 'Theoretical model', 'Time', 'Transcript', 'Triplet Multiple Birth', 'Untranslated RNA', 'Validation', 'Work', 'X Chromosome', 'base', 'chromatin modification', 'chromatin remodeling', 'cost', 'drug development', 'drug discovery', 'gene function', 'genomic data', 'high throughput technology', 'learning network', 'next generation', 'novel', 'outcome forecast', 'protein function', 'protein protein interaction', 'prototype', 'scaffold', 'software development', 'therapy development', 'tool', 'tool development', 'transcription factor', 'transcriptome', 'transcriptome sequencing', 'transcriptomics', 'user-friendly']",NIGMS,UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON,R01,2017,302225,-0.019451600179132392
"PhosphoSite. and the Phosphoproteome of Cancer    DESCRIPTION (provided by applicant): PhosphoSite(r) and the Phosphoproteome of Cancer Protein kinases and their substrates are important regulators of signal transduction pathways during normal growth and development as well as during oncogenesis. PhosphoSite is a bioinformatics resource that systematically has collected information from thousands of published reports about specific phosphorylation sites, how they are physiologically regulated, and the biological consequences of these phosphorylation events. PhosphoSite(r) was designed primarily to curate and present information from published literature, which historically focused on one or a few phosphorylation sites; curation and organization of this information was relatively simple. Using tandem mass spectrometric methodologies, the CST Cancer Biology Group and others are discovering thousand of new phosphorylation sites in human cancers which must be processed and uploaded into PhosphoSite(r). We propose to significantly reengineer PhosphoSite(r) to accommodate this abundance of data and to update the interfaces so that users can view and compare sets of phosphorylation sites associated with specific cancers and other diseases. We also propose to develop the capacity to transfer data from PhosphoSite(r) into pathway visualization programs that allow users to explore the rich regulatory interactions that are described in PhosphoSite(r). PhosphoSite(r) and the Cancer Phosphoproteome Project Narrative The PhosphoSite(r) database catalogs modification of proteins by attachment of a phosphate group - a change that can affect many cellular processes, including the transition from normal cell to cancer cell. We are improving PhosphoSite(r) so that it can accommodate the vastly increased number of phosphate modifications now being discovered. We will also release modifications discovered in our laboratories to the scientific community to further its understanding of cellular changes leading to cancer.          n/a",PhosphoSite. and the Phosphoproteome of Cancer,7473129,R44CA126080,"['Affect', 'Bioinformatics', 'Biological', 'Biology', 'Cancer Biology', 'Cataloging', 'Catalogs', 'Cell physiology', 'Class', 'Communities', 'Complex', 'Computer software', 'Data', 'Data Files', 'Databases', 'Depth', 'Development', 'Disease', 'Engineering', 'Event', 'Fostering', 'Generations', 'Growth and Development function', 'Human', 'Imagery', 'Institution', 'Laboratories', 'Language', 'Ligands', 'Literature', 'Malignant Neoplasms', 'Methodology', 'Methods', 'Modification', 'Normal Cell', 'Numbers', 'Object Class', 'Pathway interactions', 'Performance', 'Pharmaceutical Preparations', 'Phase', 'Phosphopeptides', 'Phosphorylation', 'Phosphorylation Site', 'Phosphotransferases', 'Physiological', 'Post-Translational Protein Processing', 'Process', 'Protein Kinase', 'Proteins', 'Publishing', 'Reaction Time', 'Records', 'Regulation', 'Reporting', 'Resources', 'Scientist', 'Signal Transduction', 'Signal Transduction Pathway', 'Stream', 'Technology', 'Tumor Cell Line', 'Update', 'Week', 'cancer cell', 'cell transformation', 'day', 'design', 'improved', 'information organization', 'inorganic phosphate', 'novel', 'programs', 'research study', 'tandem mass spectrometry', 'tumorigenesis', 'user friendly software']",NCI,"CELL SIGNALING TECHNOLOGY, INC.",R44,2008,448922,0.10143269842113985
"PhosphoSite. and the Phosphoproteome of Cancer    DESCRIPTION (provided by applicant): PhosphoSite(r) and the Phosphoproteome of Cancer Protein kinases and their substrates are important regulators of signal transduction pathways during normal growth and development as well as during oncogenesis. PhosphoSite is a bioinformatics resource that systematically has collected information from thousands of published reports about specific phosphorylation sites, how they are physiologically regulated, and the biological consequences of these phosphorylation events. PhosphoSite(r) was designed primarily to curate and present information from published literature, which historically focused on one or a few phosphorylation sites; curation and organization of this information was relatively simple. Using tandem mass spectrometric methodologies, the CST Cancer Biology Group and others are discovering thousand of new phosphorylation sites in human cancers which must be processed and uploaded into PhosphoSite(r). We propose to significantly reengineer PhosphoSite(r) to accommodate this abundance of data and to update the interfaces so that users can view and compare sets of phosphorylation sites associated with specific cancers and other diseases. We also propose to develop the capacity to transfer data from PhosphoSite(r) into pathway visualization programs that allow users to explore the rich regulatory interactions that are described in PhosphoSite(r). PhosphoSite(r) and the Cancer Phosphoproteome Project Narrative The PhosphoSite(r) database catalogs modification of proteins by attachment of a phosphate group - a change that can affect many cellular processes, including the transition from normal cell to cancer cell. We are improving PhosphoSite(r) so that it can accommodate the vastly increased number of phosphate modifications now being discovered. We will also release modifications discovered in our laboratories to the scientific community to further its understanding of cellular changes leading to cancer.          n/a",PhosphoSite. and the Phosphoproteome of Cancer,7938483,R44CA126080,"['Affect', 'Bioinformatics', 'Biological', 'Biology', 'Cancer Biology', 'Cataloging', 'Catalogs', 'Cell physiology', 'Communities', 'Complex', 'Computer software', 'Data', 'Data Files', 'Databases', 'Development', 'Disease', 'Engineering', 'Event', 'Fostering', 'Generations', 'Growth and Development function', 'Human', 'Imagery', 'Institution', 'Laboratories', 'Language', 'Ligands', 'Literature', 'Malignant Neoplasms', 'Methodology', 'Methods', 'Modification', 'Normal Cell', 'Pathway interactions', 'Performance', 'Pharmaceutical Preparations', 'Phase', 'Phosphopeptides', 'Phosphorylation', 'Phosphorylation Site', 'Phosphotransferases', 'Physiological', 'Post-Translational Protein Processing', 'Process', 'Protein Kinase', 'Proteins', 'Publishing', 'Reaction Time', 'Records', 'Regulation', 'Reporting', 'Resources', 'Scientist', 'Signal Transduction', 'Signal Transduction Pathway', 'Stream', 'Technology', 'Transformed Cell Line', 'Update', 'cancer cell', 'design', 'improved', 'information organization', 'inorganic phosphate', 'meetings', 'novel', 'programs', 'research study', 'tandem mass spectrometry', 'tumor', 'tumorigenesis', 'user friendly software']",NCI,"CELL SIGNALING TECHNOLOGY, INC.",R44,2009,150018,0.10143269842113985
"PhosphoSite. and the Phosphoproteome of Cancer    DESCRIPTION (provided by applicant): PhosphoSite(r) and the Phosphoproteome of Cancer Protein kinases and their substrates are important regulators of signal transduction pathways during normal growth and development as well as during oncogenesis. PhosphoSite is a bioinformatics resource that systematically has collected information from thousands of published reports about specific phosphorylation sites, how they are physiologically regulated, and the biological consequences of these phosphorylation events. PhosphoSite(r) was designed primarily to curate and present information from published literature, which historically focused on one or a few phosphorylation sites; curation and organization of this information was relatively simple. Using tandem mass spectrometric methodologies, the CST Cancer Biology Group and others are discovering thousand of new phosphorylation sites in human cancers which must be processed and uploaded into PhosphoSite(r). We propose to significantly reengineer PhosphoSite(r) to accommodate this abundance of data and to update the interfaces so that users can view and compare sets of phosphorylation sites associated with specific cancers and other diseases. We also propose to develop the capacity to transfer data from PhosphoSite(r) into pathway visualization programs that allow users to explore the rich regulatory interactions that are described in PhosphoSite(r). PhosphoSite(r) and the Cancer Phosphoproteome Project Narrative The PhosphoSite(r) database catalogs modification of proteins by attachment of a phosphate group - a change that can affect many cellular processes, including the transition from normal cell to cancer cell. We are improving PhosphoSite(r) so that it can accommodate the vastly increased number of phosphate modifications now being discovered. We will also release modifications discovered in our laboratories to the scientific community to further its understanding of cellular changes leading to cancer.          n/a",PhosphoSite. and the Phosphoproteome of Cancer,7418412,R44CA126080,"['Affect', 'Bioinformatics', 'Biological', 'Biology', 'Cancer Biology', 'Cataloging', 'Catalogs', 'Cell physiology', 'Class', 'Communities', 'Complex', 'Computer software', 'Data', 'Data Files', 'Databases', 'Depth', 'Development', 'Disease', 'Engineering', 'Event', 'Fostering', 'Generations', 'Growth and Development function', 'Human', 'Imagery', 'Institution', 'Laboratories', 'Language', 'Ligands', 'Literature', 'Malignant Neoplasms', 'Methodology', 'Methods', 'Modification', 'Normal Cell', 'Numbers', 'Object Class', 'Pathway interactions', 'Performance', 'Pharmaceutical Preparations', 'Phase', 'Phosphopeptides', 'Phosphorylation', 'Phosphorylation Site', 'Phosphotransferases', 'Physiological', 'Post-Translational Protein Processing', 'Process', 'Protein Kinase', 'Proteins', 'Publishing', 'Reaction Time', 'Records', 'Regulation', 'Reporting', 'Resources', 'Scientist', 'Signal Transduction', 'Signal Transduction Pathway', 'Stream', 'Technology', 'Tumor Cell Line', 'Update', 'Week', 'cancer cell', 'cell transformation', 'day', 'design', 'improved', 'information organization', 'inorganic phosphate', 'novel', 'programs', 'research study', 'tandem mass spectrometry', 'tumorigenesis', 'user friendly software']",NCI,"CELL SIGNALING TECHNOLOGY, INC.",R44,2007,560817,0.10143269842113985
"Analysis of Nematode Sex Determination and Dosage Compensation PROJECT SUMMARY  Studies are proposed to dissect one of the fundamental, binary development decisions that most metazoans make: their sex. The nematode C. elegans determines sex with remarkable precision by tallying X- chromosome number relative to the sets of autosomes (X:A signal): ratios of 1X:2A (0.5) and 2X:3A (0.67) signal male fate, while ratios of 3X:4A (0.75) and 2X:2A (1.0) signal hermaphrodite fate. We have discovered much about the nature and action of the X:A signal and its direct target, a master sex-determination-switch gene that also controls X-chromosome dosage compensation. However, a fundamental question remains: how is the signal interpreted reproducibly in an ""all or none"" manner to elicit fertile male or hermaphrodite development, never intersexual development? We pioneer new methods using machine learning neural networks to address this question with single-molecule and single-cell resolution. We also propose to dissect the functional interplay between chromatin modification and chromosome structure in regulating gene expression over vast chromosomal territories. X-chromosome dosage compensation in C. elegans is exemplary for this analysis: we found recently that dosage-compensated X chromosomes have (i) elevated levels of modified histone H4K20me1 compared to autosomes and (ii) a unique three-dimensional architecture. Both are imposed by the dosage compensation complex (DCC). Loss of H4K20me1 disrupts 3D architecture and elevates X gene expression. In the nematode DCC, one subunit is an H4K20me2 demethylase and five subunits are homologs of condensin subunits, which compact and resolve mitotic and meiotic chromosomes. All DCC subunits are recruited specifically to hermaphrodite X chromosomes by an XX-specific subunit that triggers binding to cis- acting regulatory elements on X (rex) to reduce gene expression by half. The DCC remodels the structure of X into topologically associating domains (TADs) using its highest affinity rex sites to establish domain boundaries. Despite this knowledge, important questions underlying the mechanisms of dosage compensation remain. What DCC subunits recognize the X-enriched motifs in rex sites to bind X directly? How does the DCC regulate RNA polymerase II to repress gene expression? What mechanisms underlie H4K20me1's control of chromosome structure, and how does DCC-mediated higher-order structure affect gene expression? Our findings should have broad implications, because (i) condensin complexes control chromosome structure from bacteria to man, (ii) H4K20me1 is enriched on the inactive X of female mammals, (iii) demethylases are linked to tumor progression, and (iv) the H4K20me2 demethylase modulates nematode growth, metabolism, and entry into the quiescent dauer state. Lastly, we will exploit our unexpected finding that rex sites have diverged across Caenorhabditis species separated by 30 MYR, retaining no functional overlap despite strong conservation of the core DCC machinery. This divergence provides an unusual opportunity to study the path for a concerted co- evolutionary change in hundreds of target sites across X chromosomes and the protein complexes that bind them. PROJECT NARRATIVE Our work dissects one of the fundamental, binary developmental decisions that most metazoans make: their sex. While we have discovered detailed molecular mechanisms about the nature and action of the signal that determines sex in the nematode C. elegans and its direct target, a critical question remains that we address: how is the sex signal interpreted reproducibly in an ""all or none"" manner to elicit fertile male or hermaphrodite development, never intersexual development? Our work also explores the functional interplay between chromosome structure, chromatin modification, and long-distance regulation of gene expression by studying X- chromosome dosage compensation. The nematode dosage compensation complex, a condensin complex, equalizes X-chromosome gene expression between the sexes by imposing a unique three-dimensional architecture onto hermaphrodite X chromosomes and by catalyzing enrichment of the modified histone H4K20me1 through a subunit that is a H4K20me2 histone demethylase. Results from exploring the connection between higher-order chromosome structure and chromatin modification should have broad implications, because (i) condensin complexes control chromosome structure from bacteria to man, (ii) H4K20me1 is enriched on the inactive X of female mammals, (iii) demethylases are linked to tumor progression, and (iv) the H4K20me2 demethylase modulates nematode growth, metabolism, and entry into the quiescent dauer state.",Analysis of Nematode Sex Determination and Dosage Compensation,9898392,R35GM131845,"['3-Dimensional', 'Address', 'Affect', 'Affinity', 'Architecture', 'Bacteria', 'Binding', 'Caenorhabditis', 'Caenorhabditis elegans', 'Cells', 'Chromosome Structures', 'Chromosome Territory', 'Chromosomes', 'Complex', 'Development', 'Dosage Compensation (Genetics)', 'Female', 'Gene Expression', 'Gene Expression Regulation', 'Growth', 'Hermaphroditism', 'Higher Order Chromatin Structure', 'Histones', 'Knowledge', 'Link', 'Machine Learning', 'Mammals', 'Mediating', 'Meiosis', 'Metabolism', 'Methods', 'Mitotic', 'Molecular', 'Nature', 'Nematoda', 'RNA Polymerase II', 'Regulatory Element', 'Resolution', 'Signal Transduction', 'Site', 'Structure', 'Switch Genes', 'Work', 'X Chromosome', 'X Inactivation', 'autosome', 'chromatin modification', 'condensin', 'dosage', 'histone demethylase', 'male', 'man', 'neural network', 'protein complex', 'recruit', 'sex', 'sex determination', 'single molecule', 'tumor progression']",NIGMS,UNIVERSITY OF CALIFORNIA BERKELEY,R35,2020,466290,0.017466957412388632
"Analysis of Nematode Sex Determination and Dosage Compensation PROJECT SUMMARY  Studies are proposed to dissect one of the fundamental, binary development decisions that most metazoans make: their sex. The nematode C. elegans determines sex with remarkable precision by tallying X- chromosome number relative to the sets of autosomes (X:A signal): ratios of 1X:2A (0.5) and 2X:3A (0.67) signal male fate, while ratios of 3X:4A (0.75) and 2X:2A (1.0) signal hermaphrodite fate. We have discovered much about the nature and action of the X:A signal and its direct target, a master sex-determination-switch gene that also controls X-chromosome dosage compensation. However, a fundamental question remains: how is the signal interpreted reproducibly in an ""all or none"" manner to elicit fertile male or hermaphrodite development, never intersexual development? We pioneer new methods using machine learning neural networks to address this question with single-molecule and single-cell resolution. We also propose to dissect the functional interplay between chromatin modification and chromosome structure in regulating gene expression over vast chromosomal territories. X-chromosome dosage compensation in C. elegans is exemplary for this analysis: we found recently that dosage-compensated X chromosomes have (i) elevated levels of modified histone H4K20me1 compared to autosomes and (ii) a unique three-dimensional architecture. Both are imposed by the dosage compensation complex (DCC). Loss of H4K20me1 disrupts 3D architecture and elevates X gene expression. In the nematode DCC, one subunit is an H4K20me2 demethylase and five subunits are homologs of condensin subunits, which compact and resolve mitotic and meiotic chromosomes. All DCC subunits are recruited specifically to hermaphrodite X chromosomes by an XX-specific subunit that triggers binding to cis- acting regulatory elements on X (rex) to reduce gene expression by half. The DCC remodels the structure of X into topologically associating domains (TADs) using its highest affinity rex sites to establish domain boundaries. Despite this knowledge, important questions underlying the mechanisms of dosage compensation remain. What DCC subunits recognize the X-enriched motifs in rex sites to bind X directly? How does the DCC regulate RNA polymerase II to repress gene expression? What mechanisms underlie H4K20me1's control of chromosome structure, and how does DCC-mediated higher-order structure affect gene expression? Our findings should have broad implications, because (i) condensin complexes control chromosome structure from bacteria to man, (ii) H4K20me1 is enriched on the inactive X of female mammals, (iii) demethylases are linked to tumor progression, and (iv) the H4K20me2 demethylase modulates nematode growth, metabolism, and entry into the quiescent dauer state. Lastly, we will exploit our unexpected finding that rex sites have diverged across Caenorhabditis species separated by 30 MYR, retaining no functional overlap despite strong conservation of the core DCC machinery. This divergence provides an unusual opportunity to study the path for a concerted co- evolutionary change in hundreds of target sites across X chromosomes and the protein complexes that bind them. PROJECT NARRATIVE Our work dissects one of the fundamental, binary developmental decisions that most metazoans make: their sex. While we have discovered detailed molecular mechanisms about the nature and action of the signal that determines sex in the nematode C. elegans and its direct target, a critical question remains that we address: how is the sex signal interpreted reproducibly in an ""all or none"" manner to elicit fertile male or hermaphrodite development, never intersexual development? Our work also explores the functional interplay between chromosome structure, chromatin modification, and long-distance regulation of gene expression by studying X- chromosome dosage compensation. The nematode dosage compensation complex, a condensin complex, equalizes X-chromosome gene expression between the sexes by imposing a unique three-dimensional architecture onto hermaphrodite X chromosomes and by catalyzing enrichment of the modified histone H4K20me1 through a subunit that is a H4K20me2 histone demethylase. Results from exploring the connection between higher-order chromosome structure and chromatin modification should have broad implications, because (i) condensin complexes control chromosome structure from bacteria to man, (ii) H4K20me1 is enriched on the inactive X of female mammals, (iii) demethylases are linked to tumor progression, and (iv) the H4K20me2 demethylase modulates nematode growth, metabolism, and entry into the quiescent dauer state.",Analysis of Nematode Sex Determination and Dosage Compensation,9699752,R35GM131845,"['3-Dimensional', 'Address', 'Affect', 'Affinity', 'Architecture', 'Bacteria', 'Binding', 'Caenorhabditis', 'Caenorhabditis elegans', 'Cells', 'Chromosome Structures', 'Chromosome Territory', 'Chromosomes', 'Complex', 'Development', 'Dimensions', 'Dosage Compensation (Genetics)', 'Female', 'Gene Expression', 'Gene Expression Regulation', 'Growth', 'Hermaphroditism', 'Higher Order Chromatin Structure', 'Histones', 'Knowledge', 'Link', 'Machine Learning', 'Mammals', 'Mediating', 'Meiosis', 'Metabolism', 'Methods', 'Mitotic', 'Molecular', 'Nature', 'Nematoda', 'RNA Polymerase II', 'Regulatory Element', 'Resolution', 'Signal Transduction', 'Site', 'Structure', 'Switch Genes', 'Work', 'X Chromosome', 'X Inactivation', 'autosome', 'chromatin modification', 'condensin', 'dosage', 'histone demethylase', 'male', 'man', 'neural network', 'protein complex', 'recruit', 'sex', 'sex determination', 'single molecule', 'tumor progression']",NIGMS,UNIVERSITY OF CALIFORNIA BERKELEY,R35,2019,466290,0.017466957412388632
"Uncovering the epitranscriptome regulatory codes using machine learning Project Summary N6-methyladenosine (m6A) is the most abundant methylation widely found in mRNAs of mammalian cells whose function is largely unknown. Recent research has accumulated increasingly strong evidence of m6A's involvement in different diseases such as leukemia, breast cancer, lung cancer, and AIDs. While m6A's close involvement in many diseases is apparent, mechanistic evidence linking m6A alterations to disease phenotypes is mostly missing. Most of the recent research is fueled by the high throughput sequencing technologies such as MeRIP-seq for transcriptome-wide profiling of m6A methylation. However, due to the innate limitations of such technologies, sophisticated machine learning based algorithms are urgently needed to address the problem of detecting m6A sites with high sensitivity and precision, accurate quantification of m6A methylation levels and the prediction of m6A sites differentially affected under disease and normal conditions and the prediction of genes whose expression levels are regulated by m6A. Without bridging these knowledge gaps, it is impossible to made inroads to the problem of finding m6A's role in regulating diseases. To address these issues, our aims in this proposal are 1) Establish a deep learning algorithm for base-resolution m6A site prediction; 2) Establish base- resolution m6A differential site prediction using a hierarchical Bayesian approach; and 3) Determine m6A- mediated genes and functions by Bayesian Negative-Binomial regression. The proposed research will employ deep learning and adversarial learned inference methods and utilize both methylation quantification and sequence information for the first time. Also, it will employ Bayesian graphical model-based methods for combining sequence and methylation level information. It is expected that the developed algorithms will have broad applications in functional study, for which we plan to closely work with our collaborators in applying these algorithms in their research of Kaposi's sarcoma-associated herpesvirus (KSHV), which will lead to the fulfillment our long term goal in the eventual validation and practical medical application of m6A research in the future. Project Narrative  This project proposes to address the problem of detecting m6A sites with high sensitivity and precision, accurate quantification of m6A methylation levels, the prediction of m6A sites differentially affected under disease and normal conditions and the prediction of genes whose expression levels are regulated by m6A. The overall goal is to elucidate m6A's role in regulating diseases.",Uncovering the epitranscriptome regulatory codes using machine learning,9937431,SC3GM136594,"['3&apos', ' Untranslated Regions', '5&apos', ' Untranslated Regions', 'Address', 'Affect', 'Algorithms', 'Area', 'Bayesian Method', 'Binding', 'Biological Process', 'Code', 'Data', 'Detection', 'Development', 'Disease', 'Future', 'Gene Expression', 'Gene Expression Regulation', 'Genes', 'Goals', 'High-Throughput Nucleotide Sequencing', 'Human Herpesvirus 8', 'Hypermethylation', 'Knowledge', 'Lead', 'Learning', 'Link', 'Machine Learning', 'Malignant Neoplasms', 'Malignant neoplasm of lung', 'Mammalian Cell', 'Mediating', 'Medical', 'Messenger RNA', 'Methods', 'Methylation', 'Modeling', 'Modification', 'Pathway interactions', 'Play', 'Problem Solving', 'Proteins', 'RNA-Binding Proteins', 'Regulation', 'Research', 'Resolution', 'Role', 'Site', 'Statistical Distributions', 'Supervision', 'Technology', 'Time', 'Transcript', 'Validation', 'Work', 'base', 'cell transformation', 'convolutional neural network', 'deep learning', 'deep learning algorithm', 'disease phenotype', 'effective therapy', 'epitranscriptome', 'gene function', 'improved', 'leukemia', 'mRNA Stability', 'machine learning algorithm', 'malignant breast neoplasm', 'metaplastic cell transformation', 'novel', 'predictive modeling', 'prevent', 'tool', 'transcriptome', 'tumorigenesis']",NIGMS,UNIVERSITY OF TEXAS SAN ANTONIO,SC3,2020,97500,0.09283769139853836
"Automating Real-Time Localization of Target Sites in Catheter Ablation of Ventricular Tachycardia Project Summary Ventricular tachycardia (VT) is an important cause of mortality and morbidity in patients with heart diseases. The majority of life-threatening VT episodes are caused by an electrical ""short circuitâ€ that travels through narrow strands of surviving tissue inside myocardial scar. Catheter ablation treats scar-related VT by â€œblockingâ€ the surviving channel that forms the circuit, commonly at the site the circuit exits from the scar. To localize a VT exit, however, remains a significant challenge. A common approach, known as pace-mapping, utilizes the principle that the VT exit serves as the origin of ventricular activation and determines the QRS morphology on 12-lead electrocardiograms (ECGs). It thus involves repetitive electrical simulation at various sites of the heart, until locating the site that reproduces the QRS of the VT on all 12 ECG leads. While the principle behind pace- mapping is time tested, the current practice is of a ""trial-and-error"" nature and requires rapid qualitative interpretation of the ECG by clinicians, which can be time-consuming and inaccurate. This research proposes to leverage modern machine learning techniques to reform the way the principle behind pace-mapping is used. It aims to learn the relationship between the origin of ventricular activation and ECG morphology, and then use it to directly predict the exit of a VT from its ECG data. To this end, this project will include the following activities: 1) to develop a population-based model to provide pre-procedural initial localizations of VT exits using standard 12-lead ECG; 2) to integrate the population-based model with a patient-specific model in clinically-usable software to provide intra-procedural real-time guidance for localizing the exit site of a clinical VT; and 3) to assess the ability of the proposed software to improve the efficiency and accuracy of pace- mapping in a prospective clinical study. This project will be carried out by a multidisciplinary team of computational and clinical scientists with a fruitful record of collaboration. The software delivered by this project will provide real-time assistance to clinicians for narrowing down a VT exit with a minimum amount of time and localization errors. This will substantially reduce the workload for ablating multiple VTs, potentially allowing clinicians to ablate more or even all VTs seen in a procedure. This may reduce the duration of an ablation procedure while improving its outcome. The development and deployment of the software also adds minimal cost or distractions to routine workflow. With a low barrier to clinical implementation, it will have a real potential to challenge and improve the standard practice of catheter ablation. Project Narrative Catheter ablation treats ventricular arrhythmia by destroying the culprit tissue responsible for the arrhythmia. To localize the culprit tissue, however, remains a tedious process with limited success in current practice. This project will develop inexpensive software to guide clinicians towards the culprit tissue in real time during the procedure, helping narrow down the ablation target with a minimum amount of time and localization errors.",Automating Real-Time Localization of Target Sites in Catheter Ablation of Ventricular Tachycardia,9590857,R15HL140500,"['Ablation', 'Arrhythmia', 'Attention', 'Cardiac ablation', 'Cicatrix', 'Clinical', 'Clinical Research', 'Collaborations', 'Computer Simulation', 'Computer software', 'Computers', 'Data', 'Data Set', 'Development', 'EKG QRS Complex', 'Electrocardiogram', 'Encapsulated', 'Goals', 'Heart', 'Heart Diseases', 'Hybrids', 'Lead', 'Learning', 'Life', 'Machine Learning', 'Modeling', 'Modernization', 'Morbidity - disease rate', 'Morphology', 'Myocardial', 'Nature', 'Outcome', 'Patients', 'Population Database', 'Procedures', 'Process', 'Recurrence', 'Research', 'Scientist', 'Site', 'Techniques', 'Testing', 'Time', 'Tissues', 'Travel', 'Variant', 'Ventricular', 'Ventricular Arrhythmia', 'Ventricular Tachycardia', 'Workload', 'clinical implementation', 'cost', 'deep learning', 'design', 'distraction', 'improved', 'interest', 'mortality', 'multidisciplinary', 'novel', 'population based', 'prevent', 'prospective', 'simulation', 'software development', 'success', 'sudden cardiac death', 'usability']",NHLBI,ROCHESTER INSTITUTE OF TECHNOLOGY,R15,2018,419810,0.04486073733557088
"Coordinating Research on Emerging Arboviral Threats Encoing the Neotropics (CREATE-NEO) Project Summary In recent decades, Central and South America have experienced spillover of endemic arthropod-borne viruses (arboviruses) from wildlife reservoirs into humans, exchange and recombination of emerging arboviruses within the region, resurgence of arboviruses previously controlled by vaccination or vector control, introduction and spread of novel arboviruses, and exportation of viruses to other regions. Furthermore, there is great concern that newly-introduced Zika virus may spill back into an enzootic transmission cycle in the Americas. Central and South America encompass enormous vertebrate and invertebrate biodiversity, and these species harbor a broad range of arboviruses whose risk of spillover and spread in humans is presently unknown. Increases in the rates of global travel, invasion of novel vector species, urban expansion, deforestation, and global climate change all elevate the risk of further arbovirus emergence, as does the breakdown of public health structures in Venezuela.  The Coordinating Research on Emerging Arboviral Threats Encompassing the Neotropics (CREATE- NEO) project will provide a network of surveillance sites in the neotropics coupled to cutting-edge modeling approaches in order to anticipate and counter emerging arboviruses. Aim 1 will identify novel and known arboviruses as well as the host-vector networks that sustain transmission of these viruses within the neotropics, map the spatial distribution of these transmission networks, and characterize virus transmission dynamics within these networks. To do so, we will collect mosquitoes and other vectors as well as non-human primates and other vertebrate hosts at multiple sites in areas of high and varied biodiversity in Panama and Brazil and screen these samples for known and novel arboviruses. These data will then be analyzed using niche modeling, machine learning to predict undiscovered hosts and vectors, and dynamical transmission models. Aim 2 will focus on prospective and retrospective analysis of human infection and disease. To do so, we will leverage ongoing human clinical cohorts at multiple sites in Brazil and Panama. We will extend and expand these cohorts, with a particular focus on the immune-mediated interactions among multiple arboviruses at sites of hyperendemicity. We will also develop novel diagnostics to capture known and novel arboviruses and model the impact of human and non-human primate movement on spillover and spillback of target arboviruses.  Data and models generated via these two aims will forewarn local, regional and global public health agencies of arboviruses within Central and South America that pose particularly high risk of spillover, emergence into transmission among humans, and/or international spread. Moreover CREATE-NEO will build local capacity to predict, detect and respond to emerging arboviruses at their point of origin, thereby maximizing the potential to avert full-blown emergence. Project Narrative Arthropod-borne viruses, such as dengue, Zika and Mayaro, are emerging at an accelerating rate in Central and South America. The Coordinating Research on Emerging Arboviral Threats Encompassing the Neotropics (CREATE-NEO) project will provide a nimble and flexible network of surveillance sites in Central and South America coupled to cutting-edge modeling approaches in order to anticipate and counter these threats to public health.",Coordinating Research on Emerging Arboviral Threats Encoing the Neotropics (CREATE-NEO),9968994,U01AI151807,"['Acute', 'Address', 'Age', 'Americas', 'Animals', 'Arbovirus Infections', 'Arboviruses', 'Area', 'Back', 'Biodiversity', 'Biological', 'Blood Circulation', 'Brazil', 'Central America', 'Chikungunya virus', 'Cities', 'Clinical', 'Cohort Studies', 'Collection', 'Coupled', 'Culicidae', 'Data', 'Deforestation', 'Dengue', 'Detection', 'Diagnostic', 'Disease', 'Emergency Situation', 'Enzyme-Linked Immunosorbent Assay', 'Frequencies', 'Genetic Recombination', 'Genetic Variation', 'Habitats', 'Human', 'Immune', 'Infection', 'International', 'Invertebrates', 'Machine Learning', 'Malaria', 'Maps', 'Measles', 'Mediating', 'Modeling', 'Movement', 'Panama', 'Public Health', 'Research', 'Risk', 'Route', 'Sampling', 'Site', 'South America', 'Spatial Distribution', 'Structure', 'Technology', 'Testing', 'Time', 'Travel', 'Vaccination', 'Vector-transmitted infectious disease', 'Venezuela', 'Virus', 'West Nile virus', 'Yellow Fever', 'ZIKA', 'Zika Virus', 'Zoonoses', 'chikungunya', 'climate change', 'cohort', 'design', 'enzootic', 'experience', 'flexibility', 'high risk', 'insight', 'nanobodies', 'nonhuman primate', 'novel', 'novel diagnostics', 'pathogen', 'prospective', 'seroconversion', 'surveillance network', 'transmission process', 'vector', 'vector control', 'viral transmission']",NIAID,UNIVERSITY OF TEXAS MED BR GALVESTON,U01,2020,1615615,0.06039615075397104
"SUPPORT SERVICES FOR THE PHARMACEUTICAL MANAGEMENT BRANCH The Pharmaceutical Management Branch (PMB), Cancer Therapy Evaluation Program (CTEP), Division of Cancer Treatment and Diagnosis (DCTD), National Cancer Institute (NCI), is charged with providing comprehensive pharmaceutical support for clinical trials sponsored by the National Cancer Institute. The DCTD sponsors intramural and extramural research for the clinical development and evaluation of potentially effective cancer treatments. The purpose of the PMB support contract is to facilitate the management and distribution of all agents supplied on CTEP supported clinical trials with respect to inventory control, order authorization, and associated document management. The contractor also manages the investigator and associate registration processes for participation in NCI sponsored cancer clinical trials. They also manage the Enterprise Core Module (ECM) and associated Help Desk. The ECM serves CTEP in the real-time maintenance (i.e., data entry, storage, reporting, analysis, retrieval) of people and organization information for those who participate on clinical trials. The information is collected from both remote investigator sites and CTEP offices and branches. Additional responsibilities include management of the Access Identity Maintenance (AIM) module which provides user accounts and access to Associates and Investigators participating in NCI-sponsored clinical trials. The contractor also supports the PMB pharmacists by providing the necessary reports concerning agent usage to facilitate the proper management of their portfolio of agents. The contractor facilitates the authorization and distribution of investigational agents for off-protocol/compassionate access to investigational agents via the Special Exception and/or Treatment Referral Center Protocols. In addition to providing the PMB with the necessary support resources as outlined above, the contractor provides word processing, data entry, photocopying, filing, telephone, faxing, scanning, and other clerical support. The contractor provides and maintains an off-site location including all equipment necessary at that site, for other personnel and file storage. In very general terms, Investigator and Associate registration work is done at the contractor site and agent related activities are handled at the government site. n/a",SUPPORT SERVICES FOR THE PHARMACEUTICAL MANAGEMENT BRANCH,8328386,02CM72200,"['Accounting', 'Authorization documentation', 'Cancer Therapy Evaluation Program', 'Charge', 'Clinical', 'Clinical Trials', 'Contractor', 'Data', 'Development', 'Division of Cancer Treatment and Diagnosis', 'Equipment', 'Equipment and supply inventories', 'Evaluation', 'Extramural Activities', 'Government', 'Human Resources', 'Location', 'Maintenance', 'Malignant Neoplasms', 'National Cancer Institute', 'Pharmaceutical Services', 'Pharmacists', 'Pharmacologic Substance', 'Photocopying', 'Process', 'Protocols documentation', 'Reporting', 'Research', 'Research Personnel', 'Resources', 'Retrieval', 'Scanning', 'Site', 'Support Contracts', 'Telefacsimile', 'Telephone', 'Time', 'Treatment Referral Center Protocol', 'Word Processing', 'Work', 'cancer diagnosis', 'cancer therapy', 'drug development', 'information organization']",NCI,"EDJ ASSOCIATES, INC.",N02,2011,1171347,0.045208902844500645
"SUPPORT SERVICES FOR THE PHARMACEUTICAL MANAGEMENT BRANCH The Pharmaceutical Management Branch (PMB), Cancer Therapy Evaluation Program (CTEP), Division of Cancer Treatment and Diagnosis (DCTD), National Cancer Institute (NCI), is charged with providing comprehensive pharmaceutical support for clinical trials sponsored by the National Cancer Institute. The DCTD sponsors intramural and extramural research for the clinical development and evaluation of potentially effective cancer treatments. The purpose of the PMB support contract is to facilitate the management and distribution of all agents supplied on CTEP supported clinical trials with respect to inventory control, order authorization, and associated document management. The contractor also manages the investigator and associate registration processes for participation in NCI sponsored cancer clinical trials. They also manage the Enterprise Core Module (ECM) and associated Help Desk. The ECM serves CTEP in the real-time maintenance (i.e., data entry, storage, reporting, analysis, retrieval) of people and organization information for those who participate on clinical trials. The information is collected from both remote investigator sites and CTEP offices and branches. Additional responsibilities include management of the Access Identity Maintenance (AIM) module which provides user accounts and access to Associates and Investigators participating in NCI-sponsored clinical trials. The contractor also supports the PMB pharmacists by providing the necessary reports concerning agent usage to facilitate the proper management of their portfolio of agents. The contractor facilitates the authorization and distribution of investigational agents for off-protocol/compassionate access to investigational agents via the Special Exception and/or Treatment Referral Center Protocols. In addition to providing the PMB with the necessary support resources as outlined above, the contractor provides word processing, data entry, photocopying, filing, telephone, faxing, scanning, and other clerical support. The contractor provides and maintains an off-site location including all equipment necessary at that site, for other personnel and file storage. In very general terms, Investigator and Associate registration work is done at the contractor site and agent related activities are handled at the government site. n/a",SUPPORT SERVICES FOR THE PHARMACEUTICAL MANAGEMENT BRANCH,8065563,02CM72200,"['Accounting', 'Authorization documentation', 'Cancer Therapy Evaluation Program', 'Charge', 'Clinical', 'Clinical Trials', 'Contractor', 'Data', 'Development', 'Division of Cancer Treatment and Diagnosis', 'Equipment', 'Equipment and supply inventories', 'Evaluation', 'Extramural Activities', 'Government', 'Human Resources', 'Location', 'Maintenance', 'Malignant Neoplasms', 'National Cancer Institute', 'Pharmaceutical Services', 'Pharmacists', 'Pharmacologic Substance', 'Photocopying', 'Process', 'Protocols documentation', 'Reporting', 'Research', 'Research Personnel', 'Resources', 'Retrieval', 'Scanning', 'Site', 'Support Contracts', 'Telefacsimile', 'Telephone', 'Time', 'Treatment Referral Center Protocol', 'Word Processing', 'Work', 'cancer therapy', 'drug development', 'information organization']",NCI,"EDJ ASSOCIATES, INC.",N02,2010,1248780,0.045208902844500645
"SUPPORT SERVICES FOR THE PHARMACEUTICAL MANAGEMENT BRANCH The Pharmaceutical Management Branch (PMB), Cancer Therapy Evaluation Program (CTEP), Division of Cancer Treatment and Diagnosis (DCTD), National Cancer Institute (NCI), is charged with providing comprehensive pharmaceutical support for clinical trials sponsored by the National Cancer Institute. The DCTD sponsors intramural and extramural research for the clinical development and evaluation of potentially effective cancer treatments. The purpose of the PMB support contract is to facilitate the management and distribution of all agents supplied on CTEP supported clinical trials with respect to inventory control, order authorization, and associated document management. The contractor also manages the investigator and associate registration processes for participation in NCI sponsored cancer clinical trials. They also manage the Enterprise Core Module (ECM) and associated Help Desk. The ECM serves CTEP in the real-time maintenance (i.e., data entry, storage, reporting, analysis, retrieval) of people and organization information for those who participate on clinical trials. The information is collected from both remote investigator sites and CTEP offices and branches. Additional responsibilities include management of the Access Identity Maintenance (AIM) module which provides user accounts and access to Associates and Investigators participating in NCI-sponsored clinical trials. The contractor also supports the PMB pharmacists by providing the necessary reports concerning agent usage to facilitate the proper management of their portfolio of agents. The contractor facilitates the authorization and distribution of investigational agents for off-protocol/compassionate access to investigational agents via the Special Exception and/or Treatment Referral Center Protocols. In addition to providing the PMB with the necessary support resources as outlined above, the contractor provides word processing, data entry, photocopying, filing, telephone, faxing, scanning, and other clerical support. The contractor provides and maintains an off-site location including all equipment necessary at that site, for other personnel and file storage. In very general terms, Investigator and Associate registration work is done at the contractor site and agent related activities are handled at the government site. n/a",SUPPORT SERVICES FOR THE PHARMACEUTICAL MANAGEMENT BRANCH,8429204,02CM72200,"['Accounting', 'Authorization documentation', 'Cancer Therapy Evaluation Program', 'Charge', 'Clinical', 'Clinical Trials', 'Contractor', 'Data', 'Development', 'Division of Cancer Treatment and Diagnosis', 'Equipment', 'Equipment and supply inventories', 'Evaluation', 'Extramural Activities', 'Government', 'Human Resources', 'Location', 'Maintenance', 'Malignant Neoplasms', 'National Cancer Institute', 'Pharmaceutical Services', 'Pharmacists', 'Pharmacologic Substance', 'Photocopying', 'Process', 'Protocols documentation', 'Reporting', 'Research', 'Research Personnel', 'Resources', 'Retrieval', 'Scanning', 'Site', 'Support Contracts', 'Telefacsimile', 'Telephone', 'Time', 'Treatment Referral Center Protocol', 'Word Processing', 'Work', 'cancer diagnosis', 'cancer therapy', 'drug development', 'information organization']",NCI,"EDJ ASSOCIATES, INC.",N02,2012,350000,0.045208902844500645
